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Summary 
Rotavirus encodes six structural and six non-structural proteins. In contrast 
to the structural proteins, the functional roles of the non-structural proteins are not 
well defined beyond a realisation that they must have a role in the viral replication 
cycle. A fuller understanding of the replication cycle must therefore rest on 
determining the specific roles played by the non-structural proteins. 
Non-structural protein NSPl shows high levels of sequence divergence. A 
generally well conserved cysteine-rich region at the amino-terminus may form a 
zinc finger structure. It has been shown to possess non-specific RNA-binding 
activity, and has been found associated with the smallest of three replication 
intermediates (RIs) found in infected cells, together with the viral proteins VPl, VP3 
and NSP3. VP2 and VP6 are added sequentially to the pre-core RI to form the core 
RI and single-shelled RI respectively. The function of NSPl in the replication cycle 
and the importance of its presence in early replication complexes has not been 
determined. 
The intermolecular interactions that occur between the components of the 
RIs have not been defined. Protein-protein interactions between NSP 1 and VP 1, 
VP2, VP3, and NSP3, from the UKtc strain of bovine rotavirus, were investigated 
using a variety of approaches, the first of which was the yeast two-hybrid system. In 
this assay a self-interaction of NSPI was not detected. Protein-protein interactions 
between NSPl and VPl, VP2, VP3, and NSP3, were also not detected. Both the 
full-length protein and a truncated NSPl, consisting of only the amino terminal third 
of the protein, were tested. A direct self-interaction of NSP3 was shown and 
quantified. Radio-immunoprecipitation analysis of in vitro translated viral proteins 
using specific anti-NSPl serum was also employed. However, it failed to detect 
direct protein-protein interactions between NSPl and VPI, VP2, and VP3. 
Immunoprecipitation of UKtc rotavirus-infected celllysates with anti-NSPl 
serum showed the co-precipitation of viral proteins VPl, VP2, VP3NP4, VP6 and 
NSP3, with NSPl. It was proposed that NSPl formed a previously unrecognised 
complex with these proteins. Immunoprecipitation of nuclease-treated infected cell 
lysates showed a reduction in the co-precipitation of VP2, VP3NP4 and NSP3 with 
NSPl. No reduction in the co-precipitation of VP6 was seen. The association of the 
complex proteins may be mediated by RNA binding. Immunoprecipitation with an 
anti-VP6 monoc1onal antibody reciprocally precipitated small amounts of NSP 1, 
VP2, VP3/VP4, and NSP3, with VP6. 
xv 
Introduction 
1.1 Rotavirus as a pathogenic agent 
1.1.1 Diarrhoeal disease 
Diarrhoeal diseases are collectively one of the most prevalent infectious 
diseases and thus represent a serious threat to human health worldwide. The problem 
is particularly acute in developing countries where they constitute a major cause of 
mortality, especially among infants and young children (Guerrant et al., 1990). It has 
been estimated that 744 million to one billion cases of diarrhoea, resulting in 4.6 
million deaths, occur annually in children less than five years in developing countries 
(Snyder and Merson, 1982). More recently, the mortality rate was found to be lower 
than previously estimated at 3.3 million deaths annually (range 1.5 to 5.1 million) 
(Bern et al., 1992), however the incidence of diarrhoea remained static. In the USA 
infectious gastroenteritis was found to be the second most common disease 
experience (Monto et al., 1983), albeit the mortality rate was significantly lower than 
in less developed countries with an estimated average of 504 deaths per year in 
children under four years (Ho et al., 1988). 
1.1.2 The discovery of rotavirus 
Until the early 1970's the causative agents of infectious diarrhoeal diseases 
remained elusive. A breakthrough came with the discovery in 1972 of the Norwalk 
virus, which was shown to be associated with viral gastroenteritis in older children 
and adults (Kapikian et al., 1972). In 1973, Bishop et al. (Bishop et al., 1973) 
visualized an agent by thin section electron microscopy (EM) of duodenal mucosa 
from infants with acute gastroenteritis. This 70 nm particle was subsequently 
identified by EM in the faeces of young children with gastroenteritis (Bishop et al., 
1974) (Flewett et al., 1973) (Kapikian et al., 1974) (Middleton et al., 1974). 
Morphologically identical viruses were then detected in faecal extracts from both 
humans and animals in all species tested worldwide (reviewed in McNulty, 1978). It 
soon became clear that these viruses were the major etiologic agents of severe viral 
gastroenteritis (Kapikian and Chanock, 1996). 
Several names were proposed for the virus and rotavirus, from the Latin 'rota' 
meaning wheel, was chosen as the virion resembles a wheel with short spokes and a 
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well-defined smooth outer rim when viewed by EM (Figure 1.1) (Flewett et al., 
1974). As the viruses differed both morphologically (Palmer et al., 1977) and 
antigenically from Orthoreoviruses and Orbiviruses (Kapikian et al., 1976) (Kalica et 
al., 1977), it was suggested that they should be included as a new genus within the 
family Reoviridae (Davidson et al., 1975). In 1978, the genus Rotavirus was officially 
recognised (Matthews, 1979). 
1.1.3 The global significance of rotavirus infection 
Rotaviruses are now known to be the single most important aetiologic agents 
of severe diarrhoeal disease in infants and young children worldwide (Kapikian and 
Chanock, 1996). In both developed and developing countries they account for the 
largest proportion of cases of severe diarrhoeal illness requiring hospitalisation 
(Figure 1.2). An Australian survey of children admitted to hospital with acute 
gastroenteritis over a year showed 50 % were infected with rotavirus, rising to a 
seasonal peak of 73 % during the winter months (Davidson et al., 1975). It has been 
estimated that rotaviruses cause 3.1 million cases of diarrhoea, 65,000 to 70,000 
hospitalisations and 125 deaths annually among infants and young children in the 
USA (Glass et al., 1991) (Matson and Estes, 1990). The economic cost of rotavirus 
infection due to hospitalisation is considerable, indeed hospitalisation costs in the 
USA alone have been estimated at $664 million per annum (Matson and Estes, 1990). 
In developing countries the mortality resulting from rotavirus infection is 
significantly higher. A study in Asia, Africa and Latin America estimated that 
rotavirus was responsible for 125 million cases of diarrhoea resulting in 870,000 
deaths (Institute of Medicine, 1985). Thus, the development of an effective vaccine is 
highly desirable, to reduce both the mortality and the economic burden of healthcare 
resulting from rotavirus infection. 
1.1.4 Overview of vaccination developments 
By the age of five years the vast majority of children, whether living in rich or 
poor countries, will have been infected with rotavirus (Glass et al., 1996). 
Improvements in food, water and hygiene have little impact on the control of rotavirus 
infection, and despite massive efforts to prevent diarrhoeal mortality with oral 
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Figure 1.1 
Figure 1.1 Transmission electron micrograph of rotaviruses 
Image reproduced from Murphy (1985). The characteristic wheel appearance of the 
virion, the inspiration for the name rotavirus (from the Latin 'rota' meaning wheel), 
can be clearly observed. Magnification X135,OOO. 
Developed Countries 
Bacteria 
Astrovirus 
Adenovirus Calicivirus 
Figure 1.2 
Developing Countries 
Other Bacteria 
Figure 1.2 Diagram showing an estimate of the role of different etiological 
agents in severe diarrhoeal illness requiring hospitalization of infants and 
young children in developed countries and developing countries 
Adapted from Kapikian and Chanock (1996). 
rehydration therapy, diarrhoea still ranks as the first or second most common cause of 
death among children in developing countries (Bern et al., 1992). Natural immunity to 
rotavirus infection was suggested by the decreased incidence of disease with 
increasing age (Bishop et al., 1983). Thus, vaccination as a means of disease control 
has been extensively investigated. 
The first rotavirus vaccine, a live vaccine prepared from bovine rotavirus, was 
effective in more than 80 % of cases in preventing clinically significant rotavirus 
diarrhoea (Vesikari et al., 1984). The moderate success of this trial paved the way for 
the development and field testing of several candidate reassortant live rotavirus 
vaccines. In 1998 the rhesus-human reassortant tetravalent (RRV -TV) rotavirus 
vaccine was licensed for use in the USA. This is a multivalent vaccine, representing 
each of the four epidemiologic ally important VP7 serotypes. The reassortants contain 
the VP7 gene derived from the human rhesus rotavirus strain, and the remaining genes 
from the bovine strains. The vaccine was recommended to be given to all children in 
the USA along with other childhood vaccines and was licensed for use in Europe 
(Vesikari, 1999). However, recently the rotavirus vaccination programme has been 
halted due to the occurrence of a number of cases of intussusception, a blockage of 
the intestine, among recently vaccinated infants. Although a direct association 
between the cases of intussusception and the rotavirus vaccine has not been shown, it 
has been recommended by the Centers for Disease Control and Prevention CCDC) that 
use of the vaccine be suspended pending an evaluation of the vaccine programme. 
In addition to the recent problems, the current vaccine only protects against 
the four main human serotypes. It does not give complete protection and in particular, 
the protective efficacy is lower in developing countries (Vesikari, 1999). Hence, a 
continued research effort is absolutely necessary. Research into alternatives using 
recombinant DNA technology to generate a non-live rotavirus vaccine has been 
performed. Several attempts have been made to produce ~-galactosidase (~-gal):VP7 
fusion proteins that will generate neutralising antibodies, with varying degrees of 
success (McCrae and McCorquodale, 1987) (Johnson and McCrae, 1989). Induction 
of rotavirus neutralising antibodies in guinea pigs and mice, following administration 
of VP4 protein expressed in a baculovirus system, has been demonstrated (Mackow et 
al., 1989) (Mackow et al., 1990). Low level anti-rotavirus and rotavirus neutralising 
antibodies were also raised in guinea pigs using baculovirus expressed VP7 
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(McGonigal et al., 1992). Recombinant vaccinia (Andrew et al., 1987) (Andrew et al .• 
1990) and recombinant adenovirus (Both et al., 1993) expressing hybrid VP7 were 
shown to raise serotype specific neutralising antibodies. Synthetic peptides (Streckert 
et al., 1988) (Ijaz et al .• 1995), virus-like particles (Crawford et al., 1994) (Con nor et 
al .• 1996), and DNA based rotavirus vaccines (Herrmann et al., 1996) (Chen et al .. 
1997), have also been explored as potential methods of vaccination against rotavirus 
infection. 
1.2 Reoviridae and other dsRNA viruses 
Viruses with a dsRNA genome infect a wide variety of host species 
encompassing vertebrate and invertebrate animals, plants, protozoa and bacteria 
(Table 1.1). At present six virus families have been defined: Birnaviridae, 
Cystoviridae, Hypoviridae, Partitiviridae, Reoviridae and Totiviridae (Murphy, 
1996). In the largest family, the Reoviridae, viruses of mammals. insects. fish, birds, 
plants, crustaceans and arachnids can be found. The members of the family 
Reoviridae share common features in their virion structure, genome and replication 
cycle. The near-spherical. non-enveloped virions are characteristically formed of a 
double or triple-layered protein shell with icosahedral symmetry. Structural data on 
the organisation of the capsid layers has lead to the proposal that the genera in the 
family Reoviridae can be divided into two distinct groups (Hill et al., 1999). The 
turreted virus group, comprising Orthoreoviruses, Aquareoviruses. Oryzaviruses. and 
Fijiviruses, have an incomplete inner capsid layer penetrated by turret-like spikes at 
the icosahedral five-fold axes. Cypoviruses, which are unusual in only having a single 
capsid layer, also have the turret structure (Payne and Mertens, 1983). The smooth-
core group of viruses, including Orbiviruses, Rotaviruses. Phytoreoviruses. and 
Coltiviruses, have channels at the five-fold axes rather than the turret-like spike 
structures. and a complete, spherical inner capsid layer (Roseto et al .• 1979) (Ludert et 
al., 1976) (Roy, 1996). Recent work on the structure of the core protein shell of the 
Orbiviruses has shown that the core layer consists of 120 protein subunits arranged 
with T=2 icosahedral symmetry (Grimes et al., 1998). This feature has been observed 
in other genera of the family Reoviridae (Lawton et al., 1997b) and in several other 
families of dsRNA viruses such as L-A (Totiviridae) and <1>6 (Cystoviridae) (Cheng et 
al .• 1994) (Butcher et al., 1997), suggesting that this structure might be ubiquitous to 
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Table 1.1 The double-stranded RNA viruses 
Family Genus Type species Segment Host Characteristic properties 
number 
Bimaviridae Aquabimavirus Infectious pancreatic necrosis virus 2 Fish 2 genome segments (A,B). A encodes polyprotein, 
A vibimavirus Infectious bursal disease virus Fowl cleaved to structural proteins, and 5' genome linked 
Entomobimavirus Drosophilia X virus Insect protein VPg. B encodes polymerase. 
Cystoviridae Cystovirus Pseudomonas phage rtt> 3 Pseudo monads Lipid envelope; polycistronic genome segments 
(S,M,L); in vitro assembly model 
Hypoviridae Hypo virus Cryphonectria hypo virus J -EP713 I Fungi dsRNA transmitted by cytoplasmic exchange when 
Varicosavirus Lettuce big-vein virus I Plants hypae fuse; replication in intracellular vesicles; 
similar to potyviruses. 
Partitiviridae Partitivirus Gaeumannomyces graminis virus OJ9/6-A 2 Fungi Encapsidated nucleic acid both genomiC and 
Chrysovirus Penicillium chrysogenum virus 3 Fungi satellite; genome divided between several different 
Alphacryptovirus White clover cryptic virus J 2/3 Plants particle types; DI copies present. 
Betacryptovirus White clover cryptic virus 2 2/3 Plants 
Reoviridae 
Totiviridae 
Orthoreovirus 
Orbivirus 
Rotavirus 
Coltivirus 
Aquareovirus 
Cypovirus 
Fijivirus 
Phytoreovirus 
Oryzavirus 
[Seadornavirus] 
[Entomovirus] 
Totivirus 
Giardiavirus 
Leishmaniavirus 
Mammalian orthoreovirus 
Bluetongue virus 
Rotavirus A 
Colorado tick fever virus 
Aquareovirus A 
Cypovirus 1 
Fiji disease virus 
Wound tumour virus 
Rice ragged stunt virus 
Banna virus (BA V) 
Hyposoter exiguae reovirus (HeR V) 
Saccharomyces cerevisiae virus L-A 
Giardia lamblia virus 
Leishmania RNA virus 1-1 
[Recently proposed genera of Reoviridae] (P.P.c. Mertens, pers. comm.) 
Reference sources for Table 1.1 
10 
10 
11 
12 
11 
10 
10 
12 
10 
12 
10 
1 
Vertebrates 
Vertebrates 
Vertebrates 
Vertebrates 
Vertebrates 
Invertebrates 
Plants 
Plants 
Plants 
Vertebrates 
Invertebrates 
Fungi 
Protozoa 
Protozoa 
Spherical virion; 2-3 protein shells with icosahedral 
symmetry; transcription of full-length mRNA from 
each genome segment within transcriptionally active 
particles; mRNA extruded from particle; replication 
in newly synthesised core particles in viral inclusion 
bodies in cytoplasm; virions are moderately resistant 
to heat, organic solvents, detergents and irradiation.; 
transmission by direct contact! fecal-oral route 
(rotavirusl reovirus) or arthropods (orbivirusl 
coltivirus) 
Satellites of L-A, Ml etc., encode killer toxins 
2 overlapping ORFs encode gag capsid protein and 
gag-pol polymerase protein by ribosomal 
frameshifting 
Fields Virology (1996), 3n1 edn. Edited by B. N. Fields, D. M. Knipe, P. M. Howley, et al .. Philadelphia: Lippincott-Raven Publishers. 
Encyclopedia of Virology (1994). Edited by R. G. Webster and A. Granoff. London: Academic Press. 
The Australian National University ICfV database on Reoviridae (http:tnife.anu.edu.aulviruses/Ictv/fs reovi.htm) 
The Reoviridae home page at The Institute for Animal Health (http://www.iah.bbsrc.ac.uklvirus/ReoviridaeD 
All the Virology on the WWW (http://www.virology.ne!L) 
dsRNA viruses. Interestingly, at present this structure has only been found in viruses 
with a dsRNA genome, suggesting that this particular structural confirmation may be 
favourable for the unique replication cycle of these viruses, or possibly that all 
currently recognised dsRNA viruses have a common ancestor (Hill et al., 1999). 
The members of the family Reoviridae have dsRNA genomes consisting of 
10-12 segments, in contrast with other dsRNA viruses that only have 1-3 segments 
(Table 1.1). All dsRNA viruses have an RNA-dependent RNA polymerase activity 
associated with the core of the virion, since cells do not have enzymes capable of 
transcribing dsRNA templates. The polymerase complex performs negative strand 
synthesis (replicase) and new positive strand synthesis (transcriptase) in a 
compartment shielded from the cytoplasm. In Rotavirus, the core protein VPI has 
been identified as the RNA polymerase, although VP2 is also required for replicase 
activity (Patton et al., 1997). Only double-layered particles (VP6 layer) have 
transcriptase activity. Similarly, in Reovirus the )..3 protein is the catalytic subunit of 
the transcriptase complex, but other core proteins are probably required for it to be 
fully functional (Starnes and Joklik, 1993). Orbivirus cores also exhibit an RNA-
dependent RNA polymerase activity, and the VPl protein of BTV is predicted to be 
the RNA polymerase (Roy et al., 1988). 
The members of the Reoviridae have a conservative transcription process that 
uses template dsRNA located within double-layered particles (Banerjee and Shatkin, 
1970) (Patton, 1986-1987). However, in other dsRNA viruses, such as the 
Birnaviridae, and some members of the Totiviridae (Aspergillus foetidus slow virus) 
and the Partitiviridae (Penicillium stoloniferum slow virus), dsRNA transcription is 
semi-conservative (Wickner, 1996). The difference between conservative and semi-
conservative transcription is whether the template (-) strand re-pairs with the parental 
(+) strand following displacement during the transcription reaction. The viruses of the 
Reoviridae family share a similar polymerase function in that the 5'-ends of the 
mRNA species are capped and methylated during transcription (Ramadevi et al., 
1998) (Mao and Joklik, 1991) (Pizarro et al., 1991). The 5' cap is required for 
efficient elongation of mRNA transcripts (Spencer and Garcia, 1984). Virions of the 
family Birnaviridae contain two forms of the RNA polymerase VPl. It is found as a 
free polypeptide, and also as a genome-linked protein (VPg) attached to the 5' ends of 
both genome segments by a serine-5' GMP phosphodiester bond (Calvert et al., 1991). 
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Transcription in viruses of the Birnaviridae is thought to proceed via an asymmetric, 
semiconservative, strand-displacement mechanism that is primed by VP 1 (Dobos, 
1995). 
In the family Reoviridae, transcription of each segment occurs within 
transcriptionally active virion particles to produce a full-length mRNA copy, which is 
then exported into the cytoplasm of the infected cell. The turret-like spike structures 
found in Cypoviruses (Hill et al., 1999) and Orthoreoviruses (White and Zweerink, 
1976) form a channel through which the newly synthesised mRNA is extruded 
(Bartlett et al., 1974). A transcription complex containing the RNA polymerase 
closely associated with the guany1yltransferase is thought to be localised at the five-
fold axes (Dryden et al., 1998). It has been suggested that this structure allows 
movement of both product and template RNAs during transcription in a so-called 
moving-template model (Joklik, 1983) (Shatkin and Kozak, 1983). Rotaviruses are 
also believed to have transcription complexes composed of the RNA polymerase and 
guanylyltransferase located at the five-fold axes (Prasad et al., 1996), and in this case 
the viral mRNAs are thought to exit through the pores at the five fold axes (Lawton et 
al., 1997a). It is thought that the RNA polymerase can reinitiate positive strand 
synthesis as transcriptase particles are able to carry out mRNA synthesis in vitro 
continuously over a period of hours (Cohen, 1977) (Spencer and Garcia, 1984). This 
implies that the same RNA polymerase can repeatedly transcribe at least one of the 
genome segments. Evidence that each of the genome segments of cytoplasmic 
polyhedrosis virus, a member of the Reoviridae, are held in a circular configuration 
suggests a model whereby the RNA polymerase could reinitiate transcription without 
releasing from the template (Yazaki et al., 1986). A moving template model of 
transcription with the transcription complex anchored at the particle five-fold axes 
may be shared by other viruses in the family Reoviridae (Dryden et al., 1998). Study 
of other dsRNA viruses has allowed comparisons to be drawn, for example the 
structure and function of the polymerase complex in <1>6 is thought to bear similarities 
with that of members of the family Reoviridae (deHaas et al., 1999). Further, the L-A 
virus of yeast (Totiviridae) is also thought to share a similar mechanism of 
transcription as the polymerase protein is constrained by its fusion to the capsid 
protein necessitating movement of the template (Wickner, 1996). Thus, it is 
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conceivable that this mechanism of transcription might be a common feature of 
dsRNA viruses. 
Immunoelectron microscopy studies of bluetongue virus-infected cells have 
been used to examine the replication cycle of Orbiviruses (Eaton et al., 1990). After 
infection the bluetongue virus (BTV) particle is uncoated and the core particles enter 
the cytoplasm. The mechanism by which the transcriptase particles of the dsRNA 
viruses are transported intact across the cell membrane and into the cytoplasm is 
poorly defined. Clearly these viruses must overcome the problem of transporting such 
a large structure across the membrane barrier. BTV particles are internalised by 
receptor-mediated endocytosis, and it is suggested that core particles then enter the 
cytoplasm by penetration of the endosomal membrane (Roy, 1996). Direct interaction 
of viral components with the cell membrane is expected to be one step in the process 
of reovirus entry (Nibert et al., 1996). This might produce a breach or a pore in the 
membrane through which the transcriptase particle can enter. Both direct penetration 
and endocytosis have been proposed as mechanisms of entry for rotavirus (Section 
1.5.2). 
Following entry to the cytoplasm, the core particles of BTV bind to the 
cytoskeleton of the cell and initiate transcription of viral mRNA (Hyatt and Eaton, 
1988). Viral inclusion bodies (VIBs), which contain newly synthesised viral mRNA, 
proteins, and particles at different stages of morphogenesis, are formed soon after the 
initiation of transcription and surround the core particle (Hyatt et al., 1987) (Hyatt et 
al., 1991) (Brookes et al., 1993). The VIBs are also believed to be the assembly site 
of core particles (Hyatt and Eaton, 1988) (Brookes et al., 1993). At present the site of 
mRNA synthesis of reovirus and rotavirus remains undetermined (Nibert et al., 1996) 
(Estes, 1996). By analogy with BTV, transcription would be expected to occur in 
viroplasms similar to YIDs, however it has been suggested that primary transcriptase 
particles of reovirus may be free in the cytoplasm (Bodkin and Fields, 1989) (Borsa et 
al., 1981). In rotavirus the viroplasm is thought to be the site of synthesis of double-
layered particles containing RNA (Petrie et al., 1984) (Richardson et al., 1986), on the 
basis of the localization of the core protein VP2 and several non-structural proteins to 
the viroplasm, and the inner capsid protein VP6 to the periphery. Viral factories 
containing dsRNA, viral polypeptides and both complete and incomplete particles are 
also found in reovirus-infected cells (Nibert et al., 1996). 
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A central question in the replication cycle of the segmented dsRNA viruses is 
the mechanism by which they accurately package one copy of each segment. 
Although a unique packaging model has been proposed for the phage <1>6 (Mindich, 
1999), the mechanism in members of the family Reoviridae, which have a greater 
number of segments, remains unknown. The genome of <1>6 consists of three segments 
of polycistronic dsRNA of different lengths, identified as segments L, M and S 
(Mindich, 1999). Genome segment L encodes the four proteins that form the 
procapsid of the virus (P 1, P2, P4 and P7). The packaging model requires a collapsed 
fully formed procapsid, which has binding sites on the outside for plus strands of 
segment S. Following packaging of S, the conformation of the procapsid changes, the 
binding sites for S disappear and those for segment M appear. Once M is packaged, 
these binding sites disappear and those for segment L appear. The change in the 
availability of the binding sites depends upon the amount of RNA inside the procapsid 
(Qiao et al., 1997). The packaging signals on the RNA segments have been localised 
to the 5'-end, and include a sequence of about 200 nucleotides that is unique for each 
segment (Gottlieb et al., 1994). The major structural protein PI is probably the 
predominant determinant of packaging specificity, possibly in association with P4 and 
P7 (Mindich, 1999). 
The synthesis of minus-strand RNA to complete the replication of the dsRNA 
genome always occurs in a procapsid structure shielded from the cell cytoplasm. 
Virus replicase particles have been well studied in the Orthoreoviruses. The earliest 
reovirus particles contain mRNAs in association with proteins 0'3, IlNS and O'NS 
(Antczak and Joklik, 1992) (Gomatos et al., 1981). The subsequent particle includes 
both inner and outer capsid proteins but lacks the non-structural proteins (Acs et al., 
1971) (Morgan and Zweerink, 1975). Minus-strand RNA synthesis occurs in this 
replicase particle (M organ and Zweerink, 1975). The outer capsid shell is then 
completed to form the virion particle (Morgan and Zweerink, 1975) (Zweerink et al., 
1976). Replication of the rotavirus genome is also thought to occur in nascent core 
particles by analogy with the reovirus system (Helmberger-Jones and Patton, 1986). 
Three replication intermediates (RIs) have been identified (Gallegos and Patton, 
1989), however it has not yet been possible to exactly characterise the rotavirus 
replicase particle. The structures of the rotavirus replicase intermediates are discussed 
in more depth in subsequent sections (Sections 1.5.4; 1.4.1.112; 1.6.7). Despite these 
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advances, much still remains unknown about the replication cycles and assembly 
processes in the viruses of the family Reoviridae. 
1.3 Structure of the rotavirus particle and genome 
1.3.1 Classification 
Rotavirus is one of nine distinct genera which make up the family Reoviridae, 
as defined by the International Committee of Taxonomy of Viruses (ICTV), together 
with Aquareovirus, Coltivirus, Cypovirus, Fijivirus, Orbivirus, Orthoreovirus, 
Oryzavirus, and Phytreovirus (Murphy, 1996). Two new genera that have recently 
been proposed are Seadornavirus and Entomoreovirus (P.P.C. Mertens, pers. comm.). 
Rotaviruses have three major antigenic specificities: group, subgroup and serotype. 
The predominant group antigen is found on VP6, though group epitopes have been 
detected on all the structural proteins (Mattion et al., 1994). Five groups (A to E) have 
been recognised, and a further two putative groups (F and G), which thus far have 
only been shown to infect avian species, have been described. Only groups A. Band 
C are associated with human disease. Group A rotaviruses are the most common 
cause of disease in infants and young children, and are the predominant group isolated 
and associated with disease to date. Group B viruses have been shown to cause 
epidemics of cholera-like illness in adults in China (Chen et al., 1985) (Hung et al., 
1987). Group C rotaviruses only cause sporadic outbreaks of gastroenteritis in humans 
(von Bonsdorff and Svensson, 1988) (Bridger et al., 1986) (Chen et al., 1988). The 
subgroups, which are also determined by VP6 antigens, have only been clearly 
defined for Group A rotaviruses and fall into four categories: subgroup I, subgroup lI, 
subgroup 1+ lI, and non-I non-lI (Hoshino et al., 1987) (Svensson et al., 1988). The 
focus of this thesis is the Group A rotaviruses which have been studied in more detail 
than any other group. 
Group A rotaviruses have been classified into 14 serotypes on the basis of 
reciprocal neutralization assays with hyper-immune sera against the major 
neutralization antigen VP7 (G serotypes) (Kapikian and Chanock, 1996). Virus 
serotype has been identified by conventional assays including neutralization of 
cytopathic effect (cpe), reduction of virus yield in tube or plate cultures, and plaque or 
focus reduction (Kapikian and Chanock, 1996). A distinct VP7 serotype is recognised 
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by a reciprocal 20-fold or greater difference in serum antibody titre when a candidate 
serotype is tested against prototype viruses representing established serotypes 
(Hoshino et al., 1984). A total of 14 VP7 (G) serotypes have been identified, 
comprising ten in humans and 13 in animals (Hoshino and Kapikian, 1994). A study 
of human isolates revealed that 95 % belonged to serotypes one to four (Beards et at., 
1989). Monoclonal antibodies to VP4 can also neutralize viral infectivity (Greenberg 
et ai., 1983), and eleven distinct serotypes (P types) have been distinguished (Hoshino 
and Kapikian, 1994). A binary classification system involving both G serotype (VP7) 
and P serotype (VP4) is now used (Hoshino and Kapikian, 1996). 
1.3.2 Morphological structure of the virus particle 
Examination of rotavirus by electron microscopy (EM) reveals three different 
types of particle each with its own distinctive morphological appearance. The 
infectious virion consists of three protein layers (triple-layered particle) enclosing the 
segmented double-stranded (ds) RNA genome, although this particle was historically 
known as double-shelled. The outer coat proteins of the triple-layered, intact virion 
are VP4 and VP7. Double-layered particles are transcriptionally active, but are not 
infectious and are equivalent to the cores of most other genera in the Reoviridae. 
Unlike the Orthoreoviruses, an infectious, transcriptionally active particle, or ISVP, is 
not found in Rotavirus. The double-layered particles lack the outer coat proteins, and 
have VP6 as surface protein. They are sometimes described as rough particles due to 
the projecting trimeric subunits of VP6 that are observed at their periphery (Estes, 
1996). The single-layered core particle consists of VPl and VP3, surrounded by an 
outer surface coat of 120 copies of VP2. These are equivalent to the subcores of other 
genera in the Reoviridae such as Orbiviruses. The VP2 shell surrounds a subcore 
consisting of VPl and VP3, however the cores are the smallest particles that have 
been observed by EM (Estes, 1996). 
Electron cryomicroscopy and image processing techniques have been used to 
resolve the three-dimensional structure of triple- and double-layered particles first to 
40 A resolution (Prasad et al., 1988), and then subsequently to 26 A resolution 
(Prasad et al., 1990) (Prasad and Chiu, 1994). It is now established that the virion is 
approximately 75 nm in diameter, and that the two outer layers have T==13/(levo) 
icosahedral symmetry (Prasad et al., 1988). The smooth outer layer that makes up the 
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majority of the outer capsid is composed of 780 molecules of the neutralization 
antigen VP7 arranged as trimers. From this smooth surface 60 spikes protrude to a 
length of approximately 120 A from the outer capsid surface (Prasad et of., 1990) 
(Yeager et al., 1990). It was established that these surface spikes are composed of 
dimers of the haemagglutinin VP4 by the binding of two Fab fragments of a 
neutralizing monoclonal antibody against VP4 to the distal ends of the spikes (Prasad 
et 01., 1990). The VP4 spikes also extend inwards and interact with both VP7 and the 
inner capsid protein VP6. The inner capsid is composed of 780 molecules of VP6 
arranged as 260 trimers in a T=131 icosahedral surface lattice (Prasad et al., 1988) 
(Bican et 01., 1982). The VP6 layer is thought to interact with the inner VP2 shell. 
High affinity interactions between the structural proteins are suggested by their self-
assembly into virus-like particles when co-expressed in insect cells (Crawford et al., 
1994) (Labbe et aI., 1991). Co-assembly of purified proteins of each layer onto 
preformed VP2 particles has also been demonstrated (Zeng et al., 1994). 
The inner VP2 capsid layer surrounds a sub-core consisting of the enzymes 
VPl and VP3 and the dsRNA genome (Labbe et aI., 1991). Electron cryomicroscopy 
and image reconstruction studies of recombinant rotavirus-like particles have 
suggested that the VP2 layer is arranged as dimers of 120 quasi-equivalent molecules 
on an icosahedrallattice (Law ton et al., 1997b). The majority of VP2 forms a smooth 
shell, however a small portion at the amino-terminus of the protein appears to extend 
inwards at the icosahedral five-fold axes where it is believed to interact with a 
transcription complex composed of VP 1 and/or VP3 (Prasad et aI., 1996) (Lawton et 
01., 1997b). The amino-terminus of VP2 has RNA-binding activity (Labbe et al., 
1994), and it is has been shown that the viral dsRNA interacts closely with VP2 and 
the enzyme complex at the five-fold axes (Prasad et al., 1996). VP2 may have a role 
during transcription and viral morphogenesis as a scaffold for the proper assembly of 
the viral RNA, and VP 1 and VP3 in the viral core (Labbe et af., 1994) (Zeng et af., 
1998). Pores surrounding the five-fold axes of VP2 are large enough to allow mRNA 
to leave during transcription, although VP2 may also undergo conformational changes 
to facilitate this (Prasad et al., 1996). 
Complexes consisting of one copy of each of the minor structural proteins 
VPl and VP3 are thought to be associated with the VP2 shell at the icosahedral five-
fold axes (Prasad et al., 1996). These two enzymes are involved in the transcription of 
the genome within the intact particle. VPl is the viral RNA-dependent RNA 
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polymerase (Patton et al., 1997) (Zeng et al., 1996). VP3 has guanylyltransferase 
activity, and is responsible for capping of viral mRNAs (Patton and Chen, 1999) 
(Pizarro et al., 1991) (Liu et al., 1988). It has also been shown to have 
methyltransferase activity (Chen et al., 1999), and thus is a multifunctional capping 
enzyme with similarities to capping enzymes of other members of the Reoviridae, 
such as VP4 of bluetongue virus (Ramadevi et al., 1998). Other enzyme activities 
associated with transcription have not yet been attributed to particular proteins. The 
dsRNA genome is packed around the enzyme complex and interacts closely with the 
inner capsid layer (Prasad et al., 1996). It is proposed that the organisation of the 
dsRNA allows movement of the RNA relative to the enzyme complex during 
transcription. 
A distinctive feature of the virion structure is the presence of 132 large 
channels linking the outer surface with the inner core (Roseto et al., 1979) (Ludert et 
al., 1986). These comprise 120 channels along the six-fold axes, and 12 along the 
five-fold axes. The function of the channels is unknown at present, although they may 
be involved in importing the metabolites required for RNA transcription and export of 
nascent RNA transcripts for subsequent viral replication processes (Estes, 1996). 
Similar channels have been observed in the virion structure of the related Orbiviruses 
(Ray, 1996). 
Recent X-ray crystallography studies on the particle structure of bluetongue 
virus (BTV), the prototype virus of the genus Orbivirus, have revealed similarities 
between the subcore of this virus and that of other members of the Reoviridae such as 
Rotavirus (Grimes et al., 1998) (Gouet et al., 1999) (Lawton et al., 1997b). The 
structure of the BTV core particle has been determined to a high resolution (Grimes et 
al., 1998). The core particle consists of an outer layer of 780 copies of the VP7(TI3) 
protein arranged as trimers on an icosahedrallattice, equivalent to the VP6 layer in 
rotavirus (Prasad et al., 1992) (Grimes et al., 1997). This layer surrounds and interacts 
with a thin subcore of 120 copies of the VP3 (T2) protein (Grimes et al., 1997) 
(Huismans et al., 1987), which bears a striking resemblance to the structure of the 
VP2 layer of rotavirus (Lawton et ai, 1997b). This arrangement of 120 subunits may 
prove to be a unique characteristic of dsRNA viruses (Grimes et aI, 1998). VP3(T2) 
also binds RN A (Loudon and Ray, 1991), and can self-assemble into core particles 
(Moss and Nuttall, 1994). Pores at both the icosahedral five-fold and three-fold axes 
have been identified (Grimes et al., 1998). Pores involved in substrate (NTP) entry to 
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the BTV core have also been identified in the VP3(T2) layer, by X-ray crstallography 
of transcription ally active BTV particles (P.P.e. Mertens, pers. comm.) (Mertens et 
al., 1999). These pores are situated at the base of the channels formed by the six 
membered rings of VP7(T13) trimers closest to the five-fold axes. The VP3(T2) exists 
as A form molecules (those adjacent to the five-fold axis) and B form (those 
positioned further out from the five-fold axis) (Grimes et al., 1999), thereby forming 
decamers around each five-fold axis. The pores, which can be seen to contain an NTP 
molecule are situated between adjacent A and B forms. There is therefore a ring of 
five of these substrate entry pores around each five-fold axis. 
Electron microscopy studies of the structure of cytoplasmic polyhedrosis 
virus, a member of the Reoviridae, suggested that the dsRNA genome was found in 
close association with proteins at the base of the spikes at the five-fold axes (Yazaki 
and Miura, 1980). Disruption of the virion released dsRNA attached to a part of the 
spike. During transcription the spike was observed to swell and dsRNA was seen with 
a protein particle, believed to be part of the spike, attached at various points along its 
length. The theory was thus suggested that the genomic dsRNA moves through the 
base of the spike containing the transcription complex, and the newly synthesised 
mRNA is released through the top. 
It has been suggested that the proteins forming the transcription complex of 
BTV attach to the VP3(T2) layer at each of the icosahedral five-fold axes before the 
formation of the complete subcore (Grimes et al., 1998). The model suggests that the 
amino-terminal 50 residues of the VP3(T2) subunit swing down to interact with the 
transcription complex, perhaps holding some of the enzyme components in the correct 
orientation, and thus suggesting an important function for this domain of VP3(T2) in 
RNA synthesis and virion morphogenesis (Gouet et ai, 1999) (Grimes et ai, 1998). 
This is similar to the structure proposed for the VP2 protein in rotavirus above. The 
dsRNA genome may then be laid down within the assembled protein shell leading to 
an ordered genome structure which may be a common feature of the Reoviridae 
(Prasad et al., 1996) (Gouet et al., 1999). The minor core proteins 112 and ).3 
(RNA-dependent RNA polymerase) of reovirus are also thought to form a similar 
transcription complex at the five-fold icosahedral axes of the inner capsid (Nibert et 
ai, 1996). Many features of the subcores of viruses in different genera of the 
Reoviridae, such as Rotavirus and Orbivirus, appear to be conserved. Although there 
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is still much work to be done in this area it is speculated that further structural and 
functional similarities between the genera will be found (Oouet et ai, 1999). 
1.3.3 Physicochemical properties 
The three different rotavirus particle types, double-shelled, single-shelled and 
core particles, possess differing biophysical and biological properties. Infectivity 
depends upon the presence of the outer capsid layer (Lopez et al., 1986), and removal 
of this layer by treatment with ca1cium-chelating agents, such as EDT A and EOT A, 
results in a loss of infectivity (Estes et al., 1979). Single-shelled particles have 
polymerase activity resulting from the loss of the outer capsid layer that activates the 
endogenous RNA-dependent RNA polymerase. 
The particles possess different densities and sedimentation values, hence 
density gradient centrifugation can be used to separate them. The double-shelled 
particle has a density of 1.36 g/cm3 in caesium chloride (CsCl) and a sedimentation 
value of 520 to 530 S in sucrose. The single-shelled particle has a density of 1.38 
g/cm3 in CsCl and sediments at 380 to 400 S (Tarn et al., 1976). Core particles have a 
density of 1.44 g/cm3 in CsCl and a sedimentation value of 280 S (Bican et al., 1982). 
The mature virion is non-enveloped, a fact that is reflected by the general 
resistance of the particle and its infectivity to treatment with fluorocarbons, ether, 
chloroform and deoxycholate (Estes et al., 1979) (Tarn et al., 1976) (Welch and 
Thompson, 1973). Virus infectivity is stable within the pH range 3 to 9, and virus 
samples can be stored at 4 °C for months (Estes et al., 1979) (Palmer et al., 1977). 
The physicochemical properties of rotaviruses are relatively consistent among viruses 
of both animal (bovine or simian) and human origin. 
1.3.4 Rotavirus genome structure 
Rotaviruses are the only known viruses of mammals or birds to have eleven 
double-stranded (ds) RNA segments, although viruses of other species with 11 
dsRNA segements are known (Eley et al., 1987). The segments range in size from 
3302 bp to 667 bp. The nucleotide sequence for all eleven RNA segments has been 
elucidated for several strains, and general features have been described. The open 
reading frame (ORF) is surrounded by conserved non-coding regions of varying 
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length dependent upon the gene segment. Each RNA segment starts with a 5' 
guanylate and ends with a 3'-terminal cytidine. The dsRNA segments are base paired 
end to end and the positive sense strand has a conserved 5' cap sequence 
m7GpppG(m)GPy (Imai et al., 1983) (McCrae and McCorquodale, 1983). The 
rota viruses share similar features, such as the 5' cap and the conserved sequence at the 
5' and 3' ends of the RNA segments, with other viruses (e.g. reovirus, cytoplasmic 
polyhedrosis virus, and viruses of the genus Orbivirus) in the family Reoviridae 
(Furuichi et al., 1975) (Kuchino et al., 1982) (Mertens and Sanger, 1985), and in other 
virus families with segmented genomes such as the Orthomyxoviridae, Arenaviridae 
and Bunyaviridae. Short sequences of about eight nucleotides at the extreme 5' and 3' 
ends are conserved on all Group A rotavirus genome segments (Desselberger and 
McCrae, 1994). Among different virus strains there are high levels of segment 
specific conservation in the non-coding regions which are suggested to contain signals 
involved with genome transcription, RNA transport, replication and assembly. 
The RNA segments are packaged within the virus core capsid. The proteins 
responsible for packaging are unknown and while VP1, VP2 and VP3 are obvious 
candidates, the non-structural proteins may also have a role. A strict limit on the 
number of segments packaged appears to operate such that only eleven segments are 
included in the virion. At present the upper limit on segment length is unknown 
(McIntyre et al., 1987), although a rotavirus variant, brvA, has been described which 
encodes a novel dsRNA, gene A, which at 2693 bp is the largest rearranged segment 
reported for the rotaviruses. This rotavirus variant can package 6 % more RNA than 
the standard rotavirus (Hua and Patton, 1994). Gene A is a head-to-tail duplication of 
1112 bp that originates from the gene 5 ORF (Hua and Patton, 1994). To date the only 
atypical genotypes described for Group A rotaviruses are rearrangements resulting 
from sequence duplications within a single genome segment. It has been suggested 
that this genome rearrangement arises during viral transcription when the RNA 
polymerase detaches from the template without releasing the nascent transcript, and 
then reinitiates transcription at an upstream site on the template (Gorziglia et al., 
1989) (Hundley et al., 1987) (Matsui et al., 1990). This mechanism supports the 
existence of a specific association between a single genome segment and a 
transcriptase complex in the transcriptionally active virus particle, possibly involving 
simultaneous contact of both ends of the genome segment during transcription. The 
isolation from Cypoviruses of an active replicase particle composed of a transcriptase 
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complex and a single genome segment also supports this mechanism of transcription 
(Wu and Sun, 1986). 
A feature of the segmented genome that has proved invaluable in studying the 
molecular biology of the virus and in vaccine development, is reassortment of the 
RNA segments between strains and recovery of infectious virus (Glass et al., 1994). 
1.3.5 Gene-Protein coding assignments 
The proteins encoded by the eleven RNA gene segments have now been fully 
ascribed (Figure 1.3). The coding assignment for each segment was determined by in 
vitro translation of mRNA or denatured dsRNA (Mason et al., 1980) (McCrae and 
McCorquodale, 1982) and the analysis of rotavirus reassortants (Greenberg et al., 
1981) (Liu et aI., 1988) (Offit and Blavat, 1986). The general consensus is that 12 
proteins are encoded, of which six are structural (Table 1.2). Early studies presented 
conflicting results as confusion arose due to the post -translational modification of the 
proteins. 
Different rotavirus strains produce a varying order of RNA segments when 
they are resolved by electrophoresis. Hence, identification of cognate genes has been 
based on hybridization with gene-specific probes (Dyall-Smith et al., 1983), 
reassortant analysis (Gombold et al., 1985), sequence homology (Green et al., 1987), 
or biochemical or immunological identification of the protein synthesized in a 
cell-free translation system programmed with mRNA specific to the gene. 
1.4 Protein structure and function 
1.4.1 Structural proteins 
1.4.1.1 Inner core proteins VP1 and VP3 
The product of genome segment one, VP1, is a minor component of the viral 
core. Early experiments demonstrated that temperature-sensitive mutants that mapped 
to genome segment one had RNA-negative phenotypes, suggesting an enzymatic role 
for VPl (Gombold and Ramig, 1987). VPl has been found to be a minor but 
consistent component of all rotavirus complexes that possess polymerase activity 
(Gallegos and Patton, 1989) (Zeng et al., 1996). It contains regions of sequence 
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dsRNA 
1 - -'-
2 - -'-
3 - -.-
4 - -'-
Protein 
VP1 - J 
VP2 - core 
VP3 -
VP4 - ---
5 - -.- NSP1 
6 - -.- VP6 - ---
7 _~~ VP7 -
8 -~ NSP2 
9 - -.- NSP3 
10 - -.- NSP4 
11 -~ NSP5 
NSP6 
Figure 1.3 
Figure 1.3 The rotavirus particle and gene-protein coding assignments 
The eleven segments of dsRNA that comprise the rota virus genome and the 
proteins encoded by each gene are shown for the UKtc strain of bovine rotavirus. 
The structural proteins which make up the triple-layered particle are indicated on a 
cryo-electron reconstruction of a rotavirus particle at 24 A resolution (cryo-
electron reconstruction courtesy of R. F. Ramig) (Prasad and Chiu 1994). The outer 
capsid is shown in yellow, the inner capsid in blue and the inner core in purple. The 
dsRNA segments are shown in green. 
Figure adapted from Estes (1996). 
Table 1.2 
Genome Protein Molecular Mature protein Location in Number 
segment product mass modified virus of 
particles molecules 
per virion 
1 VP1 125 kDa - Inner core ND 
2 VP2 94kDa - Inner core 120 
3 VP3 88kDa - Inner core ND 
4 VP4 88kDa Cleaved Outer capsid 120 
(VP5*+VP8*) 
5 NSP1 53kDa - N onstructural 
6 VP6 41 kDa - Inner capsid 780 
7 NSP2 35kDa - N on structural 
8 VP7 38kDa Cleaved signal Outer capsid 780 
sequence; 
glycosylated 
9 NSP3 34kDa - Nonstructural 
10 NSP4 28kDa Glycosylated N on structural 
11 NSP5 26kDa Phosphorylated; N onstructural 
o-glycosylated 
11 NSP6 12kDa - N onstructural 
Table 1.2 Properties of rota virus proteins 
Table reproduced and adapted from Estes (1996). The gene-protein coding 
assignments are for the UKtc strain of bovine rotavirus. Approximate molecular 
weights for the polypeptides were deduced by SDS-polyacrylamide gel 
electrophoresis. All gene segments are monocistronic with the exception of gene 11, 
which contains a second out of frame ORF known to be expressed during infection 
(Mattion et al. 1991). ND = not yet determined. 
homology with consensus motifs of the putative RNA-dependent RNA polymerases 
of several other RNA viruses of eukaryotes, by comparison to the known poliovirus 
polymerase (Cohen et al., 1989) (Fukuhara et al., 1989) (Mitchell and Both, 199Gb). 
The photoreactable nucleotide analogue [a_32p] azido ATP was shown to cross-link 
exclusively with VPl when transcriptionally active VP6 particles were exposed to 
light (Valenzuela et al., 1991). The cross-linking blocked the activity of the 
transcriptase, demonstrating that VPl is a nucleotide-binding protein and also 
implying it is the RNA polymerase. For the these reasons it is now generally accepted 
that VPl is the RNA-dependent RNA polymerase. 
Cis-acting signals. localised within the 26 3'-terminal nucleotides, of rotavirus 
mRNA are recognised by the replicase complex and used to promote replication 
(Chen et al., 1994). The essential part of the signal is composed of seven nucleotides 
at the extreme 3' end of viral mRNA (Wentz et al., 1996). VPl specifically binds the 
3' end of viral mRNA in the absence of any other proteins (Patton, 1996). This is 
further evidence for the function of VPl as the polymerase. However, it is now known 
that VPl alone is not sufficient for replicase activity, and VP2 is also required, though 
its exact function is still uncertain (Patton et al., 1997). 
The product of gene segment 3, VP3, is a basic protein that is a minor 
component of the virion core (Liu et al., 1988). It is estimated that approximately one 
or fewer molecules of VP3 per dsRNA segment are present in the core. VP3 is found 
in early replication intermediates (Rls) in the viroplasm and is thought to associate 
with viral mRNA at early stages in the virus replication cycle (Gallegos and Patton. 
1989). It is known to bind to proteins involved in RNA replication (Zeng et al., 1998) 
and transcription (Sandino et al., 1994). 
VP3 is thought to be a guanylyltransferase, and thus to have a function in 
mRNA capping by transferring GMP to the phosphate end of nascent RNAs. 
Guanylyltransferases are evolutionary conserved enzymes and have features in 
common with other members of the nucleotidyltransferase superfamily, which 
includes among others ATP-dependent DNA ligases and RNA ligases (Cong and 
Shuman, 1993) (Shuman et al., 1994) (Shuman and Schwer, 1995). VP3 is also 
known to have some sequence similarity with the RNA polymerases of the 
negative-strand RNA viruses (e.g. vesicular stomatitis virus, measles virus) 
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suggesting the protein is a component of the polymerase complex (Liu and Estes, 
1989) (Mitchell and Both, 1990b). 
Several studies have provided evidence for the role of VP3 as a 
guanylyltransferase. It has been shown that VP3 forms a reversible, covalent bond 
with GTP which is a characteristic of both eukaryotic and viral guanylyltransferases 
(Fukuhara et aI., 1989) (Liu et al., 1992). When expressed in the baculovirus system it 
binds GTP in the absence of other viral proteins, suggesting that the GTP-binding 
activity is an intrinsic property of the protein (Liu et al., 1992). VP3 is probably an 
essential component of the transcriptase complex rather than the replicase complex, 
and it has been shown that baculovirus-expressed core-like particles that lack VP3 
have replicase activity (Zeng et al., 1996). In particular, Pizarro et al. (1991) 
demonstrated that VP3 was the only viral core protein to have associated 
guanylyltransferase activity. An assay specific for guanylyltransferase activity which 
detects an intermediate of the reaction, a covalent GMP-enzyme complex made from 
GTP, was used (Cleveland et al., 1986) (Shuman, 1982) and it was shown that only 
VP3 formed a complex with the nucleotide. The GMP-VP3 complex transfers GMP 
to the pyrophosphate group of GDP, resulting in the formation of a GpppG cap. In the 
related Orbivirus system, both guanylyltransferase and methyltransferase type I and 
type II activities have been found associated with one viral protein which is the minor 
core protein VP4 of bluetongue virus (Le Blois et al., 1992) (Ramadevi et al., 1998). 
Recent evidence demonstrated that VP3 is an RNA-binding protein. Gel shift 
assays using open virion-derived cores and virus-specific RNA probes have shown 
that VP3 has a sequence-independent affinity for ss RNA, but not for dsRNA (Patton 
and Chen, 1999). The guanylyltransferase activity of VP3 was found to be non-
specific and able to cap RNAs initiating with either a guanine or an adenine residue. 
Moreover, the results also indicated that VP3 has a preferential affinity for uncapped 
rather than capped ssRN A. 
1.4.1.2 Core protein VP2 
VP2 forms the inner core layer and constitutes 12 % of the virion protein 
(Kumar et al., 1989). It encapsidates the genomic RNA and the minor structural 
proteins VPl and VP3. It is found in the viroplasm during replication, which is the 
site of assembly of single-shelled particles and replication of dsRNA (Petrie et al., 
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1982). VP2 is known to be essential for replicase activity (ManseII and Patton, 1990), 
and is also involved in transcriptase activity, although the exact domains of the 
protein involved in these diverse functions are unknown at present (Estes et al., 1983). 
Temperature-sensitive mutants were used to demonstrate that VP2 is required for 
replicase activity and the simplest structures that were able to synthesize dsRNA were 
core-like particles (ManseII and Patton, 1990). More recently, experiments with 
baculovirus-expressed proteins have suggested that VP2 is a necessary component of 
complexes that synthesize rotavirus dsRNA (Zeng et al., 1996), and that the minimal 
replicase complex is VPl and VP2 (Patton et al., 1997). 
VP2 has been shown to have sequence-independent RNA binding activity in 
north-western blotting assays (Boyle and Holmes, 1986). Although it associated with 
both ssRNA and dsRNA, it has been shown to preferentially bind to ssRNA. Deletion 
analysis of recombinant baculovirus expressed VP2 localised the nucleic acid binding 
domain to the amino terminal region between aa 1 and 132 (Labbe et al., 1994). 
Although the recombinant protein bound both double-stranded and single-stranded 
probes, it showed less affinity for dsRNA and DNA. 
Several motifs were identified in the amino-terminal domain that could 
function in RNA-binding, albeit they were not strictly conserved in all strains. The 
motifs which may play a role in the RNA-binding function of VP2 were: (i) a 
predicted helix-turn-helix structure (aa 65 to 121); (ii) heptad repeats of lysine and 
glutamic acid residues (aa 53 to 81); (iii) a motif found in several proteins known to 
bind ss- and ds-RNA (aa 64 to 76) (Lab be et al., 1994). As VP2 binds to ssRNA, it 
has been suggested that it plays a role in encapsidation of viral ssRNA (Patton, 1995). 
More recent studies have suggested that its primary role in replication is linked to its 
ability to bind the mRNA template for minus strand synthesis, because when the 
N-terminal RNA-binding domain is deleted VP2 does not co-operate with VP I to 
generate replicase activity (Patton et al., 1997). 
VP2 can self-assemble into the core particle required for dsRNA synthesis, but 
other viral products, such as viral mRNA, are probably required for the core to 
condense into its mature form (Labbe et al., 1991). It is possible that two leucine 
zippers present between aa 536 and 686 are involved in the oligomerization of VP2 
into cores (Patton, 1995). Co-expression of baculovirus recombinant proteins for VP I, 
VP2 and VP3 leads to the assembly of core-like particles (Crawford et al., 1994), 
suggesting that VPl and VP3 have specific sites of interaction with VP2 (Chen et al., 
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1994). Expression of VP2 lacking the N-terminal 92 aa showed that the truncated 
protein had lost the capacity to encapsidate VP 1 alone, VP3 alone, or a VP 1-VP3 
complex (Zeng et al., 1998). Results of far-western blotting experiments established 
the amino-terminal aa 1 to 25 of VP2 as necessary for binding VPl (Zeng et al., 
1998). It has to-date not been possible to map the domain necessary for VP3 binding 
more precisely than the N-terminal 92 aa. 
1.4.1.3 Intermediate capsid protein VP6 
VP6 is the inner capsid protein and is a major structural component of the 
virion, making up 51 % of the total protein content (Liu et al., 1988). It is the group 
antigen and also carries sub-group determinants. It has an important role in the virion 
structure, due to its interactions with both the outer capsid proteins VP4 and VP7, and 
with the core protein VP2 (Estes, 1996). VP6 spontaneously forms trimers which are 
extremely stable and contain several highly immunogenic, conserved epitopes (Estes 
et al., 1987). 
VP6 is necessary for transcriptase activity and its addition to core particles 
activates the particle-associated RNA-dependent RNA polymerase (transcriptase) and 
thus synthesis of viral mRNA. However, it is not known whether VP6 plays a 
structural or functional role in this process (Bican et al., 1982) (Sandino et al., 1986). 
Temperature-sensitive mutants were used to show that VP6 is not necessary for 
synthesis of dsRNA (replicase activity) (Mansell and Patton, 1990). Expression of 
rotavirus-like particles from baculovirus recombinants also demonstrated that VP6 is 
not an essential component of particles supporting replicase activity (Zeng et al., 
1996). Addition of VP6 to core particles activates transcription and suppresses 
replicase activity (Kohli et al., 1993), suggesting VP6 plays a role in modulating the 
enzymatic activity of single- and double-layered particles. 
1.4.1.4 Outer capsid proteins VP4 and VP7 
Although it is only a minor component of the outer capsid, forming spikes on 
the surface of the rotavirus particle (Prasad et al., 1990), VP4 is an important 
multifunctional protein. Proteolytic cleavage of VP4 to form VP5* and VP8* 
potentiates infectivity by enhancing penetration of the virus into cells, but not 
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adsorption (Fukuhara et al., 1988). The trypsin cleavage sites are conserved in every 
VP4 sequence analysed to date (Estes, 1996). 
VP4 is probably the cell attachment protein (Ruggeri and Greenberg, 1991). It 
has a putative fusion region (residues 384 to 401) that shares some homology with 
internal fusion sites in Semliki Forest and Sindbis virus proteins (Mackow et al., 
1988). As these regions have been implicated in cell fusion, it is hypothesised that the 
region might perform a similar function in VP4. This region is conserved among 
rotaviruses, suggesting is has an important function in the replication cycle (Estes. 
1996). 
VP4 was identified as the viral haemagglutinin on the basis of studies of 
reassortants produced following dual infection of a rotavirus with haemagglutination 
activity (RRV) and a rotavirus lacking this activity (bovine UK rotavirus) (Kalica et 
al., 1983). It has been implicated as a virulence determinant in mice (Offit et al., 
1986). It has also been shown to induce neutralising antibodies, which can protect 
animals experimentally infected with rotavirus (Offit et al., 1986). 
VP7 forms the smooth external surface of the outer capsid and constitutes 30% 
of the virion protein (Kapikian and Chanock, 1996). It is the major neutralisation 
antigen (Sabara et al., 1985) and is largely responsible for serotype specificity defined 
by neutralisation with hyper-immune antiserum (Matsui et al., 1989). VP7 is a 
glycoprotein containing only N-linked high mannose oligosaccharides, which are 
acquired in the endoplasmic reticulum (ER) and processed by trimming (Ericson et 
al., 1982) (KabceneU and Atkinson, 1985). It contains between one and three potential 
sites for N-linked glycosylation. VP7 is co-translationally glycosylated as it is inserted 
into the membrane of the endoplasmic reticulum (ER). Insertion is directed by a 
cleavable signal sequence, proposed to involve two regions of hydrophobic amino 
acids (aa) at the amino terminus which are cleaved at an amino terminal residue, 
glutamine 51 (Stirzaker et al., 1987) (Whitteld et al., 1987). Regions in VP7 that 
mediate the retention of the protein in the ER have been identified (Stirzaker et al., 
1987), but the mechanism by which this occurs is unknown (Estes, 1996). It has been 
proposed that VP7 is responsible for attachment of virus to host cells, although VP4 is 
now thought likely to be the main viral attachment protein (Fukuhara et al., 1988) 
(Sabara et al., 1985). 
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1.4.2 Non-structural proteins 
1.4.2.1 NSPl 
The product of genome segment five, NSPl, is a 58 kDa non-structural 
protein, which has the lowest level of expression of all the viral proteins in the 
infected cell (Johnson and McCrae, 1989). Its exact function is still unknown. despite 
the fact that several properties of the protein have been described. The primary 
sequence of NSPl is highly divergent (Xu et al., 1994), with the exception of a 
cysteine-rich sequence at the amino-terminus which may form a zinc finger structure 
(Hua et al., 1993). NSP 1 has been shown to have an affinity for zinc (Brottier et al., 
1992). It has non-specific RNA-binding activity (Brottier et al., 1992). and the 
RNA-binding site has been mapped to the amino-terminus of the protein (Hua et al., 
1994). NSP 1 localises to the cytoplasm during viral infection and accumulates in 
association with the cytoskeletal matrix (Hua et al., 1994) (Hua and Patton, 1994). It 
is a component of early replication intermediates and is thought to have a role in the 
viral replication cycle (Gall egos and Patton, 1989). Gene five from a non-defective 
mutant virus, p9Ll5, has a deletion in the coding sequence resulting in an NSP I of 
only the amino-terminal 150 aa compared to the usual 490 aa, possibly indicating that 
only the amino-terminus of the protein is essential for gene function in vitro (Tian et 
al., 1993). Non-defective rotavirus mutants carrying truncated NSP1 of about 40 aa 
and lacking the conserved amino-terminal cysteine-rich region have recently been 
identified (Taniguchi et al., 1996), suggesting that this region of NSPI may also not 
be necessary for virus replication in vitro (Taniguchi et al., 1999). The properties and 
proposed functions of NSP 1 are discussed in more detail in Section 1.6. 
1.4.2.2 NSP2 and NSP3 
NSP2 is encoded by genome segment seven in the UKtc strain of bovine 
rotavirus. It accumulates predominantly in the viroplasm in rotavirus-infected cells 
(Petrie et al., 1984). Experiments with temperature-sensitive mutants have indicated 
that NSP2 is essential for the formation of viroplasms and also for genome replication 
(Ramig and Petrie, 1984) (Gombold et al., 1985). NSP2 has intrinsic RNA-binding 
activity that is not dependent upon the presence of other viral proteins (Kattoura et al., 
1992). It has non-specific affinity for both ss and dsRNA. Kattoura et al. (1994) 
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proposed that the RNA-binding activity of NSP2 may be dependent upon its ability to 
form multimers in infected cells. Immunoprecipitation with specific monocJonal 
antibodies from UV-crosslinked rotavirus-infected cells demonstrated that NSP2 
interacted directly with all eleven dsRNA rotavirus genomic segments and with 
partially double-stranded RNA (Aponte et al., 1996). However, as NSP2 has 
previously been shown to have non-specific RNA-binding activity, it was suggested 
that it co-localised with the RNA segments in infected cells. NSP2 has been shown to 
interact with the viral polymerase VPl (Kattoura et al., 1994). Evidence has also been 
presented to suggest NSP2 is associated with an enzyme complex exhibiting replicase 
activity in rotavirus-infected cells (Aponte et al., 1996). The current view on the role 
of NSP2 is that it is involved in RNA replication and may have a role in the assembly 
of an efficient replicase complex. 
NSP3 is a slightly acidic protein found distributed in a filamentous manner in 
the cytoplasm, possibly in association with the cytoskeleton (Mattion et al., 1992). 
The secondary structure is predicted to be predominantly alpha-helical. Several 
heptad repeats of hydrophobic amino acids are found in the carboxy half of the 
protein, while a basic region, which is a candidate for a functional domain, is found in 
the amino half (Mattion et al., 1992). NSP3 forms homo-oligomers in vivo and 
deletion mutagenesis has implicated the carboxy terminus in oligomerisation (Matt ion 
et al., 1992). 
NSP3 has ssRNA and dsRNA binding activity and both monomeric and 
multimeric forms of NSP3 bind to rotavirus mRNA (Mattion et al., 1992) (Poncet et 
al., 1993). NSP3 binds the conserved consensus sequence AUGUGACC found at the 
3'-end of all rotavirus mRNAs (Poncet et al., 1994). In vitro the minimal RNA 
sequence required for binding is GACC. NSP3 was also shown to bind to the 3'-end 
of viral mRNA in infected cells (Poncet et al., 1996). The RNA-binding domain is 
believed to lie between aa 4 and 149 at the amino terminus of the protein (Piron et al., 
1999). This amino-terminal region also contains a consensus sequence found in 
ss RNA-binding proteins of both Orbiviruses (NS2) and Orthoreoviruses (0' NS). It is 
pertinent to note that the binding site of NSP3 overlaps with the 3'-terminal seven 
nucleotides which form part of the eis-acting signal that functions as the promoter for 
minus-strand RNA synthesis during genome replication (Wentz et al., 1996). This 
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suggests that NSP3 may be associated with RNA replication, perhaps by mediating 
transport of mRNA templates to the viroplasm for replication. NSP3 has 
sequence-specific RNA-binding activity and thus could play a role in discriminating 
between viral and cellular RNA. However, it is unlikely to be involved in selection of 
the 11 individual mRNA segments as it recognises a consensus sequence common to 
the 3'-end of the positive-strand of all segments. More recently, it has been suggested 
that by binding to the 3'-end of viral mRNAs, NSP3 protects them from degradation 
(Piron et al., 1999). NSP3 has also been shown to interact with the cellular protein 
eukaryotic initiation factor 4GI (eIF-4GI) (Piron et al., 1998), and the binding domain 
for eIF-4GI has been mapped to the last 107 aa of the carboxy-terminus of NSP3 
(Piron et al., 1999). It has thus been suggested that NSP3 has a role in ensuring 
efficient translation of viral mRNA. 
1.4.2.3 NSP4 
NSP4 is a transmembrane glycoprotein found in the ER (Ericson et al., 1982) 
(Kabcenell and Atkinson, 1985). It has three hydrophobic amino-terminal regions, 
which are maintained in the ER membrane, and a hydrophilic carboxy terminus that 
extends into the cytoplasm (Chan et al., 1988). NSP4 may have a role in viral 
morphogenesis, and it is thought that the cytoplasmic domain acts as a receptor for 
subviral (double-layered) particles and mediates their budding into the lumen of the 
ER (Eric son et al., 1983). It may also have a function in the acquisition of the outer 
capsid protein layer (Au et al., 1989) (Meyer et al., 1989). Evidence to support this 
role for NSP4 includes the localisation of the VP6 binding site on NSP4 to the 
cytoplasmic domain between aa 161 and 175 (Au et al., 1993) (Taylor et al., 1992) 
(Taylor et al., 1993). In addition, double-layered particles have been observed to bind 
to ER membranes containing only NSP4 (Au et al., 1989) (Meyer et al., 1989). NSP4 
also has membrane destabilization activity and glycosylated NSP4 may have a role in 
the removal of the transient envelope from budding particles during viral 
morphogenesis (Tian et al., 1996). 
NSP4 is known to be cytotoxic (Tian et al., 1994) and may function as a viral 
enterotoxin in rotavirus-induced diarrhoea by causing calcium-dependent chloride 
secretion across the mammalian small intestinal mucosa (Ball et al., 1996). It has been 
shown to induce diarrhoea when injected intraperitoneally into young mice. 
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Preliminary data showed structural changes between aa 131 and 140 in NSP4 when 
virulent and attenuated strains were compared, which suggested that this region may 
be important for the protein function (Zhang et al., 1998). 
1.4.2.4 NSP5 and NSP6 
The primary product of genome segment eleven is the 26 kDa non-structural 
protein NSP5, which is normally found in the phosphorylated 28 kDa form. However, 
it is now known that a second out-of-phase ORF (OP-ORF) in genome segment 
eleven, beginning at base 80, encodes a 12 kDa protein that is expressed in 
rotavirus-infected cells (Mattion et al., 1991). This protein, NSP6, accumulates in 
viroplasms and may function as part of a complex, but is, as yet, largely 
uncharacterised. 
The role of NSP5 in the virus replication cycle is still unclear. It is a 
phosphoprotein that exists in several different phosphorylated forms, the major 
isoforms being 26, 28 and 35 kDa, which are formed by phosphorylation of different 
serine residues (Blackhall et al., 1997). There is also evidence to suggest that NSP5 
has protein kinase activity (Poncet et al., 1997) (Blackhall et al., 1997), though this is 
not detected until all the major phosphorylated forms of NSP5 are present in the cell 
(Blackhall et al., 1998). NSP5 is found in the viroplasm in rotavirus-infected cells, but 
phosphorylation is not required for its localization there (Blackhall et al., 1998). 
NSP5 forms homo-dimers (Gonzalez et al., 1998), and is known to interact 
with NSP2 (Poncet et al., 1997). Interaction with NSP2 appears to up-regulate NSP5 
phosphorylation (Afrikanova et al., 1998). Both proteins co-localise in the viroplasm 
and it has been suggested that NSP5 may have a role in forming the structure of the 
viroplasm, and this may be mediated by its interaction with NSP2 (Fabbretti et al., 
1999). 
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1.5 Rotavirus replication cycle 
1.5.1 Overview 
Rotavirus has a lytic replication cycle, which takes place in the cytoplasm of 
infected cells. Although the natural cell tropism for rotavirus is the differentiated 
enterocyte in the small intestine, it has been mainly studied in continuous ceJl cultures 
derived from monkey kidneys, due to the difficulty in culturing intestinal cell lines 
(Estes, 1996). Rotavirus has a rapid replication cycle in these cells with a maximum 
yield of virus after 10-12 hours (McCrae and Faulkner-Valle, 1981). Viral infectivity 
is activated by proteolytic cleavage of VP4. Once the virus gains entry to the cell, the 
replication cycle proceeds solely in the cytoplasm. Viral mRNA transcripts are 
synthesised asymmetrically from the minus dsRNA template and are used both to 
produce proteins, and as a template for minus-strand synthesis. During the replication 
cycle both parental dsRNA strands remain associated with the partially uncoated viral 
particle. Replication occurs in nascent subviral particles, and dsRNA or minus strand 
ssRNA are never found free in the infected cell. Subviral particles are formed in 
association with viral inclusions in the cytoplasm, termed viroplasms. The progeny 
virus particle matures by budding through the membrane of the ER where it acquires 
the outer capsid proteins VP4 and VP7, and the particles are then released by cell 
lysis. A schematic representation of the virus replication cycle is shown (Figure 1.4). 
1.5.2 Virus attachment and entry 
A variety of approaches have been used to study the initial stages of rotavirus 
replication. Only triple-layered particles containing VP4 have been shown to attach to 
cells (reviewed by Estes, 1996). It is unclear whether virus attachment is mediated by 
VP4 or VP7 or both, however increasing evidence favours VP4 (Rugged and 
Greenberg, 1991) (Ludert et al., 1996). Recently it has been shown that the binding of 
virus-like particles to MAI04 cells requires the presence of VP4 (Crawford et al., 
1994). Further, use of viral reassortants suggested that VP4 functions as the cell 
attachment protein both in vitro and in vivo (Ludert et al., 1996). Binding to cells does 
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Figure 1.4 Schematic representation of the major features of the rota virus 
replication cycle 
The infecting (triple-layered) virus particle attaches to the cell membrane, 
probably by the interaction of VP4 with the cellular receptor (Hewish et al., 
2(00), and is internalised either by endocytosis or direct penetration. A decrease 
in calcium concentration is thought to trigger the release of the outer coat proteins, 
however the mechanism by which this occurs is not yet clear (Ruiz et al., 1997). 
Following the loss of the outer capsid, the RNA-dependent RNA polymerase 
(transcriptase) is activated and viral transcription occurs. The viral mRNAs have 
two functions: they are translated to produce viral proteins, and they also 
constitute the template for minus-strand synthesis in dsRNA replication. The 
mRNAs are translated to produce all the viral proteins required for replication. 
The mRNA segments undergo genome assortment and are transported to the 
viroplasm where RNA replication and assembly of single-shelled (double-layered) 
particles occurs. The single-shelled particle matures by budding through the ER 
membrane, and acquires the outer capsid proteins VP4 and VP7 in the ER. Mature 
progeny virions accumulate in the RER and are released following cell lysis. 
Adapted from Estes (1996). 
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not require the proteolytic cleavage of VP4 to VP5* and VP8* (Fukuhara et al., 
1988), yet this is known to enhance infectivity in many, but not all, virus strains. 
Until recently the cellular receptor for rotavirus was unknown. However, 
integrins a2~ 1 and a4~ 1 have now been implicated in rotavirus cell entry and 
infection (Coulson et al., 1997), and it has since been demonstrated that these two 
integrins can act as cellular receptors for the SAIl strain of rotavirus (Hewish et al., 
2000). It was originally thought that binding of animal rotaviruses was dependent 
upon the presence of sialic acid residues in the membrane, while human rotavirus 
strains apparently initiated infection by a sialic acid-independent mechanism 
(Fukudome et al., 1989). Neuraminidase treatment of red blood cells reduced virus 
binding, indicating a potential role for sialic acid in virus attachment for animal 
rotaviruses (Bastardo and Holmes, 1980). Human rotavirus strains were resistant to 
neuraminidase treatment (Fukudome et al., 1989) (Yolken et al., 1987). Sialic 
acid-resistant mutants retain full infectivity for cells, indicating that there are at least 
two binding sites for animal rotaviruses (Mendez et al., 1994). Recent studies have 
however demonstrated that animal rotaviruses may also be able to infect permissive 
cells in a sialic acid-independent manner. Thus, it has been suggested that an initial 
interaction occurs, which might be sialic acid-dependent or independent, then virus 
entry proceeds by attachment to a common cellular receptor (Mendez et al., 1998) 
(Ciarlet and Estes, 1999). 
After binding to permissive cells, the virus is internalised. The penetration step 
is reportedly facilitated by the proteolytic cleavage of VP4, which is known to 
enhance infectivity (Clark et al., 1981). Internalisation does not occur at less than 
4°C, and therefore active cellular processes are required (Keljo and Smith, 1988). The 
mechanism of internalization is controversial since there is evidence to support both 
receptor-mediated endocytosis and direct penetration of the virus into the cell. Initial 
EM studies suggested that virus entry occurred by endocytosis into lysosomes (Ludert 
et al., 1987) (Quan and Doane, 1983). It is known that viruses which initiate infection 
by receptor-mediated endocytosis often depend upon the acidification of endosomes 
for uncoating or cell entry (Estes, 1996). However, lysosomotrophic drugs 
(ammonium chloride, chloroquine, amantadine) have little inhibitory effect on virus 
replication (Ludert et al., 1987), as do energy inhibitors (sodium azide, dinitrophenol) 
(Kaijot et al., 1988), suggesting that conventional receptor-mediated endocytosis 
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might not represent the major entry route for productive infection. On the other hand, 
a model has been proposed recently for Ca2+-dependent endocytosis of the virus 
particle that does not require acidification of the endosome for the infectious process 
(Ruiz et al., 1997). 
The mode of rotavirus entry into cells may differ depending on whether virus 
particles have been pre-treated with trypsin. EM studies showed that trypsin-treated 
virus entered by direct penetration of the cell membrane, while non-trypsin-treated 
particles were taken up by phagocytosis over a longer period of time though entry by 
phagocytosis was not thought to lead to viral replication (Suzuki et al., 1985). Study 
of the kinetics of cell entry correlated with the EM studies described above on 
trypsin-treated and non-trypsin-treated rotavirus (Kaijot et al., 1988). Trypsin-treated 
rotavirus was internalised with a half-time of 3-5 minutes, whereas 
non-trypsin-treated rotavirus had a half-time of 30-50 minutes. Only trypsin-activated 
virus resulted in a productive infection. Trypsin-treated virus was also shown to 
mediate the rapid release of 51Cr from infected cells at 37°C, but not at 4°C. These 
data suggested that virus entry occurs by direct penetration of the cell membrane, 
resulting in permeabilisation of the cell membrane (Kaijot et al., 1988). The 
proteolytic cleavage product of VP4, VP5*, has been shown to permeabilise 
membranes in the absence of other rotavirus proteins (Denisova et al., 1999). The 
mechanism of rotavirus internalisation is therefore unclear, and it is possible that both 
endocytosis and direct penetration may be involved. 
1.5.3 Transcription 
Transcription of viral mRNA begins soon after virus entry and is at a 
maximum at 9 to 12 hours post-infection (p.i.) (Stacy-Phipps and Patton, 1987). Viral 
gene expression is regulated at the level of transcription as viral mRNAs are not 
produced in equimolar concentrations (John son and McCrae, 1989) (Stacy-Phipps and 
Patton, 1987). Regulation at the level of translation also occurs, as viral proteins are 
synthesised in the cell in relative concentrations that differ from those of viral 
mRNAs (Johnson and McCrae, 1989). 
Transcription is asymmetric, and all transcripts are full-length plus strands 
transcribed from the minus strand of the dsRNA template (McCrae and 
McCorquodale, 1983). Viral mRNAs differ from cellular mRNAs in that they contain 
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a 5'-terminal methylated cap structure (Imai et al., 1983), but lack 3' polyadenylate 
sequence (McCrae and McCorquodale, 1983). The site of transcription of viral 
mRNAs has not yet been localised either to the cytoplasm or the viroplasm. In other 
genera of the Reoviridae, such as bluetongue virus (BTV), transcription is believed to 
occur in viral inclusion bodies (VIBS) which form in the cytoplasm (Eaton et al., 
1990), as both parental and progeny virus particles are occluded within these 
structures. As yet, however, there is no firm evidence for the site of rotavirus 
transcription. 
Transcription is mediated by an endogenous viral RNA-dependent RNA 
polymerase (transcriptase) that is a component of the virion (Mason et al., 1980) 
(Sandino et al., 1986). The conversion of triple-layered particles to double-layered 
particles activates the viral transcriptase activity and it is thought that transcription in 
cells occurs from such particles (Clark et al., 1980). Other enzymatic activities known 
to be associated with the double-layered particle, such as nucleotide 
phosphohydrolase, guanylyltransferase, and methylase, are also required for RNA 
transcription (Estes, 1996). Rotavirus transcription requires a hydrolyzable form of 
ATP that may be necessary for initiation, or elongation, of RNA molecules (Spencer 
and Arias, 1981). The functions of some of the structural proteins associated with the 
transcriptase particle have been defined. VPl is thought to be the RNA-dependent 
RNA polymerase (Section 1.4.1.1), although VP2 is also required for its activity 
(Section 1.4.1.2). VP3 is probably the guanylyltransferase (Section 1.4.1.1). VP6 is 
required for transcriptase activity (Sandino et al., 1986), but its role in the process is 
unclear. It is possible that it acts as a scaffold protein in the composition of a 
functional transcriptase complex. 
1.5.4 Replication 
Analysis of the kinetics of RNA synthesis has shown that both plus- and 
minus-strand RNA synthesis can be detected in the cell by three hours p.i. (McCrae 
and Faulkner-Valle, 1981) (Stacy-Phipps and Patton, 1987). The level of minus-strand 
synthesis reaches a peak at 6 to 9 hours p.i. before the maximal level of plus-strand 
synthesis. As the level of replication does not increase in conjunction with the level of 
plus-strand synthesis, it is suggested that additional control factors must operate. 
30 
Replication is asymmetric with the viral plus-strand acting as a template for 
the synthesis of minus-strand RNA. The plus-strand RNA template IS 
indistinguishable from viral mRNA (McCrae and McCorquodale, 1983). After 
synthesis, dsRNA remains associated with subviral particles and is not found free in 
the cell. Hence, genome assortment of viral mRNA must occur prior to RNA 
replication. During this process, each individual replicase particle acquires a single 
copy of each individual genome segment. The mechanism that controls genome 
assortment is unclear, however the presence of signal sequences on each of the eleven 
species of viral mRNA is a prerequisite for such an accurate process. Signals that 
allow differentiation between viral and host mRNAs, and also between each of the 
eleven genome segments would be required. The nature of these signals is unknown, 
but sequence analysis has shown that the 5' and 3' ends of the genome segments 
contain identical 5-10 base terminal sequences (McCrae and McCorquodale, 1983). 
Sequence analysis has also shown that the entire 5' and 3' untranslated regions (UTRs) 
of homologous genome segments are highly conserved (Clarke and McCrae, 1983) 
(Desselberger and McCrae, 1994). The site of genome assortment is unknown, but 
Patton (1995) has suggested that the accumulation of non-structural proteins with 
RNA-binding properties on the cytoskeleton could serve to concentrate mRNAs prior 
to packaging. The non-structural proteins may also have a function in transport of the 
viral mRNAs from their site of synthesis to the viroplasm for packaging and 
replication. 
RNA replication probably occurs in the viroplasm (Petrie et al., 1984). Similar 
structures (VIBs) in BTV-infected cells are also thought to be the site of viral genome 
replication (Eaton et al., 1990). Characterisation of subviral particles with replicase 
activity identified three replication intermediates (RIs) in rotavirus-infected cells 
(Gallegos and Patton, 1989). The smallest RI (pre-core RI) contained the structural 
proteins VPl and VP3, and the non-structural proteins NSP1, NSP2, NSP3 and NSP5, 
although only NSPl and NSP3 reproducibly co-purify with the pre-core RIs (Patton, 
1995). A second intermediate (core RI) contained the core structural proteins VP I, 
VP2 and VP3, and the non-structural proteins NSP2, NSP3 and NSP5. VP6 was then 
added to the core RI to form the largest RI (single-shelled RI). Thus, the replicase 
complex contains the core proteins VPl and VP2, small amounts of VP6, and varying 
amounts of the non-structural proteins NSPl, NSP2, NSP3 and NSP5 (Gall egos and 
Patton, 1989). A model was proposed in which double-layered particles were 
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assembled by the sequential addition of VP2 and VP6 to the pre-core complex which 
occurred concurrently with genome replication. The positive sense RNA template 
appears to extend from the surface of early replicase particles and is then drawn into 
the particle as replication proceeds (Patton and Gallegos, 1990), supporting the 
hypothesis that morphogenesis and replication are related processes. 
The use of temperature-sensitive mutants suggested that VP2, but not VP6, 
was an essential component of replicase particles (Mansell and Patton, 1990). The 
minimal replicase complex has since been shown to consist of VPl and VP2 (Zeng et 
al., 1996) (Patton et al., 1997). VPl is thought to be the RNA-dependent RNA 
polymerase. Despite the fact that VP2 is required for replicase activity, its exact 
function is still unknown (Patton, 1996). The function of the non-structural proteins in 
replication has not yet been fully defined, but they could be involved in genome 
assortment, transport and packaging of viral mRNA, and RNA synthesis. 
A eis-acting signal involved in replication has been localised within the 26 
3 I-terminal non-coding nucleotides of a reporter template RNA in an in vitro 
replication system (Chen et al., 1994). Wentz et al. (1996) then mapped the minimal 
promoter of minus-strand RNA synthesis to the 3'-terminal seven nucleotides. It has 
since been shown that this sequence must be single-stranded to allow efficient 
minus-strand synthesis (Chen and Patton, 1998). Further, the putative RNA-dependent 
RNA polymerase, VP1, has been shown to bind to the same region of viral mRNA 
(Patton, 1996). Additional enhancement signals for replication at the 5' and 3' ends of 
the viral mRNA have also been identified (Wentz et al., 1996). 
1.5.5 Virus assembly and release 
Double-shelled particles are formed in the viroplasm, however the final stages 
of rotavirus morphogenesis, when the outer capsid proteins VP4 and VP7 are 
acquired, occurs in the ER. The double-shelled particles bud through the membrane of 
the ER and acquire a transient envelope, which is lost as the particles move towards 
the interior of the ER, and is replaced by the outer capsid to form a mature virion 
(Estes, 1996). 
The glycoproteins VP7 and NSP4 are synthesised on ribosomes associated 
with the membrane of the ER. Signal sequences at the amino terminus of each protein 
direct their co-translational glycosylation and insertion into the ER membrane 
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(Whitteld et al., 1987) (Kabcenell and Atkinson, 1985). The amino terminus of NSP4 
is maintained in the membrane whilst the carboxy terminus extends into the 
cytoplasm of infected cells, where it is proposed to act as a receptor for 
double-layered particles and thus mediate their budding into the lumen of the ER 
(Chan et al., 1988) (Petrie et al., 1983). NSP4 has a binding site for VP4 (Au et al., 
1993) and forms homo-oligomers and heterooligomeric complexes with VP4 and VP7 
(Maass and Atkinson, 1990). VP4 accumulates in the cytoplasm near the RER 
(Kabcenell et al., 1988), and is thought to associate with the double-shelled particle 
before entry into the ER (Lopez et al., 1985) (Mackow et al., 1988). The exact details 
of particle budding across the ER membrane are, as yet, not well understood. The 
transient envelope acquired by budding particles in the ER is removed during virion 
morphogenesis, and glycosylated NSP4 may have a role in this process (Petrie, 1983) 
(Suzuki et al., 1984). 
Rotavirus maturation is a calcium-dependent process, as virus yields are 
decreased when produced in cells maintained in calcium-depleted medium 
(Shahrabadi and Lee, 1986). In addition, viruses produced in the absence of calcium 
do not bud into the ER and thus lack the outer capsid proteins (Shahrabadi et al., 
1987). It has been proposed that calcium is required both for the glycosylation of 
NSP4 and in the acquisition of the protein conformations necessary for the formation 
of hetero-oligomers (Poruchynsky et al., 1991). Baculovirus-expressed NSP4 has 
been demonstrated to cause an increase in the intracellular calcium concentration 
(Tian et al., 1994), and this increase has been proposed to be an important factor in 
virus maturation (Tian et al., 1995). The presence of calcium may also stabilise or 
modulate the folding of glycosylated VP7 for subsequent assembly into virus particles 
(Shahrabadi et al., 1987). VP7 has been shown to form hetero-oligomers with both 
VP4 and NSP4 in infected cells (Maass and Atkinson, 1990). Oligomer formation and 
interaction with calcium appear to be important in the assembly of VP7 into the outer 
capsid (Dormitzer and Greenberg, 1992) (Poruchynsky et al., 1991) (Shahrabadi et 
al., 1987). However, the precise mechanisms of transient envelope removal and outer 
capsid assembly remain poorly understood. The infectious cycle ends when progeny 
virus is released by host cell lysis (Altenburg et al., 1980) (McNulty et al., 1976). 
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1.6 Non-structural protein NSPl 
1.6.1 Gene 5 shows high sequence divergence 
NSPl is unusual among the Group A rotavirus non-structural proteins in that it 
has a variable length of between 486 and 495 aa and its primary sequence has a low 
level of conservation (Hua et al., 1993) (Patton, 1995). The nucleotide sequences of 
gene five from rotaviruses of different animal origin have been shown to be extremely 
diverse and range in size from 1564 to 1611 nucleotides (Hua et al., 1993). 
Comparison of the gene segment five from the SAIl strain of simian rotavirus with 
that from the RF strain of bovine rotavirus revealed homologies of only 49 and 36 % 
at the nucleotide and amino acid levels respectively (Mitchell and Both, 1990a). By 
comparison, the other rotavirus non-structural proteins are highly conserved between 
isolates. For example, NSP2 has 78 % homology at the nucleotide level, and 83 % or 
greater homology at the amino acid level (Patton et al., 1993). In fact, gene five 
appears to be more diverse than any other rotavirus gene, including those such as VP4 
and VP7 which are subject to immune selection (Dunn et al., 1994). 
When viruses of different origin and serotype were compared, the gene five 
sequences appeared to exhibit a higher degree of sequence homology among viruses 
of the same serotype (Hua et al., 1993). For example the bovine strains UK and RF, 
which are both serotype six, showed homology of 88 and 92 % at the nucleotide and 
amino acid levels respectively. This suggested a possible correlation between gene 
five sequence divergence and rotavirus serotype. In addition, a phylogenetic tree of 
the predicted amino acid sequences for NSPI available at this time showed a 
clustering of the NSP 1 genes according to host range (Hua et al., 1993). Gene five 
sequences from viruses of the same host range were shown to be more closely related 
to each other than to those isolated from other species. Comparison of NSP 1 amino 
acid sequences from isolates from more species revealed identities ranging from 36 to 
92 % with the most evident sequence diversity between strains from different species 
(Dunn et al., 1994). Analysis of the sequence homologies and phylogenetic 
relationships again showed that NSP1 sequences were clustered according to species 
origin, with one exception which was the inclusion of the human and porcine strains 
in a single group. This work suggested that NSP 1 may have a role in determining host 
range restriction of rotavirus strains by an unknown mechanism (Section 1.6.5). It was 
proposed that NSPl might interact with a host cytoplasmic protein that also varied 
34 
between species. The putative species-specific protein could possibly be of 
cytoskeletal origin, as NSPl is known to accumulate in association with the 
cytoskeleton (Hua and Patton, 1994). 
In contrast to this, analysis of the sequence of NSPl from a larger range of 
isolates contradicted the work of Dunn et al. (1994) as it revealed that sequence 
conservation could not be correlated either with rotavirus serotype or the species of 
origin of the virus strain (Xu et al., 1994). Many interspecies related strains were 
observed. For example, two simian rotavirus isolates, SAIl and RRV, exhibited 
amongst the highest levels of sequence divergence recorded, whilst a porcine and a 
human strain showed a similar level of conservation as two bovine strains. Hence, 
even if NSPl interacted with a cellular protein, this interaction would not provide a 
major selective force for sequence divergence. 
Finally, despite the fact that NSPl shows considerable divergence of the 
primary sequence, the predicted secondary structure of the protein is remarkably 
conserved (Xu et al., 1994). For example, proline residues, which are known to 
introduce bends in polypeptide chains, are conserved at eight separate positions in 
many strains (Kojima et al., 1996). This implies the existence of a selective pressure 
to maintain the higher-order structure of the protein, despite the considerable 
sequence divergence, which is consistent with NSPl having a role in the viral 
replication cycle (Xu et al., 1994). 
1.6.2 NSPl has a highly conserved cysteine-rich region 
Despite the unusually high sequence divergence, NSPl does contain a well-
conserved cysteine-rich sequence at the amino-terminus, between aa 37 and 81 
(Mitchell and Both, 1990a). This short sequence is absolutely conserved in NSP 1 
from many sequenced strains, including human, bovine, simian, porcine and murine 
strains from both Group A and Group C rotavirus (Hua et al., 1993) (Dunn et al., 
1994) (Xu et al., 1994). The conserved sequence, 
C-Xz-C-XS-C-X2-C-X3-H-X-C-X2-C-X5-C (where C=cysteine; X= any amino acid) is 
a generalised motif for a metal binding domain (Hua et al., 1993). It is possible that 
this region could form one or two zinc fingers, and the fact that it is highly conserved 
indicates that it is a potential functional domain. A second putative metal-binding 
domain, found between residues 315 and 328 in two bovine strains, UK and RF, was 
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not shown to be conserved when more strains were sequenced (Mitchell and Both, 
1990a) (Kojima et aI., 1996). 
1.6.3 The cysteine-rich region may function as a zinc finger 
Mitchell and Both (1990a) proposed that the conserved cysteine-rich domain 
at the amino-terminus of NSPl may form one or two zinc fingers. This prediction is 
supported by the fact that recombinant baculovirus-expressed NSPl binds zinc with 
high affinity (Brottier et al., 1992). The prototype zinc finger-containing protein 
TFIIIA has the conserved cysteine motif repeated up to nine times. However, several 
viral proteins which bind zinc, including the HIV tat protein (Frankel et al., 1988) and 
the SV 40 large T antigen (Loeber et al., 1989), only have a single zinc finger element. 
The structure proposed for the cysteine-rich motif in NSP 1 is a typical TFIIIA-like 
finger linked to a second atypical zinc finger by a short spacer sequence (Patton, 
1995). Other similar proteins among the Reoviridae include the 03 protein of 
reovirus, which has a zinc finger and has been shown to bind zinc (Schiff et al., 
1988). Several proteins with conserved cysteine-histidine-rich regions have also been 
identified, including JlNS, 02 and oNS of reovirus, and NS 1 and NS2 of bluetongue 
virus (BTV) (Roy, 1989) (Weiner and Joklik, 1987) (Weiner et al., 1989). 
1.6.4 NSPl has RNA-binding activity 
NSPl was first shown to interact with RNA by the high affinity binding of 
viral specific ssRNA probes by recombinant baculovirus-expressed NSPl in a gel 
retardation assay (Brottier et al., 1992). It also recognised non-rota virus-specific RN A 
probes, indicating that the RNA-protein interaction was not RNA sequence-specific. 
In contrast to these findings, data were then presented to suggest that NSP 1 might 
have specific affinity for rotavirus mRNAs (Hua et aI., 1994). Using NSPl produced 
by in vivo expression systems and immobilised onto protein A-Sepharose with 
specific antiserum, it was shown that NSPl bound all eleven rotavirus mRNAs. The 
addition of yeast tRNA had no effect on the viral specific RNA-binding activity of 
NSPl. It was suggested by the use of virus-specific RNA probes that NSPl bound to 
the 5'-end of viral mRNAs. However, the probe consisted of 278 nucleotides of the 
5'-end of genome segment five and a consensus binding sequence common to all viral 
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mRNAs was not identified. The putative specific binding site for NSPl at the 5'-end 
of viral mRNAs has not been mapped more closely and its existence has not been 
substantiated (1. T. Patton, pers. comm.). Use of the viral RNA probes also 
demonstrated that NSPl has non-specific RNA-binding activity, as binding of a 
3'-end probe by NSPl was not resistant to competition by non-specific viral mRNA. 
Deletion mutagenesis of NSPl and analysis of the RNA-binding activity of the 
mutants showed that the RNA-binding domain was located within the first 81 aa of 
the protein (Hua et al., 1994), and the highly conserved cysteine-rich region at the 
amino-terminus was essential for RNA-binding activity. The putative zinc fingers 
found in the conserved cysteine-rich domain may function in the RNA-binding 
activity of NSP1, as analysis of such structures has shown that they generally impart 
specific nucleic acid-binding activities to proteins (Berg, 1990). 
Rotavirus variants expressing a truncated NSPl which lacks the carboxy 
terminus of the protein have been shown to be viable, non-defective mutants, 
supporting the theory that the functional domain of NSPl resides at the amino 
terminus of the protein (Hua and Patton, 1994). However, the truncated mutants 
displayed a 9-60 fold lower titre in tissue culture than the wild-type virus, and a 
50-fold reduction in mean plaque area (Tian et al., 1993). Taniguchi and co-workers 
have identified non-defective rotavirus mutants carrying NSPl that lacks the 
conserved cysteine-rich region (Taniguchi et al., 1996). Their data contradicted 
previous findings by suggesting that the cysteine-rich region of NSPl is not necessary 
for virus replication in vitro. However, given that the plaque sizes of the mutant 
viruses were extremely small, it is probable that possession of full length NSP 1 
confers some advantage upon the virus. More recently, subclones of these mutant 
viruses have been isolated which carry the truncated NSP 1 described previously while 
retaining plaque size comparable to a normal clone (Taniguchi et al., 1999). This 
suggested that, except for the amino-terminal 40 aa, NSPI was not required for 
replication in vitro. 
1.6.5 NSPl may have a role in host species specificity 
Rotaviruses exhibit marked species specificity. They are subject to host range 
restriction (HRR) and are, in general, unable to spread between species in nature. The 
gene, or genes, which confer HRR are unknown and different studies have yielded 
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varying results. Genetic reassortment studies suggested that gene five does not 
segregate randomly in vivo (Gombold and Ramig, 1986) (Broome et al., 1993). 
Therefore, it may play a role in enhancing replication and conferring a selective 
growth advantage on the virus. A study of reassortant viruses produced in vivo by 
coinfecting mice with simian rotavirus (RRV) and murine rotavirus (EDIM-RW) 
implicated the gene five product NSPl in HRR. Analysis of the virulence and species 
specificity of the reassortant viruses led to the conclusion that the major outer capsid 
proteins VP4 and VP7 were not primarily responsible for HRR (Broome et al., 1993), 
but NSPl was strongly associated with virulence and spread phenotypes, and was the 
only rotavirus gene to show this association. However, the association was not 
absolute as a few reassortants carrying the murine gene segment five had the 
virulence phenotype of the simian parent rotavirus. In contrast to these results, a study 
of porcine x human rotavirus reassortants in piglets did not implicate gene five in 
either virulence or HRR (Hoshino et al., 1995). 
In view of the conflicting results from the reassortant studies described 
previously, further investigation into the possible role of NSP 1 in HRR was 
performed (Bridger et al., 1998). A monoreassortant which possessed ten porcine 
rotavirus genes and the NSPl gene from the UK strain of bovine rotavirus was 
analysed, and it was found that possession of a heterologous NSP 1 gene did not affect 
the virulence or the ability of the monoreassortant virus to replicate in vivo as 
compared to the porcine parent virus. These findings did not support the original 
hypothesis that NSPl may play a role in virulence and HRR. The sequence homology 
of the NSPl genes used in the different studies could not be compared directly due to 
the lack of sequence data from the appropriate strains. However, by comparison of the 
sequences of NSPl genes from other rotavirus strains from the same species (Xu et 
al., 1994) (Dunn et al., 1994) it was estimated that the sequence homology between 
the NSPl genes was probably greater in the study by Bridger et al. (1998) than in the 
earlier study (Broome et al., 1993). Thus, it was suggested that in the former study the 
heterologous NSPl may be conserved enough to replace the parent NSPI and allow 
similar levels of infection and replication. Virulence and HRR are probably 
multigenic phenotypes and a possible role for NSPl remains elusive. Further studies 
are required to completely define the genetic basis of these phenotypes. 
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1.6.6 NSPl accumulates in the cytoplasm and may be associated with the 
cytoskeleton 
NSPl is found in the cytoplasm of the infected cell where it accumulates in a 
punctate-like manner throughout the cytoplasm (Hua and Patton, 1994). Analysis of 
intracellular fractions derived from infected cells by gel electrophoresis and western 
blotting demonstrated that large amounts of NSPl were present in the cytoplasm and 
also in association with the cytoskeleton (Hua et al., 1994). Indirect 
immunofluorescence assays (IF A) with full-length NSP 1 and a truncated NSP I which 
lacked the carboxy half of the protein, revealed no difference in the distribution of the 
truncated protein in the infected cell compared to the full-length protein, suggesting 
that the subcellular localisation signal in NSP 1 resides in the amino terminal half of 
the protein (Hua and Patton, 1994). Further analysis of mutant forms of NSPI by IFA 
indicated that the intracellular localisation domain was between aa 84 and 176 in the 
amino-terminal half of NSPl (Hua et al., 1994). The distribution of NSPl was shown 
to be similar to NSP3, which is also associated with the cytoskeleton of infected cells 
(Mattion et al., 1992). However, the distribution of NSPl throughout the cytoplasm 
was shown to be independent of any other viral protein (Hua et al., 1994). 
This data suggested that NSPl might interact with a cytoskeletal protein. The 
possible identity of this putative cytoskeletal protein is unknown, though it has been 
shown by double-staining of infected cells with specific antibodies that NSP I and the 
type III intermediate filament, vimentin, are similarly distributed within the cell 
(Patton, 1995). Thus, it has been suggested that perhaps NSP 1 or NSP3 may be 
responsible for the selective reorganisation of vimentin observed in rotavirus-infected 
cells (Weclewicz et al., 1994). 
1.6.7 NSPl is a component of early replication complexes 
NSP 1 is expressed at low levels early in infection and thus is thought to have a 
regulatory role in the viral replication cycle (John son and McCrae, 1989). A study to 
characterise intermediate structures in rotavirus replication identified three replication 
intermediates (RIs) in rotavirus-infected cells (Gallegos and Patton, 1989). The 
smallest RI (pre-core RI) contained the structural proteins VP 1 and VP3 and the 
non-structural proteins NSP1, NSP2, NSP3 and NSP5, although only NSPl and NSP3 
reproducibly co-purified with the pre-core RI (Patton, 1995) (Section 1.5.4). The 
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presence of NSPl in the pre-core RI suggested it had a function in the early stages of 
the viral replication cycle. Patton (1995) proposed a model to describe events in the 
early replication cycle, but the role of the non-structural proteins, including NSP 1, in 
the process is still very unclear. As both NSP 1 and NSP3 accumulate on the 
cytoskeleton and have RNA-binding activity, they could form a complex with mRNA 
that is a precursor of the pre-core RI. The pre-core RI would then be assembled on the 
cytoskeleton by the addition of VPl and VP3 to the precursor complex. VP2 must 
then interact with the pre-core RI to form the core RI and induce the viral replicase 
activity. The sequential addition of VP2 to the pre-core RI and VP6 to the core RI was 
proposed as a mechanism for the assembly of rotavirus single-shelled particles, which 
might occur concurrently with genome replication. 
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2.1 Protein-protein interactions in RNA virus replication cycles 
2.1.1 Introduction 
Protein-protein interactions are intrinsic to all biological systems and have 
been implicated in a wide variety of cellular processes (Phizicky and Fields, 1995). In 
virus-infected cells, protein-protein interactions are fundamental to every stage of the 
virus replication cycle (Knipe, 1996). Interactions occur between viral proteins in the 
formation of transcription and replication complexes and their location to specific 
promoters (Zeng et al., 1996). Further interactions occur in the assembly of progeny 
virions. By necessity, viral proteins must also associate with host cell proteins (Knipe, 
1996). Interactions must occur between virus proteins and the cellular receptor 
(Hewish et al., 2000), and also with the cellular transcription and translation apparatus 
(Ehrenfeld, 1993). During infection, interactions are likely to occur with the 
cytoskeleton that may be responsible for the movement of virus components and 
particles in the cell (Ty1er et al., 1986). Viral inclusions assembled in the cytoplasm 
of infected cells for synthesis of viral nucleic acids and assembly of virions may 
incorporate cytoskeleton components into the structure (Sharpe et al., 1982). Proteins 
composed of more than one subunit are widespread. An example of this is provided 
by viral capsid proteins which are assembled into multimeric complexes (Bican et al., 
1982) (Prasad et al., 1988). Transient protein-protein interactions, which often occur 
in the regulation of cellular processes, are by nature more difficult to characterise 
(Phizicky and Fields, 1995). A number of the techniques that can be used to study 
such interactions are described in Section 2.2. 
2.1.2 Replicative strategy of RNA viruses with a segmented genome 
2.1.2.1 The Reoviridae 
The mammalian reoviruses are the prototype viruses of the genus 
Orthoreovirus in the family Reoviridae (Nibert et al., 1996). They share many similar 
traits with the rotaviruses; indeed some details of the rotavirus replication cycle 
(Section 1.5) have been inferred from that of the closely related reovirus (Estes, 
1996). The reovirus genome consists of ten segments of dsRNA which are replicated 
in the cytoplasm of the cell (Joklik, 1983). Following attachment of the virus to the 
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cellular receptor, particles are taken up by receptor-mediated endocytosis into 
vacuoles resembling endosomes and lysosomes (Sturzenbecker et al., 1987). The 
outer capsid proteins then undergo specific proteolytic cleavage to form intermediate 
subviral particles (ISVPs) (Borsa et al., 1981) (Sturzenbecker et al., 1987). 
Subsequently, core particles derived from the ISVPs become transcriptionaIIy active, 
leading to synthesis of the viral mRNAs. It is a notable feature of the replication cycle 
that transcription occurs within icosahedral viral particles and the mRNAs are then 
extruded from the particle (Shatkin et al., 1983). In common with rotavirus, the 
virally encoded transcriptase particle produces transcripts that are methylated and 
possess a 5'-cap structure, but are not polyadenylated (Nibert et al., 1996). The viral 
transcriptase and capping enzyme must be positioned close together in the core, as 
studies have demonstrated that capping of nascent mRNAs occurs when they are only 
2 to 15 nucleotides long (Furuichi et al., 1976) (Morgan and Kingsbury, 1981). The 
putative polymerase 1-3 and guanylyltransferase A2 have been shown to interact 
(S tarnes and J oklik, 1993). 
In common with rotavirus, reovirus mRNAs function both as templates for 
viral protein production and for minus-strand synthesis in dsRNA replication. Newly 
synthesised viral proteins are detected by 2 hours p.i. and as they increase the 
synthesis of cellular proteins declines (Zarbl and Millward, 1983). The mRNAs 
associate with newly made viral proteins to form progeny "RNA assortment 
complexes", but the mechanism by which the ten unique genome segments are 
packaged remains unknown (Zweerink, 1974) (Morgan and Zweerink, 1975). It is 
clear that assortment of both rotavirus and reovirus genome segments is a specific 
event, and that it is mRNAs that are assorted rather than dsRNA. Evidence to support 
selective assortment in reovirus includes a reported particIe-to-pfu ratio as low as I 
(Spendlove et al., 1970), and the fact that the central cavity of the reovirus particle is 
too small to accommodate many more than ten unique segments (Dryden et al., 1993). 
The RNA and protein interactions that would be required to identify and package the 
ten unique viral mRNAs have not been identified. 
Reovirus non-structural proteins crNS and IlNS, and the outer capsid protein 
cr3, have been shown to associate with mRNAs soon after transcription to form small 
nucleoprotein complexes (Antczak and Joklik, 1992). Also, IlNS is known to interact 
with crNS (Lee et al., 1981). The I..lNS protein, which localises to the cytoskeleton 
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(Mora et al., 1987), is the first protein to bind mRNAs post-synthesis (Antczak and 
Joklik, 1992). The cysteine-rich O'NS protein probably binds ssRNA in a 
sequence-independent manner (Huismans and Joklik, 1976) (Gillian and Nibert, 
1998), although there is some evidence that it selectively binds members of each 
mRNA size class (Stamatos and Gomatos, 1982). Both non-structural proteins are 
thought to play a role in condensing reovirus mRNAs into assortment complexes. 
Comparisons have been made between the O'NS protein of reovirus and the 
RNA-binding non-structural proteins of rotavirus (Gillian and Nibert, 1998). NSP2 
forms multimeric complexes, as does O'NS, and shows non-specific RNA-binding 
activity (Kattoura et al., 1992). NSP3 forms oligomers (Mattion et al., 1992), and 
binds viral mRNA (Poncet et al., 1993). NSPl also shows non-specific RNA-binding 
activity (Brottier et al., 1992), and contains a cysteine-histidine-rich region, as do the 
reovirus proteins jlNS and O'NS. Despite what is known about both rotavirus and 
reovirus non-structural proteins, the mechanisms by which specific viral genome 
assortment and packaging occur remain unknown. 
Following packaging of viral mRNA, dsRNA replication occurs. Newly 
synthesised dsRNA remains within the nascent progeny particle. Studies of reovirus 
replicase particles have revealed that the major protein components are the core 
proteins AI, A2, and A3, together with jllc, 0'2 and 0'3 (Joklik and Roner, 1995). The 
sedimentation coefficients of the replicase particles ranged in size from 180 to 550 S, 
but once minus-strand synthesis was complete, all particles sedimented with about 
550S. Similar studies have been performed to identify replication intermediates (RIs) 
in rotavirus (Section 1.5.4). The Rls were also shown to undergo size changes, due to 
the recruitment of plus-strand mRNAs to the complex. 
Recently it has been suggested that reovirus genome segment assortment may 
be linked more closely to replication than previously thought (Joklik and Roner, 
1995). When the viral mRNAs associate with the non-structural proteins and 0'3, as 
noted previously, the relative proportions of the individual RNA species reflects the 
population present in the infected cell, which differs from equimolarity. Four hours 
after infection, complexes appear which contain dsRNA and also proteins A2 and A3, 
in addition to the non-structural proteins and 0'3. At this point, the relative proportions 
of the ten dsRNA species are equimolar, suggesting that assortment occurs 
concurrently with replication. 
43 
As in rotavirus-infected cells, reovirus-infected cells contain inclusion bodies 
in the cytoplasm (Anderson and Doane, 1966) (Gomatos et al., 1962), as do other 
members of the Reoviridae such as bluetongue virus where the importance of these 
viral inclusion bodies (VIBs) in viral replication and morphogenesis have been 
demonstrated (Browne and Jochim, 1967) (Eaton et al., 1990). Reovirus infection also 
causes disruption to the vimentin filament network (Sharpe et al., 1982). It has been 
suggested that the non-structural protein ~NS, which localises to the cytoskeleton, 
may associate with vimentin filaments to anchor structures involved in viral assembly 
to the network (Mora et al., 1987). In rota virus-infected cells, the viral non-structural 
protein NSP 1 and vimentin are similarly distributed throughout the cytoplasm (Patton, 
1995), and it has been proposed that NSP 1 may be responsible for the selective 
reorganisation of vimentin in infected cells (Weclewicz et al., 1994). 
2.1.2.2 The Orthomyxoviridae 
The Orthomyxoviridae have a segmented ssRNA genome, which is described 
as negative-sense since viral mRNAs are transcribed from the genome (Lamb and 
Krug, 1996). Influenza A and B have eight segments of RNA, while influenza C only 
has seven. The genome of influenza A encodes nine structural proteins and one 
non-structural protein. Influenza is unusual among RNA viruses in that both 
transcription and replication occur in the nucleus, rather than the cytoplasm (Barry et 
al., 1962) (Rott et al., 1965). 
Following infection and uncoating, which is required for mRNA synthesis to 
occur, the virion RNAs (vRNAs) are both transcribed into mRNAs and replicated. 
Influenza encodes and packages an RNA-dependent RNA polymerase. The 
transcriptase complex consists of individual vRNAs associated with the nucleocapsid 
protein (NP) and the three polymerase proteins (PB 1, PB2, and PA) (Ulmanen et al., 
1981). The P proteins interact to form a complex and are responsible for viral mRN A 
synthesis. The distinctive feature of viral mRNA synthesis is that it is primed by a 
5'-cap structure derived from newly synthesised host cell transcripts (Bouloy et al., 
1978) (Krug et al., 1979). Influenza viral mRNAs are polyadenylated as a result of the 
polymerase binding to the 51 end of the vRNA and reiteratively copying a short 
oligo(U) stretch found 17 nucleotides from the 51 end of the template (Li and Palese, 
1994). An alternative form of transcription is required for replication to occur that 
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results in the production of full length copies of the vRNAs. Viral proteins, 
specifically the NP protein, must be synthesised before replication can proceed, and 
the switch between transcription and replication may be mediated by the binding of 
NP to the polymerase complex (Mena et al., 1999). Full length template transcripts 
are replicated from the vRNAs, do not require the 5'-cap primer for initiation and are 
not terminated at the poly(A) site used during mRNA synthesis. The template RNAs 
are then copied into new vRNAs. The minimum components of the replicase 
complex, which would initiate synthesis of either template RNA or vRNA, are soluble 
NP, PB I, PB2 and PA (Huang et al., 1990). Virus type-specific protein-protein 
interactions between the replicase components and the other structural proteins must 
be required for the formation of infectious virus particles, however, these are as yet 
poorly characterised (Gomez-Puertas et al., 1999). The non-structural protein NS 1 is 
not required for replication, but functions in regulation of nuclear export of mRNA 
and inhibition of pre-mRNA splicing. 
Influenza has a segmented genome in common with the Reoviridae. In 
contrast with these viruses however, packaging of the influenza genome is thought to 
be a random process in terms of specific viral genome segments, although it is 
restricted to viral, and not cellular, RNAs. Evidence to support the random packaging 
theory is the fact that cells infected with a low multiplicity of infection (m.oj.) of 
influenza virus sometimes lack the expression of some antigens, suggesting that some 
virions lack a full set of viral RNA segments (Martin and Helenius, 1991). Also, an 
engineered influenza virus has been obtained under selective conditions which 
contains nine RNA segments, suggesting that the virus is capable of packaging more 
than the minimum eight segments (En ami et al., 1991). Calculation of the probability 
of randomly packaging the correct set of eight RNA segments reveals that, if 12 
segments are packaged, 10 % of virions will have one copy of each of the eight 
segments (Enami et al., 1991). Although evidence was presented in early reports to 
suggest that a specific assortment mechanism operated, the random packaging theory 
is generally favoured (Joklik and Roner, 1995). 
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2.2 The study of protein-protein interactions 
2.2.1 Overview 
An increasing array of methods are available to study protein-protein 
interactions and the formation of protein complexes in cells. A summary of common 
strategies to identify interacting proteins is given below. A more detailed and 
extensive review of both classical and recent developments in the study of 
protein-protein interactions can be found in Phizicky and Fields (1995). 
2.2.2 Immunoprecipitation 
Co-immunoprecipitation is a commonly used method of detecting 
protein-protein interactions. It relies on the fact that a specific antibody can precipitate 
a target protein from a complex mixture, and that heterologous proteins complexed to 
the target protein can be co-purified. The experimental procedure involves generating 
labelled cell lysates, the addition of either polyclonal or monoclonal antibody to 
precipitate the antigen, washing of the precipitate to remove adventitious material 
followed by elution and analysis of the bound proteins. As antibodies are usually 
non-precipitating, a reagent such as protein A-Sepharose is used to isolate the 
antibody-antigen complex. 
Immunoprecipitation techniques have been used to study the protein 
composition of replicase complexes found in rotavirus-infected cells (Aponte et al., 
1996). By immunoprecipitation with a range of monoclonal antibodies and specific 
antisera against viral structural and non-structural proteins, it was determined that the 
non-structural protein NSP2 was a necessary component of an intermediate complex 
with replicase activity in the infected cell. A protein complex containing NSP2, VP 1, 
VP2 and VP6, was precipitated by the monoclonal antibody specific for NSP2, 
however the reciprocal precipitation of NSP2 with antibodies against VPI, VP2 and 
VP6, was not observed. It was suggested that this finding could indicate that VP I, 
VP2 and VP6 are either buried in the complex or modified during the formation of 
viral protein-antibody complexes. 
Immunoprecipitation from crude cell Iysates has several advantages. The 
detection of a particular protein-protein interaction in the midst of all the competing 
proteins present in a crude lysate, implies a certain level of specificity. 
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Multicomponent protein complexes will already be in their natural state in the cell and 
can be readily co-precipitated. These sorts of complexes would be difficult to imitate 
in vitro, hence co-precipitation from cell lysates is the preferred method of detecting 
such protein complexes. Also, all the interacting proteins will be present in the same 
relative concentrations as found in the cell, and this avoids any artificial 
overproduction of the target protein associated with other methods. Finally, the 
normal posttranslational modification of proteins will have occurred, hence 
interactions that are dependent upon this will be realistically assessed. Analysis of the 
results of co-immunoprecipitation experiments should take account of the 
consideration that co-immunoprecipitating proteins may not necessarily represent a 
direct protein-protein interaction, since they may be components of a larger complex 
held together by other proteins and/or nucleic acid. Immunoprecipitation of proteins 
from in vitro transcription-translation reactions is an increasingly popular method to 
identify direct protein-protein interactions. However, the advantages noted previously 
for immunoprecipitation from crude cell lysates do not apply in experiments with 
extracts from in vitro translation reactions. 
2.2.3 Immunofluorescence 
Immunofluorescence is a technique commonly used to demonstrate 
co-localisation of proteins to a particular compartment of the cell. Specific proteins 
are detected in the cell using monoclonal antibodies conjugated to different 
fluorescence compounds that fluoresce at a specific wavelength when exposed to 
ultraviolet light. Experimentally, a cell monolayer can be fixed and stained with 
different fluorescent antibodies, thus locating specific proteins within the cell. 
Localisation of the rotavirus non-structural proteins to either the viroplasm or 
the cytoplasm of infected cells has been demonstrated using immunofluorescence 
assays (Mattion et al., 1992) (Hua et al., 1994), and suggested interactions between 
these proteins appear to reflect their sub-cellular localisation (Gonzeilez et al., 1998). 
Although co-localisation can be established by this method, it does not prove that a 
complex is formed or that direct interactions occur between the colocalised proteins. 
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2.2.4 Far-western blotting assay 
Far-western blotting is a technique that allows the detection of protein-protein 
interactions between a specific protein probe and a range of proteins immobilised on a 
membrane. The method is similar to western blotting, but the probe is a specific 
protein other than an antibody. Proteins are separated by SOS-polyacrylamide gel 
electrophoresis and blotted onto a membrane. The SOS is then removed by dialysis to 
allow the immobilised, denatured proteins to regain some conformational structure. 
The incubation of a specific protein probe with the blot allows interactions to occur, 
whereby the protein probe will be retained on the membrane. The blot is then overlaid 
with an antibody against the protein probe, and the results are visualised in a similar 
manner to western blotting. 
This technique was used in rotaviruses to detect interactions between the 
putative RNA-dependent RNA polymerase, VP1, and other proteins found in 
virus-like particles (Zeng et al., 1998). The analysis showed that VP 1 interacted with 
full length VP2. The use of truncated constructs of VP2 demonstrated that a domain 
within the amino-terminus of VP2 aa 1 to 25 was essential for binding VPl. It was 
thus postulated that this interaction was necessary for the encapsidation of VP 1 and 
the suspected guanylyltransferase VP3 by the core protein VP2. 
The fact that proteins are immobilised on a membrane for this method means 
that certain regions of the protein are not exposed, and therefore will not be able to 
interact or will only interact very weakly with the protein probe. This may mean that 
domains of the protein involved in the interaction are not detected. Despite the fact 
that dialysis is performed to allow the correct conformation of the proteins to reform, 
it is unlikely that the native structure will be regained when regions of the protein are 
attached to a membrane. The in vitro produced protein probe is also unlikely to 
exactly represent the native form of the protein found in vivo, due to a lack of 
posttranslational modification. While this method can be used to detect 
protein-protein interactions, the above considerations suggest that not every protein 
will be biologically active in such as assay and true protein-protein interactions may 
not always be detected. 
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2.3 The two-hybrid system 
2.3.1 The principle of the two-hybrid system 
The two-hybrid system is an in vivo method for the detection of 
protein-protein interactions. The system was originally developed by Fields and Song 
(1989) as a yeast-based genetic assay in Saccharomyces cerevisiae, where an 
interaction between two proteins of interest is detected by the activation of 
transcription of a reporter gene (Figure 2.1). The system makes use of a eukaryotic 
transcriptional activator, typically yeast GAL4, which consists of two physically 
discrete domains, one governing DNA binding and the second carrying the 
transcriptional activation function. The 881 aa GAL4 protein has a 147 aa 
DNA-binding domain at the immediate amino terminus of the protein. This region is 
involved in binding a 17 bp DNA target sequence called the galactose upstream 
activating sequence (VAS) (Keegan et al., 1986). The carboxy region of the GAL4 
protein has been shown to contain two separate activating domains, activating domain 
I (aa 148-196) and activating domain 11 (aa 768-881), both of which have a high 
content of acidic amino acids (Ma and Ptashne, 1987). The DNA-binding domain 
localises the transcription factor to specific DNA sequences upstream of the gene 
which is regulated by this factor. The activation domain interacts with other 
components of the transcription machinery required to initiate transcription. The 
presence of both domains is necessary to constitute a functional transcriptional 
activator. Normally the two domains are part of the same protein, however it has been 
demonstrated that a functional activator can be assembled in vivo from the separated 
domains expressed from plasmids, and this is the basis of the two-hybrid system (Ma 
and Ptashne, 1988) (Brent and Ptashne, 1985). The proteins of interest are fused to the 
separated domains. If there is an interaction between the two proteins of interest, then 
it will bring the two domains close together, resulting in restoration of the 
transcriptional activation function. Experimentally, the two hybrid plasmids 
expressing the GAL4 fusion proteins are co-transformed into a yeast host strain and 
transcriptional activation of expression of a reporter gene, typically lacZ, indicates a 
positive result. 
The two-hybrid system has several advantages over more conventional 
methods. The assay is a sensitive method for detection of weak or transient 
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Figure 4.1 Schematic diagrams of the Yeast Two-Hybrid System cloning 
vectors, pGBT9 and pGAD424, showing the MCS sequence and unique 
restriction sites 
Schematic diagrams of the main features of plasmid pGBT9 (panel A) and 
pGAD424 (panel B) are shown. pGBT9 generates a hybrid that contains the 
sequences for the GAL4 binding domain (amino acids 1-147) (GAL4 bd). 
pGAD424 generates a hybrid that contains the sequences for the GAL4 
activation domain (amino acids 768-881) (GAlA ad). The plasmids have 
unique restriction sites located in the MCS region at the 3' end of the open 
reading frame for either the DNA-binding or activation domain sequences. 
The gene encoding the protein of interest is ligated into the MCS in the 
correct orientation and with the correct reading frame, such that fusion 
proteins with the GAlA domains are expressed. The sequence and reading 
frame of the MCS for pGBT9 and pGAD424 are shown in the boxes below 
the appropriate plasmid diagrams. The unique restriction sites in the MCS of 
each plasmid, which can be used for cloning purposes, are indicated. Fusion 
proteins are expressed from the constitutive ADH 1 promoter (p ADH 1) and 
transcription is terminated at the ADH 1 transcription termination signal 
(f ADH1). The fusion proteins are targeted to the yeast nucleus by nuclear 
localisation sequences (.). pGBT9 and pGAD424 plasmids replicate 
autonomously in both E. coli and S. cerevisiae. The selectable markers 
carried are the bla gene which confers resistance to ampicillin in E. coli 
(AmpR), and a nutritional gene that allows yeast auxotrophs to grow on 
limiting synthetic media (TRPl in pGBT9; LEU2 in pGAD424). This figure 
is adapted from the Clontech Matchmaker Two-Hybrid system protocol. 
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interactions. It also does not require the production of purified target proteins and 
antibodies to the desired proteins. In addition, the assay is performed in vivo, and 
consequently the proteins involved are more likely to be in their native conformations, 
albeit fused to a heterologous protein. The method has been used with a wide variety 
of proteins, including those that normally reside in the nucleus, cytoplasm, are 
peripherally associated with membranes or are extracellular (Fields and Sternglanz, 
1994). Finally, an important development in the use of the two-hybrid system was its 
use to screen cDNA espression libraries to detect interacting host cell proteins (Chien 
et al., 1991). The significance of this approach is that the cloned gene encoding the 
interacting protein can be rapidly isolated. 
2.3.2 Development of the two-hybrid system 
The original two-hybrid system, which was developed in yeast, utilised the 
DNA-binding and activation domains of the GAL4 protein (Fields and Song, 1989). 
Several developments on the original system have since been made. The LexA yeast 
two-hybrid system uses the DNA-binding domain of the bacterial repressor protein 
LexA. This required the engineering of the appropriate recognition sequence for LexA 
into the DNA of specific yeast strains (Vojtek et al., 1993). An alternative LexA 
system has been developed which uses amino-terminal fusions to LexA of the protein 
of interest, rather than the more commonly used carboxy-terminal fusion (Beranger et 
al., 1997). This system detects specific protein-protein interactions equally well, and 
could be of particular value when a 'free' amino-terminus of the protein of interest is 
required. 
An alternative transactivation domain that has been successfully used is the 
VP 16 transactivating protein from herpes simplex virus (Dalton and Treisman, 1992). 
In addition, the use of different reporter genes, such as select able yeast genes such as 
HIS3 and LEU2, allows the scope and sensitivity of the assay to be varied. 
If an interaction is detected between two proteins, then deletion mutagenesis 
can be used to analyse the regions of the proteins containing the functional domains 
(Chi en et al., 1991). Point mutations can then be assayed to identify specific amino 
acid residues critical for the interaction (Li and Fields, 1993). The immediate 
availability of the cloned gene for the protein of interest aids this type of analysis. A 
reverse two-hybrid system has also been developed, whereby the interaction of the 
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two proteins of interest activates expression of a toxic gene (Leanna and Hannink, 
1996). Thus, there is selective pressure against the interaction, facilitating 
identification of mutants that have lost the ability to interact. 
The yeast system has been generally favoured, due to the ease of 
transformation of plasmids into yeast cells and the use of selectable transformation 
markers, however a mammalian cell system has also been successfully developed. 
The GAL4 DNA-binding domain and the VP16 transactivating domain from herpes 
simplex virus were used to develop a two-hybrid system in mammalian cells (Dang et 
al., 1991) (Fearon et al., 1992). Transfection of a variety of mammalian cell lines with 
plasmids expressing fusions of the proteins of interest with the DNA-binding and 
activation domains together with a reporter gene plasmid can be performed. The 
interaction of the proteins of interest activates transcription, which drives a reporter 
gene encoding chloramphenicol acetyltransferase (CAT). The CAT activity can be 
measured in vitro to quantify the protein interaction. The development of the 
mammalian cell systems allowed the detection of interactions that depend upon 
post-translational modifications which do not occur in yeast cells (e.g. tyrosine 
phosphorylation events). 
An interesting development made recently is the description of the two-bait 
system in yeast. This system allows the characterisation of the interaction of two 
proteins fused to two different DNA-binding domains with a common protein fused to 
the activation domain. The use of two different reporter genes allows differentiation 
of the interacting protein pairs. Among other uses, this system allows the 
identification of interactions that depend upon a third protein (Xu et aI., 1997). 
2.3.3 The use of the yeast two-hybrid system to study viral protein-protein 
interactions 
Viral and cellular protein interactions are central to the replication process in 
the virus infectious cycle. Defining the protein-protein interactions that occur is an 
important step towards understanding the viral replication cycle. The two-hybrid 
system has been used to an increasing extent as an important tool to dissect viral 
protein-protein interactions. There are several applications of the system, including 
testing known proteins for an interaction and subsequently defining the domains or 
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amino acids that are critical for the interaction. The assay can also be used to screen 
libraries of cellular proteins for a protein that binds to a target viral protein. 
One of the first examples of the use of the yeast two-hybrid system to 
investigate viral protein-protein interactions was in defining the multimerisation of the 
retroviral gag polyproteins (Luban et al., 1992). Using the original GALA domain 
vectors (Fields and Song, 1989), Luban et al. (1992) determined that HIV -1 gag and 
Moloney murine leukemia virus gag polyproteins formed specific homo-oligomers, 
but not hetero-oligomers. Their experiments demonstrated that the interaction 
between the gag proteins was specific for a given species of virus. The yeast 
two-hybrid system has also been used to analyse specific interactions between viral 
structural proteins in the rice dwarf phytoreovirus (RDV) (Ueda et al., 1997). RDV is 
a member of the Reoviridae and has a segmented genome consisting of 12 dsRNA 
segments. In order to investigate the process of viral morphogenesis and assembly, 
interactions among multiple structural proteins were dissected. Oligomerisation of the 
major core protein P3 was demonstrated with the yeast two-hybrid system, but 
additional interactions among the structural proteins were only revealed by 
far-western blotting, suggesting that the two-hybrid system should not be used in 
isolation when investigating protein-protein interactions. 
A protein linkage map that documents a network of interactions between the 
non-structural cleavage products of the poliovirus P2 polyprotein has been determined 
using a combination of the GALA and the LexA yeast two-hybrid systems (Cuconati 
et al., 1998). Homo-oligomeric and hetero-oligomeric protein interactions between 
the non-structural cleavage products 2BC, 2B and 2C, were described. Further 
analysis of the multimerisation of 2B by mutagenesis and selected deletion of regions 
of the protein, implicated the carboxy-terminus of the protein in the self-interaction. 
The homo-oligomerisation of 2B was thought to be required for replication of the 
positive-sense RNA genome of poliovirus. This study demonstrated the value of the 
two-hybrid system in determining the variety of different interactions that can occur 
between several viral proteins. 
The assay has been used extensively to identify specific domains involved in 
interactions between viral proteins. Li and Fields (1993) demonstrated by mutagenesis 
of p53 and analysis of the interaction of the mutants with SV40 large T antigen, that 
the yeast two-hybrid system could be used to define residues in a protein required for 
binding. They advanced the idea that this approach could be generally applicable to 
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the analysis of protein-protein interactions. An interaction was demonstrated between 
the Rinderpest virus (RPV) nUcleocapsid protein (N) and phosphoprotein (P) when 
the proteins were fused to the GAL4 domains and tested in the yeast two-hybrid 
system (Shaji and Shalia, 1999). Mapping of the domains of P protein involved in its 
interaction with N protein, revealed two domains, the amino-terminal 59 aa and the 
carboxy-terminal 32 aa, were involved in the interaction. Interestingly, the researchers 
found that a P protein mutant containing only the interaction domains, with all other 
regions of the protein deleted, retained its ability to interact with N protein. Similar 
studies on the interaction of the Nand P proteins in human respiratory syncytial virus 
(hRSV) have also been performed using the two-hybrid system (Slack and Easton, 
1998). Deletions in the carboxy-terminus of the P protein reduced its ability to interact 
with the N protein, suggesting that this region was functional in the interaction of N 
and P proteins. Use of the two-hybrid system to study the P protein of various 
negative-strand RNA viruses has revealed analogous results demonstrating that the 
assay can provide consistent data and allowing biologically relevant conclusions to be 
drawn. 
The yeast two-hybrid system has proved to be a valuable research tool in the 
identification of cellular proteins that interact with specific viral proteins. For 
example, the assay was employed to search for cellular proteins that interacted with 
the influenza A virus NS 1 protein (Wolff et al., 1996). NS 1 is the major 
non-structural protein expressed by influenza A and B viruses in infected cells, and 
although its precise function is unclear, it is thought to have a regulatory role in viral 
gene expression and/or replication. A HeLa cell library was screened using the yeast 
two-hybrid system and a cellular protein, NS I-I, which interacted with NS 1 was 
identified. The interaction was shown to be conserved among six different human and 
avian influenza virus NS 1 proteins, despite the fact that the sequence of NS I is highly 
divergent between isolates, suggesting that the NSI-NSI-I interaction had an 
important function during the virus life cycle. Once interacting cellular proteins have 
been identified, binding domains on the proteins can be mapped. The data gained 
from such studies can lead towards further characterisation of viral protein function 
and delineation of the significance of the protein interactions in viral processes. For 
example, two cellular proteins shown to interact with the influenza virus NP protein 
have been found to be involved in the nuclear import of the NP protein and of viral 
RNA (Wang et al., 1997). The cellular protein binding site was localised to the 
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amino-terminus of the NP using NP deletion mutants. It was then revealed that this 
region of the protein had nuclear localisation signal (NLS) activity, so the binding site 
for the cellular transport factors also functions as an NLS motif. Hence, binding of the 
cellular proteins to the NP protein may facilitate nuclear import. 
Clearly, the development of the yeast-two hybrid system has allowed 
significant progress in the definition of interactions between viral and cellular proteins 
which can lead towards a greater understanding of viral processes. 
2.4 Aims of the study 
The rota virus non-structural protein NSP 1 is thought to have a function in the 
early stages of the virus replication cycle, although its exact role remains to be 
defined. Specific protein-protein interactions are essential for the processes involved 
in the replication cycle, including RNA replication, and assortment and packaging of 
the segmented genome. The aim of this project was to investigate potential 
protein-protein interactions between NSPI and the viral proteins VPI, VP2, VP3, and 
NSP3, which are found associated with or subsequently added to a pre-core 
replication intermediate in the rotavirus-infected cell. A novel NSP I-containing 
complex found in rotavirus-infected cells was also examined. The overall objective 
was to further define the function of NSP 1 in the virus replication cycle. 
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Materials and Methods 
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3.1 Materials 
3.1.1 Standard solutions and buffers 
5X Protein loading buffer: 10 % (w/v) SDS, 25 % (v/v) ~-mercaptoethanol, 50 % 
(v/v) glycerol, 0.01 % (w/v) bromophenol blue. 
5X Agarose gel loading buffer: 5X TAEfTBE, 50 % (v/v) glycerol, 0.01 % (w/v) 
bromophenol blue, 0.01 % (w/v) xylene cyanol ff. 
Chloroform/Isoamyl alcohol (IAA): 96 % (v/v) chloroform, 4 % (v/v) isoamyl 
alcohol. 
Phosphate Buffered Saline (PBS): 137 mM NaCl, 2.7 mM KCI, 4.3 mM 
Na2HP04.7H20, 1.4 mM KH2P04. 
PhenoVChloroform/Isoamyl alcohol: 48 % (v/v) phenol, 48 % (v/v) chloroform, 4 
% isoamyl alcohol. 
TAE Electrophoresis buffer (IX): 40 mM Tris Acetate, 2 mM EDT A pH 8.0. 
TBE Electrophoresis buffer (IX): 89 mM Tris base, 89 mM Boric acid, 2 mM 
EDTA. 
TE: 10 mM Tris-HCI pH 8.0, 1 mM EDTA pH 8.0. 
Triton lysis solution: 2 % (v/v) Triton X-100, 50 mM Tris-HCI pH 8.0, 62.5 mM 
EDTA 
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3.1.2 Tissue culture media 
Sterile PBS, trypsin (0.25 % in Tris saline), versene (0.02 % in PBS), L-
glutamine (200 mM), 5 % NaHCO), penicillin and streptomycin sulphate 
(100,000,000 U/100 g in 200 ml PBS), 1.8 % Noble Agar, and tissue culture media 
including: Dulbecco's modification of Eagle's minimal essential medium (DMEM). 
Glasgow modification of Eagle's minimal essential medium (GMEM) plus non-
essential amino acids (NEAA; 0.89 g L-alanine, 1.15 g L-asparagine.H20, 1.33 g L-
aspartic acid, 0.75 g glycine, 1.45 g L-glutamic acid, 1.15 g L-proline and 1.05 g L-
serine per litre) IX, 2X, and GMEM minus methionine, valine, leucine and NaHCO), 
were all prepared by the media preparation staff of the Department of Biological 
Sciences, University of Warwick. Foetal Bovine Serum was purchased from Gibco 
BRL. 
3.1.3 Cell lines 
The tissue culture cell lines used in this study are shown in Table 3.1. Growth 
medium was supplemented with an appropriate concentration of FCS, L-glutamine (2 
mM), penicillin (100 U/ml) and streptomycin (1 00 ~g/ml). 
3.1.4 Virus Strains 
The bovine strain Compton UK tissue culture adapted (UKtc) (serotype 6) was 
originally provided by Dr M. Thouless, East Birmingham Hospital, Birmingham. 
Rotavirus was pre-treated with 10 J,.lg/ml trypsin for 30 minutes at 37°C before 
propagation. The recombinant vaccinia virus VR5 containing the UKtc rotavirus gene 
5 was produced by S. Stagg in the Rotavirus laboratory, University of Warwick. 
3.1.5 Animals 
The Half-Lop rabbit used for antibody production was obtained from Harlan 
UK and housed at the University of Warwick. Inoculation of the rabbit for production 
of antiserum was performed by Prof. N. J. Dimmock. 
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Table 3.1. Cell Lines 
Cell Line Origin Tissue Culture Medium 
BS-C-l African Green Monkey Kidney GMEM+5 % FCS 
(Supplied by Prof. M. A. 
McCrae, University of Warwick) 
MAI04 Rhesus Monkey Kidney GMEM+5 % FCS 
(Supplied by Prof. M. A. 
McCrae, University of Warwick) 
HeLa Human cervical epitheloid DMEM + 10 % FCS 
carcinoma 
(Supplied by Prof. M. A. 
McCrae, University of Warwick) 
L-Cells Mouse connective tissue GMEM+5 % FCS 
(Supplied by Prof. M. A. 
McCrae, University of Warwick) 
3.1.6 Antiserum 
The anti-NSPl antiserum was obtained from Dr 1. Cohen, Centre de 
Recherche Agronomique, France. The anti-UKtc rotavirus polyc1onal serum (#2148) 
was produced by S. Thomas in the Rotavirus laboratory, University of Warwick. The 
anti-VP6 monoc1onal antibody was obtained from Dr 1. Howes at BioBest, Scotland. 
The anti-VP7 antiserum was obtained from Professor M. A. McCrae, University of 
Warwick. 
3.1.7 Bacterial Strains 
The bacterial strain E. coli MC 1061 was obtained from Prof. M. A. McCrae, 
University of Warwick. 
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3.1.8 Bacterial Growth Conditions 
The E. coli strain MC1061 was grown in LB media in the presence of 
appropriate antibiotics. Liquid media was converted to solid media by the addition of 
agar (15 g/L) prior to autoclaving. 
LB media: 10 g Bacto-tryptone, 5 g Yeast extract, 5 g NaCl in 1 L water 
3.1.9 Yeast Strains 
Saccharomyces cerevisiae reporter host strains were obtained from Clontech 
Laboratories, Inc. as shown in Table 3.2. 
Table 3.2 Yeast Strains 
Strain Genotype Reporter(s) Transformation 
Markers 
SFY526 MA Ta, ura3-52, his 3-200, lacZ trp1, leu2 
ade 2-101, /ys 2-801, trp 1-
901 feu 2-3, 112, canr, gal4-
542, ga180-538, 
URA3::GAL1-facZ 
HF7c HIS3,lacZ trp1, leu2 
MA Ta, ura3-52, his3-200, 
lys2-801, ade2-101, trp1-
901, leu2-3, 112, gaI4-542, 
gaI80-538, LYS2::GAL1-
HIS3, URA3::(GAL4 17-
mersh-CYCI-lacZ 
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3.1.10 Yeast Growth Media 
YPDMedium 
20 g/l Difco peptone; 10 g/l Difco Yeast extract; 18 g/l Bacto-Agar (if needed 
for plates); filter-sterilised dextrose was added to 2 % after autoclaving. 
SD Synthetic Medium (Dropout SD Medium) 
6.7 g/l Difco yeast nitrogen base without amino acids; 20 g/l Agar; lOX 
Dropout solution to give final concentration IX; filter-sterilised dextrose was added to 
2 % after autoclaving. 
10X Dropout solution 
The Dropout solution is composed of essential amino acids required for yeast 
growth with one or more of the amino acids omitted such that only transformants 
carrying the appropriate nutritional genes can grow in the Dropout SD media. The 
concentrations of the amino acids are shown in the following table. The appropriate 
amino acid(s) for the Dropout SD medium required were omitted. The solution was 
autoclaved and stored at 4°C. 
Amino Acid mg/l 
L-Isoleucine 300 
L-Valine 1500 
L-Adenine hemisul£hate salt 200 
L-Arginine Hel 200 
L-Histidine Hel monohydrate 200 
L-Leucine 1000 
L-LJ'sine Hel 300 
L-Methionine 200 
L-Phenylalanine 500 
L-Threonine 2000 
L-Tryptophan 200 
L-Tyrosine 300 
L-Uracil 200 
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3.1.11 Vectors 
The Yeast Two-Hybrid cloning vectors, plasmid pGBT9 and pGAD424, and 
the additional control plasmids were obtained from Clontech (Palo Alto, California, 
USA). The cloning vectors pT Ag and pCR TMn were obtained from Invitrogen (R & D 
Systems Ltd, Abingdon, Oxfordshire). Plasmids containing UKtc rotavirus genes 1, 2, 
3, and 9 were obtained from Professor M. A. McCrae. Plasmids G5T7(TA), G5T7-
TAl, T7-g5-blue, T7-p9~5, and T7~5G5blue were obtained from Dr Xu Li in the 
Rotavirus laboratory, University of Warwick. Plasmids pGBT9-N and pGAD424-P 
were obtained from M. Slack, University of Warwick. 
3.1.12 Primers 
The oligonucleotide primers utilised during this study are shown in Table 3.3. 
Primers were synthesised by Genosys Biotechnologies, Inc., Cambridge. 
3.1.13 Suppliers 
General chemicals were obtained from BDH Laboratory Supplies (Merck Ltd, 
Poole, Dorset), Fisons Scientific Equipment (Loughborough, Leicestershire), and 
Sigma Chemical Company Ltd (Poole, Dorset) and were of analytical or molecular 
biology grade. All water used was double distilled. Equipment and other reagents 
were obtained from the following suppliers. 
Amersham International plc (Buckinghamshire). 
32p dCTP (111 TBq/mmol), 35S Methionine (37 TBq/mmol), Full range Rainbow ™ 
Recombinant protein molecular weight markers, Shrimp Alkaline Phosphatase (SAP), 
Hybond™ N membrane, AmpliflM fluorographic reagent, Linked T7 in vitro 
transcription-translation system, Rabbit reticulocyte lysate system, Biotinylated goat 
anti-rabbit IgG (H + L), streptavidinlbiotin horseradish peroxidase conjugate, ECL 
western blotting analysis system. 
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Table 3.3 Sequence of oligonucleotide primers. 
Primer name Sequence Complimentary region 
location (red type) 
Gene 5/5' TCGAATTCGCTATGGCTACGTTCAAAGAC UKtc gene 5 nts 45-62 
GCITGCTATCATI 
Rotgen 53' CGATCGCGAATTCTGCAGGTCACATITIAT UKtc gene 5 nts 1567-
1579 
Gene 2/5' CTGCAGAATTCGTAATGGCGTACAGGAA UKtc gene 2 nts 16-30 
Gene 2/3' TCTAGATCTGCAGGTCACATCTGACCAGT UKtc gene 2 nts 2672-
GTG 269 1 
Gene 3/5' GACTGCAGGGATCCGGATGAAAGTATIAG UKtc gene 3 nts 50-69 
CTTIAAG 
Gene 3/3' GAGCTCCGGATCCTGCAGGTCACATCTGA UKtc gene 3 nts 2576-
CCA 2590 
Gene 115' CGCTGCAGGCCCGGGCATGGGGAAGTATA UKtc gene I nts \9-36 
ATCTA 
Gene \/3' AAGCCTCGAGCTCGGCCGCGGTCACATCT UKtc gene \ nts 3290-
AAG 3302 
Gene 9/5' TAGGATCCCTGCAGCTATGCTCAAGA UKtc gene 9 nts 26-35 
Gene 9/3' CTTAAGCTTCAGCTGCAGGTCACATAACG UKtc gene 9 nts 1065-
1076 
pTAg SEQ 5' GCTATGACCATGATIACGCCAA Plasmid pTAg, 84 bp 
upstream of insert si te 
pTAg SEQ 3' TGTAAAACGACGGCCAGTGAA Plasmid pT Ag, 75 bp 
downstream of insert site 
Primer I TCATCGGAAGAGAGTAG Plasmid pGBT9, 31 bp 
from MCS start site 
Primer 2 TACCACTACAATGGATG Plasmid pGAD424, 56 
bp from MCS start site 
62 
Bio-Rad (Hemel Hempstead, Hertfordshire). 
Ammonium persulphate, N,N' -methylene-bis-acrylamide, TEMED. 
Clontech (Palo Alto, California, USA). 
MATCHMAKER Two-Hybrid system, Mammalian MATCHMAKER Two-Hybrid 
kit. 
Difco Laboratories (Basingstoke, Hampshire). 
Bacto-agar, Bacto-peptone, Bacto-tryptone, Yeast extract, Yeast nitrogen base wlo 
amino acids and ammonium sulphate. 
Fuji Photo Film Co. Ltd (Tokyo, Japan). 
Fuji medical x-ray film. 
Gibco-BRL Life Technologies Ltd (Renfrewshire, Scotland). 
Restriction and modification enzymes, Taq DNA polymerase, 1 Kb DNA ladder. 
Harlan Sera-Lab Ltd (Crawley Down, UK). 
FITC conjugate goat anti-rabbit Immunoglobulin. 
Invitrogen (R & D Systems Ltd, Abingdon, Oxfordshire). 
T A Cloning ™ System, LigA Tor cloning kit. 
Melford Laboratories Ltd (Ipswich, Suffolk). 
5-Bromo-4-chloro-3-indol yl-~-D-galactoside (X-GAL) 
New England Biolabs (UK) Ltd (Hampshire). 
Restriction enzymes. 
Promega (Madison, Wisconsin, USA). 
TNTTM Coupled Reticulocyte Lysate System, TMB stabilised substrate for HRP, Taq 
DNA Polymerase. 
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Qiagen Ltd (Crawley, West Sussex). 
QIAquick Gel extraction kit, QIAprep Spin Mini prep kit. 
Stratagene (California, USA). 
Cloned Pfu polymerase. 
Whatman International Ltd (Maidstone, Kent). 
Filter paper Grade 5 Qualitative (70mm). 
3.2 Cell Culture 
3.2.1 Maintenance of tissue culture cells 
Mammalian cell lines were maintained at 37°C in either a 5 % C02 incubator 
in a humidified atmosphere (for 150 cm2 flasks) or on a rolling bottle apparatus 
(Modular Cell Production Model IH) (for 800 cm2 roller bottles) using the appropriate 
media (see Table 3.1). When confluent, the cells were passaged as follows. Cells were 
detached by rinsing the monolayer twice with versene followed by incubation with 
trypsinlversene (1 :5) and disaggregation. Cells were reseeded at a ratio of 1 :4. Roller 
bottles were gassed with C02 to give a final concentration of 5 %. All manipulations 
were carried out under sterile conditions in a Class II Laminar Flow Cabinet using 
standard aseptic techniques. 
3.2.2 Freezing and recovery of cell stocks 
Cell stocks were prepared by suspending the cells from one 150 cm2 flask in 2 
ml of 8 % (v/v) dimethylsulphoxide (DMSO) and 30 % FCS in appropriate medium. 
Freezing vials were cooled slowly to -70°C before immersion in liquid nitrogen for 
long term storage. Cell stocks were recovered by rapidly thawing at 37°C, and adding 
the contents of one vial to a 150 cm2 flask containing pre-warmed medium. The 
medium was changed or the cells passaged the following day. 
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3.3 Virus propagation and preparation 
3.3.1 Large scale growth of rotavirus 
Confluent BS-C-l cell monolayers in roller bottles were infected at a m.o.i. of 
$0.1 and made up to a volume of 25 ml per bottle with GMEM (no FCS). Virus was 
harvested once complete c.p.e. was observed. Aprotinin (4 Jlg/ml) was added to the 
harvested virus to stabilise the triple layered virus particles (Keljo and Smith, 1988). 
3.3.2 Large scale growth of recombinant vaccinia virus 
Virus was propagated in confluent HeLa cell monolayers grown in 150 cm2 
flasks. The cells were infected at a m.oj. of 0.1 and the virus inoculum was made up 
to 25 mllflask with DMEM (1 % FCS). Virus was harvested following complete cpe 
and centrifuged at 25,000 rpm, 4°C for 90 minutes in a Beckman SW28 rotor and the 
pellets were resuspended in 1 ml 50 mM Tris-HCl pH 8.0. 
3.3.3 Purification of recombinant vaccinia virus 
The virus stock was subjected to 3 cycles of freeze/thawing and sonicated in a 
water bath for two periods of 15 seconds. The virus was then layered onto a 20-45 % 
sucrose gradient (allowing 1 flask/gradient), made up in 50 mM Tris-HCI pH 8.5, 0.5 
M NaCI, 50 mM EDTA. The sucrose gradient was centrifuged at 18,000 rpm for 28 
minutes at 4 °C in a Beckman SW28 rotor. Following centrifugation, a band of virus 
was visible in the centre of the gradient and a pellet, containing residual virus, was 
formed at the bottom of the tube. The band was recovered using a 19 gauge needle 
and a 5 ml syringe and pooled. Pooled virus bands were then pelleted in a Beckman 
SW28 rotor at 25,000 rpm for 90 minutes at 4°C, and resuspended in 1 ml 50 mM 
Tris-HCI pH 8.0 overnight at 4°C. Residual virus in the pellet from the sucrose 
gradient was extracted by a repeat banding on a 20-45 % sucrose gradient as follows. 
The pellet was resuspended in 1 ml 50 mM Tris-HCI pH 8.0 by cycles of 
freeze/thawing and sonication and centrifuged on a 20-45 % sucrose gradient at 
18,000 rpm for 15 minutes at 4°C. The virus band from this spin was recovered as 
before, pooled and pelleted in a Beckman SW28 rotor at 25,000 rpm for 90 minutes at 
4 cc. The resulting pellet was resuspended in 1 ml 50 mM Tris-HCl pH 8.0 and 
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pooled with the virus collected initially. The virus stock was then subjected to a 
second cycle of purification in a smaller volume. 0.5 ml virus/tube was layered onto 
20-45 % sucrose gradients, made up in 50 mM Tris-HCI pH 8.5, 0.5 M NaCl, 50 mM 
EDT A, and centrifuged in a SW 41 Ti rotor at 18,500 rpm for 15 minutes at 4 cc. A 
virus band was collected as before and pelleted in a SW 41 Ti rotor at 25,500 rpm foJ' 
90 minutes at 4 cc. The pellet was resuspended in 200 III 50 mM Tris-HCI pH 8.0 and 
stored at -70°C until required for titration and use. 
3.3.4 Titration of virus stocks 
Serial ten-fold dilutions of the virus stock were prepared in serum-free GMEM 
and 0.2 ml of virus dilution was added to confluent cell monolayers in 12-well dishes. 
After incubation at 37°C for I hour, 2 ml of an overlay of GMEM containing lA % 
agar, plus antibiotics, was added to each well and the cells incubated at 37°C for 4-5 
days. The cells were then fixed with formal-saline (30 % (v/v) formaldehyde in PBS) 
overnight. The agar was removed and the plaques visualised by staining the remaining 
cells with 0.1 % (w/v) crystal violet. 
3.4 Molecular Biology Techniques 
3.4.1 peR amplification of viral genes 
A standard PCR was performed in a final volume of 25 Ill. This contained 
template DNA (approximately 100 ng), 1 III primer mixture (100 ng/IlI) , IX PCR 
mixture (2.5 III lOX Cloned Pfu polymerase buffer, 250 IlM dNTPs, sterile distilled 
water) and 1.5 units Pfu DNA polymerase. The solution was overlaid with 50 III 
mineral oil and subjected to 30 cycles of 94°C for I min, 55°C for I min and 72°C for 
5 min. 5 III of the reaction was then analysed by agarose gel electrophoresis (Section 
3.4.3). In some cases adjustment of the thermal cycling parameters were necessary to 
improve amplification specificity and target DNA yield. 
3.4.2 Quantification of DNA 
DNA was quantified by spectrophotometry. Absorbance readings were taken 
at 260 nm where an absorbance of 1.0 was taken as indicating a concentration of 50 
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)lg/ml for double stranded DNA or 20 )lg/ml for single stranded DNA primers. 
Digested and dilute DNA solutions were quantified using agarose gel electrophoresis 
(Section 3.4.3) by comparing the band intensity with 100 ng pBR322 plasmid DNA. 
3.4.3 Agarose gel electrophoresis 
DNA samples were analysed on agarose gels containing between 1.0 and 1.5 
% agarose and 1 )lg/ml ethidium bromide in IX TAEfTBE. DNA samples and 1 Kb 
ladder were prepared by the addition of 115 volume of 5X T AEfTBE agarose gel 
loading buffer (Section 3.1.1) before being loaded into the preformed wells. 
Electrophoresis was performed at 70 mA in IX T AEfTBE running buffer for 60-90 
minutes. Bands were visualised using an UV Transilluminator Gel Documentation 
System (UVP), photographed using Grab-IT (UltraViolet Products Ltd, Cambridge), 
an annotating image capture system, and printed on a digital graphic printer. 
3.4.4 PhenoVChloroform extraction 
An equal volume of phenol/chloroforrnlIAA was added to the DNA solution 
and mixed by vortexing. The phenol/chloroformlIAA fraction was separated from the 
aqueous phase by centrifugation for 1 minute in a microcentrifuge. The upper aqueous 
phase was removed and the lower phase discarded. The process was repeated and the 
resulting DNA solution was ethanol precipitated. An additional extraction using 
chloroformlIAA was performed before ethanol precipitation if additional purity was 
required. 
3.4.5 Ethanol precipitation of nucleic acids 
DNA was precipitated from solution by the addition of sodium acetate pH 5.2 
to a final concentration of 0.3 M and 2.5 volumes of ice cold 100 % ethanol. After 
precipitation for 1 hour at -70°C, DNA was pelleted by centrifugation in a 
microcentrifuge for 10 min at 15,000 rpm. The pellet was washed with 70 % (v/v) 
ethanol, dried under vacuum and resuspended in 50 mM Tris-HCI pH 8.0 or TE 
buffer. 
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3.4.6 Restriction enzyme digestion of DNA 
Restriction enzyme digests were performed under the manufacturer's 
recommended conditions using the supplied 10X buffer solutions. 
3.4.7 Dephosphorylation of vector DNA 
The 5' phosphate groups were removed from DNA using shrimp alkaline 
phosphatase (SAP) under the conditions recommended by the manufacturer. SAP was 
inactivated by heating to 65°C for 15 minutes. Calf intestinal alkaline phosphatase 
(CIP) was also used for dephosphorylation under the conditions recommended by the 
manufacturer. 
3.4.8 Blunt-ending of DNA 
Protruding 5' extensions were filled using the Klenow fragment of E. coli 
DNA polymerase 1 (Maniatis et al., 1982). 
3.4.9 Recovery of DNA from agarose gels 
DNA bands were excised from agarose gels under UV light using a sterile 
scalpel blade. The DNA was recovered using the QIAquick Gel Extraction Kit 
(Qiagen) according to the manufacturers instructions. 
3.4.10 Ligation of DNA fragments 
DNA fragments were ligated into dephosphorylated DNA vector molecules. 
Ligation was allowed to proceed at 15°C overnight and contained DNA (insert (20): 
vector (1) mix) lOX ligation buffer (0.66 M Tris-HCl pH 7.6,50 mM MgCI2, 50 mM 
DTT, 100 mM ATP) and 1 unit T4 DNA ligase in a total volume of IS ~l. The DNA 
ligation mixture was ethanol precipitated and the vacuum dried pellet resuspended in 
1 0 ~l of distilled water. 
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3.4.11 Preparation of competent cells for electroporation 
Electro-competent E. coli cells were prepared by washing 200 ml of mid log 
phase bacteria (OD59o = 0.4-0.5) twice with sterile ice cold water. The bacteria were 
resuspended in 15 ml of ice cold water, washed again and resuspended in 0.5 ml 
sterile 10 % glycerol. 
3.4.12 Transformation of DNA into bacteria by electroporation 
50 J..lI electro-competent bacteria were mixed with 10 J..lI salt free ligated DNA 
or control DNA and pulsed in a BioRad Gene Pulser at 2.5 kV with 25 J..lF set as 
capacitance and 200 n set on the pulse controller. Cells were immediately transferred 
to 1.5 ml LB and allowed to recover by shaking for 30 minutes at 37 cC. The bacteria 
were then plated out onto selective agar plates and incubated overnight at 37°C. 
Recombinant clones were identified by restriction enzyme analysis of mini-prep DNA 
or by Grunstein-Hogness filter hybridisation (Grunstein and Hogness, 1975). 
3.4.13 Small scale preparation of plasmid DNA from bacteria (mini-prep) 
Individual bacterial colonies were picked from agar plates into 5 ml LB 
medium containing appropriate antibiotics and incubated overnight with continuous 
shaking at 37°C. For restriction enzyme analysis the plasmid DNA from 1.5 ml of 
culture was prepared using an alkaline lysis technique (Maniatis et al., 1982) and the 
DNA pellets resuspended in 50 J..ll 50 mM Tris-HCI pH 8.0. For sequence analysis the 
plasmid DNA from 1.5 ml of culture was isolated using the QIAprep Spin Miniprep 
kit (Qiagen) according to the manufacturer's instructions and resuspended in 50 J..lI 10 
mM Tris-HCl pH 8.0. 
3.4.14 Large scale preparation of plasmid DNA from bacteria (maxi-prep) 
The plasmid DNA from 1 L of bacterial culture was prepared using triton lysis 
followed by purification of plasmid DNA on a CsCI gradient (Maniatis et al., 1982). 
The yield of low copy number plasmids was increased by using chloramphenicol 
amplification. 10 ml of LB containing ampicillin (final concentration of 100 J.Lg/ml) 
was inoculated with a single colony and incubated overnight at 37°C with shaking. 
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The overnight culture was subcultured into 1 L of LB plus ampicillin and incubated 
for 6-8 hours at 37 QC with shaking. Chloramphenicol was added to a final 
concentration of 150 ~g/ml, the culture was incubated overnight at 37 QC with 
shaking then harvested. 
3.4.15 Nick translation of DNA 
DNA fragments purified following agarose gel electrophoresis were labelled 
with 32p dCTP by nick translation with DNA polymerase I according to the method 
reported in Maniatis et al. (1982). 
3.4.16 Grunstein-Hogness colony filter hybridisation assay 
Large numbers of putative bacterial clones were screened by Grunstein-
Hogness colony hybridisation (Grunstein and Hogness 1975) following the method 
published in Maniatis et al. (1982). 
3.4.17 Direct cloning of peR products 
DNA fragments produced by PCR were cloned directly into the pTAg vector 
using the LigATor cloning kit (Invitrogen). The TA Cloning ™ System (Invitrogen) 
was also used for direct cloning of PCR fragments. The manufacturers 
recommendations were followed in each case. 
3.4.18 DNA Sequence Analysis 
DNA cycle sequencing was carried out using the Applied Biosystems 373A 
Automated Sequencer by Mrs L. Ward, Department of Biological Sciences, 
University of Warwick, according to the manufacturers instructions. 
70 
3.5 Yeast Two-Hybrid Assay Methods 
3.5.1 Preparation of competent yeast cells for transformation (Lithium acetate 
method) 
50 ml YPD medium was inoculated with a single yeast colony (2-3 mm 
diameter) which was no more than 4 weeks old. The yeast culture was grown to 
stationary phase (00600 ~ 1.5) overnight (16-18 hours) at 30°C with shaking 
(230-250 rpm). The culture was transferred to 250 ml YPD medium to give an OD600 
reading between 0.2 and 0.3, and incubated as before for 3 hours. The cells were 
centrifuged in a Beckman J2-21 MIE centrifuge in a JAW rotor at 1000 g (2400 rpm) 
for 5 minutes at room temperature. The cell pellet was resuspended by vortexing in 
25-50 ml sterile, distilled water, and the cells centrifuged as before then resuspended 
in 1.5 ml of freshly prepared, sterile IX TE/LiAc (0.01 M Tris-HCI; 1 mM EDTA; 
0.1 M lithium acetate pH 7.5) and used for transformation immediately. 
3.5.2 Transformation of yeast cells by heat shock 
1 Jlg of each plasmid and 100 Jlg of denatured salmon sperm carrier DNA 
were mixed in an eppendorf tube. 100 JlI of yeast competent cells were added and 
mixed well, then 600 JlI of sterile PEGlLiAc (40 % PEG 4000; 0.01 M Tris-HCI; I 
mM EDTA; 0.1 M lithium acetate pH 7.5) was added to the tube and the contents 
vortexed. The reactions were incubated at 30°C for 30 minutes with shaking (200 
rpm), then 70 JlI sterile DMSO was added to 10 % final concentration and mixed 
gently. The transformation reactions were heat shocked for 15 minutes at 42°C, then 
chilled on ice and centrifuged for 5 seconds in a microcentrifuge. The cells were 
resuspended by pipetting in 0.5 ml of IX TE buffer (0.0 I M Tris-HCI; 1 mM EDT A 
pH 7.5). For single plasmid transformations, 100 JlI of the transformation mixture was 
spread onto a 90 mm plate containing the appropriate SD selection medium. For 
double plasmid transformations, 250 JlI of the transformation mixture was spread onto 
a 90 mm plate containing the appropriate double Dropout SD selection medium. 
Plates were incubated at 30°C for 4-5 days until colonies appeared and then stored, 
sealed with Parafilm, at 4 °C for 3-4 weeks. 
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3.5.3 Colony lift filter assay for ~-galactosidase 
A sterile Whatman #5 filter (70 mm) was placed over the surface of the agar 
plate containing the freshly transformed colonies (1-2 mm diameter). Additional 
sterile Whatman #5 filters were pre-soaked in 2.5 ml of Z buffer/X-Gal solution. 
Z Buffer 
16.1 g/l Na2HP04.7H20; 5.5 gll NaH2P04.H20; 0.75 g/l KCl; 0.246 g/l 
MgS04.7H20 pH 7.0. 
Z-BufferIX-gal solution 
100 ml Z-Buffer 
0.27 ml l3-mercaptoethanol 
1.67 ml X-gal (5-bromo-4-chloro-3-indolyl-I3-D-galactopyranoside) dissolved in 
N,N-dimethylformamide (DMF) at 20 mg/ml concentration. 
The filter was carefully removed and submerged, colony side up, in liquid 
nitrogen for 10 seconds then allowed to thaw at room temperature. It was then placed, 
colony side up, on the filter which was pre-soaked in Z-bufferIX-gal solution and 
incubated at 30 cC until blue colonies appeared. 
3.5.4 Liquid culture l3-galactosidase assay 
5 ml SO medium lacking the appropriate amino acids was inoculated with a 
freshly transformed yeast colony and incubated overnight at 30 cC with constant 
shaking (230-250 rpm). 8 ml YPO liquid medium was then inoculated with 2 ml of 
the overnight culture and incubated at 30°C with shaking (230-250 rpm) for 3-5 
hours until the culture was in mid-log phase (00600 = 0.5-1.0). 1.5 ml of culture was 
removed in triplicate to microcentrifuge tubes and centrifuged in a benchtop 
microcentrifuge for 30 seconds (14,000 rpm). The pellet was washed in l.5 ml of Z 
buffer and resuspended finally in 300 J..LI of Z buffer (concentration factor = 5). An 
aliquot of 100 J..Ll was removed to a clean microcentrifuge tube and the tubes placed in 
liquid nitrogen until frozen, then thawed at 37°C. A blank tube containing 100 J..Ll of 
Z buffer only was prepared and 0.7 ml Z buffer plus ~-mercaptoethanol (0.27 ml ~-
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mercaptoethanol added to 100 ml Z buffer) was added to all tubes. The timer was 
started immediately prior to adding 0.16 ml freshly prepared ONPG (o-nitrophenyl ~­
D-galactopyranoside) in Z buffer (4 mg/ml ONPG in Z buffer, pH 7.0) to the tubes. 
The reactions were incubated at 30°C until a yellow colour was observed, then 0.4 ml 
1 M Na2C03 was added and the tubes were centrifuged for 10 minutes in a 
microcentrifuge at maximum speed to pellet the cell debris. The absorbance of the 
supernatants was measured at 420 nm relative to the blank and ~-galactosidase units 
were calculated. 1 U ~-galactosidase is defined as the amount which hydrolyses 
Jlmole ONPG to o-nitrophenol and D-galactose per minute. 
~-galactosidase units = 1000 x OD4201(t X V x OD600) 
t = elapsed time (in minutes) of incubation 
V = 0.1 ml x concentration factor 
OD600 = Abs at 600 nm of 1 ml of culture 
B-galactosidase units were calculated for each OD420 reading. The mean and 
standard deviation of ~-galactosidase units were derived from the results of each 
transformation. Error bars were calculated using the 95 % confidence limits of the 
Students t test. 
3.5.5 Preparation of yeast Iysates for western blot analysis 
Freshly transformed yeast colonies were used to inoculate 5 ml of dropout SD 
medium and the cultures were incubated at 30°C until they reached mid-logarithmic 
phase (OD600 = 1.0). The cells were pelleted and the yeast lysates were prepared by 
boiling with acid washed glass beads and centrifugation as described previously (Li 
and Fields, 1993). The supernatants were fractionated on a 7.5 % SDS polyacrylamide 
gel (Section 3.6.5) and analysed by western blotting (Section 3.6.7). 
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3.6 Protein Expression and Analysis 
3.6.1 In vitro protein expression 
3.6.1.1 Zubay coupled transcription/translation 
Zubay coupled transcription/translation was performed using the Linked T7 
transcription-translation system (Amersham International plc, Buckinghamshire) 
following the manufacturers recommended protocol. The TNT ™ Coupled 
Reticulocyte Lysate System (Promega, Madison, Wisconsin, USA) was also 
occasionally used for coupled transcription/translation following the manufacturers 
recommended protocol. 
3.6.1.2 In vitro translation system 
In vitro translation was performed using the rabbit reticulocyte lysate system 
(Amersham Pharmacia Biotech, Buckinghamshire) following the manufacturers 
recommended protocol. 
3.6.1.3 Determination of in vitro translation efficiency by TeA precipitation 
1 JlI aliquots of the translation reaction were spotted onto filter paper discs, 
allowed to dry and transferred to 5 % (v/v) TCA-2 % (w/v) Cas-amino acid solution. 
The discs were boiled for 5 minutes in 5 % (v/v) TCA-2 % (w/v) Cas-amino acid 
solution under a fume hood, washed twice with 95 % (v/v) ethanol, twice with ether 
and allowed to dry. Incorporation of 35S-methionine into protein was determined by 
measuring radioactivity in a scintillation counter. 
3.6.2 Determination of protein concentration 
The Bio-Rad protein assayTM was used according to the manufacturers 
instructions using bovine serum albumin (BSA) as a standard for comparison of 
protein concentrations. 
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3.6.3 Labelling of virus proteins in infected cells 
A 12-well dish was seeded with 5x 105 cells/well of BS-C-l or MA 104 cells 
and incubated overnight at 37 cC in a humidified 5 % C02 incubator. The following 
day the medium was removed from the cells and 0.2 ml high titre UKtc rotavirus, at a 
m.oj. of approximately 20, was added to the cells and allowed to adsorb for 1 hour at 
37 cc. The cells were then overlaid with 2 mllwell methionine-free GMEM and 
incubated for a further 6 hours at 37 cc. Following the incubation the medium was 
removed and the cells were labelled with 0.1 mllweIl GMEM plus 35S-methionine 
(500 ~Ci/ml) for 20 minutes at 37 cC. The label was removed and 0.5 ml/well 50 mM 
Tris-HCI pH 8 plus PMSF (0.2 mM final concentration) was added and the cells 
harvested using a rubber policeman. If a chase sample was required then after the 
label was removed 2 ml/well GMEM plus 100X unlabelled methionine was added to 
the cells and incubated at 37 cC for 2 hours before harvesting. The cells were 
subjected to 2 rounds freeze-thaw and sonication in a water bath. Centrifugation to 
separate the cell fractions was performed in a Beckman TL-100 ultracentrifuge using 
the TLS-55 rotor for 1 hour at 4 cc. 
3.6.4 Immunoprecipitation 
Immunoprecipitation was performed with infected cell lysates or in vitro 
translated protein samples. An equivalent volume of 2X !P3 buffer was added to the 
samples, followed by an aliquot of serum and the reactions were incubated at 4 cC for 
at least 2 hours on a rotating blood-wheel. 5 mg of Protein A-Sepharose was 
pre-prepared by soaking in 1 00 ~l of IP3 buffer at 4 cC. The protein samples were 
added to the Protein A-Sepharose beads and incubated for a further 2 hours at 4 cC on 
a rotating blood-wheel. The samples were then centrifuged for 1 minute in a benchtop 
microcentrifuge and the beads resuspended in 1 ml of IP2 buffer, centrifuged again as 
before and then washed sequentially in IP2 buffer containing 1 M NaCI twice, IP3 
buffer twice and !PI buffer once. Finally the Protein A-Sepharose beads were 
resuspended in 40 ~l of 50 mM Tris-HCI pH 8.0, 10 ~l 5X protein loading buffer was 
added and the samples were boiled for 10 minutes prior to loading on a gel. 
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Jmmunoprecipitation (JP) Buffers: 
JP! 
20 mM Tris-HCL buffer pH 8.0; 100 mM NaCl; 1 mM EDT A; 1 % NP-40. 
JP2 
20 mM Tris-HCl buffer pH 8.0; 100 mM NaCl; 1 mM EDTA; 1 % NP-40; 1 % 
Na-deoxycholate; 20 mg/ml BSA. 
JP3 
20 mM Tris-HCl buffer pH 8.0; 100 mM NaCl; 1 mM EDTA; 1 % NP-40; 1 % 
Na-deoxycholate. 
3.6.5 SDS-Polyacrylamide Gel Electrophoresis 
Discontinuous single concentration and linear gradient (5-11 %) SDS-
polyacrylamide gels were prepared and run in a vertical gel electrophoresis system 
according to the method of Laemmli (Laemmli, 1970). The composition of the 
separating and stacking gels was as shown below: 
4X Separating Gel 4X Stacking Gel Buffer 
Buffer pH 8.8 pH 6.8 
Tris base 36.3 g 12.1 g 
SDS 0.8 g 0.8 g 
Distilled H20 to 200ml 200ml 
Both buffers were adjusted to the correct pH with cone. HCl. 
The composition of the gradient and linear polyacrylamide gels is shown in Tables 3.4 
and 3.5. 
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Table 3.4 Composition of 5·11 % SDS Polyacrylamide gradient gels 
5 % Separating 11 % Separating 5 % Stacking Gel 
Gel Solution Gel Solution Solution 
Acrylamide-Bis* 8 ml 17.6 ml 2 ml 
(30: 1.5) 
Glycerol 2.4 ml 4.8 ml 
-
4X Buffer 12 ml 12 ml 3 ml 
APS 6.6 %; 300 ~l 6.6 %; 150 ~l 0.28 %; 3 ml 
TEMED 20 ~l 20 ~l 15 ~l 
Distilled H20 to 48 ml 48 ml 12 ml 
* Bis = N,N' -Methylene-bis-acrylamide 
Table 3.5 Composition of 7.5 % Linear Gels 
7.5 % Separating Gel 5 % Stacking Gel 
Acrylamide-Bis* (30: 1.5) 12 ml 2ml 
Glycerol 3.3 ml -
4X Buffer 12 ml 3 ml 
APS 6.6 %; 300 ~l 0.28 %; 3 ml 
TEMED 20 ~l 15 ~l 
Distilled H20 to 48 ml 12 ml 
* Bis = N,N' -Methylene-bis-acrylamide 
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Gradient gels were run at a constant current of 35 mA with variable voltage 
for 3-4 hours at 4 QC in a buffer containing 6.32 g/l Tris, 3.99 g/l glycine and 1 g/l 
SDS (buffer pH 8.9). Linear gels were run at 50 mA for 2-3 hours at room 
temperature. 
3.6.6 Analysis of polyacrylamide gels 
Gels containing proteins labelled with 35S-methionine were fixed [10 % (v/v) 
acetic acid; 2 % (v/v) ethanol; 3 % (v/v) glycerol] overnight, treated for 15-30 
minutes with Amplify (Amersham) for fluorographic enhancement of radioactive 
emissions, dried onto paper for 2 hours under vacuum at 80 QC and exposed to X-ray 
film in an autoradiography cassette at -70°C. Quantification of protein bands was 
performed by phosphoimaging (Molecular Dynamics Corp.). Computer analysis of 
data was performed using Image Quant ™ software. 
3.6.7 Western Blotting 
Polyacrylamide gels were soaked for 30 min in transfer buffer (25 mM Tris 
base, 192 mM glycine 2 % (v/v) methanol). Proteins were then electroblotted onto 
Hybond™ N membrane (Amersham International plc) using a Bio-Rad Trans-Blot™ 
device at 70 V for 3-4 hours. The membrane was then blocked with PBS containing 5 
% milk powder for one hour at 37°C. The membrane was probed with antibodies 
following suppliers recommendations. The blot was developed either using TMB 
stabilised substrate (Promega) dried and photographed, or using the ECL western 
blotting detection reagents (Amersham) and exposed to autoradiography film 
(Hyperfilm ECL, Amersham.). 
3.7 Antibody Production 
3.7.1 Inoculation procedure 
The rabbit used for inoculation was obtained from a supplier (Rarlan UK) who 
guaranteed that the animal was free from rotavirus infection. A pre-immune bleed was 
taken and tested to ensure no antibodies to rotavirus were present. The initial 
78 
inoculation was carried out subcutaneously with 1 x 107 pfu purified VR5 (Section 
3.3.3) in 750 ~l PBS. Bleeds were taken at intervals of 2 weeks after the initial 
inoculation and 10-20 ml of blood was usually obtained. Booster inoculations of an 
equivalent amount of virus were given at 13 weeks and 17 weeks after the initial 
inoculation and bleeds taken every two weeks as before. A final boost of 1 x 108 pfu 
of purified virus was given at 29 weeks after the initial inoculation and bleeds taken 
as before. All inoculations were performed with purified VR5 virus in PBS by 
subcutaneous route and the rabbit was housed in isolation at the University of 
Warwick after each inoculation. 
3.7.2 Serum Collection 
The blood was incubated overnight at 4 °C to allow the clot to form. The 
serum was then separated from the clot by centrifuging at 2000 rpm for 5 minutes at 4 
qc. The blood clot was "ringed" using a pasteur pipette and the serum centrifuged 
again at 2000 rpm for 5 minutes at 4 qc. The serum supernatant was removed and 
stored in aliquots at -20°C, or at -70 °C for long term storage. 
3.7.3 Immunofluorescent labelling of infected cells 
Confluent BS-C-1 cell monolayers on coverslips in 12-weIl dishes were 
infected at a m.oj. of 0.1 (rotavirus) or 0.002 (VR5). At 16 hours post-infection the 
cells were washed four times in PBS and fixed with ice cold methanol on ice for 10 
minutes. The solvent was removed and the fixed cells allowed to air dry. The cells 
were washed twice with PBS, then 50 ~l of the primary antibody dilution was added 
to the coverslips and the plate incubated at 37°C for 1 hour. After two washes with 
PBS, 50 Jll of a 11100 dilution of FITC conjugate goat anti-rabbit Ig was added to the 
coverslips and the plate incubated for 1 hour at 37°C. The coverslips were washed 
twice with PBS, then placed cell side down onto a drop of 90 % glycerol and 10 % 
PBS on a glass microscope slide. Fluorescent staining was observed using a B-2H 
filter in a UV microscope (Nikon, Optiphot microscope). Photography was carried out 
using Ektachrome P1600 colour slide film (Kodak). 
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Results Chapter 1 
Cloning of rota virus genes 
into yeast two-hybrid vectors 
80 
4.1 Aims 
The overall objective of the project was to study protein-protein interactions 
between the rotavirus non-structural protein NSPl and viral proteins found with it in 
pre-core complexes in the infected cell. The yeast two-hybrid system was chosen as 
one method of studying such protein-protein interactions. This chapter describes the 
strategies employed to generate fusion protein constructs between the rotavirlls 
proteins found in pre-core complexes and both the GAL4 DNA-binding and 
activation domains for use in the yeast two-hybrid system. 
4.2 Introduction 
4.2.1 The yeast two-hybrid system 
The yeast two-hybrid system is a genetic assay for detecting protein-protein 
interactions in vivo (Fields and Song, 1989). The system makes use of a ellkaryotic 
transcriptional activator, classically the yeast GAL4 protein. This protein consists of 
two physically discrete domains, one governing DNA binding and the second carrying 
the transcriptional activation function (Keegan et al., 1986), (Ma and Ptashne, 1987). 
To set up the assay, one of the two potentially interacting proteins is fused to the 
DNA-binding domain and the other to the activation domain. If there is an interaction 
between the two proteins under analysis. then it will bring the two GAL4 domains 
close together and result in the restoration of the transcriptional activation function 
(Ma and Ptashne, 1988), (Brent and Ptashne, 1985). Experimentally the two hybrid 
proteins are co-transformed into a yeast host strain and the activation of expression of 
a reporter gene, under the control of a GAL4 regulated promoter, is measured. The 
reporter gene used in this study was lacZ, and detection of ~-galactosidase was an 
indication that the two proteins under study were interacting. The two-hybrid system 
has several advantages over more conventional biochemical methods. It is a sensitive 
method for the detection of weak and transient interactions that probably occur in 
complexes within an infected cell. Also, it is not dependent on the monospecific 
antibodies normally required for in vitro based methods of detecting protein-protein 
interactions. As the assay is performed in vivo the proteins are more likely to be in 
their native conformations. However, although the yeast two-hybrid assay has 
advantages over a bacterial expression system, it is still unlikely to represent the exact 
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conditions found in a mammalian cell. Further, as the proteins of interest are 
expressed as carboxy-terminal fusions of the GAL4 proteins in some cases this might 
adversely affect their normal folding and conformation, and also prevent detection of 
any interactions that require a free amino terminus of the protein. 
4.2.2 Use of the two-hybrid system to test for rota virus protein-protein 
interactions 
The yeast two-hybrid assay has already been used successfully to study 
protein-protein interactions in viral systems (Luban et al., 1992), (Takacs et al., 
1993), (Takacs and Banerjee, 1995), and in this project it was used for the study of 
rotavirus protein-protein interactions. NSPI has been shown to be present, with other 
viral proteins and viral mRNA, in a pre-core replication intermediate (RI) in the 
infected cell (Patton, 1995). NSPl could potentially interact with any member of this 
complex, however these interactions within the complex may be of a weak or 
transient nature, so a sensitive assay which could detect such interactions was 
required. The pre-core RI contains NSP I, NSP3 and the viral structural proteins VP I 
and VP3. VP2 is then added to this complex to produce the core RI. It was therefore 
decided that the two-hybrid system should be used to test for interactions between 
NSPI and the individual viral proteins VPl, VP2, VP3 and NSP3. The assay was also 
used to test for a potential dimerisation of NSPl. This two-hybrid assay would only 
detect a direct protein-protein interaction between NSP I and a given protein, so 
therefore a potential interaction between NSP 1 and a preformed complex of more than 
one protein would not be detected. Similarly, as viral mRNA cannot be added to the 
assay, if NSPl interacted with a complex of proteins and RNA, or if it interacted 
directly with RNA, then these interactions would also not be detected by the 
two-hybrid assay. 
The genes encoding all the required rotavirus proteins from the UKtc strain of 
bovine rotavirus had previously been cloned in the Rotavirus laboratory. 
4.2.3 Cloning vectors for the production of GAL4 fusion proteins 
The Matchmaker Yeast Two-Hybrid System (Clontech) was used to test for 
protein-protein interactions. In this system, sequences encoding the two functional 
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domains of the GAlA transcriptional activator have been cloned into two different 
shuttle/expression vectors. The vector pGBT9 contains the sequences encoding the 
GAlA DNA-binding domain, and pGAD424 contains the sequences encoding the 
GAlA transcriptional activation domain (Bartel et aI., 1993) (Figure 4.1). Plasmid 
pGBT9 is therefore used to generate a fusion of the GAlA DNA-binding domain with 
the target protein, while pGAD424 generates a fusion of the GAlA activation domain 
with a candidate interacting protein. Plasmid pGBT9 carries the TRP 1 nutritional 
gene which allows selection of transformant yeast colonies on limiting media lacking 
the amino acid tryptophan. Plasmid pGAD424 carries the LEU2 nutritional gene 
which allows selection on limiting media lacking the amino acid leucine. 
Transformant colonies carrying both pGBT9 and pGAD424 can be selected on double 
dropout media lacking both tryptophan and leucine. Both plasmids contain sequences 
encoding nuclear localisation signals, so that both hybrid proteins are targeted to the 
yeast nucleus. In pGAD424 the nuclear localisation sequence from SV40 T-antigen 
has been cloned into the vector between the ADHl promoter and the GAlA activation 
domain sequence (Chi en et aI., 1991), whereas in pGBT9 it is an intrinsic part of the 
GAlA DNA-binding domain (Silver et aI., 1984). 
4.2.4 Production of fusion proteins 
To study protein-protein interactions in the two-hybrid system, the rotavirus 
proteins must be expressed as fusion proteins with the GAlA domains. In order to 
ensure correct expression of the fusion proteins, the gene encoding the protein of 
interest must be ligated into the multiple cloning site (MCS) of the vector such that 
the orientation is correct with respect to the GAlA sequence. In addition, the reading 
frame must be preserved such that the GAlA domain and the protein of interest are 
expressed contiguously to produce a fusion protein. 
A further consideration was to ensure the sequences of the cloned genes were 
accurate so that genuine rotavirus proteins would be expressed. To ensure the fidelity 
of the PCR reactions, a thermostable DNA polymerase Pfu with 3' exonuclease, or 
"proof-reading", activity was used throughout. The 3' to 5' exonuclease activity of Pfu 
DNA polymerase can remove an incorrectly inserted base before continuing with the 
reaction. Thus, Piu DNA polymerase has a 12-fold increase in fidelity of DNA 
synthesis over Taq DNA polymerase (Stratagene), and is recommended for high 
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Figure 4.1 Schematic diagrams of the Yeast Two-Hybrid System cloning 
vectors, pGBT9 and pGAD424, showing the MCS sequence and unique 
restriction sites 
Schematic diagrams of the main features of plasmid pGBT9 (panel A) and 
pGAD424 (panel B) are shown. pGBT9 generates a hybrid that contains the 
sequences for the GAL4 binding domain (amino acids 1-147) (GAL4 bd). 
pGAD424 generates a hybrid that contains the sequences for the GAL4 
activation domain (amino acids 768-881) (GAL4 ad). The plasmids have 
unique restriction sites located in the MCS region at the 3' end of the open 
reading frame for either the DNA-binding or activation domain sequences. 
The gene encoding the protein of interest is ligated into the MCS in the 
correct orientation and with the correct reading frame, such that fusion 
proteins with the GAlA domains are expressed. The sequence and reading 
frame of the MCS for pGBT9 and pGAD424 are shown in the boxes below 
the appropriate plasmid diagrams. The unique restriction sites in the MCS of 
each plasmid, which can be used for cloning purposes, are indicated. Fusion 
proteins are expressed from the constitutive ADHl promoter (p ADHl) and 
transcription is terminated at the ADH 1 transcription termination signal 
(f ADH1). The fusion proteins are targeted to the yeast nucleus by nuclear 
localisation sequences (.A). pGBT9 and pGAD424 plasmids replicate 
autonomously in both E. coli and S. cerevisiae. The selectable markers 
carried are the bla gene which confers resistance to ampicillin in E. coli 
(AmpR), and a nutritional gene that allows yeast auxotrophs to grow on 
limiting synthetic media (TRPl in pGBT9; LEU2 in pGAD424). This figure 
is adapted from the Clontech Matchmaker Two-Hybrid system protocol. 
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fidelity and long PCR reactions. Sequencing was used to verify the junction regions 
and 5'-ends of each cloned rota virus gene. In addition, genes cloned into TA vectors 
were expressed in vitro and full-length proteins were produced in each case (Section 
4.4). 
Attachment of the GAL4 domains to the proteins of interest can cause 
complications when the fusion proteins are expressed and tested in the two-hybrid 
system. In some cases an interaction may be observed if a protein of interest is fused 
to one GAL4 domain but not if it is fused to the other domain (Estojak et a/., 1995). 
Thus, if possible, each protein of interest should be tested as fusions with both GAL4 
domains. A second possible complication arises if a protein of interest has intrinsic 
transcriptional activation properties and thus may activate transcription when fused to 
the GAL4 DNA-binding domain. This problem may produce a false positive result in 
the two-hybrid assay, but can be avoided by fusing the protein of interest to the GAL4 
activation domain. The rotavirus genes encoding the proteins of interest were cloned 
into both two-hybrid vectors so that fusions of each protein with both GAL4 domains 
were generated. 
4.3 Production of constructs to express NSPI-GAL4 domain fusion proteins 
4.3.1 Strategy for production of NSPI-GAL4 domain fusion proteins 
A cDNA of gene 5, which encodes NSPI, from the UKtc strain of bovine 
rotavirus, was used to produce NSPI-GAL4 domain fusion proteins by sub-cloning 
the gene 5 sequence into pGBT9 and pGAD424 (Figure 4.2). Fusions of NSPl with 
both the DNA-binding and the transcriptional activation domains were produced. The 
most important considerations in the production of the fusion proteins were that gene 
5 was ligated into the MCS of the vectors in the correct orientation with respect to the 
GAL4 domain sequence, and that the reading frame was maintained. The orientation 
of the gene was ensured by using a forced cloning procedure, whereby the gene was 
ligated into the MCS using different restriction sites at the 5' end and 3' end. To allow 
this, gene 5 sequences were amplified by PCR using specially designed primers to 
introduce specific restriction sites at the termini of the amplified sequences of the 
gene 5 cDNA. The introduced restriction sites could then be used for cloning the gene 
into both vectors. The sites were positioned such that, after ligation, the reading frame 
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Figure 4.2 Cloning strategy for construction of fusion proteins of NSPl 
with the GAlA DNA-binding and activation domain proteins 
Gene 5 of the UKtc strain of bovine rotavirus, which encodes NSP1, was 
amplified by PCR with primers Gene 5/5' and Rotgen 5/3' (Table 3.3) 
(Section 3.4.1). Gene 5/5' was designed such that additional DNA sequence, 
including an EcoR I site, was added to the 5' end of the amplified DNA. 
fragment. The addition of the EcoR I site allowed gene 5 to be cloned, in 
frame, into the MCS of either pGBT9 or pGAD424. Rotgen 5/3' added 
additional DNA sequence, including a PsI I site, to the 3' end of the amplified 
DNA fragment, which was used for cloning gene 5 into the MCS of either 
pGBT9 or pGAD424. The gene 5 PCR product was digested with EcoR I and 
PsI I (Section 3.4.6) and ligated into pGBT9 and pGAD424 that had also 
been digested with EcoR I and PSI I (Section 3.4.10). The framing of the 
junction region, between the GAlA domain and gene 5, is shown. 
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of the GAL4 domain sequence was maintained and thus a fusion protein would be 
expressed. Following isolation of the fusion constructs, the junction region between 
the GAL4 domain and gene 5 was sequenced to ensure that the reading frame was 
correct. In each case, approximately 200-300 bp at the 5' end of each rotavirus gene 
was also checked against the original sequence data to ensure accuracy. The ligation 
of gene 5 into both pGBT9 and pGAD424 allowed the hypothesis that NSP I interacts 
with itself to form dimers to be tested. It also provided for the possibility, discussed in 
Section 4.2.4, that one of the rotavirus proteins to be tested might have intrinsic 
transcriptional activating properties thus forcing the use of a particular vector. 
4.3.2 Cloning of gene 5 into the GAL4 DNA-binding domain vector pGBT9 to 
generate construct pGBT9-Gene 5 
Gene 5 of the UKtc strain of bovine rotavirus was amplified by PCR using 
primers Gene 5/5' and Rotgen 5/3' (Figure 4.3). A band on the gel corresponding to 
gene 5 (1579 bp) can be clearly seen. The larger band at approximately 5000 bp in the 
G5 lane was not identified. The gene 5 band was gel purified prior to cloning to avoid 
contamination with this larger PCR product. The Gene 5/5' primer was designed to 
introduce an EcoR I restriction enzyme site to the 5' end of the gene, immediately 
prior to the ATG start site. EcoR I was chosen because it was also present in the MCS 
of the yeast two-hybrid vectors, thus it could be utilised for cloning purposes. The 
framing of the EcoR I site in relation to the A TG of gene 5 and the ORF of the GAL4 
domain was designed to maintain the reading frame when gene 5 was cloned into the 
vector, resulting in the production of a fusion protein of the GAL4 domain and the 
gene 5 product NSPl. The vector pGBT9, which contains sequence encoding the 
GAL4 DNA-binding domain, was digested with EcoR I and Pst I and 
dephosphorylated with calf intestinal alkaline phosphatase (CIP) to reduce 
recircularisation of the vector. The amplified DNA fragment, which had been 
similarly digested with EcoR I (5' end) and Ps! I (3' end), was ligated into the 
prepared vector pGBT9 to generate a pGBT9-Gene 5 construct. Recombinant clones 
were screened by double-digestion with EcoR I and Pst I which released the gene 5 
insert. Two clones containing gene 5 inserts were identified: G5(7) and G5( I 0) 
(Figure 4.4). Further restriction enzyme digestions with Xho I and Xba I were 
performed to confirm the positive orientation of the gene 5 insert with respect to the 
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Figure 4.3 Amplification of the UKtc strain of bovine rota virus gene 5 
from plasmid G5T7(TA), and gene .15 from plasmid p9DL\5, with primer 
pair Gene 5/5' and Rotgen 5/3' 
5 J.lI of the PCR products amplified using primers Gene 5/5' and Rotgen 5/3' 
(Table 3.3) were analysed by electrophoresis on a 1.5 % TAB agarose gel 
(Section 3.4.3). The predicted size of the gene 5 DNA fragment (05) is 1579 
bp, and the predicted size of the gene L\5 fragment is 1271 bp. +ve refers to the 
positive control for the PCR reaction which is adenovirus DNA of 
approximately 500 bp. Lanes marked L were loaded with 1 Kb DNA ladder. 
The sizes of the markers are given in base pairs. 
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Figure 4.4 Identification of recombinant clones pGBT9-gene 5 and pGBT9-
gene .15 by restriction enzyme digestion 
Plasmid DNA from 20 independent clones, created following the ligation reactions 
between pGBT9 and either peR amplified gene 5 or gene .15, was prepared by 
mini-prep (Section 3.4.13) and double-digested with EcoR I and Pst I (Section 
3.4.6). The products were analysed by electrophoresis on a 1.5 % TAB agarose gel 
(Section 3.4.3). Double-digestion of pGBT9 with EcoR I and Pst I resulted in 
linearisation of the plasmid and a band at 5500 bp. Gene 5 inserted into PGBT9 
was released by double digestion with EcoR I and Pst I resulting in bands at 5500 
bp and 1579 bp. Two clones of pGBT9-gene 5 were identified [G5(7); G5(l0)]. 
Gene.15 inserted into pGBT9 was released by double digestion with EcoR I and 
Pst I resulting in bands at 5500 bp and 1271 bp. Two clones of pGBT9-gene ~5 
were identified [~5(7); ~5(l0)]. Lanes marked L were loaded with I Kb DNA 
ladder. The sizes of the markers are given in base pairs. 
GAL4 domain sequence in pGBT9 in both clones (Figure 4.5). The junction region 
between the GAL4 domain sequence and gene 5 was also sequenced. Initially, 
sequencing of both G5(7) and G5(1O) revealed that additional sequence (68 bp) had 
been incorporated into the construct at the 5' end of gene 5 (Figure 4.6A). The 
presence of this additional 68 bp of sequence resulted in the ATG start site of gene 5 
being out-of-frame with respect to the GAL4 domain sequence in pGBT9 hence the 
desired fusion protein would not be produced. As the additional sequence was short 
(68 bp) and did not disrupt the restriction sites, it was not observed during 
electrophoretic examination of the clones (Figures 4.4 and 4.5), and was only 
discovered by sequencing. The additional sequence corresponded to the T7 vector, 
primer and leader sequence of gene 5 from plasmid G5T7(T A) from which gene 5 
was amplified. It was thought that the presence of this sequence was due to incorrect 
priming during the PCR reaction. The sequence was excised by restriction enzyme 
digestion with Nco I and EcoR I, which cut at unique sites either side of it, and the 
free ends were blunt-ended and religated (Figure 4.6B). The correct clones were 
identified by digestion with a restriction enzyme (Ace I) which had lost a site during 
the procedure so that different sized bands were now produced. Sixteen new clones 
were identified (Figure 4.6B), and clones G5(1) and G5(5) were sequenced. The 
procedure resulted in the correct junction region and the establishment of a contiguous 
reading frame between the GAL4 domain sequence and gene 5 (Figure 4.6C). In 
addition, approximately 300 bp at the 5' end of gene 5 was compared with the original 
sequence data, and it was verified that the sequence was accurate. 
4.3.3 Cloning of a mutant gene 5 (gene L\5) into the DNA.binding domain vector 
pGBT9 to generate construct pGBT9·~5 
A truncated variant of gene 5, p9L\5, has been described (Tian et al., 1993). 
This gene 5 (L\5) variant has a single 308 bp deletion, between nucleotides 460 and 
768, in the centre of the wild-type gene 5 sequence. This deletion causes a frameshift 
in the gene, introducing a stop codon, so that a truncated protein consisting only of the 
amino-terminal third of the protein is produced. This variant was studied in addition 
to the full-length protein, as it contains the conserved regions of NSPl which are 
thought to be the functional domains (Xu et al., 1994). 
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Figure 4.5 Confirmation of correct cloning and orientation of the UKtc strain of 
bovine rotavirus gene 5 and gene ~ in pGBT9 
Clones suspected to contain gene 5 or gene M ligated into the MCS of pGBT9 were 
analysed by restriction enzyme double-digest with Xho I and Xba I to confirm the 
orientation of the insert. The products were analysed by electrophoresis on a 1.5 % 
TAE agarose gel (Section 3.4.3) (Panel A). The lane marked pGBT9 is the vector 
only, digested with the enzymes indicated. The lanes marked G5(7) and G5(10) are 
specific clones of pGBT9-gene 5, digested with the enzymes indicated. The lanes 
marked M(7) and M(10) are specific clones of pGBT9-gene M, digested with the 
enzymes indicated. Lanes marked L were loaded with 1 Kb DNA ladder. The sizes of 
the markers are given in base pairs. The predicted sizes of the fragments obtained 
with each digest are shown below. 
Plasmid Restriction Predicted fragment sizes (bp) 
enzyme digest correct orientation 
pGBT9 Xho I1 Xba I 4404 + 1096 
pGBT9-Gene 5 Xho I1 Xba I 4430, 1449 + 1200 
pGBT9-M Xho 11 Xba I 4430, 1209 + 1132 
Panel B is a schematic diagram to show cloning of gene 5 (1579 bp) and gene M 
(1271 bp) into pGBT9 (5500 bp). The EcoR I site (879 bp) and the Pst I site (905 bp) 
in the MCS of pGBT9 were used for cloning purposes. The positions of the other 
restriction enzyme sites in pGBT9 and gene 5 /gene M which were used for analysis 
are indicated. 
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Figure 4.6 Sequence analysis of the junction region of clone pGBT9-gene 5 
A. Sequence analysis of clone pGBT9-gene 5 [G5(7)] showing additional 
sequence at the junction region resulting in an out-of-frame ATG site 
Clone pGBT9-Gene 5 [G5(7)] DNA was amplified and purified by maxi-prep 
(Section 3.4.14) and sequenced using Primer 1 (Table 3.3) which recognizes 
sequence 31 bp upstream of the MCS start site in pGBT9 (Figure 4.1). Sequence 
analysis (Section 3.4.18) was performed to confirm the orientation and framing of 
gene 5 at the junction between the GAL4 domain sequence in pGBT9 and gene 5. 
The analysis revealed that additional sequence had been incorporated into the 
junction region between pGBT9 and gene 5. As a result the ATG site of gene 5 was 
out-of-frame with respect to the pGBT9 sequence. 
B. Cloning strategy to remove additional sequence and restore reading frame, 
and identification of new clones pGBT9-gene 5 
The presence of unique restriction sites EcoR I and Nco I at the junction region 
allowed the additional unwanted sequence to be precisely excised. The plasmid 
DNA was digested with EcoR I and Nco I and gel purified to remove the excised 
sequence. Following treatment with the Klenow fragment of E. coli DNA 
polymerase I to produce blunt ends (Section 3.4.8), the ends of the plasmid were re-
ligated (Section 3.4.10). 
EeoRI 
... 
TCG CCG GAA TIC ...... erA TGG 
Nco I 
Plasmid DNA from 21 independent clones was prepared by mini-prep (Section 
3.4.13), and positive clones were identified by re triction enzyme digest analysis 
with Ace I. The products were analysed by electrophoresis on a 1.5 % TAB agarose 
gel (Section 3.4.3). An Ace I site wa de troyed during the procedure to remove the 
extra equence, so digestion of the new clone with thi enzyme produced a 
different pattern of bands to the original clone: 
pGBT9-gene 5 [GS(7)] 
pGBT9-gene 5 new clones 
3800, 900, 860, 670, 500, 280 bp 
3800, 1500, 900, 500,280 bp 
Lanes marked L were loaded with 1 Kb ladder. The ize of the marker are given 
in base pairs. 
c. Sequence analysis of clone pGBT9-gene 5 [G5(1)new] 
Clone pGBT9-gene 5 [G5(l)new] DNA wa amplified and purified by maxi-prep 
(Section 3.4.14) and sequenced using Primer 1 a before. Sequence analysis 
(Section 3.4.18) was performed to confirm that the additional sequence had been 
successfully removed, and that the orientation and framing of gene 5 at the junction 
between the GAL4 domain sequence in pGBT9 and gene 5 wa now correct (Figure 
4.2). Approximately 300 bp of sequence at the 5' end of gene 5 was aJ 0 checked. 
Sequence analysis was repeated twice. 
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Gene ~5 was amplified from plasmid p9~5 by PCR using primers Gene 5/5' 
and Rotgen 5/3' (Figure 4.3) as described previously (Section 4.3.1). The primers 
which were used for the full length gene 5 could also be used for p9~5 as the deletion 
is in the centre of the gene while the 5' and 3' ends are conserved. The vector pGBT9 
was digested with EcoR I and Pst I and dephosphorylated with CIP. The amplified 
DNA was digested with EcoR I and Ps! I and ligated into the prepared vector pGBT9 
to generate a pGBT9-gene ~5 construct. Recombinant clones were screened by 
double-digestion with EcoR I and Ps! I which released the gene ~5 insert. Two clones 
containing gene 5 inserts were identified: ~5(7) and ~5( 10) (Figure 4.4). Further 
restriction enzyme digestions with Xho I and Xba I were performed to confirm the 
positive orientation of the gene ~5 insert with respect to the GAL4 domain sequence 
in pGBT9 in both clones (Figure 4.5). The junction region of ~5( 1 0) was sequenced, 
and it was confirmed that the reading frame between the GAL4 domain sequence and 
gene ~5 was maintained, ensuring the production of the desired fusion protein (Figure 
4.7). In addition, approximately 250 bp at the 5' end of gene ~5 was compared with 
the original sequence data, and it was verified that the sequence was accurate. 
4.3.4 Cloning of gene 5 into the activation domain vector pGAD424 to generate 
construct pGAD424-Gene 5 
A cDNA of gene 5 from the UKtc strain of bovine rotavirus was amplified by 
PCR using primers Gene 5/5' and Rotgen 5/3' (Figure 4.3) as described previously 
(Section 4.3.1). The vector pGAD424, which contains sequence encoding the GAL4 
activation domain, was digested with EcoR I and Pst I and dephosphorylated with 
CIP. The amplified DNA was digested with EcoR I and Pst I, and ligated into the 
prepared vector pGAD424 to generate construct pGAD424-gene 5. Two recombinant 
clones were identified by restriction enzyme digestion with EcoR I and Ps! I which 
released the gene 5 insert: pGAD424-gene5(l5) and pGAD424-gene5(18) (Figure 
4.8, Panel A). Further restriction enzyme digestion with Hind III was performed to 
confirm the orientation of the insert in pGAD424. Bands at 5900 bp and 2250 bp were 
produced, confirming the correct orientation of the gene 5 insert with respect to the 
GAL4 domain sequence in pGAD424-gene5(15) (Figure 4.8, Panel B). The junction 
region of pGAD424-gene5(l5) was sequenced to confirm that the reading frame 
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Figure 4.7 Sequence analysis of the junction region of clone pGBT9-gene .15 
Clone pGBT9-.15(1O) DNA was amplified and purified by maxi-prep (Section 
3.4.14) and sequenced using Primer I (Table 3.3) which recognizes sequence 31 bp 
upstream of the MCS start site in pGBT9 (Figure 4.1). Sequence analysis (Section 
3.4.18) was performed to confirm the orientation of gene .15, and the framing at the 
junction between the GAlA domain sequence in pGBT9 and gene .15. The EcoR I 
site preceding the ATG site of gene .15 was introduced by PCR and allowed the 
gene to be cloned, in frame, into pGBT9. The sequence analysis revealed that the 
reading frame was maintained (Figure 4.2). Approximately 250 bp at the 51 end of 
gene ~5 was compared with the original sequence data, and it was verified that the 
sequence was accurate. Sequence analysis was repeated twice. 
Figure 4.8 Identification of recombinant clones pGAD424-gene 5 by 
restriction enzyme digestion analysis 
Panel A. Plasmid DNA from 20 independent clones, created following the 
ligation reaction between pGAD424 and peR amplified gene 5, was prepared 
by mini-prep (Section 3.4.13) and double-digested with EcoR I and Pst I 
(Section 3.4.6). The products were analysed by electrophoresis on a 1.5 % T AE 
agarose gel (Section 3.4.3) (lanes 1-20). Double-digestion of pGAD424 with 
EcoR I and Pst I resulted in linearisation of the plasmid and a band at 6600 bp. 
Gene 5 inserted into pGAD424 was released by double digestion with EcoR I 
and Pst I resulting in bands at 6600 bp and 1579 bp. The arrow indicates the 
band at 1579 bp in lanes 15 and 18. 
Panel B. Clones 15 and 18 (as indicated in Panel A) were digested with EcoR 
IIPst I and Hind ill (Section 3.4.6) and analysed by electrophoresis on a l.5 % 
TAB agarose gel (Section 3.4.3). Digestion of pGAD424 with Hind III resulted 
in bands at 5900 bp and 695 bp. Digestion of clone G5(15) with Hind III 
resulted in bands at 5900 bp and 2250 bp. Lanes marked L were loaded with 1 
Kb DNA ladder. The sizes of the markers are given in base pairs. 
The schematic diagram (see below) shows the restriction enzyme sites EcoR I 
and Pst I in the MCS of pGAD424 which were used for cloning of gene 5. The 
position of the Hind ill sites in pGAD424 which were used for analysis are also 
shown. 
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between the GAL4 domain sequence and gene 5 was maintained, ensuring the 
production of the desired fusion protein (Figure 4.9). In addition, approximately 250 
bp at the 5' end of gene 5 was compared with the original sequence data, and it was 
verified that the sequence was accurate. 
4.4 Production of constructs to express viral core proteins as GAL4 domain 
fusion proteins 
4.4.1 Strategy for production of GAL4 domain fusion proteins with viral core 
proteins VPl, VP2 and VP3 
The genes encoding the viral core proteins VP 1 (gene 1), VP2 (gene 2) and 
VP3 (gene 3), were cloned into the vectors pGBT9 and pGAD424 in order to produce 
GAL4 domain fusion proteins. Fusions of each protein with both the GAL4 
DNA-binding domain and the GAL4 transcriptional activation domain were 
produced. The genes were cloned into both vectors to allow for the possibility that 
one of the rotavirus proteins under investigation had intrinsic transcriptional 
activating properties thereby negating the use of one of the vectors. 
A sub-cloning procedure was followed for each gene whereby, after PCR 
amplification of the gene, it was ligated directly into a TA vector without the need for 
restriction enzyme digestion (Figure 4.10). Each gene was then excised from the TA 
vector with the appropriate restriction enzymes and ligated into the two-hybrid 
vectors. This approach was found to be considerably more successful than attempting 
to ligate the PCR product directly into the two-hybrid vectors. 
The most important considerations in the production of the fusion proteins 
were that each gene was ligated into the MCS of the vectors in the correct orientation 
with respect to the GAL4 domain sequence, and that the reading frame was 
maintained. The orientation of each gene was ensured by using a forced cloning 
procedure, whcreby the genes were ligated into the MCS using specific restriction 
sites at the 5' and 3' ends. The genes were amplified by PCR using primers designed 
to introduce particular restriction sites which could then be used for cloning into the 
MCS of each vector. The sites were positioned such that, after ligation, the reading 
framc of the GAL4 domain sequence would be maintained and fusion proteins would 
be expressed. The junction regions, between the GAL4 domain sequence and the 5' 
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Figure 4.9 Sequence analysis of the junction region of clone pGAD424-gene 5 
Clone pGAD424-gene5(15) DNA was amplified and purified by maxi-prep 
(Section 3.4.14) and equenced using Primer 2 (Table 3.3) which recognizes 
sequence 56 bp upstream of the MCS start site in pGAD424 (Figure 4.1). 
Sequence analysis (Section 3.4.18) was performed to confirm the orientation of 
gene 5, and the framing at the junction between the GAL4 domain sequence in 
pGAD424 and gene 5. The EcoR I site preceding the ATG site of gene 5 was 
introduced by peR and allowed the gene to be cloned, in frame, into pGAD424. 
The sequence analysis revealed that the reading frame wa maintained (Figure 
4.2). Approximately 250 bp at the 5' -end of gene 5 was compared with the 
original sequence data, and it was verified that the sequence wa accurate. 
Sequence analysis was repeated twice. 
Figure 4.10 Sub-cloning strategy employed for cloning of the UKtc 
strain of bovine rotavirus genes into pT Ag and two-hybrid vectors 
pGBT9 and pGAD424 
An overview of the sub-cloning strategy used to clone rota virus genes I, 2, 
3 and 9, first into the TA vector pTAg, and subsequently into the two-hybrid 
cloning vectors, pGBT9 and pGAD424, is shown. The rotavirus genes were 
amplified by PCR using primers designed to introduce specific restriction 
sites to the 5' and 3' ends of the gene. The PCR amplified genes were ligated 
directly into pTAg by means of the single A overhangs added by the Taq 
enzyme during PCR amplification. The pT Ag vector has complementary T 
overhangs which can be used for direct ligation to the PCR product. If a 
proof-reading DNA polymerase (e.g. Pfu), which has a 3' to 5' exonuclease 
activity, is used for PCR amplification then the product will not have 3' A 
overhangs. However, the vector can still be used, provided a dA tailing 
reaction with Taq is performed after amplification. The pT Ag vector has a 
versatile polylinker (MCS) including the following restriction sites: EcoR I. 
BamH I, Mlu I, Pst I, Sph I, Kpn I (5' end); Sal I, Hind Ill, Xho I, Xba 1(3' 
end). The LacZ gene facilitates blue/white screening for recombinants. The 
presence of white colonies indicates interruption of the LacZ gene caused by 
the insertion of the gene into the vector. The vector has two selectable 
markers, ampicillin resistance (AmpR) and kanamycin resistance (KanR), 
which can be used as appropriate to avoid the selection of false positive 
colonies. The vector also contains the T7 promoter. 
The pT Ag clones were used for sub-cloning genes into the two-hybrid 
vectors pGBT9 and pGAD424. The genes were excised from pT Ag by 
cutting at the restriction sites introduced by PCR, and were cloned into the 
relevant restriction sites in the MCS of the two-hybrid vectors. This 
procedure ensured that the genes were cloned in frame into the two-hybrid 
vectors, with respect to the GAlA domain sequence. The orientation and 
framing of the inserts were analysed by restriction enzyme digestion and 
sequencing. 
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end of each rotavirus gene, were sequenced to ensure that the reading frames were 
correct. The data generated by this sequencing also allowed approximately 200-300 
bp at the 5' end of each cloned rotavirus gene to be checked against the original 
sequence data to ensure that it was correct. In addition, each rotavirus gene that was 
cloned into a TA vector was expressed in vitro to produce a full-length protein 
product of the expected size (Chapter 6). This data indicates that mutations encoding 
stop codons were not introduced during PCR of the rotavirus genes, and lends support 
to the assumption that full-length rotavirus proteins would be expressed as GAL4 
fusions following cloning into the two-hybrid vectors. 
4.4.2 Cloning of Gene 1 into pGBT9 and pGAD424 
A cDNA of gene 1 from the UKtc strain of bovine rotavirus, which encodes 
VP I, was amplified by PCR (Section 3.4.1) using primers Gene 1/5' and Gene 1/3' 
(Table 3.3). The Gene 1/5' primer was designed to introduce a specific restriction 
enzyme site, Sma I, to the 5' end of the gene immediately prior to the A TG start site. 
A Sma I restriction site is also present in the MCS of both yeast two-hybrid vectors, 
so it could be utilised for cloning purposes. The framing of the Sma I site, in relation 
to the ATG of gene 1 and the ORF of the GAL4 domain, was designed such that the 
reading frame would be maintained when gene 1 was cloned into either vector, 
resulting in the production of fusion proteins of the GAL4 domains with the gene 1 
product VP 1. The PCR amplified gene 1 was ligated directly into the pTAg vector 
using the Invitrogcn LigA Tor cloning kit (Section 3.4.16). This sub-cloning approach 
was followed as earlier attempts at direct cloning of gene 1 into pGAD424 were 
unsuccessful. A full-length protein product corresponding to VPl was expressed in 
vitro from pT Ag-gene I (Figure 6.12). Gene 1 was excised from pT Ag-Gene 1 by 
digestion with Sma I, which cuts at the 5' end of gene 1, and Xho I, which cuts at the 
3' end of gene 1. Vector pGAD424 was digested with Sma I and Sal I (Sal I and Xho I 
are compatible restriction sites). Gene 1 was ligated into the MCS of pGAD424 to 
generate clone pGAD424-gene 1. Recombinant clones were identified by 
Grunstein-Hogness colony hybridisation assay (Section 3.4.15), as the frequency of 
recombination appeared to be extremely low, and confirmed by restriction enzyme 
digestion with Sma I/ Pst I which released the gene 1 insert (Figure 4.11, Panel A). 
The orientation of gene 1 in the positive clones was confirmed by restriction enzyme 
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Figure 4.11 Analysis of pGAD424-Gene 1 by restriction enzyme digestion 
and sequencing of the junction region 
A. Restriction enzyme digestion analysis of pGAD424-gene 1 
Plasmid DNA from a clone created following the ligation of gene 1 into the Sma I 
and Sal I sites of pGAD424 was prepared by mini-prep (Section 3.4.13) and 
analysed by restriction enzyme digestion (Section 3.4.6). The products of the 
digests were analysed by electrophoresis on a 1.0 % T AE agarose gel (Section 
3.4.3). Lanes marked pGAD424 contain the vector dige ted with the enzymes 
indicated. Lanes marked G 1 contain the clone pGAD424-gene 1 dige ted with the 
enzymes indicated. Digestion of pGAD424 with Sma IIPst Ilineari e the plasmid 
(6600 bp). Digestion of pGAD424-gene 1 with Sma IIPst I releases the insert 
(6600 bp and 3300 bp). Digestion of pGAD424 with EcoR I linearise the plasmid 
(6600 bp). Predicted band sizes for digestion of pGAD424-gene 1, containjng 
positively orientated gene 1, with EcoR I are 8400 bp, 850 bp and 650 bp. Lanes 
marked L were loaded with 1 kb DNA ladder. The size of the marker are given 
in base pairs. 
pGAD424 
6600 bp PstI (860) 
B. Sequence analysis of pGAD424-gene 1 junction region 
The junction region of plasmid pGAD424-genel [6(1)] at the 5' end of gene 1 was 
sequenced (Section 3.4.18) using Primer 2 (Table 3.3) to en ure the correct 
framing for the production of the desired fusion protein. An original sequence 
trace and a schematic diagram of the junction region are shown. The equence at 
the junction region, wIDch includes the GAL4 activation domain sequence (blue 
on the schematic diagram), the UKtc gene 1 sequence (yellow) and the Sma I 
cloning site (red) which was used to produce the in-frame clone, is shown. The 
ATG start site in gene 1 is underlined in bold. Approximately 300 bp of equence 
at the 5' end of gene 1 was also checked in tIDS analysis. The equence analysis 
was repeated at least twice to confirm the sequence of the junction region. 
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digestion analysis with EcoR 1. Bands of 8400 bp, 850 bp and 650 bp were produced 
when the orientation of the gene 1 insert was correct (Figure 4.11, Panel A). The 
junction region was sequenced to confirm that the reading frame between the GAL4 
domain sequence and gene 1 was maintained, ensuring the production of the desired 
fusion protein (Figure 4.11, Panel B). In addition, approximately 300 bp at the 5' end 
of gene 1 was also sequenced and checked against the original sequence (data not 
shown). 
Plasmid pGBT9-Gene 1 was produced by sub-cloning from pGAD424-Gene 
1. Gene 1 was excised from pGAD424-Gene 1 by Sma I (5' end) and Pst I (3' end). 
Vector pGBT9 was digested with Sma I and Pst I and dephosphorylated with shrimp 
alkaline phosphatase (SAP) (Section 3.4.6). Gene 1 was then ligated into pGBT9 to 
generate clone pGBT9-Gene 1. Recombinant clones were screened and identified by 
restriction enzyme digestion with Sma If Pst I which released the insert (Figure 4.12, 
Panel A). The orientation of gene 1 in the positive clones was confirmed by restriction 
enzyme digestion with separate reactions of EcoR I and EcoR V. The reactions with 
EcoR I (bands of 7300 bp, 860 bp and 640 bp) and EcoR V (bands of 7400 bp and 
1400 bp) confirmed the positive orientation of the gene 1 insert in the two clones 
(Figure 4.12, Panel A). The junction region was sequenced to confirm that the reading 
frame between the GAL4 domain sequence and gene 1 was maintained, ensuring the 
production of the desired fusion protein (Figure 4.12, Panel B). In addition, 
approximately 300 bp at the 5' end of gene 1 was also sequenced and checked against 
the original sequence (data not shown). 
4.4.3 Cloning of Gene 2 into pGBT9 and pGAD424 
A cDNA of gene 2 from the UKtc strain of bovine rotavirus, which encodes 
VP2, was amplified by PCR (Section 3.4.1) using primers Gene 2/5' and Gene 2/3' 
(Table 3.3). The Gene 2/5' primer was designed to introduce an EcoR I restriction site 
to the 5' end of gene 2 immediately prior to the ATG start site. An EcoR I site is also 
present in the MCS of both of the yeast two-hybrid vectors. The framing of the EcoR 
I site, in relation to the ATG of gene 2 and the ORF of the GAL4 domain, was 
designed to maintain the reading frame when gene 2 was cloned into either vector, 
resulting in the production of fusion proteins of the GAL4 domains with the gene 2 
product VP2. The PCR amplified gene 2 was ligated directly into the pT Ag vector 
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Figure 4.12 Analysis of pGBT9-Gene 1 by restriction enzyme digestion and 
sequencing of the junction region 
A. Restriction enzyme digestion analysis of clone pGBT9-Gene 1 
Plasmid DNA from the sub-cloning of gene 1 into the Sma I (5' end) and Sal I 
(3' end) sites of pGBT9 was prepared by mini-prep (Section 3.4.13) and 
analysed by restriction enzyme digestion (Section 3.4.6). The product of the 
digests were analysed by electrophoresis on a 1.0 % T AE agarose gel (Section 
3.4.3). The lane marked pGBT9 contains the vector digested with Sma 11 Pst I. 
Lanes marked G1 contain the clones of pGBT9-gene l [GI (5); G1(6)] digested 
with the enzymes indicated. Digestion of pGBT9 with Sma 11 Pst 1 lineari es the 
plasmid (5500 bp). Digestion of pGBT9-gene1 with Sma IIPst 1 relea es the 
insert (5500 bp and 3300 bp). Predicted band sizes for dige tion of pGBT9-
gene1 , containing positively orientated gene 1, with EcoR I are 7300 bp, 860 bp 
and 640 bp. Predicted band sizes for digestion of pGBT9-gene I, containing 
positively orientated gene 1, with EcoR V are 7400 bp and 1400 bp. Lane 
marked L were loaded with 1 kb DNA ladder. The ize of the marker are 
given in base pairs. 
pGBT9 
5500 bp 
I Gene 1 - 3302 bPI 
RI (639) 
__ .o.;."vR V (2580) 
B. Sequence analysis of pGBT9-Gene 1 junction region. 
The junction regions of both clones [G1(S); G1 (6)] ofpJa mid pGBT9-gene1 at 
the 5 ' end of gene 1 was sequenced (Section 3.4.18) u ing Primer 1 (Table 3.3) 
to ensure the correct framing for the production of the de ired fu ion protein. 
An original sequence trace of G1(S), and a schematic diagram of the junction 
region are shown. The sequence at the junction region, which include the 
GAlA DNA-binding domain equence (blue on the chematic diagram), the 
UKtc gene 1 sequence (yellow) and the Sma I cloning ite (red) which was 
used to produce the in-frame clone, i shown. The ATG tart ite in gene 1 i 
underlined in bold. Approximately 300 bp of equence at the 5' end of gene 1 
was also checked in this analysis. The sequence analy i was repeated at lea t 
twice to confirm the junction region sequence. 
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using the Invitrogen LigATor cloning kit (Section 3.4.16). This sub-cloning approach 
was followed as earlier attempts to directly clone gene 2 into pGAD424 were 
unsuccessful. This produced clones with inserts ligated into pTAg in both a positive 
and negative orientation. Plasmid pTAg-gene2, containing gene 2 in a positive 
orientation, was used for in vitro expression studies and a full-length protein product 
corresponding to VP2 was produced indicating that no deleterious mutations were 
introduced during PCR (Figure 6.11). A clone containing gene 2 in the negative 
orientation in pT Ag was used for the sub-cloning procedure into pGAD424. To excise 
the insert the clone was digested with EcoR I since it cuts at the 5' end of PCR 
amplified gene 2 and also in the MCS of pTAg at the 3' end of gene 2 when in the 
negative orientation. Vector pGAD424 was digested with EcoR I and 
dephosphorylated with CIP. Gene 2, digested with EcoR I, was then ligated into the 
EcoR I site of pGAD424 to generate clone pGAD424-gene 2. Recombinant clones 
were screened and identified by restriction enzyme digestion analysis. A clone 
containing gene 2 was identified by digestion with EcoR I which released the insert 
(Figure 4.13, Panel A). The positive orientation of gene 2, with respect to the GAL4 
domain sequence in pGAD424, was then confirmed by carrying out further restriction 
enzyme digestions. Digestion with EcoR V (bands of 5900 bp and 3400 bp), EcoR 
UPst I (bands of 6600 bp, 1900 bp and 800 bp) and Cia UMiu I (bands of 4800 bp, 
3600 bp and 800 bp) identified the correct orientation of gene 2 in clone 
pGAD424-gene 2 (Figure 4.13, Panel A). The junction region was sequenced to 
confirm that the reading frame between the GAL4 domain sequence and gene 2 was 
maintained, ensuring the production of the desired fusion protein (Figure 4.13, Panel 
B). The nucleotide sequence of the gene 2 insert was compared with the published 
sequence for gene 2 from the UKtc strain of bovine rotavirus (Tian et al., 1990). 
Nucleotide sequence variation, resulting in three amino acid changes at the 
amino-terminus, was found in the gene 2 insert compared to the published sequence. 
These changes were probably introduced during the PCR amplification of gene 2. 
However, these three amino acid changes were present in the gene 2 sequence from 
the SA 11 strain of simian rotavirus, suggesting that this Iow level of sequence 
variability is acceptable. 
Plasmid pGBT9-Gene 2 was produced by sub-cloning from pGAD424-Gene 
2. Gene 2 was excised from pGAD424-Gene 2 by digestion with EcoR I. Vector 
pGBT9 was digested with EcoR I and dephosphorylated with SAP (Section 3.4.6). 
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Figure 4.13 Analysis of pGAD424-Gene 2 by restriction enzyme digestion 
and sequencing of the junction region 
A. Restriction enzyme digestion analysis of pGAD424-Gene2 [G2(lO)] 
Plasmid DNA from a clone [G2(1O)] created following the ligation of gene 2 
into the EcoR I site of the MCS of pGAD424, was prepared by mini-prep 
(Section 3.4.13) and digested with combinations of restriction enzymes (Section 
3.4.6). The products of the digests were analysed by electrophoresis on a 0.8 % 
TAE agarose gel (Section 3.4.3). Lanes marked pGAD424 contain the vector 
only digested with the enzymes indicated. Lanes marked G2 contain pGAD424-
gene 2 [G2(1O)] digested with the enzymes indicated. Digestion of pGAD424 
with EcoR I linearises the plasmid (6600 bp). Digestion of pGAD424-gene 2 
with EcoR I releases the insert (6600 bp and 2700 bp). Predicted band sizes for 
digestion of pGAD424-gene 2 containing positively orientated gene 2, with 
EcoR V are 5900 bp and 3400 bp, and with EcoR V PS! I are 6600 bp, 1900 bp 
and 800 bp. Digestion of pGAD424 with Cia V MLu I re ults in band of 4800 
bp and 1800 bp. Predicted band sizes for digestion of pGAD424-gene 2 
containing positively orientated gene 2, with Cia V Mlu I are 4800 bp, 3600 bp 
and 800 bp. Lanes marked L were loaded with 1 kb DNA ladder. The izes of 
the markers are given in base pairs. 
Mlu I EcoRI 
(72~ 
pGAD424 
6600 bp EcoR I (834) PSi 1(860) 
B. Sequence analysis of pGAD424-Gene2 junction region 
The junction region of plasmid pGAD424-gene2 [G2(1O)] at the 5' end of gene 
2 was sequenced (Section 3.4.18) using Primer 2 (Table 3.3) to ensure the 
correct framing for the production of the desired fu ion protein. An original 
sequence trace and a schematic diagram of the junction region are shown. The 
sequence at the junction region, which includes the GAlA activation domain 
sequence (blue on the schematic diagram), the UKtc gene 2 sequence (yellow) 
and the EcoR I cloning site (red) which was used to produce the in-frame clone, 
is shown. The ATG start site in gene 2 is underlined in bold. Approximately 250 
bp of sequence at the 5' end of gene 2 was also checked in this analysis. The 
sequence analysis was repeated at least twice to confirm the junction region 
sequence. 
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Gene 2 was then ligated into the EcoR I site of the MeS of pGBT9 to generate clone 
pGBT9-Gene 2. Recombinant clones were screened and identified by restriction 
enzyme digestion with EcoR I which released the insert (Figure 4.14, Panel A). A 
clone containing gene 2 in a positive orientation, with respect to the GAlA domain 
sequence in pGBT9, was identified by digestion with EcoR V which produced bands 
sized 5200 bp and 3000 bp with the correct pGBT9-gene 2 clone (Figure 4.14, Panel 
B). The junction region was sequenced to confirm that the reading frame between the 
GAlA domain sequence and gene 2 was maintained, ensuring the production of the 
desired fusion protein (Figure 4.14, Panel e). In addition, approximately 350 bp at the 
5' end of gene 2 was also sequenced and checked against the original sequence (data 
not shown). 
4.4.4 Cloning of Gene 3 into pGBT9 and pGAD424 
A cDNA of gene 3 from the UKtc strain of bovine rotavirus was amplified by 
peR (Section 3.4.1) from plasmid pGS62-gene 3 with primers Gene 3/5' and Gene 
3/3' (Table 3.3). The Gene 3/5' primer was designed to introduce a BamH I restriction 
site at the 5' end of gene 3, immediately prior to the ATG start site. A BamH I site is 
also present in the Mes of both of the yeast two-hybrid vectors. The framing of the 
BamH I site, in relation to the ATG of gene 3 and the ORF of the GAlA domain, was 
designed to maintain the reading frame when gene 3 was cloned into either vector, 
resulting in the production of fusion proteins of the GAlA domains with the gene 3 
product VP3. The peR amplified gene 3 was ligated directly into the pTAg vector 
using the Invitrogen LigA Tor cloning kit (Section 3.4.16). This sub-cloning approach 
was followed as earlier attempts to directly clone gene 3 into pGAD424 were 
unsuccessful. A full-length protein product corresponding to VP3 was expressed in 
vitro from pT Ag-gene3 (Figure 6.15), indicating that no deleterious mutations were 
introduced during peR. To sub-clone gene 3 into pGAD424, the gene was excised 
from pT Ag by restriction enzyme digestion with BamH I (5' end) and Bgl 11 (3' end). 
Vector pGAD424 was digested with BamH I and Bgl 11 and de phosphorylated with 
SAP. The digested gene 3 was ligated into the MeS of pGAD424 to generate a 
pGAD424-gene 3 construct. Recombinant clones were identified by restriction 
enzyme digestion analysis. Digestion with enzymes BamH I plus Bgl 11 linearised all 
the recombinant plasmids rather than releasing the gene 3 insert as expected. This 
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Figure 4.14 Analysis of pGBT9-Gene2 by restriction enzyme digestion and 
sequencing of the junction region 
A. Identification of clones containing the gene 2 insert by restriction enzyme 
digestion with EcoR I 
Plasmid DNA from the sub-cloning of gene 2 into the EcoR I site of the MCS of 
pGBT9 was prepared by mini-prep (Section 3.4.13) and dige ted with EcoR I 
(Section 3.4.6). The products of the digests were analysed by electrophoresis on a 
1.0 % TAB agarose gel (Section 3.4.3). The lane marked pGBT9 contains the 
vector digested with EcoR I (5500 bp). Lanes 1-10 contain pia mid DNA from the 
sub-cloning digested with EcoR 1. Digestion with EcoR I linearises pGBT9 (5500 
bp) and releases the gene 2 insert (5500bp and 2700 bp). The identity of the 3.5kb 
bands in lanes 3 and 8 was not determined and this plasmid DNA was discarded. 
Lanes marked L were loaded with 1 kb DNA ladder. The sizes of the markers are 
given in base pairs. 
B. Determination of the orientation of the gene 2 insert in pGBT9 by 
restriction enzyme digestion with EcoR V 
Plasmid DNA, as described above (A), was digested with EcoR V (Section 3.4.6). 
The products of the digests were analysed by electrophore i on a 1.0 % T AE 
agarose gel. The lane marked pGBT9 contains the vector dige ted with EcoR V 
(5500 bp). Lanes 1,2 and 4-6 contain plasmid DNA from the sub-cloning dige ted 
with EcoR V. The predicted band sizes for digestion of pGBT9-gene 2 with EcoR 
V are 5200 bp and 3000 bp (positive orientation) and 7200 bp and 1000 bp 
(negative orientation). 
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c. Sequence analysis of pGBT9-Gene2 junction region 
The junction region of plasmid pGBT9-gene2 [G2(2)] at the 5' end of gene 2 was 
sequenced (Section 3.4.18) using Primer 1 (Table 3.3) to en ure correct framing 
for the production of the desired fusion protein. An original equence trace and a 
schematic diagram of the junction region are shown. The sequence at the junction 
region, which includes the GAL4 DNA-binding domain equence (blue in the 
schematic diagram), the UKtc gene 2 sequence (yellow) and the EcoR I cloning 
site (red) which was used to produce the in-frame clone, i hown. The ATG start 
site in gene 2 is underlined in bold. The nucleotide at po ition 55 on the equence 
trace has been incorrectly assigned and should be A. Approximately 350 bp of 
sequence at the 5' end of gene 2 was also checked in this analysis. The equence 
analysis was repeated at least twice to conftrm the junction region equence. 
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suggested that one of the enzyme sites in the recombinant plasmids had been 
destroyed. Digestion with enzymes Bgl 11 plus EcoR I produced bands consistent with 
an EcoR I only digest, suggesting that the Bgl 11 site, which should lie at the 3' end of 
gene 3 in the recombinant plasmids, had been destroyed during the cloning procedure. 
Hence, a series of digests with other restriction enzymes were used to identify positive 
clones. Clones containing gene 3 in a positive orientation, with respect to the GAL4 
domain sequence in pGAD424, were identified by restriction enzyme digestion 
analysis with BamH I!Sph I (bands 5200 bp, 3200 bp and 800 bp) and EcoR 1(7200 
bp and 1800 bp) (Figure 4.15, Panel A). The junction region was sequenced to 
confirm that the reading frame between the GAL4 domain sequence and gene 3 was 
maintained, ensuring the production of the desired fusion protein (Figure 4.15, Panel 
B). In addition, approximately 250 bp at the 5' end of gene 3 was also sequenced and 
checked against the original sequence (data not shown). 
Plasmid pGBT9-Gene 3 was produced by sub-cloning from pGAD424-Gene 
3. Gene 3 was excised from pGAD424-Gene 3 by digestion with BamH I (5' end) and 
Pst I (3' end). Vector pGBT9 was digested with BamH I and Pst I and 
dephosphorylated with SAP (Section 3.4.6). Gene 3 was ligated into the MCS of 
pGBT9 to generate a pGBT9-gene 3 construct. Recombinant clones were screened 
and identified by restriction enzyme digestion with BamH I!Pst I which released the 
insert (Figure 4.16, Panel A). Clones containing gene 3 in a positive orientation, with 
respect to the GAL4 domain sequence in pGBT9, were identified by digestion with 
EcoR I which produced bands sized 6100 bp, 1900 bp and 180 bp with the correct 
pGBT9-gene 3 clones (Figure 4.16, Panel A). The junction region was sequenced to 
confirm that the reading frame between the GAL4 domain sequence and gene 3 was 
maintained, ensuring the production of the desired fusion protein (Figure 4.16, Panel 
B). In addition, approximately 250 bp at the 5' end of gene 3 was also sequenced and 
checked against the original sequence (data not shown). 
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Figure 4.15 Analysis of pGAD424-Gene 3 by restriction enzyme digestion 
and sequencing of the junction region 
A. Restriction enzyme digestion analysis of clone pGAD424-Gene3 
Plasmid DNA from a clone created following the ligation of gene 3 into the 
BamH I and BgI IT sites of the MCS of pGAD424 was prepared by mini-prep 
(Section 3.4.13) and analysed by restriction enzyme digestion (Section 3.4.6). 
The products of the digests were analysed by electrophore i on a 0.8 % TAB 
agarose gel (Section 3.4.3). Lanes marked pGAD424 contain the vector digested 
with the enzymes indicated. Lanes marked G3 contain the clone pGAD424-gene 
3 digested with the enzymes indicated. Digestion of pGAD424 with BamH IJSph 
I results in bands of 5200 bp, 800 bp and 600 bp. Predicted band ize from the 
digestion of pGAD424-gene 3, containing po itively orientated gene 3, with 
BamH IJSph I are 5200 bp, 3200 bp and 800 bp. Dige tion of pGAD424 with 
EcoR I linearises the plasmid (6600 bp). Predicted band ize from the dige tion 
of pGAD424-gene 3, containing po itively orientated gene 3, with EcoR I are 
7200 bp, 1800 bp and 150 bp. Lanes marked L were loaded with 1 kb DNA 
ladder. The sizes of the markers are given in ba e pajr . 
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6600 bp 
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B. Sequence analysis of pGAD424-Gene 3 junction region 
The junction region of plasmid pGAD424-gene3 [G3(4)) , at the 5' end of gene 3, 
was sequenced (Section 3.4.18) using Primer 2 (Table 3.3) to en ure the correct 
framing for the production of the desired fu ion protein. An original equence 
trace and a schematic diagram of the junction region are hown. The equence at 
the junction region, which includes the GAIA activation domain equence (blue 
on the schematic diagram), the UKtc gene 3 equence (yellow) and the BamH I 
cloning site (red) which was used to produce the in-frame clone, i hown. The 
ATG start site in gene 3 is underlined in bold. Approximately 250 bp of equence 
at the 5' end of gene 3 was also checked in thi analy i . The equence analy is 
was repeated at least twice to confirm the junction region equence. 
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Figure 4.16 Analysis of pGBT9-Gene 3 by restriction enzyme digestion and 
sequencing of the junction region 
A. Restriction enzyme digestion analysis of clone pGBT9-Gene 3 
Plasmid DNA from the sub-cloning of gene 3 into the BamH I (5' end) and Pst I 
(3' end) sites of the MCS of pGBT9 wa prepared by mini-prep (Section 3.4.13) 
and analysed by restriction enzyme dige tion (Section 3.4.6). The product of the 
digests were analysed by electrophore i on a 1.0 % T AE agaro e gel (Section 
3.4.3). The lane marked pGBT9 contain the vector dige ted with BamH UPst I. 
Lanes marked G3(2) and G3(3) contain clone of pGBT9-gene3 dige ted with the 
enzymes indicated. Digestion of pGBT9 with BamH UPst I lineari e the pIa mid 
(5500 bp). Digestion of pGBT9-gene3 with BamH UPst 1 relea e the in ert 
(5500 bp and 2590 bp). Predicted band ize from the dige tion of pGBT9-gene 
3, containing po itively orientated gene 3, with EcoR I are 6100 bp, 1900 bp and 
180 bp. The 180 bp band is too faint to be een on thi gel. Lane marked L were 
loaded with 1 kb DNA ladder. The ize of the marker are given in base pair . 
pGBT9 
5500 bp 
B. Sequence analysis of pGBT9-Gene 3 junction regi n 
The junction region of pIa mid pGBT9-gene3 [G3(2)] , at the 5' end f gene 3, 
wa sequenced (Section 3.4.18) u ing Primer 1 (Table 3.3) to en ur the c rrect 
framing for the production of the de ired fu ion pr tein. An rigin I equence 
trace and a chematic diagram of the junction regi n are h wn. The equence at 
the junction region, which include the GAlA D A-binding d main equence 
(blue on the chematic diagram), the UKtc gene 3 equence (yell w) and the 
BamH I cloning ite (red) which wa u ed to pr duce the in-fr me cl ne, i 
hown. The ATG tart ite in gene 3 i underlined in Id. Appr ximately 250 bp 
of sequence at the 5' end of gene 3 w al 0 checked in thi an ly i . The 
sequence analy i wa repeated at lea t twice to confirm the juncti n regi n 
sequence. 
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4.5 Production of constructs to express rotavirus protein NSP3 as GAL4 domain 
fusion proteins 
4.5.1 Strategy for production of GAL4 domain fusion proteins with NSP3 
A cDNA of gene 9 from the UKtc strain of bovine rotavirus, which encodes 
the rotavirus non-structural protein NSP3, was used to produce NSP3-GAL4 domain 
fusion proteins. The PCR amplified gene 9 sequence was initially ligated directly into 
the TA vector pCR2.1 ™ (lnvitrogen) and the rotavirus cDNA was then sub-cloned 
into the two-hybrid vectors pGBT9 and pGAD424 to create fusion proteins with the 
GAL4 DNA-binding and transcriptional activation domains respectively. The same 
considerations made when cloning the viral core proteins (Section 4.4.1), which were 
the correct orientation of the cloned rotavirus cDNA with respect to the GAL4 
domain sequence and the maintenance of the reading frame, were also applied here. In 
addition, sequence at the 5' end of gene 9 was also checked to ensure that errors had 
not been introduced during PCR amplification of the gene. 
The NSP3-GAL4 domain fusion proteins were created to investigate the 
hypothesis that NSP3 interacts with NSPl. Both proteins are found in the pre-core RI 
in the rotavirus-infected cell and it was postulated that an interaction could occur 
between them. In addition, previous work suggested that NSP3 formed dimers in the 
infected cell (Mattion et al., 1992). The two-hybrid system could be used to 
demonstrate a direct, independent self-interaction of NSP3, and this could then be 
used as an internal positive control in the two-hybrid assay screen for further rotavirus 
protein-protein interactions. NSP3-GAL4 domain fusion proteins were created with 
both GAL4 domains such that the dimerisation of NSP3 could be investigated. 
4.5.2 Cloning of gene 9 into pGBT9 and pGAD424 
A cDNA of gene 9 from the UKtc strain of bovine rotavirus was amplified by 
PCR (Section 3.4.1) from plasmid pGS62-gene 9 with primers Gene 9/5' and Gene 
9/3' (Table 3.3). The Gene 9/5' primer was designed to introduce BamH I and Pst I 
restriction enzyme sites to the 5' end of gene 9. These restriction enzyme sites are also 
present in the MCS of both of the yeast two-hybrid vectors. The framing of the 
restriction sites in relation to the ATG of gene 9 and the ORF of the GAL4 domain 
was designed to maintain the reading frame when gene 9 was cloned into either 
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vector, resulting in the production of fusion proteins of the GAL4 domains with the 
gene 9 product NSP3. The PCR amplified gene 9 was ligated directly into the 
pCR2.1 ™ TA vector using the Invitrogen PCR cloning kit (Section 3.4.16) and 
positive clones containing the insert were identified by restriction enzyme digestion 
analysis. 
Plasmids pGBT9-gene 9 and pGAD424-gene 9 were produced by sub-cloning 
from the TA vector containing gene 9. The Pst I sites at the 5' end and 3' end of gene 
9, which were introduced by PCR, were used for cloning into the two-hybrid vectors. 
However, gene 9 could not be excised from the TA vector with Pst I as digestion of 
the TA vector with this enzyme produced a band of a similar size to gene 9, which 
made gel purification of the gene difficult. Hence, gene 9 was initially excised from 
the TA vector by digestion with BstX I which produced a uniquely sized band. Gene 9 
was then digested with Pst I to produce the correct ends for ligation into the 
two-hybrid vectors. Vector pGBT9 was digested with PSI I and dephosphorylated 
with SAP (Section 3.4.6). Gene 9 was ligated into the Pst I site of pGBT9 to generate 
clone pGBT9-gene 9. Recombinant clones were screened and identified by restriction 
enzyme digestion with Pst I which released the insert (Figure 4.17, Panel A). Clones 
containing gene 9 in a positive orientation, with respect to the GAL4 domain 
sequence in pGBT9, were identified by digestion with EcoR I which produced bands 
sized 5725 bp and 825 bp with the correct pGBT9-gene 9 clones (Figure 4.17, Panel 
A). The junction region was sequenced to confirm that the reading frame between the 
GAL4 domain sequence and gene 9 was maintained, ensuring the production of the 
desired fusion protein (Figure 4.17, Panel B). In addition, approximately 100 bp at the 
5' end of gene 9 was also sequenced and checked against the original sequence (data 
not shown). 
Plasmid pGAD424-gene 9 was produced as described for pGBT9-gene 9, by 
cloning gene 9 into the Pst I site of vector pGAD424. Recombinant clones were 
screened and identified by restriction enzyme digestion with Pst I which released the 
insert (Figure 4.18, Panel A). Clones containing gene 9 in a positive orientation, with 
respect to the GAL4 domain sequence in pGAD424, were identified by digestion with 
EcoR I which produced bands sized 6825 bp and 825 bp with the correct 
pGAD424-gene 9 clones (Figure 4.18, Panel A). The junction region was sequenced 
to confirm that the reading frame between the GAL4 domain sequence and gene 9 
was maintained, ensuring the production of the desired fusion protein (Figure 4.18, 
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Figure 4.17 Analysis ofpGBT9-Gene 9 by restriction enzyme digestion and 
sequencing of the junction region 
A. Restriction enzyme digestion analysis of clone pGBT9-Gene 9 
Plasmid DNA from the sub-cloning of gene 9 into the PS! I site in the MCS of 
pGBT9 was prepared by mini-prep (Section 3.4.13) and analysed by restriction 
enzyme digestion (Section 3.4.6). The products of the dige ts were analy ed by 
electrophoresis on a 1.0 % TAE agarose gel (Section 3.4.3). The lanes marked 
pGBT9 contain the vector digested with the enzymes indicated. Lane marked 
G9 contain clones of pGBT9-gene9 dige ted with the enzyme indicated. 
Digestion of pGBT9 with PS! I or EcoR I linearise the plasmid (5500 bp). 
Digestion of pGBT9-gene 9 with Ps! I releases tbe in ert (5500 bp and 1076 bp). 
Predicted band sizes from the digestion of pGBT9-gene 9 with EcoR I are 5725 
bp and 825 bp (positive orientation; clones 3, 6, and 7) and 6300 bp and 250 bp 
(negative orientation; clones 8 and 9). Lane marked L were loaded with I kb 
DNA ladder. The sizes of the markers are given in ba e pair. 
pGBT9 
5500 bp 
I Gene 9 - 1076 bPI 
Psi 1 (905) 
B. Sequence analysis of pGBT9-Gene 9 junction region 
The junction region of plasmid pGBT9-gene9 [G9(3)] , at the 5' end of gene 9, 
was sequenced (Section 3.4.18) using Primer 1 (Table 3.3) to en ure the correct 
framing for the production of the desired tu ion protein. An original equence 
trace and a schematic diagram of the junction region are hown. The equence at 
the junction region, which includes the GAlA DNA-binding domain equence 
(blue on the schematic diagram), the UKtc gene 9 sequence (yellow) and the Ps! I 
cloning site (red) which was used to produce the in-frame clone, is hown. The 
ATG start site in gene 9 is underlined in bold. The nucleotide at po ition 56 and 
57 on the sequence trace have been incorrectly a igned and hould read C and 
G. Approximately 100 bp of sequence at the 5' end of gene 9 wa al 0 checked in 
this analysis. The sequence analysis was repeated at least twice to confirm the 
junction region sequence. 
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Figure 4.18 Analysis of pGAD424-Gene 9 by restriction enzyme digestion 
and sequencing of the junction region 
A. Restriction enzyme digestion anaJysis of clone pGAD424-Gene 9 
Plasmid DNA from clones created following the ligation of gene 9 into the Pst I 
site of the MCS of pGAD424, was prepared by mini-prep (Section 3.4.13) and 
analysed by restriction enzyme digestion (Section 3.4.6). The product of the 
digests were analysed by electrophore i on a 1.0 % T AE agaro e gel (Section 
3.4.3). Lanes marked pGAD424 contain the vector dige ted with the enzyme 
indicated. Lanes marked G9 contain clone of pGAD424-gene9 dige ted with the 
enzymes indicated. Digestion of pGAD424 with Pst I or EcoR I lineari e the 
plasmid (6600 bp). Digestion of pGAD424-gene 9 with P t I release the in ert 
(6600 bp and 1076 bp). Predicted band ize from the dige tion f pGAD424-
gene 9 with EcoR I are 6825 bp and 825 bp (po itive orientation; clone 3, 4, 7 
and 10) and 7400 bp and 250 bp (negative orientation; clone 2 and 9). One clone 
had bands at both 825 bp and 250 bp (clone 6). Lane marked L were I aded with 
1 kb DNA ladder. The size of the marker are given in b e pair . 
pGAD424 
6600 bp 
I Gene 9 - 1076 bPI 
Pt I (860) 
B. Sequence analysis of pGAD424-Gene 9 junction region 
The junction region of pIa mid pGAD424-gene9 [G9(3)], at rh 5' nd f gene 9, 
was sequenced (Section 3.4.18) u ing Primer 2 (Table 3.3) t en ure the c rrect 
framing for the production of the d ired fu ion pr tein. An riginal quence 
trace and a schematic diagram of the junction regi n are h wn. The equence at 
the junction region , which include the GALA activati n d main e uence (blue 
on the schematic diagram), the UKtc gene 9 equence (yell w) nd the P t I 
cloning ite (red) which wa u ed to produce the in-fr me cl ne, i hown. The 
ATG start site in gene 9 i underlined in bold. The nucleotide at p ilion 57-60 
on the sequence trace have been incorrectly igned nd h uld all read A. 
Approximately 50 bp of equence at the 5' end of gene 9 wa al checked in thi 
analy is. The equence analy i w repeated at lea t twice t c nfirm the 
junction region equence. 
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B. pGAD424-Gene 9 junction region sequence 
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Panel B). In addition, approximately 50 bp at the 5' end of gene 9 was also sequenced 
and checked against the original sequence (data not shown). 
4.6 Conclusions 
This chapter describes the cloning of rota virus genes from the UKtc strain of 
bovine rotavirus into the yeast two-hybrid vectors (pGBT9 and pGAD424) to create 
constructs which could express fusion proteins of the GAL4 DNA-binding and 
activation domains with the proteins VPI (gene 1), VP2 (gene 2), VP3 (gene 3), 
NSP 1 (gene 5) and NSP3 (gene 9). A complete list of all the clones generated is given 
(Table 4.1). The constructs created were all analysed by restriction enzyme digestion 
to ensure the correct orientation of the insert. The junction region between the GAL4 
domain and the rotavirus gene in each case was sequenced to ensure that the reading 
frame was maintained and thus the relevant fusion protein would be produced. 
Sequence at the 5' end of each rotavirus gene was checked against the original 
sequence data to ensure that no deleterious mutations had been introduced during 
PCR amplification. Further, the expression of some of the PCR amplified rotavirus 
genes was verified in an in vitro expression system when full-length proteins of the 
appropriate size were produced. 
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Table 4.1 Identification of clones generated during construction of plasmids for use 
in the yeast two-hybrid assay 
Plasmids Total clones Identification Sequence data Additional notes 
generated 
pGBT9-gene5 2 GS(7) Both clones GS(7) used for 
GS(10) contained subsequent cloning 
additional to produce correct 
sequence at S'-end S'-end 
16 GS(1);GS(2); All clones had GS(1) used for 
GS(S);GS(7);G5(9) correct S'-end and assays 
junction region 
pGBT9-genedS 2 ~S(7);~5(1O) ~5(10)-correct ~5(1O) used in 
junction region assays 
pGAD424-gene5 2 GS(lS); G5(18) GS( 15)-correct GS(15) used in 
junction region assays 
pTAg-gene1 6 G 1(6):(8):(12): - G 1 (8) used for 
(14):(1S):(17). sub-cloning 
pGAD424-genel 1 Clone 6: 6(1); 6(2) 6(1)-correct Clone 6 identified 
junction region by Grunstein assay 
(3.4.16). Stock 
6( 1) used in assays 
pGBT9-gene1 2 Gl(S); G1(6) Both clones Sub-cloned from 
correct junction 6(1); G l(S) used in 
assays 
pTAg-gene2 13 G2(2):(4-6): - G2(6), G2(8) 
(8):( 1 0-16):(20) (negative 
orientation) used 
for sub-cloning 
pGAD424-gene2 1 G2(1O) Correct junction G2(1O) used for 
assays and sub-
cloning 
pGBT9-gene2 1 G2(2) Correct junction G2(2) used for 
assc!ys 
pTAg-gene3 4 G3(1):(1O):(lS): - G3(17) used for 
(17) sub-cloning 
j>GAD424-gene3 3 G3(2);G3(4);G3(7) Correct junction -
pGBT9-gene3 7 G3(2);G3(3); G3(2);G3(3)- G3(2) used in 
G3( 4 );G3(7);G3(9; correct junction assays 
G3(1O);G3(ll). region 
pCR2.l-gene9 S G9(1):(3):(5):(6): - G9(3) used for 
(7) sub-cloning 
pGBT9-gene9 3 G9(3);G9(6);G9(7) G9(3) sequenced- G9(3) used in 
correct junction assays 
pGAD424-gene9 4 G9(3);G9(4); G9(3) sequenced- G9(3) used in 
G9(7);G9( 10). correct junction assays 
Results Chapter 2 
Analysis of rotavirus protein-protein interactions 
using the yeast two-hybrid system 
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5.1 Aims 
This chapter describes the use of the yeast two-hybrid system to analyse 
rotavirus protein-protein interactions. The aim was to determine if direct 
protein-protein interactions occurred between the rotavirus non-structural protein 
NSPl and other viral proteins. The proteins which were chosen for analysis were 
either those found in an initial complex with NSP 1 identified in infected cells (Patton, 
1995), or those added to the complex at later times in the replication cycle. A 
secondary aim was to determine if NSP 1 interacted with itself to form dimers. 
5.2 Introduction 
The exact functions of the viral-encoded non-structural proteins in the 
rotavirus replication cycle are, as yet, unknown. However, it is probable that they are 
involved in a variety of events, such as genome replication and gene assortment. The 
viral non-structural protein NSP I is expressed at low levels early in infection and is 
thought to function at an early stage of viral replication (Johnson and McCrae, 1989). 
It has been identified as a component of a pre-core replication intermediate (RI) 
together with the viral proteins VP 1, VP3 and NSP3 (Gall egos and Patton, 1989). The 
core RI is formed by the addition of VP2 to the pre-core RI. In order to gain insight 
into the role that NSP 1 plays in the viral replication cycle, potential protein-protein 
interactions between NSP1 and the other components of the pre-core and core RIs 
were investigated using the yeast two-hybrid system, which has been shown to be a 
sensitive method for detection of protein-protein interactions in vivo (Fields and Song, 
1989) (Section 4.2.1). 
The cDNAs of selected genes from the UKtc strain of bovine rotavirus were 
cloned into two-hybrid vectors in order to produce fusions of each rotavirus protein 
with both the GAlA DNA-binding and activation domains (Chapter Four). The 
objective was then to test these constructs in the yeast two-hybrid system and 
investigate potential interactions between NSP 1 and the other components of the 
pre-core RI, VP1, VP3 and NSP3, and also VP2 which is added subsequently to form 
the core RI. Possible dimerisation of the non-structural proteins, NSPl and NSP3, was 
also investigated. 
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A cDNA of a mutant gene 5, encoding a truncated NSPl consisting of only the 
amino terminal third of the protein, was also utilised to produce GAL4 fusion 
proteins. The mutant gene 5, p9~5, was obtained during plaque purification 
undertaken as part of the biological cloning of a field isolate of virus (Tian et al., 
1993). It has a single 308 bp deletion in the centre of the normal gene 5 sequence, 
which causes a frameshift resulting in a stop codon eight amino acids (a a) 
downstream of the deletion. The resulting truncated protein product has a predicted 
size of 150 aa compared to the normal size of NSPI of 490 aa. Viruses containing this 
truncated mutant gene 5 (~5) are non-defective in tissue culture (Tian et al., 1993), 
indicating that the carboxy terminus of the protein may not be essential for gene 
function in tissue culture, although it might still have an important function in natural 
infections. A highly conserved cysteine-rich region, which contains a generalised 
motif for a metal binding domain, has been recognised near the amino terminal end of 
the gene (MitcheII and Both, 1990a). The fact that this region is conserved may be 
indicative of its functional importance. The truncated mutant NSPl was studied as it 
is viable in vivo and contains the proposed functional domains of the protein. 
Yeast strains were transformed with the constructs and transformant colonies 
were selected on limiting media according to the nutritional gene (TRPl or LEU2) 
carried on the plasmids encoding the GALA fusion proteins (Figure 4.1). In the assay 
for protein-protein interactions, colonies co-transformed with constructs expressing 
fusions with both GALA domains were selected on limiting media lacking both the 
amino acids tryptophan and leucine. As the reporter gene used in the assay was lacZ, 
an assay for p-galactosidase activity was then used to determine if a protein-protein 
interaction was occurring. 
Blue/white screening of transformant yeast colonies, using a colony lift filter 
assay for p-galactosidase, was most commonly used to detect expression of the 
reporter gene. A liquid p-galactosidase assay was also used to provide a quantitative 
evaluation of the level of expression of lacZ, which has been suggested to reflect 
semi-quantitatively the stability of the interaction between the proteins under study 
(Li and Fields, 1993) (Estojak et al., 1995). The filter assay for p-galactosidase used 
X-gal as the chromogenic substrate, which is approximately 106 times more sensitive 
than ONPG, which was the substrate for the liquid assay. Transient or weak 
two-hybrid interactions may not be quantifiable by ONPG. Hence, the filter assay 
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with X-gal was used to screen for protein interactions, which once identified were 
subsequently quantified using the liquid assay with ONPG. 
Before screening for protein-protein interactions commenced, the GAL4 
fusion constructs were tested alone in the yeast two-hybrid system. It is important to 
ensure, prior to analysis, that the proteins under test do not have intrinsic 
DNA-binding or transcriptional activating properties that would produce a false 
positive in the assay. If a protein does have intrinsic DNA-binding or transcriptional 
activating properties, which can compensate for the missing function of the other 
GAL4 domain, then transcription of the reporter gene will be activated and a false 
positive result will be obtained. Thus, to obtain meaningful results in the assay, each 
construct was tested to ensure it did not activate the reporter gene when present alone. 
5.3 Preliminary control experiments for the yeast two-hybrid system 
5.3.1 Yeast reporter strains 
The genotypes of the Saccharomyces cerevisiae yeast reporter strains, which 
were used in this study, have been described previously (Table 3.2). The 
Saccharomyces cerevisiae strain SFY526 was recommended for use when testing for 
an interaction between known proteins, and was the strain most frequently used in this 
study. A second Saccharomyces cerevisiae strain, HF7c, was also used to verify the 
initial results. The main difference between the strains for the purpose of this study 
was in the promoter elements for the reporter gene lacZ. In SFY526, the GALl 
upstream activating sequence (VAS) and the TATA portion of the GALl promoter 
are fused to the lacZ reporter gene. In HF7c, three copies of the GAL4 17-mer 
consensus sequence and the TAT A portion of the eye 1 promoter are fused to the 
lacZ reporter gene. The GALl VAS and the GAL4 17-mers are both responsive to the 
GAL4 transcriptional activator. Thus, the promoter elements in the yeast strains differ 
significantly with only the GAL4-responsive element in common. Therefore, a 
positive interaction which is observed in both yeast strains must be the result of the 
GAL4 DNA-binding domain binding specifically to the GAL4-responsive elements. 
As the promoter strengths differ between the two yeast strains, interactions which are 
observed in SFY526 may not be observed in HF7c. SFY526 gives stronger p-
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galactosidase signals due to the GALl promoter driving expression of the lacZ gene, 
thus it was the reporter strain of choice in the study. 
5.3.2 Phenotype verification of the yeast reporter strains 
The nutritional requirement phenotypes of the yeast reporter strains SFY526 
and HF7c were verified prior to transformation with the experimental two-hybrid 
plasmids. These two yeast strains are auxotrophic for both tryptophan and leucine, 
hence the untransformed yeast strains should not grow on media lacking these amino 
acids. Both yeast strains also have deletions in the his3 gene, hence they will not grow 
on media lacking histidine. Strain HF7c contains the HIS3 reporter gene under control 
of GAlA-responsive sequences, which are the GALl UAS and the TAT A portion of 
the GALl promoter. This reporter gene is expressed in the presence of the GAlA 
transcriptional activator. 
Freshly grown yeast colonies were streaked onto plates containing the 
appropriate SD medium for testing each of the following four nutritional 
requirements: tryptophan (Trp), leucine (Leu), histidine (His) and uracil CUra). After 6 
days incubation at 30°C both yeast strains had grown on the plates without Ura but 
not on the other three media as expected. Slow growth of strain HF7c was observed 
on the media lacking His, which was due to a low level leaky expression of the HIS3 
reporter gene. This test confirmed the nutritional requirement phenotypes of the yeast 
reporter strains. 
5.3.3 Two-hybrid system control plasmids 
Positive and negative control reactions were included in each two-hybrid 
assay. The control plasmids used are described in Table 5.1. The positive control 
plasmid for the assay, pCLl, encodes and expresses the full-length, wild-type GAlA 
protein (Fields and Song, 1989). A second positive control used was a model of 
interacting proteins provided by plasmids pVA3 and pTDl. Plasmid, pVA3, encodes 
a fusion of the GAlA DNA-binding domain with murine p53 (Iwabuchi et al., 1993), 
and pTDl encodes a fusion of the GAIA activation domain with SV40 large 
T-antigen (Li and Fields, 1993) (Chien et al., 1991). Murine pS3 and SV40 large T-
antigen have been shown to interact; indeed pS3 was originally identified as a protein 
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Table 5.1 
Plasmid Control Description 
pCLl positive control plasmid wild-type, full-length GAL4 gene 
LEU2, ampR 
pVA3 positive control plasmid murine pS3(72-390) in pGBT9 
TRPI, ampR 
pTDI positive control plasmid SV40 large T-antigen(84-708) in 
pGAD3F 
LEU2, ampR 
pLAMS' false positive detection plasmid Human lamin C(66-230) in pGBT9 
TRPI, ampR 
Table 5.1 Yeast two-hybrid system control plasmids 
The table shows the control plasmids used to provide positive and negative controls in 
the yeast two-hybrid system. A description of each plasmid is given, detailing the type 
of control reaction it was used for and the genes carried on the plasmid. The 
abbreviations LEU2 and TRPI refer to the wild-type genes for Leucine and 
Tryptophan. AmpR refers to the resistance gene for ampicillin. The plasmids were 
provided in the Matchmaker Two-Hybrid System (Clontech). 
bound to large T -antigen in SV 40-transformed cells (Lane and Crawford, 1979) 
(Linzer and Levine, 1979). Thus, the purpose of this positive control transformation 
was to verify that the system was detecting an expected protein-protein interaction 
between two known interacting proteins. The plasmid pLAM5' encodes a human 
Lamin C/GAL4 DNA-binding domain hybrid (Barte1 et al., 1993). The transformation 
of yeast with pLAM5' and pTD 1 was used as a negative control, as human Lamin C 
does not interact with SV 40 large T -antigen. 
5.3.4 Interaction of the human respiratory syncytial virus Nand P proteins in 
the yeast two-hybrid system 
A second positive control was used in addition to those provided in the 
Matchmaker Two-Hybrid System (C10ntech). The yeast two-hybrid system was used 
to characterise an interaction between the phosphoprotein (P) and the nucleocapsid 
protein (N) of the human respiratory syncytial virus (hRSV) (Slack and Easton, 1998). 
The yeast strain SFY526 was transformed with plasmids encoding fusions of the two 
hRSV proteins (pGBT9-N and pGAD424-P) and an interaction was detected in the 
two-hybrid system. 
5.3.5 Transformation of SFY526 with control fusion plasmids 
Table 5.2 shows the results of the initial two-hybrid assay control experiments 
which were performed in the SFY526 yeast host strain. These control reactions were 
subsequently performed for each two-hybrid assay screening for rotavirus 
protein-protein interactions. The SFY526 yeast reporter strain was transformed with 1 
~g of each plasmid, as indicated in the table. Initially 0.1 ~g of each plasmid was 
used, however 1 ~g was found to give a greater transformation efficiency. 
Transformant colonies were selected on dropout SD medium according to the 
nutritional gene (TRP 1 or LEU2) carried on the plasmid. The following results were 
obtained in a p-galactosidase filter assay. Yeast colonies transformed with pCLl 
expressed high p-galactosidase levels, as indicated by the fact that transformants 
turned blue in the presence of X-Gal in the filter assay within 15 minutes of the assay 
start time. Transformants carrying the positive control plasmids pVA3 and pTDl, 
which encode a model of interacting proteins, turned blue in the presence of X-Gal 
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Table 5.2 
Plasmid 1 Plasmid 2 Control Selection on Result in 
DNA-Binding Activation Domain SDmedium B -Galactosidase 
Domain Assay 
pCLl - Positive - Leu +++ 
pGBT9 pGA0424 Negative - Leu, - Trp -
pVA3 pGA0424 Negative - Leu, - Trp -
pGBT9 pTO! Negative - Leu, - Trp -
pVA3 pTOl Positive - Leu, - Trp ++ 
pLAM5' pTOl Negative - Leu, - Trp -
pGBT9-N pGAD424-P Positive - Leu, - Trp +++ 
Table 5.2 Results of the two-hybrid system control reactions in strain SFYS26 
The table shows the results of a ~-galactosidase filter assay performed with colonies 
of the yeast reporter strain SFY526 transformed with the two-hybrid system control 
plasmids. The yeast two-hybrid system control plasmids and the control reactions they 
provide are shown. Transformation of SFY526 with the hybrid plasmids indicated in 
the table was performed by the lithium acetatelheat shock method as described 
(Section 3.5.1 and 3.5.2). The transformed yeast were plated on SO selection media 
(Section 3.1.10) lacking the amino acids leucine (-Leu) and/or tryptophan (-Trp). The 
~-galactosidase filter assay was performed using plates containing the freshly 
transformed colonies (Section 3.5.3), and the filters were incubated in the Z bufferlX-
gal solution at 30 °C until blue colonies appeared or until background expression of 
the reporter gene was observed at 480 minutes (8 hours). The colour of the colonies 
was described as white (negative) (-) or blue (positive) (+, + +, or + + +) depending 
on the relative strength of the blue colour reaction. 
within 30 minutes. Transformants carrying pGBT9-N and pGAD424-P, which encode 
a model of interacting proteins from hRSV, also turned blue in the presence of X-Gal 
in less than 30 minutes. Thus, all positive control reactions gave the expected result in 
the J3-galactosidase filter assay. The human Lamin C protein, encoded by pLAM5', 
does not interact with SV40 large T-antigen, so the reaction with plasmids pLAM5' 
and PTD 1 was included to detect false positives. In addition, SFY526 was 
co-transformed with the vectors pGBT9 and pGAD424 to ensure that the reporter 
gene was not activated when the GALA domains were expressed separately. 
Additional negative control reactions were also performed as described in Table 5.2. 
All the control reactions gave the expected results, indicating that the assay was 
functioning correctly. 
In addition to the control two-hybrid reactions, it was also necessary to 
transform the SFY526 yeast reporter strain with the experimental hybrid constructs 
alone (e.g. pGBT9-gene9) and together with the opposing empty vector (e.g. pGBT9-
gene9 plus pGAD424), prior to screening for protein-protein interactions. These 
transformations were performed to verify that the experimental hybrid constructs did 
not activate the reporter gene when present alone to give a false positive result in the 
assay. It was a test for any inherent DNA-binding or transcriptional activation 
properties in the rota virus proteins cloned into the two-hybrid vectors. Transformation 
of the constructs with the opposing empty vectors was performed to detect any false 
positives generated by an interaction between the protein of interest and either of the 
GALA domains. In most cases the results of these experimental transformations were 
negative, with the notable exception of the transformation of pGBT9-gene 9 (Section 
5.4.2). These results are fully discussed with the results of the appropriate two-hybrid 
assay (Sections 5.4 -5.7). 
5.3.6 Expression of two-hybrid fusion proteins in the yeast reporter strain 
SFY526 
The cDNAs encoding each rotavirus protein to be studied were cloned into the 
two-hybrid vectors so that a fusion protein would be produced with each GAL4 
domain. The junction regions between the genes encoding the GAL4 domain and the 
rotavirus protein were checked by sequence analysis for each construct to ensure that 
a fusion protein would be produced. It was also desirable that the expression of each 
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GAL4 fusion protein in yeast was confirmed. Expression of the fusion proteins can be 
verified by western blotting provided specific antibodies are available. The fusion 
proteins must be stably expressed in the yeast cell for the two-hybrid assay to 
function. However, the fusion proteins are expressed from a truncated ADH 1 
promoter and the low level of expression means they can be extremely difficult to 
detect on a western blot. In addition, monoc1onal antibodies that bind specifically to 
the major activation domain (aa 768-881) or the DNA-binding domain (aa 1-147) of 
the yeast GAL4 protein do not detect fusion proteins generated with the low 
expression GALA two-hybrid cloning plasmids pGBT9 and pGAD424 on a western 
blot. Despite this fact, other researchers have proven protein-protein interactions using 
constructs generated with pGBT9 and pGAD424 when expression could not be 
detected by western blotting (Slack, 1998). 
Analysis of expression of the fusion proteins in yeast reporter strain SFY526 
was attempted using antibodies raised against rotavirus proteins. To detect fusion 
proteins of NSPl, a mono specific anti-NSPl serum was used. A polyclonal serum 
raised against the UKtc strain of bovine rotavirus was used to analyse expression of 
GALA fusion proteins of VP1, VP2 and VP3. A biotinylated goat anti-rabbit IgG 
antibody was used as the secondary antibody in each case. However, analysis of the 
western blot did not reveal any unique bands corresponding to GAL4 fusion proteins 
(data not shown). The failure to detect the GAL4 fusion proteins on western blots was 
probably due to the low expression of the proteins from the two-hybrid plasmids. 
However, despite the low expression of the fusion proteins the fact that positive 
interactions were detected in some cases demonstrates that this system could be 
successfully used to detect interactions between rotavirus proteins (Section 5.4). 
5.4 Analysis of dimerisation of NSP3 in the yeast two-hybrid system 
5.4.1 NSP3 may form dimers in rotavirus-infected cells 
The rota virus non-structural protein NSP3 has been shown to form oligomers 
in rotavirus-infected cells, insect cells and in a cell-free translation system (Mattion et 
al., 1992). NSP3 is encoded by gene 7 in the SA 11 4F strain of simian rotavirus and 
by gene 9 in the UKtc strain of bovine rotavirus. Mattion et al. (1992) described 
homo-oligomers of NSP3 in insect cells infected with a baculovirus expression vector 
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expressing the SAIl 4F gene 7 product NSP3. They found different sized oligomers, 
Cl and C2, by analysis of complexes from infected cells on non-reducing gels and by 
western blotting. C2 was thought to be a homodimer, while Cl was likely to be a 
multimer of NSP3. Both homo-oligomers were also seen in a cell-free translation 
system, however in SAll-infected MAI04 cells only the dimer of NSP3 (C2) was 
seen. A complex thought to be a dimer of NSP3 was detected in SAll-infected 
MA 104 cells on a non-reducing gel by western blotting with antiserum produced 
against recombinant NSP3. The complex which was detected migrated to the same 
position on the gel as C2, and therefore was thought to be analogous to it. However, 
this result did not confirm a direct self-interaction of NSP3 in mammalian cells, or 
rule out the possible presence of small amounts of another protein(s) in this complex. 
A conserved region of hydrophobic repeats and a leucine zipper at the carboxy 
terminus of the protein was implicated in the oligomerisation. It has also been 
suggested that conserved cysteine residues in the protein may form disulphide 
bridges, thus stabilising the intermolecular interaction. However, given the highly 
reducing environment of the cytoplasm, it is possible that disulphide-linked oligomers 
might be formed following cell lysis and are not actually present in the cell (Piron et 
al., 1999). Therefore, dimerisation of NSP3 in vivo was not directly demonstrated. 
5.4.2 Dimerisation of NSP3 can be quantified in the yeast two-hybrid system 
Previous work has suggested that NSP3 forms a dimer in SA 11 
rotavirus-infected cells (Mattion et al., 1992). Hence, it was expected that 
dimerisation of NSP3 would also occur with the protein from the UKtc strain of 
bovine rotavirus. The yeast two-hybrid system was used to demonstrate a direct 
self-interaction of NSP3 from the UKtc strain. Plasmids encoding fusions of the 
GAlA DNA-binding and activation domains with NSP3 were created (Section 4.5) 
and tested alone in the two-hybrid system. A f3-galactosidase filter assay showed 
SFY526 colonies transformed with pGBT9-gene 9 alone produced a blue colour, 
indicating activation of the reporter gene, after 120 minutes incubation at 30°C. By 
contrast, colonies transformed with the plasmid pGAD424-gene 9 gave a negative 
result, even after a maximum incubation time of eight hours. This positive result was 
repeated in the HF7c yeast reporter strain, although the time taken for the blue colour 
to appear in colonies transformed with pGBT9-gene 9 was longer (4 hours). This may 
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have been due to the weaker promoter in the HF7c strain. This result suggested that 
NSP3 may have some intrinsic transcriptional activation properties, which can 
complement the DNA-binding activity of the GAL4 domain expressed by pGBT9, to 
activate the reporter gene. 
A two-hybrid assay was performed to determine if dimerisation of NSP3 could 
be detected in vivo. The SFY526 yeast reporter strain was transformed with the 
two-hybrid plasmids encoding NSP3, pGBT9-gene 9 and pGAD424-gene 9, and the 
appropriate control plasmids. Co-transformation efficiencies were approximately 103 
cfu/Jig DNA (see Appendix 1.2 for equation) and thus within the expected range of 
103 _104 cfu/Jig DNA for the double plasmid transformation. The transformed colonies 
were screened using a ~-galactosidase filter assay to detect expression of the lacZ 
reporter gene (Table 5.3). Colonies co-transformed with the two plasmids encoding 
fusions of NSP3 (pGBT9-gene 9 and pGAD424-gene 9) turned blue within 30 
minutes of the assay start time, indicating that a dimerisation of NSP3 was occurring. 
The control plates containing colonies transformed with pGBT9-gene 9 alone turned 
blue 120 minutes after the assay start time which was a false positive result. As the 
gap between the appearance of the blue colour in the colonies co-transformed with 
both gene 9 hybrid plasmids and the false positive of pGBT9-gene 9 alone was 
considerable, it seems likely that a true self-interaction of NSP3 did occur. If it were 
merely a false positive, then the colonies transformed with both constructs and those 
transformed with a single construct would be expected to turn blue at a similar time. 
To confirm and quantify this result, a liquid culture ~-galactosidase assay 
(ONPG assay) was performed. Colonies screened by the ~-galactosidase filter assay 
were allowed to regrow, then picked into SD selection media and the ONPG assay 
was performed as described (Table 5.3). B-galactosidase units were calculated for 
each transformation. Colonies transformed with the positive control plasmid pCLI, 
which is a wild-type GAL4 control, produced a very high level of ~-galactosidase 
(466.1 ± 52.2 ~-galactosidase units) as expected. The model of interacting proteins 
provided by p V A3 and pTO 1 also produced a high level of ~-galactosidase (78.9 ± 22 
~-galactosidase units). Although the margin of error appears to be quite large, it is in 
fact less than the variation reported by other researchers (Iwabuchi et al., 1993) 
(Chien et al., 1991). Results equating to extremely low levels of ~-galactosidase (~­
galactosidase units ~ 0.1), such as those obtained for the control transformation, 
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Table 5.3 
DNA-binding Activation Selection on Result of Time elapsed in Result of ONPG 
domain hybrid domain SDmedium ~-galactosidase ~-galactosidase assay 
plasmid hybrid filter assay filter assay <p -galactosidase 
plasmid (minutes) units) 
pCLI 
-
-Leu +++ 30 406.1 ± 52.2 
pVA3 pTDI -Leu, -Trp ++ 30 78.9 ± 22 
pGBT9 pGAD424 -Leu, -Trp - 360 0.02 ± O.OOt) 
pGBT9-Gene9 - -Trp ++ 120 0.57 + 0.07 
-
pGAD424- -Leu - 360 0.02 ± 0.001 
Gene9 
pGBT9-Gene9 pGAD424 -Leu, -Trp ++ 120 0.59 + 0.09 
pGBT9 pGAD424- -Leu, -Trp - 360 0.07 ± 0.03 
Gene9 
pGBT9-Gene9 pGAD424- -Leu, -Trp ++ 30 37.3±7.5 
Gene9 
Table 5.3 Dimerisation of NSP3 can be quantified in the yeast two-hybrid system 
The results of a yeast two-hybrid assay to analyse and quantify the dimerisation of 
NSP3 are shown. Transformation of SFY526 with the hybrid plasmids indicated in 
the table was performed by the lithium acetate/heat shock method as described 
(Section 3.5.1 and Section 3.5.2). The transformed yeast were plated on SO selection 
media (Section 3.1.10) lacking the amino acids leucine (-Leu) and/or tryptophan (-
Trp). All the control reactions detailed previously (Table 5.2) were performed in 
conjunction with the experimental reactions and gave the expected results. The 
~-galactosidase filter assay was performed using plates containing the freshly 
transformed colonies (Section 3.5.3), and the filters were incubated in the Z bufferlX-
gal solution at 30°C until blue colonies appeared or until background expression of 
the reporter gene was observed at 360 minutes (6 hours). The colour of the colonies 
was described as white (negative) (-) or blue (positive) (+, + +, or + + +) depending 
on the relative strength of the blue colour reaction. The liquid culture ~-galactosidase 
assay (ONPG assay) was performed as described (Section 3.5.4). SD medium was 
inoculated with yeast colonies transformed with the hybrid plasmids and the cultures 
incubated overnight at 30°C with shaking. The overnight culture was then used to 
inoculate fresh YPO medium and the culture was incubated as before for 
approximately 240 minutes (four hours) until the required 00600 reading (00600 = 
0.5-1.0) was obtained. The ON PG assay was performed in triplicate with two 
dilutions of the culture (concentration factor = 5 and concentration factor = 3) for 
each transformation (i.e. six times for each transformation). The assay was stopped 
when the yellow colour developed and 00420 readings were taken (00420 = 0.02-1.0). 
00420 readings must be within the margin 0.02-1.0 in order for ~-galactosidase units 
to be calculated accurately. The assay was incubated overnight to allow weaker 
interactions to develop. B-galactosidase units were calculated from the OD420 
readings obtained. The mean was derived and error bars were calculated within the 95 
% confidence limits of the Students t test. (Appendix 1.1). 
pGBT9 plus pGAD424, were considered negative. The ~-galactosidase levels for the 
controls of pGBT9-gene 9 alone or with vector pGAD424, which gave false positive 
results in the filter assay, were considerably less than that reported for the co-
transformation (~-galactosidase units < 1) and were considered to be negative. The 
result for the colonies co-transformed with pGBT9-gene 9 and pGAD424-gene 9 in 
the ONPG assay was 37.3 ± 7.5 ~-galactosidase units. This was a sufficient increase 
in the level of ~-galactosidase activity for the interaction to be considered a true 
positive. Indeed, a two to four fold increment from background activity has been 
considered significant, as such increments in activity from background enzyme levels 
have previously been associated with specific protein-protein interactions (Li and 
Fields, 1993) (Rossi et al., 1996). 
The NSP3 fusion proteins were expressed in yeast, and interacted to form a 
dimer such that the interaction could be detected in the yeast two-hybrid system. A 
positive result was produced both in a colony lift filter ~-galactosidase assay and in a 
liquid (ONPG) ~-galactosidase assay. The interaction was quantified as 37.3 ± 7.5 ~­
galactosidase units. This result suggests that the self-interaction of NSP3 is 
approximately half as strong as the interaction between p53 and SV40 large T-antigen 
in this assay. The interaction of the NSP3 protein could be considered as an internal 
positive control in two-hybrid assays for protein interactions between other rotavirus 
proteins. 
5.5 Analysis of NSPl using the yeast two-hybrid system 
5.5.1 Two-hybrid assay to determine whether NSPl forms dimers 
The yeast two-hybrid system was employed to examine the hypothesis that 
NSP 1 may interact with itself to form a dimer. Dimerisation of NSP3, which is 
present in early replication complexes with NSP 1, has already been shown (Section 
5.4.2.). However, the possibility that NSP 1 may also undergo dimerisation has not 
been previously investigated. 
Plasmids encoding fusions of the GAIA DNA-binding and activation domains 
with both full length and truncated NSPl were created (Section 4.3) and tested in the 
two-hybrid system. When the SFY526 yeast reporter strain was transformed with each 
experimental plasmid alone, a negative result was obtained in the ~-galactosidase 
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filter assay (Table 5.4). This result was repeated with the HF7c yeast strain 
transformed with the plasmids separately and tested in a ~-galactosidase filter assay 
with a maximum incubation time of eight hours (data not shown). 
A two-hybrid assay was performed with yeast strain SFY526 which was 
co-transformed with the two-hybrid plasmids encoding full length NSP 1 (pGBT9-
gene 5 and pGAD424-gene 5) and the truncated mutant of NSP 1 (pGBT9-gene .15 
and pGAD424-gene 5), together with the appropriate control plasmids. Co-
transformation efficiencies for the experimental plasmids were approximately lOJ 
cfu/Jlg DNA (see Appendix 1.2). The transformed colonies were screened using a 
~-galactosidase filter assay to detect expression of the lacZ reporter gene (Table 5.4). 
Colonies transformed with the control reaction of plasmids pGBT9-gene .15 and 
pGAD424 turned very pale blue 240 minutes after the assay start time. This false 
positive result was probably due to a Iow level leaky expression of the reporter gene 
which occasionally occurred. The control co-transformation of pGBT9 and 
pGAD424-gene 5 also gave a false positive result after 300 minutes incubation. The 
co-transformation of the experimental constructs, pGBT9-gene .15 and 
pGAD424-gene 5, gave a weakly positive result, as indicated by faint blue colonies, 
after 300 minutes. However, this was also thought to be a false positive result and due 
to leaky expression of the reporter gene, as with the control reactions. Colonies 
co-transformed with the two plasmids encoding fusions of full length NSP 1 remained 
white, even after a maximum assay incubation time of eight hours. This negative 
result suggested that a dimerisation of NSP 1 did not occur. In conclusion, 
dimerisation of NSPI was not detected, either between full length NSPl or with the 
amino terminus of the protein only, under the conditions of the two-hybrid assay. 
5.6 Investigation of protein-protein interactions between NSPl and NSP3 
5.6.1 Assay for a potential interaction between NSPl and NSP3 
The yeast two-hybrid system was employed to test for a potential interaction 
between the viral non-structural proteins NSP 1 and NSP3. Both proteins are found in 
the pre-core RI at an early stage of the viral replication cycle (Section 5.2). Although 
NSPl and NSP3 both localise to the cytoplasm and are known to bind mRNA, it was 
not known whether a protein-protein interaction occurred between the two proteins. 
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Table 5.4 
DNA-binding Activation Selection on Result of Time elapsed in 
domain hybrid domain SD medium ~-galactosidase ~-galactosidase 
plasmid hybrid filter assay filter assay 
vlasmid (minutes) 
peLl 
-
-Leu +++ 30 
pGBT9 pGAD424 -Leu, -Trp 
- 300 
pVA3 pTDI -Leu, -Trp ++ 30 
pLAMS' pTDI -Leu, -Trp 
-
300 
pGBT9-N pGAD424-P -Leu, -Trp +++ 30 
pGBT9-,gene 5 
-
-Trp 
-
300 
pGBT9-gene ~S - -Trp - 300 
-
pGAD424- -Leu 
-
300 
,gene 5 
pGBT9-gene 5 pGAD424 -Leu, -Trp 
-
300 
pGBT9-~ene ~5 pGAD424 -Leu, -Trp + /- 240 
pGBT9 pGAD424- -Leu, -Trp +/- 300 
gene 5 
pGBT9-gene 5 pGAD424- -Leu, -Trp - 300 
,gene 5 
pGBT9-gene ~5 pGAD424- -Leu, -Trp +/- 300 
gene 5 
Table 5.4 Two-hybrid assay for potential dimerisation of NSPl 
The results of a yeast two-hybrid assay for a potential dimerisation of NSP 1 are 
shown. Transformation of SFY526 with the hybrid plasmids indicated in the table was 
performed by the lithium acetatelheat shock method as described (Section 3.5.1 and 
3.5.2). The transformed yeast were plated on SD selection media (Section 3.1.10) 
lacking the amino acids leucine (-Leu) and/or tryptophan (-Trp). All the control 
reactions detailed previously (Table 5.2) were performed in conjunction with the 
experimental reactions and gave the expected results. The ~-galactosidase filter assay 
was performed using plates containing the freshly transformed colonies (Section 
3.5.3), and the filters were incubated in the Z buffer/X-gal solution at 30°C until blue 
colonies appeared or until background expression of the reporter gene was observed at 
300 minutes. The colour of the colonies was described as white (negative) (-) or blue 
(positive) (+. + +, or + + +) depending on the relative strength of the blue colour 
reaction. A faint blue colour, which appeared after several hours incubation and was 
thought to be background was also described (+/-). The results presented represent 
three repeats of the experiment. 
The yeast reporter strain SFY526 was transformed with plasmids expressing 
fusions of NSPl and NSP3 with both the GALA DNA-binding and activation domains 
in all possible combinations and with the appropriate controls, and a p-galactosidase 
filter assay was used to screen for potential interactions. The efficiency of the doubJe 
plasmid co-transformation was calculated to be approximately 5 x 102 cfulJlg DNA 
and was found to be slightly higher for the experimental constructs compared to the 
control constructs. 
The results of the p-galactosidase filter assay for the controls and experimental 
transformations are shown (Table 5.5). All the control transformations gave the 
expected results. After 120 minutes incubation, colonies transformed with plasmid 
pGBT9-gene 9 alone or together with vector pGAD424, gave a false positive result. 
As discussed previously (Section 5.4.2), this was due to activation of the reporter gene 
by NSP3 fused to the GALA DNA-binding domain, and was thought to be due to a 
transcriptional activation property of NSP3. Colonies co-transformed with 
pGBT9-gene 9 and the construct expressing a fusion of NSPl with the GALA 
activation domain (pGAD424-gene 5), turned blue after 180 minutes incubation. 
However, colonies transformed with constructs expressing the proteins fused to the 
opposite GALA domains (Le. pGBT9-gene 5 and pGAD424-gene 9), produced a 
negative result. Hence, a true protein-protein interaction was not detected between 
NSPl and NSP3. A liquid (ONPG) p-galactosidase assay also failed to detect an 
interaction between NSP 1 and NSP3. A similar level of p-galactosidase was obtained 
for yeast colonies transformed with pGBT9-gene 9, irrespective of whether 
pGAD424-gene 5 was present. This indicated that the positive result which was 
observed in the filter assay was probably due to the activation of the reporter gene by 
NSP3 in yeast colonies transformed with plasmid pGBT9-gene 9, and thus a false 
positive result. A co-transformation was also performed with pGAD424-gene 9 and 
the plasmid expressing the truncated mutant of NSPl, pGBT9-gene ~5 (Section 
4.3.3). The results of the p-galactosidase assay for this co-transformation were also 
negative, confirming that an interaction could not be detected between NSPl and 
NSP3. 
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Table 5.5 
DNA-binding Activation Selection on Result of Time elapsed in Result of ONPG 
domain hybrid domain SDmedium p-galactosidase p-galactosidase assay 
plasmid hybrid filter assay filter assay (p-galactosidase 
plasmid (minutes) units) 
pCLI 
-
-Leu +++ 30 466.1 + 52.2 
pVA3 pTDI -Leu, -Trp ++ 30 78.9 + 22 
pGBT9 pGAD424 -Leu, -Trp 
-
360 0.02 + 0.006 
pGBT9-Gene9 - -Trp ++ 120 057 + 0.07 
-
pGAD424- -Leu 
-
360 0.02 ± (lOO I 
Gene9 
pGBT9-Gene5 - -Trp - 360 -
-
pGAD424- -Leu 
-
360 
-
Gene5 
pGBT9-Gene9 pGAD424 -Leu, -Trp ++ 120 059 ± 0.0«,) 
pGBT9 pGAD424- -Leu, -Trp - 360 0.07 ± 0.03 
Gene9 
pGBT9-Gene5 pGAD424 -Leu, -Trp - 360 -
pGBT9 pGAD424- -Leu, -Trp - 360 0.08 ± 0.01 
Gene5 
pGBT9-Gene5 pGAD424- -Leu, -Trp - 360 -
Gene9 
pGBT9-Gene9 pGAD424- -Leu, -Trp ++ 180 0.6 ± 0.05 
Gene5 
Table 5.5 Yeast two-hybrid analysis of a potential protein-protein interaction 
between NSPl and NSP3 
The results of a yeast two-hybrid assay to analyse and quantify a potential interaction between 
NSPl and NSP3 are shown. Transformation of SFY526 with the hybrid plasmids indicated in 
the table was performed by the lithium acetate/heat shock method as described (Section 3.5.1 
and 3.5.2). The transformed yeast were plated on SO selection media (Section 3.1.10) lacking 
the amino acids leucine (-Leu) andlor tryptophan (-Trp). All the control reactions detailed 
previously (Table 5.2) were performed in conjunction with the experimental reactions and 
gave the expected results. The ~-galactosidase filter assay was performed using plates 
containing the freshly transformed colonies (Section 3.5.3), and the filters were incubated in 
the Z bufferlX-gal solution at 30 °C until blue colonies appeared or until background 
expression of the reporter gene was observed at 360 minutes (6 hours). The colour of the 
colonies was described as white (negative) (-) or blue (positive) (+, + +, or + + +) depending 
on the relative strength of the blue colour reaction. The results presented represent three 
repeats of the experiment. The liquid culture ~-galactosidase assay (ONPG assay) was 
performed as described (Section 3.5.4). SO medium was inoculated with yeast colonies 
transformed with the hybrid plasmids and the cultures incubated overnight at 30 °C with 
shaking. The overnight culture was then used to inoculate fresh YPO medium and the culture 
was incubated as before for approximately 240 minutes (four hours) until the required 00600 
reading (00600 = 0.5-1.0) was obtained. The ONPG assay was performed in triplicate with 
two dilutions of the culture (concentration factor = 5 and concentration factor = 3) for each 
transformation (i.e. six times for each transformation). The assay was stopped when the 
yellow colour developed and 00420 readings were taken (00420 = 0.02-1.0). The assay was 
incubated overnight to allow weaker interactions to develop. B-galactosidase units were 
calculated from the 00420 readings obtained. 00420 readings must be within the margin 0.02-
1.0 in order for ~-galactosidase units to be calculated accurately. When the 00420 readings 
were less than 0.02, ~-galactosidase units could not be calculated and no result is given for 
the ONPG assay. The mean value of p-galactosidase units was derived and error bars were 
calculated within the 95 % confidence limits of the Students t test. (Appendix 1.1). 
5.6.2 Conclusions 
A protein-protein interaction was not detected between NSP3 and either the 
full-length NSPl or the truncated mutant NSPl. The results of a solid phase ~­
galactosidase filter assay and a liquid ~-galactosidase assay (ONPG assay) confirmed 
this observation. In contrast to this result, an interaction between NSPl and NSP3 
from the YM strain of porcine rotavirus has been shown recently (Gonzalez et al., 
1998). An interaction producing 3.4 units of ~-galactosidase was detected in the yeast 
two-hybrid system. Although this value was only approximately two to four fold 
above background activity, it was considered to be significant and associated with a 
specific protein-protein interaction. It is not clear why different results were obtained 
in the yeast two-hybrid assays for an NSPI-NSP3 interaction, although it is not 
without precedent as a failure to detect demonstrated protein-protein interactions in 
the two-hybrid system has been documented previously (Van Aelst et al., 1993) 
(Fields and Sternglanz, 1994). The results may have been due to differences in the 
virus strains used, leading to the production of fusion products which interact with 
differing affinities or are unable to interact. The nucleotide sequence of gene 5 from 
the YM strain of porcine rotavirus, which was used in the study by Gonzalez et af. 
(1998), has not been published. Therefore, a direct comparison of the sequence 
differences with gene 5 from the UKtc strain of bovine rotavirus used in this study 
was not possible. However, previous studies have shown considerable sequence 
divergence between the bovine UKtc strain and other porcine strains, such as OSU 
(Xu et al., 1994). On the basis of these observations, it is conceivable that the 
sequences of gene 5 from the strains used in the two studies were sufficiently different 
such that the resulting proteins might have different properties. 
5.7 Investigation of potential protein-protein interactions between NSPl and 
structural proteins of the virus core 
5.7.1 Assay for a potential interaction between NSPl and VPl 
The yeast two-hybrid system was used to screen for a potential protein-protein 
interaction between NSPl and the viral structural protein VPI, both of which are 
found in the viral pre-core RI. The yeast reporter strain SFY526 was transformed with 
experimental plasmids encoding fusions of NSPl and VPI with both the GAIA 
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DNA-binding and activation domains (Chapter Four) in all possible combinations and 
with the appropriate controls, and a ~-galactosidase filter assay was used to screen for 
potential interactions (Table 5.6). The efficiency of the double plasmid 
co-transformation was calculated and it was found to be in the range 102-1 03 cfu/~g 
DNA and thus slightly lower than the expected range of 103_104 cfu/Jlg DNA. It was 
particularly notable that the transformation efficiency for the plasmid pGAD424-gene 
1 was consistently lower compared to the other plasmids. It is possible that VPl may 
have a slightly toxic effect when expressed in the yeast cell as a fusion protein with 
the GAIA activation domain. This may account for the low transformation efficiency 
obtained with this particular plasmid. 
The results of the ~-galactosidase filter assay for the controls and experimental 
transformations are shown (Table 5.6). All the control transformations gave the 
expected results. After 240 minutes incubation the appearance of a very pale blue 
colour was observed with colonies that had been transformed with the experimental 
constructs alone, or together with the two-hybrid vector. False positive results can 
arise after prolonged incubation and may be due to a low level leaky expression of the 
reporter gene. It was observed that colonies transformed with the experimental 
constructs expressing NSPl and VPl in either GAIA domain remained white. This 
result indicated that a protein-protein interaction was not detected between full length 
NSPl and VPl in the yeast two-hybrid system. The results of a liquid (ONPG) ~­
galactosidase assay also confirmed that an interaction could not be detected between 
NSPI and VPl. It was not possible to calculate ~-galactosidase units for the strength 
of the interactions, as the OD420 readings obtained in the assay were too Iow to be 
analysed (OD42o < 0.02) (data not shown). 
The SFY526 yeast reporter strain was transformed with plasmids pGBT9-gene 
.15 and pGAD424-gene 1, which express GAIA fusion proteins with truncated NSP 1 
and VPI respectively. A p-galactosidase assay was performed and it was observed 
that colonies transformed with both the experimental constructs remained white, 
indicating that an interaction between NSPl and VPl did not occur (Table 5.7). In 
conclusion, protein-protein interactions between VPI and both full-length and 
truncated NSP 1 were not detected in the two-hybrid system. 
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Table 5.6 
DNA-binding Activation Selection on Result of Time elapsed in 
domain hybrid domain SDmedium ~-galactosidase ~-galactosidase 
plasmid hybrid filter assay filter assay 
plasmid (minutes) 
peLl 
- -Leu +++ 15 
pGBT9 pGAD424 -Leu, -Trp 
-
360 
pVA3 pTD) -Leu, -Trp ++ 30 
pLAM5' pTD) -Leu, -Trp 
- 360 
pGBT9-N pGAD424-P -Leu, -Trp +++ 30 
pGBT9-,gene I 
-
-Trp 
- 360 
-
pGAD424- -Leu +1- 240 
gene 1 
pGBT9-,gene 5 
-
-Trp 
-
360 
-
pGAD424- -Leu 
- 360 
gene 5 
pGBT9-,gene ) pGAD424 -Leu, -Trp +1- 240 
pGBT9 pGAD424- -Leu, -Trp 
-
360 
gene I 
pGBT9-,gene 5 pGAD424 -Leu, -Trp - 360 
pGBT9 pGAD424- -Leu, -Trp - 360 
gene 5 
pGBT9-gene 1 pGAD424- -Leu, -Trp - 360 
,gene 5 
pGBT9-gene 5 pGAD424- -Leu, -Trp - 360 
gene) 
Table 5.6 Two-hybrid assay for a potential interaction between NSPl and VPl 
The results of a yeast two-hybrid assay for a potential interaction between NSP 1 and 
VPl are shown. Transformation of SFY526 with the hybrid plasmids indicated in the 
table was performed by the lithium acetatelheat shock method as described (Section 
3.5.1 and 3.5.2). The transformed yeast were plated on SD selection media (Section 
3.1.10) lacking the amino acids leucine (-Leu) and/or tryptophan (-Trp). All the 
control reactions detailed previously (Table 5.2) were performed in conjunction with 
the experimental reactions and gave the expected results. The ~-galactosidase filter 
assay was performed using plates containing the freshly transformed colonies (Section 
3.5.3), and the filters were incubated in the Z buffer/X-gal solution at 30°C until blue 
colonies appeared or until background expression of the reporter gene was observed at 
360 minutes (6 hours). The colour of the colonies was described as white (negative) 
(-) or blue (positive) (+, + +, or + + +) depending on the relative strength of the blue 
colour reaction. A faint blue colour, which appeared after several hours incubation 
and was thought to be background was also described (+/-). The results presented 
represent three repeats of the experiment. 
Table 5.7 
DNA-binding Activation Selection on Result in Time elapsed in 
domain hybrid domain SDmedium f3-galactosidase ~-galactosidase 
plasmid hybrid filter assay filter assay 
plasmid (minutes) 
peLl 
-
-Leu +++ 30 
pGBT9 pGA0424 -Leu, -Trp 
-
480 
pVA3 pTOl -Leu, -Trp ++ 60 
pLAMS' pTO] -Leu, -Trp 
-
480 
pGBT9-N pGA0424-P -Leu, -Trp +++ 30 
pGBT9- - -Trp - 480 
.E(ene ~5 
-
pGA0424- -Leu - 480 
~ene 1 
pGBT9- pGA0424- -Leu, -Trp - 480 
gene ~5 gene 1 
Table 5.7 Two-hybrid assay for a potential interaction between truncated NSPl 
and VPl 
The results of a yeast two-hybrid assay to detect a potential interaction between a 
truncated mutant of NSPl, encoded by gene A5, and VPl are shown. Gene A5 
encodes a protein consisting of the amino terminal third of the full-length NSPl 
protein. Transformation of SFY526 with the hybrid plasmids indicated in the table 
was performed by the lithium acetatelheat shock method as described (Section 3.5.1 
and 3.5.2). The transformed yeast were plated on SD selection media (Section 3.1.10) 
lacking the amino acids leucine (-Leu) and/or tryptophan (-Trp). All the control 
reactions detailed previously (Table 5.2) were performed in conjunction with the 
experimental reactions and gave the expected results. The ~-galactosidase filter assay 
was performed using plates containing the freshly transformed colonies (Section 
3.5.3), and the filters were incubated in the Z bufferlX-gal solution at 30 °C until blue 
colonies appeared or until background expression of the reporter gene was observed at 
480 minutes (8 hours). The colour of the colonies was described as white (negative) 
(-) or blue (positive) (+, + +, or + + +) depending on the relative strength of the blue 
colour reaction. The results presented represent two repeats of the experiment. 
5.7.2 Assay for a potential interaction between NSPl and VP2 
The yeast two-hybrid system was used to screen for a potential interaction 
between NSPl and the viral structural protein VP2. VP2 is the inner-core structural 
protein, and is added to the pre-core complex at an early stage in the viral replication 
cycle. The yeast host strain SFY526 was transformed with experimental plasmids 
expressing fusions of NSPl and VP2 with both the GAlA DNA-binding and 
activation domains (Chapter Four) in all possible combinations and with the 
appropriate controls, and a p-galactosidase filter assay was used to screen for 
potential interactions. The efficiency of the double plasmid co-transformation was 
found to be approximately 103 cfulllg DNA. 
The results of the p-galactosidase filter assay for the controls and experimental 
transformations are shown (Table 5.8). All the control transformations gave the 
expected results. After 240 minutes incubation a faint blue colour was observed in 
colonies transformed with both experimental hybrid constructs expressing NSP 1 and 
VP2 as GAlA fusion proteins. However, this was matched by colonies transformed 
with the experimental constructs alone or together with the two-hybrid vector, and 
was probably due to a low level leaky expression of the reporter gene, and thus a false 
positive result. The results of a liquid (ONPG) p-galactosidase assay confirmed that 
an interaction could not be detected between NSPl and VP2. It was not possible to 
calculate p-galactosidase units as the 00420 readings obtained in the assay were too 
low to be analysed (OD420 < 0.02) (data not shown). Thus, a protein-protein 
interaction was not detected between full length NSP 1 and VP2 in the yeast 
two-hybrid system. 
The SFY526 yeast reporter strain was transformed with plasmids pGBT9-gene 
~5 and pGAD424-gene 2, which express GAlA fusion proteins with truncated NSP 1 
and VP2 respectively. A p-galactosidase assay was performed and it was observed 
that colonies transformed with both the experimental constructs remained white, 
indicating that an interaction between NSPl and VP2 did not occur (Table 5.9). In 
conclusion, protein-protein interactions between VP2 and both full-length and 
truncated NSP 1 were not detected in the two-hybrid system. 
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Table 5.8 
DNA-binding Activation Selection on Result of Time elapsed in 
domain hybrid domain SDmedium p-galactosidase p-galactosldase 
plasmid hybrid filter assay filter assay 
plasmid (minutes) 
peLl 
-
-Leu +++ 30 
pGBT9 pGAD424 -Leu. -Trp +/- 240 
pVA3 pTD) -Leu. -Trp ++ 30 
pLAM5' pTDI -Leu. -Trp - 420 
pGBT9-N pGAD424-P -Leu. -Trp +++ 30 
pGBT9-gene 2 
-
-Trp +/- 240 
-
pGAD424- -Leu 
-
420 
gene 2 
pGBT9-gene 2 pGAD424 -Leu. -Trp +/- 240 
pGBT9 pGAD424- -Leu. -Trp +/- 240 
gene 2 
pGBT9-gene 5 pGAD424 -Leu. -Trp +/- 240 
pGBT9 pGAD424- -Leu. -Trp +/- 240 
gene 5 
pGBT9-gene 2 pGAD424- -Leu, -Trp +/- 240 
gene 5 
pGBT9-gene 5 pGAD424- -Leu, -Trp +/- 240 
gene 2 
Table 5.8 Two.hybrid assay screen for an interaction between NSPl and VP2 
The results of a yeast two-hybrid assay screen for a potential interaction between 
NSP 1 and VP2 are shown. Transformation of SFY526 with the hybrid plasmids 
indicated in the table was performed by the lithium acetatelheat shock method as 
described (Section 3.5.1 and 3.5.2). The transformed yeast were plated on SO 
selection media (Section 3.1.10) lacking the amino acids leucine (-Leu) and/or 
tryptophan (-Trp). All the control reactions detailed previously (Table 5.2) were 
performed in conjunction with the experimental reactions and gave the expected 
results. The p-galactosidase filter assay was performed using plates containing the 
freshly transformed colonies (Section 3.5.3), and the filters were incubated in the Z 
buffer/X-gal solution at 30°C until blue colonies appeared or until background 
expression of the reporter gene was observed at 420 minutes (7 hours). The colour of 
the colonies was described as white (negative) (-) or blue (positive) (+, + +, or + + +) 
depending on the relative strength of the blue colour reaction. A faint blue colour, 
which appeared after several hours incubation and was thought to be background was 
also described (+/-). The results presented represent three repeats of the experiment. 
Table 5.9 
DNA-binding Activation Selection on Result in Time elapsed in 
domain hybrid domain SD medium p-galactosidase p-galactosidase 
plasmid hybrid filter assay filter assay 
plasmid (minutes) 
peLl 
- -Leu +++ 30 
pGBT9 pGA0424 -Leu. -Trp - 480 
pVA3 pTD) -Leu. -Trp ++ 60 
pLAM5' pTO I -Leu. -Trp 
-
480 
pGBT9-N pGAD424-P -Leu. -Trp +++ 30 
pGBT9-
-
-Trp 
-
480 
.l!ene .15 
-
pGAD424- -Leu 
-
480 
l!;ene 2 
pGBT9- pGAD424- -Leu. -Trp - 480 
l!;ene .15 gene 2 
Table 5.9 Two-hybrid assay for a potential interaction between truncated NSPl 
and VP2 
The results of a yeast two-hybrid assay to detect a potential interaction between a 
truncated mutant of NSP1, encoded by gene Ll5, and VP2 are shown. Gene Ll5 
encodes a protein consisting of the amino terminal third of the full-length NSPl 
protein. Transformation of SFY526 with the hybrid plasmids indicated in the table 
was performed by the lithium acetate/heat shock method as described (Section 3.5.1 
and 3.5.2). The transformed yeast were plated on SD selection media (Section 3.1.10) 
lacking the amino acids leucine (-Leu) and/or tryptophan (-Trp). All the control 
reactions detailed previously (Table 5.2) were performed in conjunction with the 
experimental reactions and gave the expected results. The p-galactosidase filter assay 
was performed using plates containing the freshly transformed colonies (Section 
3.5.3), and the filters were incubated in the Z bufferlX-gal solution at 30°C until blue 
colonies appeared or until background expression of the reporter gene was observed at 
480 minutes (8 hours). The colour of the colonies was described as white (negative) 
(-) or blue (positive) (+, + +, or + + +) depending on the relative strength of the blue 
colour reaction. The results presented represent three repeats of the experiment. 
5.7.3 Assay for a potential interaction between NSPl and VP3 
The yeast two-hybrid system was also used to screen for a potential 
protein-protein interaction between NSPl and the viral structural protein VP3. VP3 is 
found together with NSPl in the pre-core RI at an early stage in the viral replication 
cycle. The yeast reporter strain SFY526 was transformed with experimental 
constructs encoding fusions of NSPl and VP3 with both the GAIA DNA-binding and 
activation domains (Chapter Four) in all possible combinations and with the 
appropriate controls, and a p-galactosidase filter assay was used to screen for 
potential interactions. The efficiency of the double plasmid co-transformation was 
found to be approximately 103 cfulJlg DNA. 
The results of the p-galactosidase filter assay for the controls and experimental 
transformations are shown (Table 5.10). All the control transformations gave the 
expected results. After 240 minutes incubation a faint blue colour was observed in 
colonies co-transformed with both the experimental hybrid constructs expressing 
GAIA fusion proteins of NSPI and VP3. However, this was matched in colonies 
transformed with the experimental constructs either alone or together with the other 
two-hybrid vector (e.g. pGBT9-gene 3 and pGAD424). This was considered to be a 
false positive result and was probably due to a Iow level leaky expression of the 
reporter gene. The results of a liquid (ONPG) p-galactosidase assay confirmed that an 
interaction could not be detected between NSP 1 and VP3. It was not possible to 
calculate p-galactosidase units as the OD42o readings obtained in the assay were too 
low to be analysed (OD420 < 0.02) (data not shown). Thus, a protein-protein 
interaction was not detected between full length NSP 1 and VP3 in the yeast 
two-hybrid system. 
The SFY526 yeast reporter strain was transformed with plasmids pGBT9-gene 
~5 and pGAD424-gene 3, which express GAlA fusion proteins with truncated NSP I 
and VP3 respectively. A ~-galactosidase assay was performed and it was observed 
that colonies transformed with both the experimental constructs remained white, 
indicating that an interaction between NSP 1 and VP3 did not occur (Table 5.11). In 
conclusion, protein-protein interactions between VP3 and both full-length and 
truncated NSPl were not detected in the two-hybrid system. 
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Table 5.10 
DNA-binding Activation Selection on Result of Time elapsed in 
domain hybrid domain SDmedium p-galactosidase p-galactosidase 
plasmid hybrid filter assay filter assay 
plasmid (minutes) 
peLl 
- -Leu +++ 30 
pGBT9 pGAD424 -Leu, -Trp +/- 240 
pVA3 pTD) -Leu, -Trp ++ 60 
pLAM5' pTD) -Leu, -Trp 
-
380 
pGBT9-N pGAD424-P -Leu, -Trp +++ 30 
pGBT9-gene 3 - -Trp - 380 
-
pGAD424- -Leu 
-
380 
~ene 3 
pGBT9-gene 5 
-
-Trp 
-
380 
-
pGAD424- -Leu 
-
380 
J.':ene 5 
pGBT9-gene 3 pGAD424 -Leu, -Trp +/- 240 
pGBT9 pGAD424- -Leu, -Trp +/- 240 
J.':ene 3 
pGBT9-J.':ene 5 pGAD424 -Leu, -Trp +/- 240 
pGBT9 pGAD424- -Leu, -Trp +/- 240 
j!ene 5 
pGBT9-gene 3 pGAD424- -Leu, -Trp +/- 240 
J.':ene 5 
pGBT9-gene 5 pGAD424- -Leu, -Trp +/- 240 
gene 3 
Table 5.10 Two-hybrid assay for a potential interaction between NSP1 and VP3 
The results of a yeast two-hybrid assay to detect a potential interaction between NSP 1 
and VP3 are shown. Transformation of SFY526 with the hybrid plasmids indicated in 
the table was performed by the lithium acetate/heat shock method as described 
(Section 3.5.1 and 3.5.2). The transformed yeast were plated on SD selection media 
(Section 3.1.10) lacking the amino acids leucine (-Leu) and/or tryptophan (-Trp). All 
the control reactions detailed previously (Table 5.2) were performed in conjunction 
with the experimental reactions and gave the expected results. The B-galactosidase 
filter assay was performed using plates containing the freshly transformed colonies 
(Section 3.5.3), and the filters were incubated in the Z bufferlX-gal solution at 30°C 
until blue colonies appeared or until background expression of the reporter gene was 
observed at 380 minutes (6.33 hours). The colour of the colonies was described as 
white (negative) (-) or blue (positive) (+, + +, or + + +) depending on the relative 
strength of the blue colour reaction. A faint blue colour, which appeared after several 
hours incubation and was thought to be background was also described (+/-). The 
results presented represent three repeats of the experiment. 
Table 5.11 
DNA-binding Activation Selection on Result in Time elapsed in 
domain hybrid domain SD medium ~-galactosidase ~-galactosidase 
plasmid hybrid filter assay filter assay 
plasmid (minutes) 
peLl 
-
-Leu +++ 30 
pGBT9 pGAD424 -Leu, -Trp 
-
480 
pVA3 pTDI -Leu, -Trp ++ 60 
pLAM5' pTDI -Leu, -Trp 
-
480 
pGBT9-N pGAD424-P -Leu, -Trp +++ 30 
pGBT9-
-
-Trp 
-
480 
gene ~5 
-
pGAD424- -Leu 
-
480 
Rene 3 
pGBT9- pGAD424- -Leu. -Trp - 480 
~ene ~5 gene 3 
Table 5.11 Two-hybrid assay for a potential interaction between truncated NSPI 
and VP3 
The results of a yeast two-hybrid assay to detect a potential interaction between a 
truncated mutant of NSPl, encoded by gene .15, and VP3 are shown. Gene .15 
encodes a protein consisting of the amino terminal third of the full-length NSP 1 
protein. Transformation of SFY526 with the hybrid plasmids indicated in the table 
was performed by the lithium acetate/heat shock method as described (Section 3.5.1 
and 3.5.2). The transformed yeast were plated on SD selection media (Section 3.1.10) 
lacking the amino acids leucine (-Leu) and/or tryptophan (-Trp). All the control 
reactions detailed previously (Table 5.2) were performed in conjunction with the 
experimental reactions and gave the expected results. The ~-galactosidase filter assay 
was performed using plates containing the freshly transformed colonies (Section 
3.5.3), and the filters were incubated in the Z buffer/X-gal solution at 30°C until blue 
colonies appeared or until background expression of the reporter gene was observed at 
480 minutes (8 hours). The colour of the colonies was described as white (negative) 
(-) or blue (positive) (+. + +. or + + +) depending on the relative strength of the blue 
colour reaction. The results presented represent three repeats of the experiment. 
5.7.4 Conclusions 
In this chapter qualitative data from ~-galactosidase filter assays generated in 
several yeast two-hybrid experiments has been presented. The aim was to determine if 
NSPI interacted with any of the structural proteins found with it in early replication 
complexes. However, protein-protein interactions could not be detected between 
NSPI and the rotavirus structural proteins VPl, VP2 and VP3 in this assay. 
There are two obvious conclusions which can be drawn from this result. 
Firstly, it is possible that NSPl does not interact with the structural proteins found in 
the early replication complexes. The second possible conclusion is that although 
protein-protein interactions might occur between NSPI and one or all of these 
proteins, these interactions could not detected by this assay. The reasons to support 
this suggestion will be discussed subsequently (Section 5.8.1). 
The yeast strain SFY526 was used throughout for the two-hybrid assays. The 
use of the second available strain HF7c was considered and preliminary control 
experiments were performed. However, as this strain has a weaker promoter than 
SFY526. it was considered that the use of HF7c would be unlikely to reveal an 
interaction that was not detected in strain SFY526. 
5.S Discussion 
5.S.1 Discussion 
The yeast two-hybrid system was employed to determine if direct 
protein-protein interactions occurred between NSPI and itself, and with other proteins 
present in viral complexes formed at early times in the infected cell. Dimerisation of a 
second viral non-structural protein, NSP3, was also studied. 
Two-hybrid assays to investigate potential interactions between NSP I and the 
viral proteins VP1, VP2, VP3 and NSP3, all yielded negative results in 
~-galactosidase filter assays. These results suggested either that direct protein-protein 
interactions do not occur between NSPI and these proteins, or that although 
interactions might occur they cannot be detected under the conditions of this assay. 
The hypothesis that NSPI might form a dimer was also studied, however a negative 
result was obtained in the ~-galactosidase assay. Thus, NSPl does not form a dimer 
under the conditions of the yeast two-hybrid system. 
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A negative result in the two-hybrid system is not strong evidence against a 
specific interaction, as there are several possible explanations for why a 
protein-protein interaction might not be detected. For example, the protein-protein 
interactions may be too weak to be detected by the assay, or the conditions of the 
assay might not be favourable. As the assay was performed in yeast and not in a 
mammalian cell it is unlikely to represent the exact conditions that would be found in 
the mammalian cell. Although, the dimerisation of NSP3 was clearly shown with the 
yeast two-hybrid system, other protein interactions which do occur may not be 
detectable. In this case, it is possible that a two-hybrid assay in a mammalian cell 
system may give a different result. 
A further consideration is that the proteins must be able to fold and exist stably 
in the yeast cell and to retain activity as fusion proteins for protein-protein 
interactions to occur. The fusion proteins could not be detected with polyclonal 
antiserum on a western blot, probably due to the low expression from the two-hybrid 
plasmids. Specific monoclonal antibodies against the GAIA domain proteins do not 
detect fusion proteins expressed from the two-hybrid vectors pGBT9 and pGAD424 
for this reason. Although it was not possible to ascertain the level of expression of the 
fusion proteins in the yeast cell, it does not necessarily mean that they were not 
expressed. Other researchers have proven protein-protein interactions using fusion 
proteins which were only expressed at extremely low levels (Tsui and Schubach, 
1994), or when expression could not be detected by western blotting (Slack,1998). 
In this two-hybrid assay the rotavirus proteins were expressed as carboxy-
terminal extensions of the GALA domains (Section 4.2.1). It has been suggested that 
in some cases this might result in a protein-protein interaction site at the amino 
terminus of the protein of interest becoming occluded (Fields and Sternglanz, 1994). 
The fusion of the GALA domain might also interfere with the appropriate folding of 
the protein such that protein-protein interactions are prevented. This could be a 
possible explanation for the failure to detect protein-protein interactions in this study. 
The amino-terminal regions of some of the proteins studied may have functional 
significance, which could possibly have been affected by the fusion to the GAIA 
domains. The proposed functional region in the amino-terminus of NSP 1 has been 
noted previously (Section 1.6.2), and is reflected in the viability of the truncated 
mutant containing only the amino terminus of the protein (Section 5.2). Also, by 
analogy with the bluetongue virus system, there may be a requirement for a flexible 
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and free amino-terminus of VP2 that is probably functionally important (Gouet et al., 
1999). 
Although the yeast two-hybrid assay did not detect direct protein-protein 
interactions between NSPl and itself, or the other protein components of the pre-core 
RI, this does not mean that protein-protein interactions do not occur between these 
proteins. Failure in the identification of protein-protein interactions in the yeast 
two-hybrid system, which can be demonstrated in other systems, has been reported 
previously (Black et al., 1998) (Van Aelst et al., 1993). 
5.8.2 NSP3 forms dimers and activates transcription when fused to the GAL4 
DNA-binding domain alone 
It has been shown previously that NSP3 forms a dimer in infected cell 
(Mattion et al., 1992), and this was confirmed in a yeast two-hybrid assay. The 
strength of the self-interaction of NSP3 was quantified using a p-galactosidase assay 
and the level of enzyme activity was found to be 37 p-galactosidase units. This result 
suggested that in this assay the self-interaction of NSP3 was approximately half as 
strong as the interaction between p53 and SV40 large T-antigen, a well-characterised, 
relatively strong interaction (Li and Fields, 1993). Recently, results have been 
published which quantify the dimerisation of NSP3 in the YM strain of porcine 
rotavirus in the yeast two-hybrid system (Gonzalez et al., 1998). A similar strong blue 
phenotype was detected in the p-galactosidase filter assay, however the level of 
p-galactosidase activity recorded was considerably lower (1.31 p-galactosidase units) 
than the value stated here. The reason for this difference is unknown, although it was 
noted that all the recorded values of p-galactosidase units were lower than those 
obtained in this work. The researchers similarly found that NSP3 activated 
transcription when fused to the GAlA DNA-binding domain in the absence of a 
fusion counterpart in the GAlA activation domain. 
When the yeast strains were transformed with plasmid pGBT9-gene 9 
encoding a fusion of the GAlA DNA-binding domain with NSP3, activation of the 
reporter gene was observed. This result suggested that NSP3 may have some intrinsic 
transcriptional activation properties, which can complement the DNA-binding activity 
of the GAL4 domain to activate the reporter gene. NSP3 is an acidic protein with a 
predicted net negative charge at pH 7.0 of -2.5 (Mattion et al., 1992). The secondary 
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structure is predicted to be predominantly alpha-helical in nature. A short acidic 
region, consisting of nine glutamic acid or aspartic acid residues over a stretch of 19 
amino acids (aa), has also been described. This acidic region is adjacent to a 
conserved basic region at the amino terminus of the protein which may be the location 
of the RNA-binding domain reported as being present in NSP3 (Patton, 1995). At the 
carboxy terminus of the protein is the conserved region which has been implicated in 
dimerisation (Mattion et al., 1992). Proteins with transcriptional activation properties 
often contain highly acidic activating sequences. Ma and Ptashne (1987) identified 
novel acidic activating sequences which varied in length from 12-81 aa and showed 
no obvious sequence homology when compared with activating regions of GAL4 or 
GCN4 or among themselves. The novel acidic activators were identified by fusion of 
the sequence to the GAL4 DNA-binding domain and assaying for a functional GAL4 
transcriptional activator. The fusion of NSP3 to the GAL4 DNA-binding domain, as 
described above, identified NSP3 as having transcriptional activation properties in an 
identical manner. It is possible that the acidic region of NSP3, between aa 150-169, 
may be responsible for the activation of transcription of the reporter gene which was 
observed. 
5.8.3 Future work 
This study has produced several constructs (Table 4.1) which will be valuable 
in future studies of rotavirus proteins. In particular, the availability of plasmids 
expressing rotavirus proteins VPl, VP2, and VP3, suggests further experiments with 
the yeast two-hybrid assay, which could potentially generate interesting data on the 
interactions between the enzymes, VPl and VP3, in the transcriptional complex. In 
addition, interactions of the components of the transcriptional complex with the core 
protein VP2 could be studied. Investigation of these interactions would allow parallels 
to be drawn with recent structural studies (Prasad et al., 1996) (Lawton et al., 1997b), 
and the suggestion that VP2 may have a role during transcription and viral 
morphogenesis as a scaffold for the proper assembly of the viral RNA, and VPl and 
VP3 in the viral core (Labbe et al., 1994) (Zeng et al., 1998). The interacting domains 
of these proteins could then be mapped. 
Dimerisation of full-length NSP3 was demonstrated, although the interacting 
site was not mapped. Further experiments with these constructs, which are clearly 
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functional, could include mapping of the dimerisation domain and an investigation of 
potential interactions between NSP3 and the structural proteins VPl, VP2 and VP3. 
Alternatively, the NSP3 constructs could be used to screen a cDNA expression library 
for interactions with cellular proteins. Indeed, it has been suggested previously that 
NSP3 might have an association with the cell cytoskeleton (Mattion et al., 1992). 
In this study the rotavirus proteins were expressed as carboxy-terminal 
extensions of the GAlA domains, which possibly could have resulted in a protein-
protein interaction site at the amino terminus of the protein becoming occluded. The 
use of the alternative LexA system, which uses amino-terminal fusions to LexA of the 
protein of interest instead of carboxy-terminal fusion (Beranger et al., 1997), would 
allow the detection of interactions which require a 'free' amino-terminus of the 
protein. 
118 
Results Chapter 3 
Analysis of rotavirus protein-protein interactions 
by radio-immunoprecipitation 
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6.1 Aims 
The aim of the work described in this chapter was to investigate potential 
direct protein-protein interactions between NSPl and viral structural proteins present 
in early replication complexes by means of co-immunoprecipitation analysis. An in 
vitro approach, using viral proteins translated in a rabbit reticulocyte system, was 
chosen as a complement to the in vivo analysis used in the yeast two-hybrid system. 
6.2 Introduction 
Protein-protein interactions are intrinsic to many viral processes within the 
infected cell. An ability to identify these interactions is integral to dissection of the 
virus replication cycle and understanding of the interactions between virus and host 
cell at the molecular level. Co-immunoprecipitation is the classical method for 
investigating protein-protein interactions. The use of a rabbit reticulocyte system to 
produce translated proteins allows the examination of individual proteins and the 
direct interactions between them. This method of co-immunoprecipitation, in contrast 
to the use of infected celllysates where proteins may be interacting indirectly as part 
of a complex, means that direct protein-protein interactions can be unambiguously 
examined. This method of examining viral protein-protein interactions was 
successfully used by Shepard et al. (1996) in their study of the interactions between 
the reovirus capsid proteins 0'3 and J..ll, where they defined the amino-terminal zinc-
binding motif of cr3 as the potential interacting domain by the in vitro expression of 
0'3 deletion mutants which failed to co-immunoprecipitate with J..ll (Shepard et al., 
1996). 
Co-immunoprecipitation was chosen as a method of studying rotavirus 
protein-protein interactions as an in vitro complement to the genetic method of the 
yeast two-hybrid system. NSPl has been shown to be present in early replication 
complexes with the viral structural proteins VPl and VP3, and the non-structural 
protein NSP3 (Gallegos and Patton, 1989) in a complex that has been termed the 
pre-core replication intermediate (RI). VP2 is added to the pre-core RI to form the 
core RI. The function of NSPl in these complexes is unknown but it is almost certain 
to involve the interaction of NSPl with other components of the complex. It has been 
suggested that the pre-core RI assembles on the cytoskeleton by the interaction of 
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VPl and VP3 with NSPIINSP3-mRNA complexes (Patton, 1995), therefore 
interactions between these proteins must be a prerequisite for formation of the pre-
core RI. It is for this reason that the structural proteins VP I, VP2 and VP3 were 
chosen for expression in vitro and used in co-immunoprecipitation experiments with 
NSPl. 
6.3 Production of Antiserum 
6.3.1 Recombinant vaccinia virus VR5 
The decision to develop radio-immunoprecipitation as a method of studying 
protein-protein interactions necessitated the production of a monospecific antiserum 
against NSPl. A recombinant vaccinia virus, VR5, expressing the gene 5 protein 
product NSP 1 from the UKtc strain of bovine rotavirus, which was produced in the 
Rotavirus laboratory at the University of Warwick by S. Stagg, was chosen as the 
source of rotavirus antigen. Expression of NSP 1 by the vaccinia recombinant VR5 
was confirmed by positive fluorescence in indirect immunofluorescence assays 
carried out on VR5-infected cells and stained with polyclonal anti-bovine rotavirus 
serum (Heath et al., 1997). 
It has been shown that immunisation of animals with recombinant vaccinia 
viruses can successfully produce monospecific antisera that recognise native proteins 
by immunoprecipitation, immunofluorescence and western blotting (Tine et al., 1993) 
(Vafai and Yang, 1991). Also, the use of a recombinant virus for immunisation should 
allow a large quantity of the antigen to be easily grown and purified. Immunisation of 
a rabbit was expected to give a large quantity of specific antiserum that could be used 
for the intended experimental methods. The antiserum from the rabbit could be 
expected to be of a more consistent quality than from several batches of mice, and the 
use of a single, larger animal was also considered to be an easier approach. 
6.3.2 Growth and purification of VR5 
The strategy for the production of the antigenic material was to grow stocks of 
high titre VR5 and purify it by centrifugation through sucrose gradients. HeLa cells 
were chosen to grow the virus as they are known to consistently give high yields of 
vaccinia virus (Ausubel et al., 1996). Briefly, HeLa cells were infected with VR5 at a 
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low multiplicity of infection (m.o.i.) and incubated until complete cytopathic effect 
(cpe) was observed. The virus was harvested and, as vaccinia virus is known to be 
extremely ceU associated, careful freeze-thawing and sonication were performed to 
ensure adequate release of the virus. The virus was concentrated by low speed 
centrifugation before purification through a 20-40 % sucrose gradient (McCrae, 
1975). Following centrifugation a band of virus was visible in the middle of the 
gradient and this was collected and the bands pooled. The virus stock was then further 
purified using a second sucrose gradient and concentrated in a small volume. A 
plaque assay was performed prior to use to ensure a sufficiently high titre of the virus. 
Highly purified virus stocks of 107_108 pfu/ml were obtained by this method and used 
for inoculation procedures. 
6.3.3 Inoculation procedure 
Rotaviruses are an extremely common infection of young animals and 
consequently the rabbit used for inoculation was obtained from a supplier who 
guaranteed that the animal was free from rotavirus infection and thus carried no anti-
rotavirus antibodies. Prior to inoculation a sample of serum was taken and tested at 
dilutions between 10-2 and 10-3 by immunofluorescence though, as expected, no 
rotavirus antibodies were detected in the pre-immune serum (Figure 6.1, panel E). 
The inoculations were performed as described previously (Section 3.7.1). The serum 
was separated as described (Section 3.7.2) and was tested for the presence of the 
desired antibodies by immunofluorescence and immunoprecipitation analysis. 
6.3.4 Analysis of the antiserum by immunofluorescence 
The pre-immune and hyper-immune sera obtained from each bleed were tested 
for the presence of anti-VR5 and anti-rotavirus antibodies using an 
immunofluorescence assay. VR5-infected cells were used to test for the presence of 
anti-VR5 antibodies. The pre-immune serum did not react with the VR5-infected cells 
(Figure 6.1, panel A) as expected. All the hyper-immune sera were tested (data not 
shown for all bleeds) and each hyper-immune serum reacted strongly with the 
VR5-infected cells. Figure 6.1 (panel B) shows a typical fluorescence photograph 
obtained when the cells were stained with hyper-immune serum (bleed 2 weeks post 
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Figure 6.1 ImmunoOuorescence assay analysis or hyper-immune serum 
raised against VRS 
BS-C-l cells grown on coverslips were infected with VR5 at a low m.o.i. (2x 10-3), 
incubated until plaques were visible (approximately 24 hours) then fixed. A 10-2 
dilution of pre-immune serum (Panel A) and a 10-2 dilution of hyper-immune 
serum from a bleed 2 weeks post boost I (Section 3.7.1) (Panel B) were added to 
separate coverslips and incubated at 37°C for 1 hour. The coverslips were washed 
and incubated with a 10-2 dilution of ATC conjugate goat anti-rabbit 
Immunoglobulin as described (Section 3.7.3). 
BS-C-I cells grown on coverslips were infected with UKtc rotavirus (m.o.i. = 
lxlO- I), incubated for 16 hours and fixed. The cells were incubated with a 10-2 
dilution of polyclonal anti-UKtc serum (Panel C). hyper-immune serum from a 
bleed 2 weeks post boost III (Section 3.7.1) (Panel D). and pre-immune serum 
(Panel E) for I hour at 37°C. followed by a similar incubation with a 10-2 dilution 
of FITC conjugate goat anti-rabbit Immunoglobulin as described (Section 3.7.3). 
The cells were examined by UV microscopy and photographed. 
A. VRS-infected cells 
pre-immune serum 
c. UKtc-infected cell 
anti-UKtc serum 
Figure 6.1 
B. VRS-infected cells 
hyper-immune serum 
D. UKtc-infected cells 
hyper-immune serum 
E. UKtc-infected cells 
pre-immune serum 
boost n. These results indicated that anti-vaccinia (VR5) antibodies had been 
generated and were present in the serum. 
A similar assay was performed with UKtc rotavirus-infected cells to determine 
if anti-NSPl antibodies had been generated. On analysis, it could be seen that the 
pre-immune serum did not react with the UKtc rotavirus-infected cells (Figure 6.1, 
panel E), while a positive control of polyclonal anti-rotavirus serum showed a strong 
fluorescence when examined by UV microscopy (Figure 6.1, panel C). However, all 
samples of hyper-immune sera (data shown for bleed 2 weeks post boost III but not 
for all bleeds tested) failed to react with the infected cells (Figure 6.1, panel D). 
Therefore, although anti-vaccinia antibodies were generated, indicating that VR5 was 
an efficient immunogen, the serum did not contain high enough levels of anti-NSP 1 
antibodies to be detectable by this assay. 
6.3.5 Analysis of the antiserum by radio-immunoprecipitation 
Hyper-immune sera obtained from each bleed were analysed by 
radio-immunoprecipitation to determine if NSPI could be specifically precipitated by 
antibodies in the sera. The experiment was performed with in vitro translated NSPI 
and also with infected celllysates. Hyper-immune sera from all bleeds were tested in 
immunoprecipitation reactions with in vitro translated NSPl and the results are shown 
in Figure 6.2. The positive control immunoprecipitation reaction, which used a 
specific anti-NSPI antiserum known to precipitate NSPl (lane 1), produced a broad 
band at approximately 50 kDa which corresponds to NSPl. The smaller bands below 
are incomplete translation products of NSP 1. The pre-immune serum (lane 2) did not 
precipitate NSPI as expected. Several different hyper-immune sera, including those 
from bleeds taken after booster inoculations were given, were tested and all sera failed 
to precipitate visible amounts of NSPI (lanes 3-7). The fluorograph shown (Figure 
6.2) represents a 4-week exposure of the gel. Although faint bands can be seen in 
lanes 3-7 they are only marginally above background and are only visible on an 
overexposed fluorograph. 
A potential explanation for the failure of the sera to precipitate NSPl was the 
possibility of antigenic differences between the recombinant vaccinia virus expressed 
protein and the in vitro translated protein, such that hyper-immune serum raised 
against the vaccinia expressed protein may fail to recognise the in vitro translated 
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Figure 6.2 Immunoprecipitation of in vitro translated NSPl with hyper-
immune serum from a rabbit infected with VRS 
35S-methionine-Iabelled NSPl protein was produced by in vitro coupled 
transcription-translation (Section 3.6.1). Equal aliquots of the translation reactions 
were incubated with 5 J!l of antisera overnight at 4 °C (Section 3.6.4), precipitated 
with protein A-Sepharose and washed with a series of buffers. The precipitates 
were loaded onto a 5-11 % gradient polyacrylamide gel (Section 3.6.5) and 
analysed by dry gel fluorography after a four week exposure of the gel (Section 
3.6.6). A known specific anti-NSPl antiserum was used as the positive control (lane 
1). Pre-immune serum from the rabbit was used as a negative control (lane 2). 
Lanes 3-11 represent immunoprecipitation reactions with hyper-immune sera from 
a rabbit infected with a vaccinia recombinant virus expressing NSP 1 (VR5) at the 
following times post inoculation: 2 weeks (lane 3); 7 weeks (lane 4); 2 weeks post 
boost I (lane 5); 4 weeks post boost I (lane 6); 2 weeks post boost IT (lane 7); 4 
weeks post boost IT (lane 8); 6 weeks post boost IT (lane 9); 2 weeks post boost ill 
(lane 10); 4 weeks post boost ill (lane 11). 
protein. For example, if antibodies were raised against a conformational epitope 
displayed in the vaccinia expressed protein in vivo, which was not present in the in 
vitro expressed protein due to a difference in protein folding, then NSP I would not be 
precipitated by the serum. Indeed, proteins expressed in reticulocyte systems 
sometimes have different properties and structure to the native protein (Ausubel et al., 
1996). A second possible explanation may have been that the antigen-antibody 
interaction was of relatively low affinity and therefore may have been disrupted by 
the stringent conditions used for immunoprecipitation leading to a negative result. 
To investigate these possibilities, immunoprecipitation experiments were 
performed to determine if the hyper-immune seta could precipitate NSP 1 from 
infected cell lysates (Figure 6.3). A specific anti-NSPI serum known to precipitate 
NSPl was used as the positive control (lane 2) and a band corresponding to NSPI can 
be seen on the fluorograph. The pre-immune serum was tested (lane 3) and did not 
precipitate NSPI. Hyper-immune sera from three different bleeds were tested in the 
experiment shown, but in others (data not shown) all samples of hyper-immune sera 
collected were tested. None of the hyper-immune sera tested precipitated NSPI from 
the infected cell lysates. However, the results show that there was precipitation of 
other viral proteins, in particular VP2 and VP6, by the hyper-immune serum. These 
proteins were also non-specifically precipitated by the pre-immune serum. VP6, 
which is the sub-group specific antigen (Greenberg et al., 1983) and a major structural 
protein within the virus (Prasad et al., 1988), is considered to be a particularly 
"sticky" protein (M. A. McCrae, pers. comm.), hence non-specific interactions may 
occur between antibodies in the serum and epitopes on VP6. 
All hyper-immune sera were tested by immunoprecipitation in two separate 
assays for antibodies against NSPl. In vitro translated NSPI was not precipitated by 
the hyper-immune sera, and in addition, NSP I was not precipitated from lysates made 
from cells infected with the UKtc strain of bovine rotavirus. These results indicated 
that no specific antibodies were produced by the inoculation procedure which could 
precipitate NSP 1 in immunoprecipitation reactions. 
6.3.6 Anti·NSPl serum 
The specific anti-NSPl serum used as a positive control in the preceding 
experiment (Section 6.3.5) was generously donated by Dr Jean Cohen at the Institut 
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Figure 6.3 Immunoprecipitation of UKtc rotavirus-infected cell Iysates with 
hyper-immune sera from a rabbit infected with VRS 
Hyper-immune sera from a rabbit infected with a vaccinia recombinant virus 
expressing NSPl (VR5) was analysed by immunoprecipitation for specific 
antibodies to NSPl. UKtc rotavirus-infected BS-C-l celllysates were labelled with 
35S-methionine (Section 3.6.3) and equal aliquots were incubated with 5 III of 
antisera (Section 3.6.4). The lysates were precipitated with protein A-Sepharose and 
loaded onto a 5-11 % gradient SDS-polyacrylamide gel (Section 3.6.5) and 
analysed by dry gel fluorography after a one week exposure of the gel (Section 
3.6.6). An aliquot of the infected cell lysate was run on the gel (lane 1) to show the 
characteristic pattern of rotavirus protein expression. Viral proteins are labelled on 
the left. The positive control for the immunoprecipitation reaction was a known 
specific anti-NSPl serum (lane 2). Pre-immune serum from the rabbit was used as 
the negative control (lane 3). Lanes 4-6 represent immunoprecipitation with hyper-
immune sera from bleeds 2 weeks post inoculation (lane 4), 2 weeks post boost I 
(lane 5), and 2 weeks post boost III (lane 6). The position of NSPl is indicated by 
an arrow. 
National de la Recherche Agronomique, Jouy-en-Josas, France. A monoclonal 
antibody against NSPl was also obtained from Dr Cohen, however it did not 
precipitate NSPl when used in radio-immunoprecipitation experiments (data not 
shown). 
The anti-NSPl serum was raised in New Zealand white rabbits which were 
inoculated with a crude lysate of Spodoptera Jrugiperda cells infected with a 
recombinant baculovirus containing gene 5 (Brottier et al., 1992). Inoculation with 
protein purified by preparative PAGE or FPLC failed to give reacting sera. The serum 
was tested for the presence of antibodies by immunoprecipitation and western blotting 
and the specificity was confirmed by immunoprecipitation of in vitro translated NSP 1 
protein. The serum was shown to specifically precipitate NSPl from infected cell 
lysates, while the pre-immune serum did not. Also, the anti-NSPl serum did not react 
with a lysate of mock-infected cells. The researchers noted that VP2 and VP6 were 
also precipitated by the anti-NSPl serum, suggesting that either these proteins were 
associated with NSPI in some way or that the rabbit had been in contact with 
rotavirus during the immunisation period (Brottier et al., 1992). 
In addition to the analysis performed by Cohen's group, the anti-NSPl serum 
was tested for its specificity in an immunofluorescence assay before use in this 
project. UKtc rotavirus-infected cells fixed onto coverslips were stained with 
anti-NSPl serum and patches of fluorescent cells were observed (Figure 6.4, panels A 
and C). It was estimated that 15-20 % of the cells in each field of view were 
fluorescent. The same cells were then restained with polyclonal anti-rotavirus serum 
at the same dilution and examined. Again approximately 15-20 % of the cells were 
fluorescent - a figure which must represent the distribution of rotavirus infected cells 
(Figure 6.4, panels B and D). The fact that a similar proportion of cells were seen to 
fluoresce with each antibody suggested that only infected cells were stained in each 
case. It therefore appeared that the anti-NSPl serum was specific to rotavirus-infected 
cells and did not cross-react with proteins in uninfected cells. The difference in the 
intensity of the fluorescence apparent in Figure 6.4 could reflect the fact that NSP 1 is 
a minor protein in the infected cell. 
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Figure 6.4 
A. Anti-NSPl serum B. Anti-UKtc serum 
c. Anti-NSPl serum D. Anti-UKtc serum 
Figure 6.4 Immunofluorescence photographs of UKtc-infected BS-C-l cells 
stained with anti-NSPl serum or anti-UKtc serum 
BS-C-l cells infected with UKtc rotavirus (m.oj. = 0.2) and fixed onto coverslips 
were incubated with a 10-3 dilution of anti-NSPl serum (Panels A and C) for 1 hour 
at 37 °C, followed by a similar incubation with a 10-2 dilution of mc conjugate 
goat anti-rabbit Immunoglobulin (Section 3.7.3). The cells were examined by UV 
micro copy and photographed. The cells were washed and then incubated with a 
10-3 dilution of polyclonal anti-UKtc serum, followed by a 10-2 dilution of FITC 
conjugate goat anti-rabbit Immunoglobulin as before (panels B and D). 
6.3.7 Summary 
Inoculation of a rabbit with a recombinant vaccinia virus expressing NSP I 
(VRS) failed to generate anti-NSPl antibodies. The serum did not immunoprecipitate 
NSPl either from infected celllysates or from a reaction containing in vitro translated 
NSPI. The serum reacted with VR5-infected cells but not with rotavirus-infected cells 
in an immunofluorescence assay, suggesting that anti-vaccinia, but not anti-rotavirus, 
antibodies were generated. This failure to produce a hyper-immune serum could be a 
result of the low antigenicity of NSPl. Also, it should be noted that other researchers 
have had difficulties in the production of an antiserum against this protein (Brottier et 
al., 1992). As a result, the limited quantity of the anti-NSPI serum obtained from Dr 
Cohen was used for all the immunoprecipitation experiments described here. 
6.4 Construction of plasmids for in vitro expression of rotavirus proteins 
6.4.1 Cloning strategy 
The linked T7 transcription-translation system enables in vitro synthesis of 
proteins from DNA templates containing T7 promoters upstream of coding sequences. 
It was decided that this system would be a convenient one in which to produce 
proteins that could be used to test for co-precipitation of viral proteins with NSP 1. A 
consequence of this was the need to produce plasmids containing rotavirus genes 
under control of the T7 promoter. 
A plasmid containing UKtc rotavirus gene 5 coupled to the T7 promoter 
(GST7-TAI) had already been constructed by Dr XU Li in the Rotavirus laboratory. 
Gene S was cloned directly into the peR TMrr vector (lnvitrogen) by TA cloning and 
the gene was flanked by EcoR I sites and under control of the T7 promoter. 
6.4.2 Cloning rota virus genes 1, 2 and 3 into pT Ag 
peR products of rotavirus genes 1,2 and 3 had previous} y been cloned directly 
into the TA vector pTAg as part of a sub-cloning procedure (Section 4.4). This vector 
contains the T7 promoter immediately adjacent to an MCS into which peR products 
can be directly ligated by TA cloning (Figure 4.10). Therefore, these plasmids could 
be used for in vitro transcription-translation. 
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The orientation of the rotavirus genes in relation to the T7 promoter was 
confirmed by restriction enzyme digest analysis of mini-prep DNA (Figure 6.5). 
Clones of T7-pTAg-genel were digested with EcoR I and produced fragments of 
5600 bp, 900 bp and 600 bp which indicated that all the clones analysed were in the 
correct orientation in relation to the T7 promoter. Clones of T7-pTAg-gene2 were 
digested with Hind HI and Mlu I. Digests with Hind ITI produced fragments of 5300 
bp, 800 bp and 340 bp. Digests with Mlu I produced fragments of 5800 bp and 700 
bp. Thus, all clones of T7-pTAg-gene2 analysed were in the correct orientation with 
respect to the T7 promoter. Clones of T7-pT Ag-gene3 were digested with EcoR I and 
produced fragments of 4400 bp, 1800 bp and 200 bp, again indicating that they were 
correctly orientated in relation to the T7 promoter. 
Prior to using these plasmids for in vitro transcription-translation, additional 
cloning steps were performed to remove an ATG codon present in the 5' sequence of 
pT Ag between the T7 promoter and the ATG start codon of the inserted rota virus 
gene. This additional ATG codon could have led either to initiation of out-of-frame 
translation, or the addition of extra amino acids to the amino terminus of the 
translated protein. both of which were clearly undesirable. Removal of this upstream 
A TG was achieved by cutting the plasmids on either side of the codon at unique 
restriction sites, blunt ending the DNA with T4 DNA polymerase and ligating the free 
ends to recreate the plasmid. For example, the extra ATG in pT Ag-gene3 was 
removed by cutting with Kpn I and Mlu I to excise the unwanted sequence, and then 
religating to create plasmid T7-pTAg-gene3 (Figure 6.6). The procedure resulted in 
the concomitant loss of a Pst I site. thus restriction enzyme digestion analysis with Pst 
I was used to identify the new clone. Digestion of the new plasmid with Pst I resulted 
in linearisation when previously the insert had been released. Sequence analysis 
revealed that the extra ATG site had been removed, but several additional nucleotides 
had also been removed in the process. However. this did not affect the T7 promoter or 
the ATG initiation codon of gene 3, and the gene 3 sequence was found to be intact. 
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Figure 6.5 Restriction enzyme digestion analysis of clones T7-pTAg-Genel, 
T7-pTAg-Gene2 and T7-pTAg-Gene3 
A. Restriction enzyme digestion analysis of new clones 
Plasmid DNA from clones produced from the ligation of rota virus genes I, 2 and 3 
into pTAg (3816 bp) was prepared by mini-prep (Section 3.4.13). Restriction 
enzyme digests (Section 3.4.6) were performed to determine the correct 
orientation of the gene in relation to the T7 promoter in pT Ag and the results 
analysed by gel electrophoresis on a 1 % agarose gel (Section 3.4.3). Bands 
smaller than 500 bp are too faint to be visualized on this photograph. The 
individual clones of each plasmid construct are identified at the top of the gel. 
Lanes marked L were loaded with I Kb DNA ladder. Sizes of the markers are 
given in base pairs. 
B. Schematic diagrams to show the restriction enzyme sites in each clone 
T7-pTAg-Genel digested with EcoR I produces fragments of 5600 bp, 900 bp and 
600 bp when in the correct orientation (Panel A, Gene 1 lanes). T7-pTAg-Gene2 
digested with Hind III produces fragments of 5300 bp, 800 bp and 340 bp when in 
the correct orientation (Panel A, Gene 2 lanes, Hind Ill). T7-pTAg-Gene2 digested 
with Mlu I produces fragments of 5800 bp and 700 bp (Panel A, Gene 2 lanes, Mlu 
I). T7-pTAg-Gene3 digested with EcoR I produces fragments of 4400 bp, 1800 bp 
and 200 bp when in the correct orientation (Panel A, Gene 3 lanes). 
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Figure 6.6 Analysis of the removal of sequence containing an 
additional A TG start site upstream of the 5' end of gene 3 in clone 
pTAg-Gene 3 
A. Restriction enzyme digestion analysis 
Clone pTAG-gene 3 was digested with re triction enzyme Kpn I and Mlu 
I (Section 3.4.6) which cut either side of the equence containing the 
unwanted ATG start site in the pTAg MCS. The 5' and 3' end overhang 
which were created, were blunt ended with T4 D A polymer e and the 
Klenow fragment (Section 3.4.8). The blunt end of the plasmid were then 
religated (Section 3.5.10). Pia mid DNA wa amplified and purified by 
mini-prep (Section 3.4.13) and the new plasmid, 17-pTAg-gene3, was 
identified by restriction enzyme dige tion (Section 3.4.6). The product of 
the dige ts were analy ed by electrophore i on a 1.0 % T AE agaro e gel 
(Section 3.4.3). Lane marked G3 contain the old pi mid pTAg-gene 3 
digested with the enzyme indicated. Lane marked G3* contain the new 
plasmid 17-pTAg-gene 3 dige ted with the enzyme indicated. Dige tion 
of both pTAg-gene 3 and 17 -pT Ag-gene 3 pia mid with BamH I relea ed 
the insert, resulting in band at 3816 bp and 259 bp. Digesti n with PS! I 
lineari ed the new pia mid 17-pTAg-gene 3 (64 bp) ut rele ed the 
gene 3 in ert in the old pia mid pTAg-gene 3 (3 I and 259 p), due t 
the 10 of a P S! I ite during the procedure. Lane marked L were loaded 
with 1 Kb DNA ladder. The ize of the marker are given in ba e pair . 
B. Sequence analysis 
The 5' end of gene 3 in plasmid pTAg-gene 3 w equenced ( ecti n 
3.4.18) with primer pTAg SEQ 5' (Table 3.3). Analy i f th equence 
revealed that an extra ATG ite wa pre ent in the M f P Ag twe n 
the 17 promoter and the ATG tart ite in gene 3, a wn in th figure. 
Pia mid pTAg-gene 3 wa cut with Kpn I and Mlu J t exci e the regi n 
containing the extra ATG ite and thu ere le pt mid TI-pTAg-gene 3. 
The new pia mid 17-pTAg-gene 3 wa equenced a ~ re. Th 
re triction enzyme ite are hown in red. Th P I 1 ite which wa 
removed during thi procedure i hown in yell w. Th initiati n c d n ~ r 
gene 3 i underlined in blue. B HI 
Mlu I am 
Pstl ... ~, 
Kpnl " 
pTAg 
3816 bp 
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pTAg-Gene 3 (G3) 
KpnI 
T 
TCGGTACCACGCATG 
GTGATTATCCGGATG 
T7-pTAg-Gene 3 (G3*) 
MluI 
T 
ACGCGTTACGTATCGGATCCAGAATTC 
P. t I 
TCGTATCGGATCCAGAATTCGTGATTATCCGGATG 
6.5 Expression of NSPl in vitro 
6.5.1 In vitro coupled transcription-translation of Gene 5 
A coupled T7 transcription-translation system (Section 3.6.1), based on 
transcription with T7 RNA polymerase followed by translation in an optimised rabbit 
reticulocyte lysate, was used to produce viral proteins for use in immunoprecipitation 
experiments. Optimisation of the in vitro coupled transcription-translation reaction 
was performed to ensure sufficient levels of full-length NSPI and only minimum 
incomplete translation products were produced. It was desirable that only a single, 
full-length protein was produced as this leads to cleaner immunoprecipitation 
reactions, the results of which are less open to misinterpretation. Therefore 
optimisation of the production of NSP I was performed initially. 
The two variables which were tested in the coupled transcription-translation 
system were the concentration of plasmid G5T7-TAl, which contained gene 5 under 
control of the T7 promoter, and the quantity of the label 35S-methionine which was 
added to the reaction. Increasing the concentration of plasmid DNA in the reaction 
was thought to increase the quantity of the translation product. The incorporation of 
the 35S-methionine label depends upon the efficiency of translation and the number of 
methionine residues in the protein. The amount of label used was optimised so that 
the translation product could be easily visualised by autoradiography. A positive 
control plasmid, the E. coli p-galactosidase gene cloned into a pCITE vector, was 
translated to ensure efficiency of the reactions and a strong band at approximately 118 
kDa, which corresponds to E. coli p-galactosidase, could be seen (Figure 6.7). A 
number of smaller bands which probably correspond to incomplete translation 
products were also seen. A blank reaction containing no plasmid DNA was performed 
to ensure there was no contamination of the reaction components with DNA from 
extraneous sources. As expected no protein was produced in this reaction (data not 
shown), indicating that the reaction components were not contaminated. Two different 
concentrations of G5T7 -TA 1 were compared for their translation efficiency [0.5 Jlg 
(lane 2); 1 Jlg (lane 3)]. In each case a protein band of approximately 53 kDa, which 
corresponds to NSPl, and only minimal incomplete translation products were seen. 
By inspection it appears that the quantity of protein in these NSPl bands (lanes 2-3) 
are approximately equal. A translation reaction containing twice as much 35S_ 
methionine as the previous reaction (20 JlCi) but the same quantity of plasmid DNA 
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Figure 6.7 Optimization of expression of NSPl from plasmid G5T7 -TAl in an 
ill vitro coupled transcription-translation system 
G5T7-TA1 was purified by phenol extraction (Section 3.4.4) and ethanol 
precipitation (Section 3.4.5) and used to programme in vitro coupled transcription-
translation reactions (Section 3.6.1) for expression of NSPl. A positive control 
plasmid, the E. coli p-galactosidase gene cloned into a pCITE vector, was also 
translated. The products of the translation reactions were analysed on a 7.5 % 
polyacrylamide gel (Section 3.6.5) and visualized by dry gel fluorography after a 
three hour exposure of the gel (Section 3.6.6). Translation of the positive control 
plasmid produced a band at approximately 118 kDa (lane 1). The tran lation 
product of G5T7-TAl is NSP1 (53 kDa) which is indicated on the figu re. Lane 2 
shows NSPl (53 kDa) translated from O.S Ilg of GST7-TAl plasmid. Lane 3 shows 
NSP 1 translated from 1.0 IJ,g of GST7 -TA 1 plasmid. Lane 4 shows NSPl translated 
from 1.0 IJ,g ofG5T7-TAl plasmid with double the concentration of 35S-methionine 
(20 IJ,Ci). The sizes (in kDa) of the markers are indicated on the left of the gel. 
(1.0 Jlg) produced more labelled protein, however more incomplete translation 
products were also seen (lane 4). After consideration of these results, 10 JlCi of 35S_ 
methionine and 1 Jlg ofG5T7-TAl plasmid DNA was used in future in vitro coupled 
transcription-translation reactions to produce NSPl protein for immunoprecipitation 
experiments. 
6.5.2 Titration of anti-NSPl serum. 
A titration series was performed with the anti-NSPl serum to determine the 
optimum dilution for effective precipitation of NSPl from the in vitro translation 
reaction, and also the minimum amount of serum which could be used for the 
immunoprecipitation reactions. The objective was to reduce precipitation of 
incomplete translation products of NSP 1 so that only the full length protein was 
visible on the gel. This would result in cleaner, easier to interpret 
immunoprecipitation reactions. Titration of polyclonal antiserum to determine the 
minimum amount required to precipitate the antigen often helps to lower the non-
specific background. Therefore, it was thought that the use of a low concentration of 
anti-NSPl serum may reduce any non-specific precipitation of other proteins. This 
experiment examined the immunoprecipitation of NSPl only, although it was thought 
that determination of the minimum serum concentration required at this stage may 
reduce non-specific precipitation of other proteins in future co-precipitation 
experiments. 
A serial two-fold dilution of the antiserum was made and immunoprecipitation 
reactions were performed with equal aliquots of NSPI (Figure 6.8). All the serum 
dilutions precipitated visible amounts of NSP 1, although the highest dilution (1/16) 
gave a considerably fainter protein band. A 118 dilution of the serum was chosen as 
the working dilution as this precipitated a quantity of NSPl which was clearly visible 
on a gel after a short exposure and fewer incomplete translation products than lower 
dilutions. 
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Figure 6.8 Titration of anti-NSPl serum against in vitro translated NSPl 
An in vitro coupled transcription-translation system (Section 3.6.1) was used to 
produce NSPI protein. A serial two-fold dilution of specific anti-NSPI serum was 
made and reactions were prepared containing equal aliquots of NSPI protein (5 J.lI) 
with each dilution. The reactions were incubated overnight at 4 °C then precipitated 
with protein A-Sepharose (Section 3.6.4). The reactions were analysed on a 7.5 % 
polyacrylamide gel (Section 3.6.5) and the results visualised by dry gel 
fluorography after a 3 day exposure of the gel to X-ray film (Section 3.6.6). The 
dilution of antiserum used in the reaction is indicated at the top of the appropriate 
lane. A protein band at 53 kDa, corresponding to NSPl, was seen for each reaction. 
The unprecipitated control was 3 J.lI of the in vitro translate reaction run on the 
same gel. The positions of the size markers (in kDa) are indicated. 
6.6 Co-Immunoprecipitation studies with NSPl and structural proteins of the 
virus core 
6.6.1 Co-Immunoprecipitation of NSPl and VP2 
An initial study was performed to determine if in vitro synthesised VP2 was 
co-immunoprecipitated with NSPl. NSPl and VP2 were produced both in separate 
and co-translation reactions in the in vitro system (Section 3.6.1). Four separate 
immunoprecipitation reactions were prepared: (i) NSP 1 only; (ii) VP2 only; (iii) 
NSPl and VP2 translated separately then mixed together; (iv) NSPl and VP2 co-
translated. The reactions were incubated with anti-NSPl serum before precipitation 
with protein A-Sepharose (Section 3.6.4). This experiment showed co-precipitation of 
VP2 with NSPl, however significant amounts of VP2 were also precipitated by the 
anti-NSPl serum when VP2 was present alone (Figure 6.9, lanes 13-16). 
As a result of the initial study described previously, further experiments were 
designed to analyse the observed co-precipitation of VP2 with NSP1. Although VP2 
was shown to be co-precipitated with NSPl, it was also precipitated by the serum 
when NSPl was not present. VP2 may have been precipitated by specific antibodies 
in the serum. Alternatively, background precipitation of VP2 caused by the protein 
sticking to the protein A-Sepharose or forming a particulate structure which spins 
down with the Sepharose, may have been the cause of the precipitation. Therefore, in 
addition to immunoprecipitation reactions with the anti-NSPl serum, reactions were 
performed with no serum to determine if VP2 was precipitating as a result of a 
non-specific reaction with the protein A-Sepharose. A reaction with pre-immune 
serum was performed, and a polyclonal anti-rotavirus serum was also tested for 
precipitation of either protein. The experimental design was altered slightly in that the 
number of washes containing 2 % detergents and 1 M NaCI were increased in an 
attempt to improve the efficiency of removal of non-specifically bound proteins. 
The results of the immunoprecipitation reactions containing NSPl and VP2 
with no serum (Figure 6.9, lanes 1-4) clearly showed that none of the proteins were 
precipitated. However, on a longer exposure of this gel (approximately four times 
longer) a faint band corresponding to VP2 could be seen in the immunoprecipitation 
reaction containing a mixture of NSPl and VP2 (lane 4). This suggested that a small 
quantity of the VP2 protein was associated with the protein A-Sepharose. The results 
of the immunoprecipitation reactions with the polyclonal anti-rotavirus serum (Figure 
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Figure 6.9 Co-immunoprecipitation of VP2 and NSPl 
NSP1 and VP2 were translated in an in vitro coupled transcription-translation 
sy tern (Section 3.6.1). Immunoprecipitation reactions with different sera, as 
indicated below, were performed as described (Section 3.6.4). The reactions 
were analysed on 7.5 % polyacrylamide gels (Section 3.6.5), and the results 
visualized by dry gel fluorography after a 24 hour exposure of the gel (Section 
3.6.6). The unprecipitated in vitro translated proteins are shown on the far left 
of the gel, and the size of each protein is indicated above. Lanes 1-4 represent 
imrnunoprecipitation reactions of NSP1 (lane 1), VP2 (lane 2), NSP1 + VP2 
cotranslated (lane 3) and NSP1 + VP2 mixed (lane 4) with no serum. Lanes 5-8 
represent irnmunoprecipitation reactions with polycIonal anti-rotavirus serum 
(ample order as previously). Lanes 9-12 represent imrnunoprecipitation 
reactions with pre-imrnune serum (sample order as previously). Lanes 13-16 
represent irnmunoprecipitation reactions with anti-NSP1 serum (sample order 
as previously). The sizes of the marker (in kDa) are indicated on the left of the 
gel. 
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6.9, lanes 5-8) showed that when the proteins were present individually VP2 (lane 6). 
but not NSPl (lane 5). was precipitated by this serum. In the immunoprecipitation 
reaction containing both NSPl and VP2 (Figure 6.9, lanes 7-8), a band corresponding 
to VP2 was observed. however there was no co-precipitation of NSP 1 with VP2. Faint 
bands can be seen at approximately 50 kDa. however these are thought to be 
incomplete translation products of VP2. This result suggested that NSP I does not 
bind to VP2 as it was not co-precipitated with VP2 using the anti-rotavirus serum. 
Immunoprecipitation of NSPl and VP2 with pre-immune serum (Figure 6.9. lanes 9-
12) failed to precipitate either protein. It should be noted that since the pre-immune 
serum taken from the same rabbit as the anti-NSPl serum was not obtained. the pre-
immune serum used in this case was from a rabbit used to raise antisera against 
rotavirus proteins at the University of Warwick. The results of immunoprecipitation 
reactions with the anti-NSPl serum confirmed the initial observations (Figure 6.9, 
lanes 13-16). In a reaction containing both NSPl and VP2 (lanes 15-16), VP2 co-
precipitated with NSPl. However. when NSPI was not added to the reaction (lane 
14). VP2 was still precipitated by the anti-NSPl serum. 
It was observed that immunoprecipitation reactions with specific anti-NSP 1 
serum resulted in co-precipitation of VP2 with NSPl. However. the result of the 
negative control reaction showed that VP2 was precipitated by the anti-NSPl serum 
when NSPI was not present. This could suggest that the co-precipitation of VP2 with 
NSP 1 was not a true co-precipitation resulting from an interaction between the two 
proteins. but was actually entirely non-specific precipitation of VP2. The possibility 
also exists however that an interaction between NSP 1 and VP2 might be masked by 
the significant non-specific precipitation of VP2. Although VP2 was not precipitated 
by the pre-immune serum, a small quantity was precipitated by the protein A-
Sepharose. This suggested a degree of non-specific precipitation of VP2 with the 
protein A-Sepharose. VP2, but not NSP1, was precipitated by the anti-rotavirus 
serum. Co-precipitation of NSPI with VP2 was not observed in the reaction with 
anti-rotavirus serum, suggesting there may not be a direct interaction between the two 
proteins in vitro. 
VP2 appeared to be specifically precipitated by the anti-NSPI serum. VP2 has 
been shown to be precipitated from celllysates by the anti-NSPl serum as mentioned 
previously (Brottier et al., 1992). It was suggested that the rabbit used to raise this 
serum may have become infected with rotavirus during serum production, however as 
131 
VP2 is the inner core protein it seems unlikely that antibodies specific to VP2 would 
have been raised as a result. Hence an alternative suggestion in this case is that in 
vitro expressed VP2 shares a common epitope with NSP1, resulting in precipitation of 
VP2 by the anti-NSPl serum. 
6.6.2 VP2 may share a common epitope with NSPl 
To test the proposal that in vitro expressed VP2 shares a common epitope with 
NSPl which causes it to be precipitated by the anti-NSPl serum, a number of 
truncated VP2 proteins were produced and analysed by immunoprecipitation. The 
failure of the serum to precipitate a shorter protein might indicate the loss of the 
proposed common epitope, which could then be mapped to a particular region of the 
protein. 
Truncated VP2 proteins were generated by digesting the T7 -pT Ag-gene2 
plasmid used in the coupled transcription-translation reactions with various restriction 
enzymes prior to addition to the reaction. The T7 -pT Ag-gene2 plasmid was first 
linearised with Sal I which cuts in pTAg immediately adjacent to the 3' end of gene 2. 
A number of different restriction enzyme sites in gene 2 were chosen as the second 
cutting site with the following considerations. The sites were chosen, as far as 
possible, at approximately equal intervals of 300 bp from the 3' end. It was noted that 
only the full length VP2 protein was precipitated by the anti-NSPl serum (Figure 
6.9), while the incomplete translation products were not precipitated. Hence, this 
suggested that the common epitope must lie towards the carboxy terminus of the 
protein and was the rationale for incrementally removing this region of the protein. 
The second consideration was that the chosen enzymes must be single cutters in 
T7 -pT Ag-gene2. It was also necessary that digestion with the enzyme produced either 
a 5' overhang or a blunt end, as 3' overhangs can cause aberrant transcription from the 
non-coding strand by T7 RNA polymerase (Schenborn and Mierendorf, 1985). The 
combination of enzymes and the position in gene 2 at which they cut is shown in 
Figure 6.10. The lack of suitable restriction sites, by the criteria defined above, 
between 885 bp and 1886 bp, meant that the middle third of the protein could not be 
dissected as closely as desired. 
DNA was cut sequentially with Sal I and a second enzyme as indicated 
(Figure 6.10), gel purified and used to programme in vitro transcription-translation 
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Figure 6.10 Scheme employed to produce truncated VP2 proteins by 
restriction enzyme digestion of T7-pTAg-Gene2 
Truncated VP2 proteins were produced by digesting the T7 -pTAg-gene2 plasmid 
with various restriction enzymes. Sal I, which cuts in pTAg at the 3' end of gene 2, 
was used to linearise the plasmid. Restriction enzymes which cut at different points 
in gene 2 were then used to incrementally remove the 3' terminus of the gene. The 
positions at which the restriction enzymes cut in gene 2 are indicated in the figure. 
Translation of the digested plasmids in the in vitro system resulted in the production 
of a series of truncated proteins with different fragments of the carboxy terminus of 
VP2 removed. The predicted sizes of the truncated proteins are indicated in the 
table. 
reactions. Translation products were examined by polyacrylamide electrophoresis and 
the rate of incorporation of the radiolabel was examined by TeA precipitation assay 
(Section 3.6.2). Protein translated from the linearised plasmid (Sal I only) could not 
be visualised on a gel, and appeared to be inefficiently translated. However, the 
remaining truncated proteins were clearly visible on a gel, although they were 
translated with different efficiencies. The protein bands for the truncated VP2 proteins 
of 89 kDa, 66 kDa, and 31 kDa were of approximately equal strength. Each truncated 
VP2 protein was added to an immunoprecipitation reaction with anti-NSPl serum and 
the results analysed (Figure 6.11). The first three lanes on the left side of the gel show 
NSPl and full-length VP2 precipitated with the anti-NSPl serum and as this is a long 
exposure these lanes are very over-exposed. The immunoprecipitation of NSPl and 
VP2 by the anti-NSPl serum confirmed the result described previously (Section 
6.6.1). The results of the immunoprecipitation reactions with the truncated VP2 
proteins from 90 kDa to 31 kDa are shown. Protein bands of the expected sizes can 
clearly be seen in lanes 90 kDa to 66 kDa (the 94 kDa protein was not expressed 
sufficiently to visualise on a gel). However, no protein band was visible in lane 31 
kDa although it is known that this protein was efficiently expressed. This suggested 
that the 31 kDa VP2 protein had lost the epitope recognised by the anti-NSPl serum, 
thus placing the proposed common epitope between 31 kDa and 66 kDa in the middle 
third region of the protein. As mentioned previously, a lack of suitable restriction sites 
in this region denied the possibility of more accurate location of this epitope. The 
production of a truncated VP2 protein, representing the amino-terminal third of the 
protein, resulted in the loss of immunoprecipitation by the anti-NSPl serum, implying 
that a proposed epitope for the serum in VP2 had been removed. This epitope has 
been mapped to the middle third region of the protein. Alternatively, the truncation of 
the protein might have disrupted the overall conformation such that a conformational 
epitope was no longer recognised by the anti-NSPl serum. 
6.6.3 Co.lmmunoprecipitation of VPl with NSPl 
The coupled transcription-translation system, programmed with T7 -pT Ag-
genel, was used to produce VPI in vitro. Analysis of the translation products by 
polyacrylamide gel electrophoresis revealed a band believed to correspond to VP I, 
which has a predicted molecular weight of 125 kDa (Figure 6.12, lane 2). A second 
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Figure 6.11 Location of an epitope in VP2 for anti-NSPl serum by 
immunoprecipitation of in vitro expressed truncated VP2 proteins 
Plasmid TI-pTAg-gene2 was specifically digested with a combination of 
restriction enzymes to give different sized fragments of gene 2 (Figure 6.10). 
Truncated VP2 proteins were expressed in an in vitro coupled transcription-
translation system (Section 3.6.1) programmed with the specifically digested 
TI-pTAg-gene2 plasmids. Aliquots of the truncated VP2 protein reactions 
were incubated overnight at 4°C with a 1/8 dilution of anti-NSP1 serum and 
precipitated with protein A-Sepharose (Section 3.6.4). The 
immunoprecipitation reactions were loaded onto a 7.5 % polyacrylamide gel 
(Section 3.6.5), and the results analysed by dry gel fluorography after a 4 
week exposure of the gel (Section 3.6.6). Immunoprecipitation reactions of 
NSP1, VP2, and co-translated NSP1 and VP2 are shown (lanes 1-3). The 
results of immunoprecipitation reactions with the truncated VP2 proteins are 
also shown (lanes 4-9). The sizes of the truncated VP2 proteins are indicated 
at the the top of the gel. The 94 kDa protein (lane 4) was not expressed. The 
sizes of the markers (in kDa) are indicated on the left of the gel. 
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Figure 6.12 Co-immunoprecipitation of NSP1 and VPl with anti-NSPl 
serum 
PIa mid G5T7-TAl and T7-pTAg-Genel were used to programme in vitro 
coupled tran cription-translation reactions to express NSPl and VPl 
respectively (Section 3.6.1). Approximately equal quantities of NSPl and VPl 
(judged by visualisation on a fIuorograph) were incubated overnight at 4 °C 
with a 118 dilution of anti-NSPl serum and precipitated with protein A-
Sepharo e (Section 3.6.4). The immunoprecipitation reactions were loaded 
onto a 7.5 % polyacrylamide gel (Section 3.6.5) and the results analysed by dry 
gel fluorography after a three day exposure of the gel (Section 3.6.6). Aliquots 
of the translation reactions of NSPl (lane 1) and VPl (lane 2) before 
immunoprecipitation were analysed on the gel. The position and size of each 
protein i indicated on the right of the gel. NSPl (lane 3) and VPl (lane 4) 
were each incubated alone with the anti-NSPl serum. An immunoprecipitation 
reaction containing VPl mixed with NSPl was incubated with the anti-NSPI 
erum (lane 5). The sizes of the markers (in kDa) are indicated on the left of 
the gel. 
distinct band at approximately 105 kDa was also observed which could be a 
premature termination product of VPl. Several smaller bands, also believed to be 
incomplete translation products, were present. 
Co-immunoprecipitation studies were performed with in vitro translated VP 1 
and NSPl. A mixture of in vitro translated NSPl and VPl was immunoprecipitated 
with anti-NSPl serum. Immunoprecipitation reactions with the separate proteins were 
performed as controls. The results showed that NSPl alone was strongly precipitated 
by the serum as expected (Figure 6.12, lane 3). However, VPI alone was also weakly 
precipitated (lane 4). When the two proteins were mixed together and 
immunoprecipitated, both VPl and NSPI protein bands were observed. The VP 1 
band was several times stronger in this case, indicating a possible co-precipitation of 
VPI with NSPl. 
In the previous experiment VP 1 appeared to co-precipitate with NSP 1, 
however non-specific precipitation of VPI was also observed. To try and eliminate 
this non-specific binding and thus show a true co-precipitation, the experimental 
protocol was modified to include an incubation with pre-immune serum prior to 
incubation with the anti-NSPI serum. The incubation with the pre-immune serum was 
intended to act as a clearing step to remove any non-specific binding activity. 
Translation reactions of NSPI and VPI, both separately and mixed together as before, 
were precipitated with pre-immune serum then centrifuged in a microfuge and the 
supernatant retained. The supernatants from these reactions were then incubated with 
anti-NSPI serum. The result of the immunoprecipitation of NSPI and VPI mixed 
together is shown (Figure 6.13, lane 5). A faint VPI band and a stronger NSPI band 
were observed, however the faint VP 1 band was matched by a similar faint band in 
the negative control (VPI lane 4). This suggested that the incubation with the 
pre-immune serum removed most of the non-specific binding activity. A true co-
precipitation of VPI with NSPl was probably not observed when the in vitro 
translated proteins were mixed and immunoprecipitated with anti-NSPI serum. 
6.6.4 Co-Immunoprecipitation of VP3 with NSPI 
VP3 was translated in vitro in a coupled transcription-translation system 
programmed with plasmid T7-pTAg-Gene3. To ensure efficiency of expression of 
VP3, two different concentrations of the plasmid T7 -pT Ag-Gene3 (1 Jlg and 2 Ilg) 
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Figure 6.13 Co-immunoprecipitation of NSPl and VPl with pre-immune 
and anti-NSPl serum 
Plasmids G517-TAl and T7-pTAg-Genel were used to programme in vitro 
coupled transcription-translation reactions to express NSPl and VPl 
respectively (Section 3.6.1). Approximately equal quantities of NSPl and VPl 
(judged by vi ualisation on a fluorograph) were incubated with pre-immune 
serum for 2 hours at 4°C, precipitated with protein A-Sepharose (Section 
3.6.4), then centrifuged in a microfuge for 1 min. and the supernatants retained. 
The supernatants from these reactions were then incubated overnight at 4 °C 
with a 118 dilution of anti-NSPl serum and precipitated with protein A-
Sepharose. The immunoprecipitation reactions were loaded onto a 7.5 % 
polyacrylamide gel (Section 3.6.5) and the results analysed by dry gel 
fluorography after a two-week exposure of the gel (Section 3.6.6). Aliquots of 
the translation reactions of NSPI (lane I) and VPl (lane 2) before 
immunoprecipitation were analysed on the gel. Lane 2 is over-exposed. The 
position and size of each protein is indicated on the right of the gel. NSPI (lane 
3) and VPl (lane 4) were each incubated separately with pre-imrnune serum 
followed by anti-NSPl serum. A immunoprecipitation reaction containing VPI 
mixed with NSPI was also incubated with pre-immune serum followed by 
anti·NSPl serum (lane 5). The sizes of the markers (in kDa) are indicated on 
the left of the gel. 
were translated and compared (Figure 6.14). Significantly more VP3 was obtained 
when the reaction was primed with 2 ~g of plasmid (lane 2) compared to a reaction 
initiated with only 1 ~g of plasmid (lane 1). Several smaller bands, corresponding to 
incomplete translation products of VP3, were also observed. When VP3 and NSP 1 
were co-translated (lane 4), one of the incomplete translation products of VP3 was 
seen to migrate at a similar position to NSP I, making it difficult to determine the 
efficiency of translation of NSPl when co-translated with VP3. Although NSPI was 
efficiently translated alone (lane 3), it appeared to be much reduced when VP3 was 
also translated in the same reaction (lane 4). 
Immunoprecipitation reactions containing NSP1, VP3, and NSPl mixed with 
VP3, were performed with anti-NSPl serum. An initial analysis of translated VP3 
compared to NSP 1 gave an approximate ratio of the proteins in the translation 
reactions of 2: 1 (NSPl :VP3) (Figure 6.14 lanes 2 and 3) and this was used to 
determine approximately equal aliquots of the proteins to be mixed for the 
immunoprecipitation reactions. When NSPI and VP3 were mixed together and 
immunoprecipitated with anti-NSPl serum, VP3 was co-precipitated with NSPl 
(Figure 6.15, lane 6). However, VP3 was also precipitated by the serum in the absence 
of NSPl (negative control, lane 5), suggesting that the proposed co-precipitation 
must, in part, be composed of non-specific precipitation of VP3. The non-specific 
precipitation of VP3 might also mask a true co-precipitation of VP3 with NSP 1. 
Further immunoprecipitation experiments were designed to determine the 
exact nature of the proposed co-precipitation of VP3 with NSPl. Immunoprecipitation 
with pre-immune serum was carried out to see if there was binding by non-specific 
antibodies in the serum. An immunoprecipitation reaction with no serum was also 
performed to test for non-specific binding to the protein A-Sepharose. Polyclonal anti-
rotavirus serum was tested to see if it would precipitate either protein. Finally, as a 
clearing step to remove any non-specific binding activity, an incubation with pre-
immune serum was carried out, prior to precipitation with the anti-NSPl serum. In 
this last reaction, after incubation with pre-immune serum the reaction was 
centrifuged and the supernatant, containing any proteins not bound by the pre-immune 
serum, was removed and incubated in a second reaction with anti-NSPl serum. The 
results of these immunoprecipitation reactions are shown in Figure 6.16. VP3 was 
precipitated by the pre-immune serum, suggesting that it is recognised by specific 
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Figure 6.14 Co-expression of VP3 and NSPl in an in vitro coupled 
transcription-translation system 
Plasmids G5TI-TAl and TI-pTAg-Gene3 were used to programme in vitro 
coupled transcription-translation reactions to express NSPl and VP3 
respectively (Section 3.6.1). The products of the translation reactions were 
loaded onto a 7.5 % polyacrylamide gel (Section 3.6.5) and the results 
analysed by dry gel fluorography after a 20 hour exposure of the gel to x-ray 
film (Section 3.6.6). Two different concentrations of the plasmid TI-pTAg-
gene3 (1 ~g and 2 ~g) were tested. A reaction containing both plasmids 
G5TI-TAl and TI-pTAg-Gene3 was analysed for co-translation efficiency of 
NSPl and VP3. The plasmid and quantity of DNA used is indicated at the top 
of the corresponding lane. The positions of the protein bands corresponding to 
NSPl and VP3 are indicated on the right of the gel. The sizes of the markers 
(in kDa) are indicated on the left of the gel. 
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Figure 6.15 Co-Immunoprecipitation of in vitro translated NSP1 and VP3 
with anti-NSP1 serum 
Plasmids G517-TAl and 17-pTAg-Gene3 were used to programme in vitro 
coupled transcription-translation reactions to express NSPl and VP3 
respectively (Section 3.6.1). A positive control plasmid, the E. coli ~­
galactosidase gene cloned into a pCITE vector, was also translated. 
Approximately equal quantities of NSPl and VP3 (judged by visualisation on a 
fluorograph) were incubated overnight at 4 °C with a 1/8 dilution of anti-
NSPl serum and precipitated with protein A-Sepharose (Section 3.6.4). The 
immunoprecipitation reactions were loaded onto a 7.5 % polyacrylamide gel 
(Section 3.6.5) and the results analysed by dry gel fluorography after a one day 
exposure (lanes 1-3) and a one week exposure (lanes 4-6) of the gel (Section 
3.6.6). The positive control translation reaction was analysed on the gel and a 
protein band at approximately 118 kDa was observed (lane 1). Aliquots of the 
translation reactions of NSPl (lane 2) and VP3 (lane 3) before 
immunoprecipitation were analysed on the gel. The position and size of each 
protein band is indicated on the right of the gel. NSPl (lane 4) and VP3 (lane 
5) were each incubated alone with the anti-NSPI serum. An 
immunoprecipitation reaction containing VP3 mixed with NSPl was incubated 
with the anti-NSPl serum (lane 6). The sizes of the markers (in kDa) are 
indicated on the left of the gel. 
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Figure 6.16 Immunoprecipitation of NSPl and VP3 with pre-immune 
serum, anti-NSPl serum, anti-rotavirus serum and protein A·Sepharose 
only 
Plasmids G517-TAl and 17-pTAg-Gene3 were used to programme in vitro 
coupled transcription-translation reactions to express NSPl and VP3 
respectively (Section 3.6.1). Reactions containing approximately equal 
quantities of NSPl and VP3 (judged by visualisation on a fluorograph) were 
incubated overnight at 4 QC with different sera and precipitated with protein 
A-Sepharose (Section 3.6.4). The immunoprecipitation reactions were loaded 
onto a 7.5 % polyacrylamide gel (Section 3.6.5) and the results analysed by dry 
gel fluorography after 17 days exposure of the gel (Section 3.6.6). NSPl (lane 
1), VP3 (lane 2) and NSPl mixed with VP3 (lane 3) were immunoprecipitated 
with different sera as indicated on the figure. Panel A shows the results when 
the reactions were incubated with pre-immune serum, anti-rotavirus serum and 
without serum. Panel B shows the results with anti-NSPl serum and with pre-
immune serum followed by anti-NSPl serum. The unprecipitated control was 
aliquots of the in vitro translation reactions of NSPI (2 JlI) and VP3 (4 JlI) run 
on the same gel (4 days exposure). The positions of NSPl and VP3 on the gel 
are indicated. The sizes of the markers (in kDa) are shown on the left of the 
gel. 
antibodies in the serum. NSP1 was not precipitated by this serum. When only protein 
A-Sepharose was present and no serum had been added to the reaction, VP3 was 
precipitated very slightly so that faint bands were visible. Again, NSP 1 was not 
precipitated in this reaction. This precipitation of VP3 could represent either non-
specific binding of the protein by formation of non-covalent bonds with the protein A-
Sepharose beads, or possibly an aggregation of the protein that results in a complex 
which is recovered by centrifugation. In either case, these results suggest that a 
proportion of the VP3 which is precipitated is due to non-specific background 
precipitation. 
VP3 was precipitated by the polyclonal anti-rotavirus serum however, as 
described previously NSP1 was not precipitated by this serum (Section 6.6.1). 
Although VP3 was precipitated from the mixture of NSPl and VP3 by the polyclonal 
anti-rotavirus serum, there was no obvious co-precipitation of NSPl with VP3. As 
noted before, an incomplete translation product of VP3 migrated at a similar position 
as NSPl on the gel (-50 kDa), therefore if NSPl had been weakly co-precipitated 
with VP3 it would have been difficult to distinguish it from the VP3 band. Indeed it 
could be argued that the relevant band at 50 kDa is stronger in the co-precipitation 
reaction (lane 3) than in the reaction containing VP3 alone (lane 2), a difference 
which may be accounted for by the presence of NSPl. However, as this evidence was 
not very convincing, it was concluded that NSPl was not co-precipitated with VP3 by 
the anti-rotavirus serum. 
The results of the immunoprecipitations in which a clearing reaction with 
pre-immune serum was performed prior to the incubation with anti-NSP 1 serum 
suggested that an approximately equal quantity of VP3 was co-precipitated with 
NSP 1. However, a similar protein band was seen when VP3 was present alone. These 
results (Figure 6.16) suggest that the observed co-precipitation of VP3 with NSP 1 was 
probably due to an interaction of VP3 with either non-specific antibodies in the serum 
or with the protein A-Sepharose complex. However it is also possible that an 
interaction between VP3 and NSP1 was masked by the non-specific precipitation of 
VP3. 
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6.6.5 Co.Immunoprecipitation of VP3 with NSPl can be blocked with 
ovalbumin 
As indicated above, the results of immunoprecipitation reactions with a 
mixture of NSP 1 and VP3 were ambiguous due to a high background of VP3 
precipitation. In an attempt to reduce this non-specific precipitation, a quantity of 
ovalbumin was added to the reaction mixture to act as a blocking reagent. A BioRad 
protein assay (Section 3.6.2) was used to determine the protein concentrations of the 
reactions containing in vitro translated NSPl and VP3. Approximately five times this 
concentration of ovalbumin was added prior to immunoprecipitation of NSP I and 
VP3 with anti-NSPl serum. The addition of ovalbumin resulted in an overall 
reduction of the amount of protein precipitated (Figure 6.17, lanes 4-6), when 
compared to the precipitation reactions without this addition (Figure 6.17, lanes 1-3). 
The reduction in VP3 was such that the bands were barely visible, even on a two 
week exposure of the gel. The blocking of non-specific interactions with the serum or 
the protein A-Sepharose by the addition of ovalbumin resulted in the virtual 
disappearance of the co-precipitation of VP3 with NSPl, lending further support to 
the conclusion that the apparent co-precipitation of VP3 was merely due to a non-
specific interaction. 
6.6.6 Summary 
The co-immunoprecipitation experiments initially suggested that the viral core 
proteins VP 1, VP2 and VP3, could be individually co-precipitated with NSP 1. 
However, in each case it was also noted that the negative control reactions 
(VPINP2NP3 without NSPl) showed precipitation of the core proteins to varying 
degrees. VP2 was strongly precipitated by the anti-NSPl serum, leading to the 
conclusion that in vitro translated VP2 may share a common epitope with NSPI and 
thus be specifically precipitated by the serum. To this end, a series of truncated VP2 
proteins were produced and the proposed common epitope was mapped to the middle 
third of VP2 between 31-66 kDa. The truncation of the protein could also reflect the 
disuption of an appropriate conformation rather than the loss of a specific amino acid 
sequence. Treatment of cell lysates by boiling with ~-mercaptoethanol prior to 
immunoprecipitation with anti-NSPl serum resulted in a decrease in the precipitation 
of VP2, which could reflect the disruption of a conformational epitope recognised by 
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Figure 6.17 Co-precipitation of VP3 with NSP1 is blocked by the addition 
of ovalbumin 
PIa mid G5TI-TAl and TI-pTAg-Gene3 were used to programme in vitro 
coupled transcription-translation reactions to express NSPl and VP3 
respectively (Section 3.6.1). Reaction containing approximately equal 
quantities of NSPl and VP3 (judged by visualisation on a fluorograph) were 
incubated overnight at 4 °C with a 118 dilution of anti-NSPl erum and 
precipitated with protein A-Sepharose (Section 3.6.4). The 
irnmunoprecipitation reactions were loaded on a 7.5 % polyacrylamide gel 
(Section 3.6.5), and the results analysed by dry gel fluorography after a two 
week expo ure of the gel (Section 3.6.6). Immunoprecipitation reactions were 
prepared containing NSPl alone (lane 1); VP3 alone (lane 2); approximately 
equal quantitie of NSPl and VP3 mixed (lane 3). Reactions were also 
prepared containing approximately five times the in vitro translated protein 
volume of ovalbumin added prior to immunoprecipitation of NSP 1 alone (lane 
4); VP3 alone (lane 5); approximately equal quantities of NSPl and VP3 
mixed (lane 6). The po ition of each protein band is indicated on the right of 
the gel. The ize of the markers (in kDa) are indicated on the left of the gel. 
the serum (Section 7.3.4). When a pre-clearing step using pre-immune serum was 
introduced, prior to the precipitation of the mixture of NS PI and VP 1, the co-
precipitation of VPI with NSPI almost disappeared, suggesting that there was no 
specific protein-protein interaction between them. VP3 was observed to precipitate 
with pre-immune serum and with protein A-Sepharose only, suggesting that the 
precipitation of VP3 was due to non-specific binding. Supporting this conclusion was 
the fact that the addition of ovalbumin as a blocking agent prevented the co-
precipitation. The use of polyclonal anti-rotavirus serum resulted in the precipitation 
of each viral pre-core protein but no corresponding co-precipitation of NSP 1, 
suggesting a lack of a true interaction between the two. 
6.7 Discussion 
Complexes formed early in the rotavirus replication cycle have been shown to 
contain NSP 1 and several viral structural proteins and it has been suggested that 
protein-protein interactions might occur between them. Co-immunoprecipitation 
experiments with in vitro translated proteins did not demonstrate direct 
protein-protein interactions between NSPI and the structural proteins found in virus 
core complexes. Co-precipitation of the core proteins with NSPl was observed, 
however the high background meant that the validity of the co-precipitations was not 
substantiated. However, as it is still possible that specific co-precipitations were 
masked by the non-specific interactions, the existence of specific interactions between 
NSPI and the core proteins cannot be completely dismissed. Reactions with a 
polyclonal anti-rotavirus serum precipitated the core proteins but NSPl was not co-
precipitated with them. This serum was raised against a preparation of the UKtc strain 
of bovine rotavirus and not the individual core proteins, so reciprocal 
immunoprecipitation reactions with sera specific for each core protein are required to 
confirm these results. The following conclusions can be drawn from the results of the 
experiments described in this chapter. Although NSPI is found in early replication 
complexes with the core proteins it may not form direct protein-protein interactions 
with them. Alternatively, potential interactions with NSPI were not identified due to 
the non-specific binding of the core proteins. It is also possible that the protein-protein 
interactions were not stable under the conditions of this assay. 
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An alternative explanation for the apparent failure of the proteins to interact in 
vitro could be due to a lack of viral mRNA in the reaction mixture. The pre-core RI 
complex described by Patton contains viral mRNA in addition to NSPl and the viral 
structural proteins VPl and VP3 (Patton, 1995). These proteins have been shown to 
have some degree of RNA-binding activity and consequently a scenario where the 
proteins interact indirectly with each other by means of their interactions with RNA 
can be envisaged. Another consideration is the possibility that a prior interaction with 
a third protein may be necessary before two given proteins can interact, for example 
to produce the correct confirmation or expose a hidden binding site. It is also 
sometimes the case that protein interactions which are observed in vivo cannot be 
recreated in an in vitro system (Black et al., 1998). These results suggested that the 
use of infected cell lysates in co-immunoprecipitation experiments with anti-NSP 1 
serum might be a more effective way of investigating NSPl protein-protein 
interactions. 
In the assessment of the co-precipitation results, some consideration should 
also be given to the experimental design. In addition to co-translation of viral 
proteins, the proteins were also translated separately then mixed on ice for protein 
binding to occur. It is possible that optimum conditions for protein binding to occur in 
the mixture of proteins were not achieved and perhaps a longer incubation at an 
optimum temperature should have been investigated. 
An experiment to be included in future work is immunoprecipitation with 
specific antisera against the other core proteins to determine if NSP 1 is co-
precipitated. That is the reciprocal of the experiments described in the present study. 
The feasibility of such experiments would clearly depend on the availability of 
specific antisera to these proteins which is not currently available in the Rotavirus 
laboratory. 
A significant hindrance to the progression of this project was the failure to 
produce a specific antiserum against NSP 1, although several attempts were made. 
Viruses are known to be highly immunogenic, and the use of recombinant vaccinia 
virus to produce specific antiserum has been documented (Section 6.3.1). The rabbit 
was primed with the antigen and given booster inoculations, including an inoculation 
at a higher dose, however this failed to produce a specific antiserum against NSP 1. As 
discussed previously (Section 6.3.7), other researchers have had difficulty in 
producing an antiserum to this protein due to its low antigenicity. Perhaps a different 
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approach, such as the use of an alternative animal species (e.g. mice) or a method to 
increase the antigenicity of NSPl in order to produce a serum response could be 
investigated in future. The production of a specific antiserum is essential to allow 
work on NSP 1 to continue. 
In this study it was shown that in addition to NSPl, in vitro translated VP2 
was precipitated by the anti-NSPl serum. Adsorption of the serum to remove the 
cross-reacting antibodies was not performed due to the difficulty in preparing suitable 
rotavirus-infected cell extracts to adsorb the serum against. Also, only a small volume 
of serum was available for the immunoprecipitation experiments. In an effort to 
reduce the background, the serum was titrated to determine the highest dilution that 
would still precipitate a sufficient quantity of NSPl from a reaction mixture. 
An epitope in VP2, recognised by the anti-NSPl serum, was mapped to the 
middle third of the protein in the region lying between 31 kDa and 66 kDa from the 
amino terminus. The remarkable strength of the precipitation of VP2 by this serum 
perhaps suggests that this epitope has some functional significance in the virus 
replication cycle. For example, it might reflect the interaction of NSPl and VP2 with 
the same site on mRNA or another protein during replication and assembly of the 
virus particle. 
An experiment was designed to give further support to the location of the 
common epitope, whereby the middle third of the protein could be excised from the 
protein so only the terminal thirds were translated. Immunoprecipitation with the anti-
NSPl serum could then be performed to determine if the epitope had been removed. 
This experiment would help to confirm the existence of the proposed epitope 
recognised by the anti-NSPl serum. The manipulative steps required to allow in 
frame translation of the two sections of the protein were however fairly complex, and 
this experiment was not deemed to have a sufficiently high priority to be done within 
the time frame of this study. The epitope in VP2 recognised by the anti-NSPl serum 
could not be mapped more closely than the middle third of the protein due to the lack 
of suitable restriction sites in this region. Other researchers have successfully 
generated truncated proteins directly from peR amplified cDNA copies in a vaccinia 
T7 system (P.P.C. Mertens, pers. comm.). It is thought that this method could also be 
applied in a linked T7 transcription-translation system, such as the one described in 
this study (Section 6.5.1). The cDNA copies are produced using a PCR primer with a 
built in T7 promoter and appropriate start site, while the second primer is designed to 
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give a product of a given length such that the desired truncated protein will be 
expressed. This approach would circumvent the problem of limited, appropriate 
restriction sites, and should be considered if this study was to be extended. 
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Results Chapter 4 
Co-Immunoprecipitation studies 
using rotavirus-infected cells 
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7.1 Aims 
The aim of the work described in this chapter was to examine the protein 
composition of viral complexes containing NSPl found in the rotavirus-infected cell 
by co-immunoprecipitation studies carried out on lysates made from cells infected 
with the UKtc strain of bovine rotavirus. 
7.2 Introduction 
7.2.1 NSPl is found in early replication complexes 
Studies to determine the composition of the rotavirus replicase complex have 
led to the characterisation of three distinct replication intermediates (RIs) (Gallegos 
and Patton, 1989). The protein composition of these RIs was elucidated by 
electrophoresis on polyacrylamide gels. The smallest intermediate, the pre-core RI, 
contained the structural proteins VPl and VP3 and the non-structural proteins NSPl 
(NS53), NSP2 (NS35), NSP3 (NS34) and NSP5 (VP9), although subsequently only 
NSPl and NSP3 were considered to be truly present in the complex (Patton, 1995). 
The second intermediate, the core RI, contained VP1, VP2, VP3, NSP2, NSP3 and 
NSP5. The third and largest intermediate, the single-shelled RI, contained VP1, VP2, 
VP3, VP6, NSP2, NSP3 and NSP5, although the presence of the non-structural 
proteins NSP2 and NSP5 in the core and single-shelled RIs was equivocal. Pulse-
chase analysis suggested that the core RI was formed by the addition of VP2 to a 
precursor such as the pre-core RI. The single-shelled particle was then formed by the 
subsequent addition of VP6 to the core RI. It was concluded in these early studies that 
NSPl was not usually found in the single-shelled RI. However, the limitations of the 
experimental methods used made it impossible to confirm the absolute composition of 
the RIs, as there was potential for contamination with proteins from different 
fractions, from transcriptase particles or single-shelled virions. 
All of the proteins which are associated with the RIs, with the exception of 
VP6, have RNA-binding activity, suggesting an important role for them in the 
replication process. NSPI has been shown to bind to the 5'-end of rotavirus mRNAs 
(Hua et al., 1994), while NSP3 has been shown to bind to the 3' end of rotavirus 
mRNA (Poncet et al., 1993). VPl and VP3 also bind viral mRNA and their binding 
sites probably overlap those of NSP3 and NSPl respectively. Thus, it has been 
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suggested that the pre-core RI may be formed by the interaction of VPI and VP3 with 
the NSPIINSP3-mRNA complex (Patton, 1995). VP2, which has non-specific 
RNA-binding activity, then interacts with the pre-core RI to form the core RI. 
On the basis of this work, a pathway for genome replication and virus 
assembly, with the corresponding protein interactions, was proposed (Patton, 1995). 
Briefly, it suggested that NSPl and NSP3 form a complex with mRNA assembling on 
the cytoskeleton. The pre-core RI is then formed by the interaction of VP 1 and VP3 
with this complex, although it is not known what interactions occur at this stage. 
Movement of the complex to the viroplasm is accompanied by the loss of NSP 1 and 
NSP3 and the sequential addition of VP2, to form the core RI, and subsequently VP6 
to form the single-shelled RI. The precise stage at which the non-structural proteins 
are lost from the complex has not been defined. Clearly, protein-protein and 
protein-RNA interactions must occur with the proteins of the pre-core RI complex, 
and also with the proteins added to form subsequent RIs. 
In a more recent investigation, immunoprecipitation from RF rotavirus-
infected cell lysates was used to examine the structure of the rotavirus replicase 
complex (Aponte et al., 1996). Antisera specific for different rotavirus proteins were 
used to immunoprecipitate complexes from infected cells which were then tested for 
replicase activity. The only complex shown to have replicase activity in the 
solid-phase assay developed was that precipitated with an anti-NSP2 monoc1onal 
antibody (mAb), suggesting that the presence of NSP2 is essential for replicase 
activity. The protein composition of the complexes precipitated with the antisera were 
examined. The complex precipitated with the anti-NSP2 mAb was found to be 
different to the replicase complexes described by Patton (Helmberger-Jones and 
Patton, 1986; Patton and Gallegos, 1988) in that only VPI, VP2, VP6 and NSP2 were 
precipitated, and NSP1, NSP3 and NSP5 were not present. However, the complex 
containing NSP2 could not be reciprocally precipitated with anti-VP6 and anti-VP2 
mAbs. Immunoprecipitation with two separate anti-VP6 mAbs gave rise to two kinds 
of complex with different protein compositions - one containing only VP2 and VP6, 
and the second containing VP3, NSP1, NSP2 and NSP3 in addition to VP2 and VP6. 
Clearly there are still many details in the process of rotavirus 
replication/assembly which remain obscure, although detailed examination of 
replication complexes will help to dissect the sequence of events which occur in the 
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cell. Co-immunoprecipitation from rotavirus-infected cell lysates represents one 
approach for examining the protein composition of these complexes. 
7.2.2 Co-Immunoprecipitation can be used to study viral complexes 
Co-immunoprecipitation has been used as a method of studying viral 
complexes formed during the replication cycle of a number of RNA viruses, including 
those with segmented genomes. In the influenza system, eight single-stranded RN A 
segments of negative polarity encode ten proteins, only one of which, NS 1, is a non-
structural protein. Studies with NS I-specific serum have shown that the components 
of the RNA polymerase complex, subunits PBI, PB2 and PA, and the nucleoprotein 
(NP), were co-immunoprecipitated with NS 1 (Mari6n et al., 1997). These results were 
confirmed by western blot analysis using specific serum against NP and the RNA 
polymerase complex subunits. Dot blot hybridisation experiments using NP-specific 
riboprobes showed that viral mRNA and virion RNA were also co-
immunoprecipitated by the anti-NS 1 serum. However, the co-immunoprecipitates 
were not sensitive to treatment with RNase. These results led to the hypothesis that 
NS 1 may be involved in a transcription-replication complex in influenza virus-
infected cells, although it could not be determined whether this association involved 
direct protein-protein interactions or was mediated by RNA binding. Clearly, this 
approach can be used successfully to gain information about the association of 
specific proteins into viral complexes within the infected cell. 
7.2.3 Co-Immunoprecipitation with anti-NSPl serum from UKtc 
rota virus-infected celllysates 
Immunoprecipitation analysis of rotavirus-infected cell lysates with specific 
antiserum allows characterisation of the type of complex in which NSP 1 is found in 
the infected cell and identification of the constituent proteins. In contrast to the other 
methods utilised in this study, which focus on examining direct protein-protein 
interactions between NSP I and selected viral proteins, immunoprecipitation from cell 
lysates allows investigation of the nature of NSPI-containing complexes found in the 
infected cell. It also allows analysis of complexes which may not be held together 
primarily by direct protein-protein interactions but indirectly, possibly by 
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RNA-protein interactions, or which require an interaction with additional factors 
(RNA or protein) to expose a binding site. 
UKtc rotavirus-infected cell lysates were produced as described for use in 
immunoprecipitation experiments (Section 3.6.3). Lysates were prepared at 7 hours 
post-infection (p.i.) in most experiments. Studies on the kinetics of protein synthesis 
in rotavirus-infected cells have shown that by 4 hours p.L cellular polypeptide 
synthesis is strongly inhibited and replaced by viral protein synthesis (McCrae and 
Faulkner-Valle, 1981). Viral transcription and RNA replication have been shown to 
begin by 3 hours p.i. and gradually increase so that synthesis of plus-strand RNAs 
(transcription) is maximal at 9 to 12 hours p.L, while RNA replication reaches 
maximal levels at 6 to 9 hours p.i. (Stacy-Phipps and Patton, 1987). Thus, RNA 
replication peaks several hours earlier than transcription. It has also been shown that 
virions released from rota virus-infected cells can be detected by 6 hours p.i. (Stacy-
Phipps and Patton, 1987). Hence, harvesting cells at 7 hours p.L, when RNA 
replication is at maximum levels, ensures the presence of high levels of viral proteins 
and RIs in the infected cell. A high m.o.L was used to ensure synchronous infection 
(McCrae and Faulkner-Valle, 1981), such that detectable levels of viral protein would 
be present in the celllysates. 
7.3 Co-Immunoprecipitation of proteins from UKtc rotavirus-infected cell 
Iysates 
7.3.1 Production of UKtc rotavirus-infected celllysates 
UKtc rotavirus-infected cell lysates were produced essentially as described 
previously (Section 3.6.3). BS-C-l cells, derived from African green monkey kidney 
(Hopps et al., 1963), and MA-104 cells, derived from Rhesus monkey kidney 
(Whitaker and Hayward, 1985), were used interchangeably as they have a similar 
epithelial morphology and both cell lines support growth of rotaviruses. A high m.o.L 
was always used when infecting the cells. One methodological change adopted to 
increase the amount of radioactivity incorporated into samples was to extend the 
labelling period to 2 hours. This enabled easier detection of NSPl which is only 
present at low levels in the infected cell (John son and McCrae, 1989). Figure 7.1 
shows mock-infected and UKtc rotavirus-infected BS-C-l celllysates analysed by gel 
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Figure 7.1 Production of 3SS-methionine labelled UKtc rotavirus-
infected celllysates and analysis of viral polypeptide synthesis 
Confluent BS-C-l cells were infected with a high m.o.i. of the UKtc strain 
of bovine rotavirus (m.o.i. = 20), or mock-infected, and incubated for 7 
hours at 37 °C. The cells were pulsed with 35S-methionine for 20 minutes, 
chased with lOOX cold methionine for 2 hours and harvested (Section 3.6.3). 
Labelled samples (40 ,.11) were analysed on a 5-11 % gradient 
polyacrylamide gel (Section 3.6.5), and the results visualized by dry gel 
fluorography (24 hours exposure time) (Section 3.6.6). Pulse only and pulse-
chase mock- and UKtc-infected cell lysates are shown. The identity of the 
viral polypeptides are indicated on the left of the lanes. VP indicates viral 
structural proteins. NSP indicates viral non-structural proteins. The arrow 
indicates the position of actin in the mock-infected celllysates. 
electrophoresis. Pulse-chase labelling of the cells was performed to allow analysis of 
the viral polypeptide synthesis. Comparison of the pulse-labelled mock and 
virus-infected cell lysates revealed that at 7 hours p.i. the host cell protein synthesis 
was significantly inhibited and replaced by rotavirus protein expression. With the 
exception of NSP5, which is only present at low levels, all the viral proteins are 
sufficiently labelled by this procedure to be visible on a polyacrylamide gel. The viral 
structural proteins VP3 and VP4 migrate at the same position and cannot be 
distinguished on this gel. The non-structural proteins NSP2 and NSP3 also migrate at 
a similar position, although separate protein bands can be detected in this case. 
Comparison of the pulse and the pulse-chase samples revealed that VP7 can be chased 
to the end product VP7c during the chase period. The unglycosylated precursor of 
VP7 is vpr7, which is only seen when glycosylation is blocked by the addition of 
tunicamycin (McCrae and Faulkner-Valle, 1981). VP7c, which is found in the virion, 
is the chase product of VP7, produced by an, as yet, undefined event. NSP4 is also 
glycosylated and is seen to have a slightly increased mobility by the end of the chase 
period. The identity of the polypeptide migrating at a similar position to VP6 in the 
mock-infected cell lysates is the cellular protein actin. Pulse-labelled UKtc 
rotavirus-infected cell lysates were used for subsequent immunoprecipitation 
experiments with specific antiserum against individual proteins. 
7.3.2 Titration of monospecific polyclonal anti-NSPl serum by 
immunoprecipitation of UKtc rota virus-infected celllysates 
A monospecific polyclonal anti-NSPl serum and an anti-NSPl monoclonal 
antibody were available for immunoprecipitation of NSPl from celllysates (Section 
6.3.6). Titration of the monospecific polyclonal anti-NSPl serum was performed to 
determine the lowest concentration of serum that would precipitate NSPl from 
infected cell lysates (Figure 7.2). This procedure was employed to try and minimise 
any background precipitation of other proteins from the celllysates. The anti-NSPl 
monoclonal antibody was also tested in an immunoprecipitation reaction with the 
infected cell lysates to determine whether it would precipitate NSPl from the 
reaction. 
A positive control reaction was performed using a 100,00QXg supernatant 
(S 100 supernatant) of the cell lysate incubated with monospecific anti-VP7 serum 
which had been shown previously to precipitate VP7 from infected cell lysates 
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Figure 7.2 
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Figure 7.2 Titration of anti-NSPl serum against UKtc rotavirus-
infected MAI04 celllysates 
UKtc rotavirus-infected MAI04 cell lysates were prepared and centrifuged 
at Ioo,OOOXg, a described previously (Section 3.6.3). 50 Jl.I aliquots of the 
Ioo,OOOXg supematant were irnmunoprecipitated (Section 3.6.4) with 
increasing dilutions of anti-NSPI serum. The irnmunoprecipitates were 
analyzed on a 5-11 % gradient polyacrylamide gel (Section 3.6.5), and the 
results visualized by dry gel fluorography (20 hours exposure time) (Section 
3.6.6). The characteristic pattern of rotavirus protein expression is shown 
before irnmunoprecipitation (lane 1). Immunoprecipitation with 
monospecific anti-VP7 serum was used as a positive control (lane 2). 
Immunoprecipitation with pre-irnmune serum was used as a negative control 
(lane 3). Three dilutions of anti-NSPl serum were tested - 1:20 (lane 4); 
1 :50 (lane 5); 1: 100 (lane 6). The position of the bands corresponding to 
NSPl are indicated. The identity of the viral polypeptides are indicated on 
the left of the lanes. VP indicates viral structural proteins. NSP indicates 
viral non-structural proteins. 
(McCrae and McCorquodale, 1987). As expected, VP7 was precipitated from the cell 
lysate by this serum (Figure 7.2, lane 2). No proteins were precipitated by the pre-
immune serum which was used as a negative control reaction (lane 3). Increasing 
dilutions of anti-NSPl serum (1:20, 1:50 and 1:100) were tested for efficient 
precipitation of NSPl from the celllysates and NSPl was clearly precipitated by all 
dilutions (lanes 4-6). Hence the highest dilution of 1: 100 was used as the standard for 
immunoprecipitation reactions. The co-precipitation of viral protein VP2 with NSP 1 
in the reactions was noted, and this will be discussed in subsequent sections. 
Two dilutions (1: 10 and I: 100) of the anti-NSPI monoc1onal antibody were 
tested in immunoprecipitation reactions for precipitation of NSPl. The monoc1onal 
antibody was found to precipitate NSPl considerably less efficiently than the 
monospecific polyc1onal serum and was too weak to be used in experimental reactions 
(data not shown). It was noted that VP2 was also weakly precipitated with NSPI by 
this monoclonal antibody. 
7.3.3 Immunoprecipitation of a viral protein complex from UKtc 
rota virus-infected cells with anti-NSPl serum 
As discussed in previous chapters, direct protein-protein interactions between 
NSPI and other viral proteins have not been shown. However, these results do not 
exclude the possibility that NSPI is associated with other viral proteins in a complex 
in the infected cell, perhaps through an interaction with viral RNA. To investigate this 
possibility, NSPI was immunoprecipitated from UKtc rotavirus-infected cells with 
anti-NSPl serum and the co-precipitating viral proteins were examined by 
fluorography (Figure 7.3). The precipitated proteins were also detected by 
phosphoimaging, quantified using ImageQuant™ software and the data analysed 
using Excel™ software (Microsoft) (Appendix 2.1). 
An immunoprecipitation reaction using anti-NSP 1 serum was performed to 
examine the viral proteins which co-precipitated with NSPl. Immunoprecipitation of 
cell lysates which had been boiled with protein cracking buffer (4 % SDS; 10 % 
B-mercaptoethanol) prior to precipitation with anti-NSPl serum was also carried out. 
Boiling the cell lysate in cracking buffer would disrupt any specific protein-protein or 
protein-RNA interactions, thus breaking up viral complexes which might be 
precipitated. Control reactions with pre-immune serum and no serum were performed 
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Figure 7.3 Imrnunoprecipitation of UKtc rotavirus-infected cell Iysates with 
anti-NSPl serum 
Confluent MAI04 cells were infected with a high m.o.i. of the UKtc strain of 
bovine rota virus (m.o.i. = 20) and incubated for 7 hours at 37 0c. The cells were 
pulsed with 35S-methionine for 2 hours and harvested (Section 3.6.3). The cell 
lysate was centrifuged for 1 min. in a microfuge prior to use. A 10 III aliquot of the 
cell lysate was run on the gel to show the characteristic pattern of rotavirus protein 
expression before irnmunoprecipitation (lane 1). Immunoprecipitation reactions 
were performed with 10 III aliquots of the cell lysate incubated with 1 III 10 mg/m! 
ovalbumin/no serum (lane 2), pre-immune serum (lane 3) and anti-NSPl serum 
(lane 4) (Section 3.6.4). A 10 III aliquot of the cell lysate was boiled for 2 mins 
with cracking buffer (4 % SDS; 10 % ~-mercaptoethanol) and diluted 1O-fold with 
water prior to incubation with anti-NSPl serum (lane 5). The immunoprecipitates 
were analyzed on a 5-11 % gradient polyacrylamide gel (Section 3.6.5), and the 
results visualized by dry gel fluorography (Section 3.6.6). Lane 1 represents a 24 
hour exposure of the gel to x-ray film, while lanes 2-5 are a 5 day exposure. The 
identity of the viral polypeptides are indicated on the left of the lanes. VP indicates 
viral structural proteins. NSP indicates viral non-structural proteins. 
so that the specificity of the reactions could be validated. In the control reaction 
lacking serum, an equivalent amount of a 10 mg/ml solution of ovalbumin was added 
to compensate for the lack of protein from the serum. The standard protein 
concentration of serum is known to be 10 mg/ml (M. A. McCrae, pers. comm.). The 
purpose of this no serum control was to determine if any viral proteins were 
precipitated by a non-specific reaction with the protein A-Sepharose or were carried 
over during the centrifugation stages of the reaction, although a pre-clearing spin was 
performed prior to the immunoprecipitation to minimise the latter. 
Analysis of the immunoprecipitation reaction with anti-NSPI serum showed a 
number of viral proteins co-precipitating with NSP I, including VP I, VP2, VP3/VP4, 
VP6 and NSP3 (Figure 7.3). As VP3 and VP4 migrate to a similar position on the 
gradient gel it was unclear which was precipitated, although VP3 was the most 
obvious candidate (Section 7.3.5). As NSP2 and NSP3 also migrate to a similar 
position the identity of the NSP3 band was also difficult to substantiate, although 
these protein bands are more easily distinguished than VP3 and VP4. Also, as NSP3 
has previously been shown to be part of an early replication complex with NSP 1 
(Patton, 1995), it seems likely that this was the co-precipitating protein. It was 
particularly notable that neither VP7 or NSP4, both of which are present at significant 
levels in the infected cell, co-precipitated with NSPI suggesting that the 
immunoprecipitation reaction was specific. 
Analysis of the control reactions with no serum and with pre-immune serum 
showed small quantities of VP2, VP3NP4 and VP6 were present. Similar quantities 
of each protein were precipitated from both reactions and therefore it did not seem 
likely that the proteins were being specifically precipitated by antibodies in the 
pre-immune serum. This in turn suggested that the proteins were pelleted with the 
protein A-Sepharose during the centrifugation stages of the immunoprecipitation 
reactions. Quantification of the proteins by phosphoimaging showed that in the case 
of VP2 and VP6 the amounts co-precipitated with NSPI by the specific anti-NSPI 
serum were approximately 10 times greater than those precipitated in the no serum 
and pre-immune controls. The amount of VP3NP4 co-precipitated with NSPI using 
the anti-NSPl serum was approximately 5 times greater than that precipitated with the 
pre-immune control. NSPI was not precipitated in either of the control reactions. It 
was therefore concluded that the proteins precipitated in the no serum and 
pre-immune controls represented non-specific background precipitation. 
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The results suggested that the co-precipitation of the viral proteins with NSP 1 
in the reaction with anti-NSPl serum were specific, as the amounts of co-precipitating 
proteins were considerably greater than those seen in the controls. From these 
observations it can be postulated that VPI, VP2, VP3NP4, VP6 and NSP3 form a 
complex with NSPl which is specifically precipitated by the anti-NSPl serum. The 
co-precipitation with NSPl of the viral structural proteins that form the transcriptional 
complex, and both the core and inner capsid shells, led to the suggestion that an actual 
complex containing NSP 1 was precipitated. This complex would be similar to the 
early replication complex suggested by Patton (1995), however with the notable 
addition of both VP2 and VP6. 
7.3.4 Boiling the cell lysate prior to immunoprecipitation with anti-NSPl serum 
changed the amounts of the proteins co-precipitating with NSPl 
The cell lysate was boiled prior to immunoprecipitation in an attempt to 
disrupt specific protein-protein and protein-RNA interactions, thus breaking up viral 
complexes in the cell lysate. Comparison of the precipitated proteins with those in the 
unboiled reaction allowed speculation on the nature of complex which had been 
disrupted. A reaction was performed with cell lysates which had been boiled with 
protein cracking buffer (4 % SDS; 10 % ~-mercaptoethanol) prior to 
immunoprecipitation with anti-NSPl serum. This precipitation produced a distinctly 
different result to the unboiled sample (Figure 7.3). Although a similar quantity of 
NSP 1 was precipitated, a significant decrease in the quantities of co-precipitating 
VPl, VP2 and VP6 was evident. These results suggested that VPl, VP2 and VP6 
have disassociated from a complex with NSP I, due to the disruption of specific 
interactions. The quantity of VP3NP4 appeared to remain the same. In contrast, the 
quantity of NSP3 was markedly increased after boiling by approximately 6 times by 
phosphoimager analysis. This increase could be explained in a number of ways. NSP3 
appears to interact with denatured NSPl that has disassociated from a complex (Lane 
5), however when VP2 and VP6 are precipitated with NSPl the amount of NSP3 is 
much reduced (Lane 4). This observation might suggest that NSP3 interacts with 
NSP 1 alone, but is displaced from the complex after the addition of VP2 and VP6. 
Alternatively, it is possible that the boiling process revealed a specific epitope which 
allowed immunoprecipitation by the anti-NSPI serum, resulting in precipitation of 
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greater quantities of the protein. Another possibility was an aggregation of the protein, 
formed as a result of the boiling process, was non-specifically precipitated with the 
protein A-Sepharose. Finally, it is possible that this protein band could represent the 
accumulation of breakdown products of other proteins which are non-specifically 
precipitated after the boiling process. 
The process of boiling the cell lysate in protein cracking buffer would also 
serve to disrupt conformational epitopes in the proteins. The fact that a similar 
quantity of NSPl was precipitated by the anti-NSPl serum after boiling indicates that 
the site on NSPl that reacts with this serum is not conformational. In vitro translated 
VP2 is also specifically precipitated by this serum (Section 6.6.2), hence the 
observation in this experiment that a reduced quantity of VP2 is precipitated after 
boiling might reflect the disruption of a conformational epitope in VP2 recognised by 
the anti-NSPl serum. 
7.3.5 Analysis of V8 protease digestion products of the VP3IVP4 band which 
co-immunoprecipitated with NSPl from infected celllysates 
Several proteins were shown to co-immunoprecipitate with NSP 1 from UKtc 
rotavirus-infected cell lysates (Figure 7.3), however not all of them were clearly 
identified. The band at approximately 90 kDa could have been either VP3 or VP4 as 
they both migrate to a similar position on the gel. The bands cannot be easily 
distinguished, even on a 5-11 % polyacrylamide gradient gel, which has been shown 
to give optimal separation of rotavirus proteins from infected cell lysates (M. A. 
McCrae, pers. comm.). Although the proteins were not easily distinguished on a gel, it 
was thought that the band at approximately 90 kDa was probably VP3. As VP3 is an 
inner core protein it is more likely to be found in a early replication complex with 
NSP 1 than VP4 which is an outer capsid surface protein. However, it was desirable 
that this assumption was tested to rule out the slight possibility that VP4 was 
non-specifically precipitated by the serum. 
To try and determine the identity of the protein in the VP3NP4 band, an 
experiment was devised based on the method of McCrae and Joklik (1978) to 
differentiate the VP3 and VP4 bands. Digestion of proteins with the Type XVII-B 
protease from Staphylococcus aureus strain V8 (V8 protease) gives an unique pattern 
of peptide bands when resolved on an acrylamide gel. Comparison of the peptide 
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profile produced by digestion of an unknown protein with profiles of known proteins 
allows identification of the protein. The unknown 90 kDa protein band, found 
co-precipitating with NSPl from infected cell lysates, was cut from the gel (Figure 
7.4, Panel A). The protein was solubilised and incubated with 5 J.lg/ml or 50 J.lg/ml V8 
protease and the resulting peptides were resolved on a polyacrylamide gel. To identify 
the co-precipitating protein, bands corresponding to VP3 and VP4 from infected cell 
lysates (Panel A) and in vitro translated VP3 (Panel B) were also excised from gels, 
digested with V8 protease and resolved on the gel with digests of the co-precipitating 
protein. 
Comparison of the pattern of peptide bands produced by the unknown protein 
with known samples should enable identification of the co-precipitating protein. The 
in vitro translated VP3 protein was clearly digested by the V8 protease to produce a 
profile of peptide bands (Panel C). With 5 J.lg/ml of V8 protease peptide digestion 
products were seen, however there was still some full length protein remaining. 
However, with 50 J.lg/rnl of V8 protease much less full length protein remained and 
there were many more peptide products, suggesting further digestion of the protein 
had occurred. The VP3NP4 protein band was also successfully digested by the V8 
protease. However, analysis of the gel by fluorography and phosphoimaging did not 
reveal a sufficiently clear image of the unknown sample which could be compared 
with the known pattern of peptides for VP3 and VP4. The results of this experiment 
remain inconclusive, as even an extremely long exposure of the gel to x-ray film (16 
weeks; Figure 7.4) did not reveal a clear profile of peptide bands for the unknown 
sample. A possible explanation for this result is that the protein in the sample was 
insufficiently radiolabelled to permit analysis of the peptide digestion products. If the 
peptides contained very few methionine residues, visualization of the peptide profile 
would prove extremely difficult or even impossible. Therefore, the protein at 
approximately 90 kDa (VP3NP4) that co-precipitated with NSPl could not be 
unequivocally identified as either VP3 or VP4. It will be described henceforth as 
VP3NP4, however as discussed previously, VP3 is considerably more likely to be 
contained in an early replication complex with NSPI than VP4. 
As VP3 is a GTP-binding protein, a GTP-binding assay can also be used to 
identify VP3 in a mixture of proteins (Zeng et al., 1996). A similar assay could be 
used in this case to prove the presence of VP3 in the immunoprecipitates. however 
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Figure 7.4 Polyacrylamide gel analysis or the VS protease digestion products 
of the VP3/VP4 band which co-precipitated with NSPl from UKtc rotavirus-
infected celllysates 
A. UKtc-infected celllysates 
Confluent BS-C-I cells were infected with a high m.oj. of the UKtc strain of 
bovine rotavirus (m.oj. = 20) and incubated for 7 hours at 37°C. The cells were 
pulsed with 35S-methionine for 2 hours and harvested (Section 3.6.3). 10 J.LI of the 
cell lysate was run on the gel to show the pattern of bands before 
immunoprecipitation (lane 1). 50 J.LI aliquots of the cell lysate were 
immunoprecipitated (Section 3.6.4) with 1 J.LI of pre-immune (lane 2) or anti-
NSPI serum (lane 3). The immunoprecipitates were analysed on a 5-11 % 
gradient polyacrylamide gel (Section 3.6.5), and the results visualized by dry gel 
fluorography after a 19 hour exposure of the gel (Section 3.6.6). The bands 
corresponding to VP3 and VP4 in the cell lysate (lane 1) and the unknown 
VP3NP4 band co-immunoprecipitating with NSPl (lane 3) which were excised 
from the gel are indicated. The size of the protein markers (in kDa) are indicated 
on the left of the gel. 
B. In vitro translated VP3 
Plasmid T7-pTAg-gene3 was purified by phenol extraction (Section 3.4.4) and 
ethanol precipitation (Section 3.4.5) and used to programme an in vitro coupled 
transcription-translation reaction at concentrations of 1 J.Lg or 2 J.Lg of DNA for 
expression of VP3 (Section 3.6.1). The products of the translation reactions were 
analysed on a 7.5 % polyacrylamide gel (Section 3.6.5) and visualized by dry gel 
fluorography after a 18 hour exposure of the gel (Section 3.6.6). The positions of 
the translated VP3 bands which were excised from the gel are indicated by the 
arrow. 
C. VS protease digests 
The protein bands which were excised from the gels [(i) In vitro translated VP3 
(control reaction) (Panel B):(ii) Unknown, immunoprecipitated VP3NP4 band 
(experimental reaction) (Panel A, lane 3):(iii) VP3NP4 band from cell lysate 
(control reaction) (Panel A, lane I)] were incubated with 5 J.Lg/ml or 50 J.Lg/ml of 
Type XVII-B protease from Staphylococcus aureus strain V8 for 30 minutes at 
37°C according to the method of McCrae and Joklik (1978). The digestion 
products were analysed on a 5-11 % gradient polyacrylamide gel (Section 3.6.5), 
and the results visualized by dry gel fluorography after a 16 week exposure of the 
gel (Section 3.6.6). The enzyme concentrations used for each sample are indicated 
at the top of the gel. The position of the full length VP3 protein is indicated on the 
right of the gel. The size of the protein markers (in kDa) are indicated on the left 
of the gel. 
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this assay would not rule out the possibility that VP4 was also precipitated. Another 
experiment which might distinguish between VP3 and VP4 is based on the fact that 
VP4 is cleaved by proteases to VP5* and VP8*. Mild trypsin treatment of the 
immunoprecipitates would change the migration of the unknown band if it was VP4, 
but would have no effect on VP3 (Fukuhara et al., 1989). These experiments might be 
used in future immunoprecipitations to distinguish bands migrating at the position of 
VP3NP4. 
7.4 Analysis of viral complexes containing NSPl 
7.4.1 Immunoprecipitation of viral complexes containing NSPl from different 
cell fractions 
The purpose of this experiment was to determine the nature of 
NSPI-containing viral complexes in different cellular fractions. The presence of 
NSPl in a complex with other viral proteins suggests either that protein-protein 
interactions occur between NSPl and these viral proteins or that they are interacting 
indirectly, possibly via RNA-protein interactions. To study this, rotavirus-infected cell 
lysates were fractionated by centrifugation. The cell lysate was first subjected to 
centrifugation at 10,OOOXg to remove the cell nuclei and large protein complexes. The 
1O,OOOXg supernatant was centrifuged at 30,OOOXg, and the resulting supernatant was 
then centrifuged at lOO,OQOXg producing a supernatant fraction containing only 
soluble proteins. Equal fractions of the supernatant and pellet from each sample were 
saved for analysis. Co-immunoprecipitation analysis was performed using anti-NSPI 
serum with each cell fraction and the precipitates analysed on a 5-11 % gradient 
polyacrylamide gel (Figure 7.5). Phosphoimager analysis was also used to quantify 
the immunoprecipitated proteins (Appendix 2.2). Analysis of the 
immunoprecipitations with anti-NSPI serum from the unfractionated cell lysate 
(Figure 7.5, lane 3) confirmed the result discussed previously (Section 7.3.3) that 
several viral proteins co-precipitated with NSP1, including VP1, VP2, VP3/VP4, VP6 
and a small quantity of NSP3. As before (Section 7.3.3), it was noted that small 
amounts of VP2, VP3NP4 and VP6 were non-specifically precipitated from the 
unfractionated cell lysate in the pre-immune serum control reaction. Quantification of 
the relative amounts of each protein again showed that considerably greater amounts 
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Figure 7.S Immunoprecipitation of viral protein complexes with anti-NSPl 
serum from cell fractions created by centrifugation at lO,OOOXg, 30,OOOXg 
and lOO,OOOXg 
Confluent MA104 cells were infected with a high m.o.i. of the UKtc strain of 
bovine rotavirus (m.o.i. = 20) and incubated for 7 hours at 37 °C. The cells were 
labelled with 35S-methionine for 2 hours and harvested (Section 3.6.3). The cell 
lysate was fractionated by spinning at 1O,OOOXg (11,000 rpm) in a Beckman TL 
100 ultracentrifuge using the TLS 55 rotor for 1 hour at 4 °C. The pellet was 
resuspended in an equivalent volume of 50 mM Tris.HCI pH 8.0 and samples of 
both the pellet and the supernatant were saved for analysis. The supernatant was 
then centrifuged at 30,OOOXg (19,000 rpm) as before. The pellet was resuspended 
in an equivalent volume of 50 mM Tris.HCI pH 8.0 and samples of the pellet and 
the supernatant were saved. The supernatant was then centrifuged at 1oo,OOOXg 
(34,000 rpm) as before. The pellet was resuspended in an equivalent volume of 
50 mM Tris.HCI pH 8.0 and samples of the pellet and the supernatant were 
saved. 
50 III aliquots of the pellet and supernatant of each cell fraction and also an 
unfractionated sample of the cell lysate were immunoprecipitated (Section 3.6.4) 
with 1 III of pre-immune or anti-NSPl serum. The immunoprecipitates were 
analyzed on a 5-11 % gradient polyacrylamide gel (Section 3.6.5), and the results 
visualized by dry gel fluorography (Section 3.6.6). A sample of the 
unfractionated cell lysate (10 Ill) was loaded on the gel to show the characteristic 
pattern of rotavirus protein expression before immunoprecipitation (lane 1). This 
lane represents a gel exposure time of 1 day. Immunoprecipitation of a sample of 
the unfractionated cell lysate with pre-immune serum (lane 2) and with anti-
NSPl serum (lane 3) was performed. Immunoprecipitation of the following cell 
fractions with anti-NSPl serum was performed: 10,OOOXg pellet (lane 4); 
1O,OOOXg supernatant (lane 5); 30,OOOXg pellet (lane 6); 30,OOOXg supernatant 
(lane 7); 1oo,OOOXg pellet (lane 8); 1oo,OOOXg supernatant (lane 9). Lanes 2-9 
represent a gel exposure time of 4 days. The identity of the viral polypeptides are 
indicated on the left of the lanes. VP indicates viral structural proteins. NSP 
indicates viral non-structural proteins. 
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were specifically co-precipitated with the anti-NSPl serum compared to the 
pre-immune serum control. 
7.4.2 Analysis of the immunoprecipitated protein volumes in different cell 
fractions 
The different quantities of each protein contained in the cell fractions were 
determined by phosphoimager analysis (Appendix 2.2). Visual inspection of the 
protein bands suggested that almost equivalent quantities of NSPl were present in the 
unfractionated cell lysate and the 1O,OOOXg and 30,OOOXg supernatants. 
Phosphoimager analysis confirmed that the approximate amount of NSP 1 contained in 
the 1O,OOOXg supernatant sample was almost equal to the amount contained in the 
unfractionated cell lysate, while the 30,OOOXg supernatant contained almost two 
thirds of this quantity. There was a loss of NSPl to the pellet at each centrifugation 
stage, however a large proportion of NSP 1 remained in the soluble fraction. 
The approximate quantities of the proteins which co-precipitated with NSP 1 in 
each cell fraction were also determined. A small amount of VP 1 was found in the 
unfractionated cell lysate and in the soluble supernatant fraction after each 
centrifugation stage. Analysis of the VP2 bands showed that a proportion of the 
protein was pelleted during the lO,OOOXg centrifugation stage, however a large 
amount still remained in the 1O,OOOXg supernatant. The 30,OOOXg supernatant and 
pellet consisted of approximately equal proportions of protein, and the majority of the 
remaining soluble protein was pelleted by the lOO,OOOXg centrifugation step. 
Analysis of the bands corresponding to VP3NP4 suggested that the majority of the 
protein remained in the soluble supernatant fraction until the lOO,OOOXg 
centrifugation stage, although there was a slight loss of protein to the pellet at each 
stage. NSP3 was found at low levels in each fraction with the notable exception of the 
lOO,OOOXg pellet where there was an increase in the quantity of NSP3 present. Given 
the disproportionate increase in NSP3 compared to the protein present in the 
30,OOOXg supernatant fraction, a possible explanation was that the band represented 
degraded protein. Analysis of the bands corresponding to VP6 showed that more than 
half of the total quantity of VP6 contained in the cell lysate was pelleted during the 
lO,OOOXg centrifugation step. This suggested that a large proportion of VP6 is held in 
an insoluble complex in the cell. The equivalent orbivirus protein VP7(T13), which 
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shares structural conservation with VP6, sometimes forms large crystalline assemblies 
in infected cells that are pelleted rapidly on centrifugation of cell lysates (P.P.c. 
Mertens, pers. comm.). These structures are formed by protein-protein interactions 
similar to those found in the outer core layer, which is composed entirely of 
VP7(T13). By analogy with this system, it is possible that VP6 also forms similar 
macromolecular structures in the infected cell, and this would explain the pelleting of 
large quantities of VP6 during the first centrifugation stage. 
It was apparent from the gel that there was a significant loss of proteins in the 
lOO,OOOXg cell fractions compared to the 30,OOOXg supernatant fraction from which 
they were produced. Although there was a broad band of NSPI in the 30,OOOXg 
supernatant fraction, there was very little NSPI protein in either the lOO,OOOXg 
supernatant or pellet fractions. The amount of VP2 present was also less than 
expected, although not to the same extent as NSPl. These observations made using 
fluorographs were confirmed by phosphoimager analysis of the appropriate bands. 
There are several possible explanations for the decrease in the amounts of these 
proteins including the possibility that a proportion of NSPI was degraded during the 
IOO,OOOXg centrifugation stage or that it was not efficiently resuspended from the 
compact pellet produced during high speed centrifugation, and thus less protein was 
available for immunoprecipitation. If a smaller amount of NSPl was precipitated, 
then this would obviously result in less co-immunoprecipitation of other proteins. 
7.4.3 NSPl may be a component of a viral protein complex with VP6 
The immunoprecipitation experiments described above showed different 
amounts of viral proteins co-precipitating with NSP 1 from the cell fractions. These 
results suggested that NSPl may be a component of a number of different viral 
complexes in the infected cell. Immunoprecipitation of NSPl from the unfractionated 
cell lysate resulted in co-precipitation of VPl, VP2, VP3NP4, VP6 and NSP3. When 
the cell lysate was subjected to centrifugation at 1O,OOOXg, a complex containing 
NSPl, VP2 and VP6 with small amounts of VP3NP4 and NSP3 was seen in the 
pellet fraction. It is proposed that this represents a novel NSP I-containing complex. 
An anti-VP6 monoclonal antibody also co-precipitated NSPl with VP6 from these 
fractions (Figure 7.8). Immunoprecipitation of the soluble supernatant fraction with 
anti-NSPl serum resulted in the co-precipitation ofVPl, VP3NP4 and small amounts 
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of VP2 and NSP3 with NSP 1. It is proposed that this represents a second 
NSP1-containing complex which does not contain VP6. This latter complex is similar 
to the pre-core RI described by Patton (Patton, 1995). 
The majority of precipitated NSPl was present in the soluble protein fraction. 
Hence, only a small proportion of the total amount of NSPl must be contained in the 
complex with VP6. Quantitative analysis of the protein bands revealed that only about 
10 % of the total NSPl contained in the unfractionated cell lysate was present in the 
1O,OOOXg pellet fraction which probably represents the proportion contained in a 
complex with VP6 (Appendix 2.2). 
7.5 NSPI may be held in the viral complex by an interaction with RNA 
7.5.1 Co-immunoprecipitation of viral proteins with NSPI might be due to 
binding to RNA 
The results described above have demonstrated that several viral proteins 
co-immunoprecipitate with NSPl and it is proposed that these proteins form a 
complex in the infected cell. However, it did not prove possible to detect direct 
protein-protein interactions between NSPl and the co-precipitating proteins using a 
yeast two-hybrid assay. Since these proteins have all been shown to have 
RNA-binding activity, it could be argued that co-immunoprecipitation of the proteins 
with NSPl might be due to binding to RNA. To address this question, an experiment 
was designed such that the cell lysate was treated with RNAase prior to 
immunoprecipitation with anti-NSPl serum. If NSPl was held in the complex by 
binding to RNA then successful degradation of the RNA would result in a decrease in 
the co-immunoprecipitation of the proteins contained in the complex with NSP 1. 
However, if RNA was not involved in the formation of the complex then treatment 
with the RNA-degrading agent would have no effect on the quantity of proteins which 
were immunoprecipitated. Micrococcal nuclease was used as it is known to efficiently 
degrade RNA. Cell lysate samples were incubated with micrococcal nuclease for 
varying lengths of time at room temperature. It was not known how the RNA might 
be packaged with the protein complex, so a longer incubation time might be required 
if it was protected from nuclease attack. The nuclease-treated samples were then 
immunoprecipitated with anti-NSPl serum to determine whether the degradation of 
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RNA made a difference to the protein complex which was co-immunoprecipitated 
with NSPl. 
7.5.2 Micrococcal nuclease efficiently destroys RNA in the cell lysate 
A problem was anticipated with the potential results of this experiment if no 
change was observed in the proteins immunoprecipitated by the anti-NSP 1 serum 
after treatment with the micrococcal nuclease. If this was the case, then a valid 
conclusion could not be drawn as it would be unclear whether the micrococcal 
nuclease actually had an effect. To address this problem, a control experiment was 
designed to run in conjunction with the immunoprecipitation reactions to demonstrate 
the activity of the micrococcal nuclease. To perform the control experiment, the 
labelled infected cell lysate was divided into two aliquots, one of which was incubated 
with micrococcal nuclease for 90 minutes and a second which was not. The nuclease 
was then destroyed by treatment with proteinase K and a phenol/chloroform 
extraction was performed with both samples to remove protein from the cell extract. 
The RNA in the samples was then extracted by ethanol precipitation. An aliquot was 
removed at this point to confirm that the labelled viral proteins had been removed 
from the cell extracts (data not shown). The extracted samples were then added to a 
rabbit reticulocyte lysate translation system so that any RNA present would be 
translated to protein. The translation reactions were immunoprecipitated with serum 
raised against a preparation of the UKtc strain of bovine rotavirus and analysed on a 
polyacrylamide gel. The sample which was not treated with nuclease contained viral 
RNA which was translated to protein. The sample was divided and 
immunoprecipitated with pre-immune serum (Figure 7.6, lane 8) and anti-UKtc serum 
(Figure 7.6, lane 9) to show that viral proteins were present. If the nuclease treatment 
was effective, then the RNA in the nuclease-treated sample would be destroyed and 
hence no viral proteins would be produced for immunoprecipitation. 
Immunoprecipitation of the nuclease-treated sample with pre-immune serum (Figure 
7.6, lane 10) and anti-UKtc serum (Figure 7.6, lane 11) showed that no viral proteins 
were present in the extract. Thus, this control experiment demonstrated that the 
nuclease-treatment successfully degraded viral mRNA in the cell extract. 
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Figure 7.6 Immunoprecipitation with anti-NSPl serum oC UKtc rotavirus-
infected celllysates pre-treated with micrococcal nuclease for varying lengths 
of time 
Confluent MAI04 cells were infected with a high m.o.i. of the UKtc strain of 
bovine rotavirus (m.o.i. = 20) and incubated for 7 hours at 37°C. The cells were 
labelled with 35S-methionine for 2 hours and harvested (Section 3.6.3). 10 ,.11 
aliquots of the cell lysate were treated with micrococcal nuclease by adding 2.5 J.11 
of lOO mM CaClz and 2.5 J.11 of I mglml micrococcal nuclease. An equivalent 
volume of 50 mM Tris.HO pH 8.0 was added to the untreated samples in place of 
the nuclease. The samples were incubated at room temperature for 10, 30, 60 or 
90 mins. The experimental samples were then immunoprecipitated with 1 J.1l of 
pre-immune serum, anti-NSPl serum or anti-UKtc serum (Section 3.6.4). 
The control samples were treated with 100 J.1g1ml proteinase K in buffer (1 % 
SDS: 0.1 M Tris.HO pH 7.5: 12.5 mM EDTA: 0.15 M NaCl) to destroy the 
nuclease, and the RNA was extracted with phenol-chloroform (Section 3.4.4) and 
ethanol precipitation (Section 3.4.5) and resuspended in 10 J.11 of RNAse-free H20. 
The RNA samples were translated in a rabbit reticulocyte lysate system (Section 
3.6.1.2) and the resulting proteins immunoprecipitated with pre-immune or anti-
UKtc serum (Section 3.6.4). The immunoprecipitates were analyzed on a 5-11 % 
gradient polyacrylamide gel (Section 3.6.5), and the results visualized by dry gel 
fluorography (Section 3.6.6). 
Untreated celllysates were immunoprecipitated with pre-immune serum (lane 1) 
and anti-NSPI serum (lane 2). 10 J.11 aliquots of the cell lysate were treated with 
micrococcal nuclease for 10 minutes (lane 3), 30 minutes (lane 4), 60 minutes 
(lane 5) and 90 minutes (lane 6) then immunoprecipitated with anti-NSPl serum. 
An untreated aliquot was also incubated at room temperature for 90 minutes 
before immunoprecipitation with anti-NSPI serum (lane 7). As a control for the 
micrococcal nuclease activity, RNA was extracted and translated from two 
untreated aliquots and the samples immunoprecipitated with pre-immune serum 
(lane 8) and anti-UKtc serum (lane 9). RNA was also extracted from aliquots 
treated with micrococcal nuclease for 90 minutes. The samples were translated 
and immunoprecipitated with pre-immune serum (lane 10) and anti-UKtc serum 
(lane 11). A sample of the unprecipitated cell lysate was not run on this gel. 
However, a 10 J.11 sample from the same stock of cell lysate that was used in this 
experiment is shown on a previous gel (Figure 7.S, lane I). This figure represents 
a gel exposure time of 1 week. The identity of the viral polypeptidcs are indicated 
on the left of the lanes. VP indicates viral structural proteins. NSP indicates viral 
non-structural proteins. 
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7.5.3 Immunoprecipitation with anti·NSPl serum of micrococcal nuclease 
treated celllysates 
Micrococcal nuclease-treated rota virus-infected cell lysates were 
immunoprecipitated with anti-NSPl serum as described (Section 7.5.3) and the results 
were analysed on a 5-11 % gradient polyacrylamide gel by fluorography of the dried 
gel (Figure 7.6). Phosphoimager analysis of the gel was used to provide estimates of 
the protein content of the immunoprecipitated protein bands (Appendix 2.3). 
Immunoprecipitation of the untreated lysate with anti-NSPl serum (lane 2) showed 
the complex described previously (Section 7.3.3) which consists of VP2, VP3/VP4, 
VP6 and small quantities of VPl and NSP3 co-immunoprecipitating with NSPl. On 
examination of the immunoprecipitates from the nuclease-treated samples, a 
considerable reduction in the quantity of NSP 1 and VP3NP4 could be seen as the 
incubation time increased (lanes 3-6). The quantity of NSP3 also appeared to be less 
in the nuclease-treated samples. However, VP2 and VP6 appeared to be constant 
throughout the time course. A sample of untreated lysate was incubated at room 
temperature for 90 minutes to determine whether any protein degradation was 
occurring due to inherent proteases in the cell lysate. If considerable degradation of 
the viral proteins occurred it might obscure the result of the nuclease-treated samples. 
By fIuorographic examination of the gel it appeared that visible levels of protein 
degradation did not occur in the cell lysate during the incubation period (lane 7). 
Quantification of the protein bands by phosphoimager analysis showed that the 
amount of VP6 did not decrease throughout the time course treatment with 
micrococcal nuclease (Appendix 2.3). However, similar analysis of VP2, VP3/VP4 
and NSPl showed a decrease in the amount of protein immunoprecipitated from cell 
lysates treated with micrococcal nuclease over time. The quantity of NSP3 which 
co-precipitated was not sufficient for phosphoimager analysis. 
The protein bands resulting from the immunoprecipitation from cell lysates 
treated with micrococcal nuclease for 10 minutes were analysed and the approximate 
amounts of protein were determined by phosphoimager analysis (Appendix 2.3). The 
amount of NSPl precipitated by the anti-NSPl serum did not decrease after 10 
minutes incubation with nuclease. However, the quantities of VP2 and VP3/VP4 
which were co-precipitated were reduced to approximately 70 % of those present in 
the initial reaction (no nuclease). If NSPl, VP2 and VP3NP4 were held together in 
the complex by RNA-protein interactions, then degradation of the RNA would result 
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in a decrease in the quantities of these proteins held in the complex, and thus a 
corresponding decrease in the co-precipitation of VP2 and VP3NP4 with NSP 1. This 
result suggested that the nuclease was active in degrading RNA within the first 10 
minutes of the reaction, and the decrease in co-precipitation of VP2 and VP3/VP4 
with NSPl which was observed could be due to degradation of RNA holding the 
proteins together in the complex. 
In the reactions incubated with nuclease for between 30 and 90 minutes there 
was a reduction in the quantity of NSPl which was immunoprecipitated by the 
anti-NSP 1 serum. There was also a decrease in the quantities of VP2 and VP3NP4, 
however the change was slower than in the 10 minute reaction and could be due to the 
fact that less NSP 1 was immunoprecipitated. The decrease in immunoprecipitation of 
NSP 1 could be due to the degradation of the complex, resulting in the release of NSP 1 
which might be inefficiently precipitated when free in the lysate compared to when it 
is held in a large complex. A slight decrease in the quantity of NSP 1 was also noted in 
the reaction which was incubated without nuclease for 90 minutes, perhaps indicating 
that NSPl was subject to low level degradation by ubiquitous proteases in the lysate. 
The latter might therefore also account for the decrease in immunoprecipitation of 
NSP lover time. 
Quantification of the VP6 protein bands by phosphoimager analysis showed 
that the amount of VP6 did not decrease throughout the time course treatment with 
micrococcal nuclease. As VP6 does not appear to have RNA-binding activity it is 
unlikely to be held in the complex by RNA-protein interactions, as suggested for the 
other components, and thus would not be expected to be affected by treatment with 
nuclease. VP6 is the inner capsid protein and the most abundant protein in the virus. 
As it is such an abundant protein it seems likely that there would be a high ratio of 
molecules of VP6 to NSP 1 in the complex. If the proportion of VP6 in the complex 
was considerably higher than the proportion of NSP 1, a small decrease in NSP 1 might 
not necessarily produce a noticeable decrease in the quantity of VP6 precipitated. 
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7.6 Analysis of NSP1 production and complex formation during the early stages 
of virus infection 
7.6.1 Time course analysis of NSPl complex formation in vivo 
To examine the formation of NSPl-containing complexes in the early stages 
of rotavirus infection, pulse-chase labelled infected cell lysates were harvested at 
various times p.i. and immunoprecipitated with anti-NSP 1 serum. It was thought that 
immunoprecipitation of NSPI at different time points and analysis of the 
co-precipitating proteins might offer some insight into the protein components of the 
complex, how it was formed and how it changed over time. Immunoprecipitation of 
the samples after a two hour chase with cold methionine would show whether the 
co-precipitating proteins had changed during that time period. 
Cells were pulse-labelled for 30 minutes with 35S-methionine at 1, 3, 5 and 7 
hours p.i. with the UKtc strain of bovine rotavirus. Following the pulse-labelling, one 
sample of cells was harvested immediately (pulse sample) and a second sample was 
chased for 2 hours with unlabelled methionine (pulse-chase sample). In the 
experiments described earlier in this chapter, rotavirus-infected cells were 
pulse-labelled at 7 hours p.i. and harvested without a chase period. The alternative 
labelling regimes described in this section were designed to show which proteins 
co-precipitated with NSPl during the earlier stages of infection and whether the 
NSPI-containing complex was maintained in the cell during the chase period. 
Polyacrylamide gel analysis of immunoprecipitates made from pulse-labelled 
samples revealed that NSPl was not detected in the cell until 3 hours p.i. (Figure 7.7). 
This indicated that in the very early stages of infection either no NSP 1 or only 
undetectable amounts of the protein were present. However, by 3 hours p.i. it can be 
clearly seen that NSPl was precipitated from both the pulse and pulse-chase samples. 
Analysis of the protein bands using phosphoimaging revealed that approximately the 
same amounts of NSPl were precipitated from both the pulse and the pulse-chase 
samples (Appendix 2.4.1). Small quantities of other viral proteins, including VPI, 
VP2, VP3IVP4, VP6 and a protein thought to be NSP3, co-precipitated with NSP 1. 
Approximately equal quantities of each co-precipitating protein were found in both 
the pulse and the pulse-chase samples (Appendix 2.4.1). No proteins were precipitated 
by the pre-immune serum suggesting that the co-precipitation of these proteins with 
NSP 1 was due to a specific interaction between them. 
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Figure 7.7 Immunoprecipitation ofUKtc rotavirus-infected celllysates pulse-
chase labelled with 3sS-methionine at regular time intervals 
MAI04 cells were grown to confluence then incubated in methionine-free media 
overnight. The cells were infected with a high m.oj. of the UKtc strain of bovine 
rotavirus (m.oj. = 20) and incubated for varying lengths of time at 37°C (Section 
3.6.3). The cells were pulse-labelled, in duplicate, with 35S-methionine for 30 
minutes at 1, 3, 5, or 7 hours post-infection. After the pulse-labelling period, one 
well of cells was harvested and the second was chased with media containing 
l00X unlabelled methionine for 2 hours before harvesting. 50 III of each sample 
was immunoprecipitated with 1 III of pre-immune serum or 1 III anti-NSPl serum 
(Section 3.6.4). The immunoprecipitates were analyzed on a 5-11 % gradient 
polyacrylamide gel (Section 3.6.5), and the results visualized by dry gel 
fluorography (Section 3.6.6). 
The times of pulse-labelling at 1,3,5 and 7 hours post-infection are indicated on 
the figure. There are four reactions for each incubation time showing the 
immunoprecipitation of the pulse (P) and pulse-chase (C) samples with both pre-
immune and anti-NSPl serum. This figure represents a gel exposure time of 3 
weeks. The identity of the viral polypeptides are indicated on the left of the lanes. 
VP indicates viral structural proteins. NSP indicates viral non-structural proteins. 
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At 5 hours p.i. several proteins, VPl, VP2, VP3NP4, VP6 and NSP3, were 
again co-precipitated with NSP 1 from both the pulse and pulse-chase samples. 
Phosphoimager analysis of the protein bands showed there was a sharp increase in the 
amount of NSPl precipitated at 5 hours p.i. compared to 3 hours p.i. (Appendix 
2.4.1). This increase in NSP 1 was matched by an increase in the co-precipitating 
proteins. In addition, considerably more NSPl was precipitated from the pulse sample 
compared to the pulse-chase sample at this time point. This observation was also true 
for the viral proteins co-precipitating with NSPI. This suggested that NSPl may be 
contained in a transient complex with these proteins which is rapidly turned over such 
that only small quantities remain to be precipitated from the pulse-chase sample after 
the 2 hour chase period. 
At 7 hours p.i., the viral proteins were again co-precipitated with NSPI. At 
this stage, similar quantities of each protein were precipitated from both the pulse and 
pulse-chase samples. These results suggested that by this time point the 
co-precipitating proteins were found associated in a complex with NSP 1 which was 
either stable during the 2 hour chase period, or was present at a constant level in the 
infected cell. 
At 5 and 7 hours p.i. small quantities of proteins were precipitated by the 
pre-immune serum. Using phosphoimager analysis, the amounts precipitated by the 
pre-immune serum were compared to that co-precipitated by the anti-NSP I serum 
(Appendix 2.4.3). In all cases the amounts co-precipitated with NSPl by the 
anti-NSPl serum were considerably higher, suggesting they were specifically 
co-precipitated with NSP I. 
7.6.2 Summary 
Analysis of the data produced from the immunoprecipitation of a time course 
of pulse-chase labelled samples by examination of the gel and phosphoimager 
quantification of the protein bands allowed speculation about the nature of a complex 
formed with NSP 1. Several viral proteins consistently and specifically co-precipitated 
with NSPI over the time course and it is suggested that NSPI forms a complex with 
these proteins. The proteins were first detected at 3 hours p.i .. By 7 hours p.i. similar 
amounts of each protein were precipitated from the pulse and pulse-chase samples, 
indicating either that the NSP I-containing complex was stable during the chase period 
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or that it was now at a constant level in the cell. This was in contrast to the situation at 
5 hours p.i. when the quantity of each protein in the pulse sample greatly exceeded the 
quantity precipitated from the pulse-chase sample, which could be due to high levels 
of a transient NSP I-containing complex at this time. The length of the time course 
was chosen with the consideration that RNA replication is maximal at 6-9 hours, and 
virions can be detected by 6 hours p.i. (McCrae and Faulkner-Valle, 1981) (Stacy-
Phipps and Patton, 1987). However, future experiments might include an extension of 
the time course in order to determine how the complex changes after 7 hours p.i .. 
Shorter intervals between the pulse times may also reveal additional information 
about the nature of the NSP I-containing complex. 
7.7 Analysis of NSPl complex by co-immunoprecipitation studies with anti-VP6 
monocIonal antibody 
7.7.1 Co-immunoprecipitation of NSPl with VP6 
Previous work in this chapter has described a novel NSP1-containing complex 
in UKtc rotavirus-infected celllysates. This complex contained VP1, VP2, VP3NP4, 
VP6, and NSP3 in addition to NSPl. The presence of the viral structural proteins 
associated with the double-layered virus particle led to the suggestion that a novel 
NSP1-containing complex or particle had been precipitated. As VP6 has not 
previously been found in an NSP1-containing complex, an experiment was designed 
to determine whether NSP 1 would co-precipitate with VP6 using a specific anti-VP6 
antibody. An anti-VP6 monoc1onal antibody (mAb) was obtained and it was 
confirmed that it could immunoprecipitate VP6 from UKtc rotavirus-infected cell 
lysates (data not shown). 
Earlier immunoprecipitation experiments using anti-NSPI serum and carried 
out on cell fractions (Figure 7.5) showed that more than half of the total amount of 
VP6 co-precipitating with NSPI was found in the 1O,OOOXg centrifugation stage 
pellet sample. Most of the remaining VP6 protein was found in the 30,OOOXg 
centrifugation stage pellet sample. Therefore, the 1O,OOOXg supematant and pellet and 
the 30,OOOXg pellet fractions were chosen for analysis in the present experiment using 
the anti-VP6 mAb. A sample of the unfractionated cell lysate was also analysed by 
immunoprecipitation with the anti-VP6 monoc1onal antibody. VP6 was precipitated 
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from the unfractionated cell lysate and also from each of the cell fractions analysed 
(Figure 7.8). The pre-immune serum precipitated a small quantity of VP6 from the 
unfractionated sample equivalent to 1.5 % of the total protein precipitated by the 
specific anti-VP6 antibody (as determined by phosphoimager analysis), and this was 
considered to be a negligible quantity (Appendix 2.5.1). The amount of VP6 
precipitated from· the 1O,OOOXg pellet fraction was over a third of the total 
precipitated from the cell lysate, and of the remaining VP6 protein in the fraction, 
almost a half was then precipitated from the 30,OOOXg pellet fraction. Clearly, 
although much VP6 was pelleted by low speed centrifugation, a significant amount 
remained in the supernatant fractions. 
The proteins co-precipitating with VP6 were examined. Small quantities of 
NSPl were found co-precipitating with VP6. Although the bands were faint on the 
fluorograph of the gel, they were detectable by phosphoimager analysis (Appendix 
2.5.1). NSP3 was also co-precipitated with VP6, although a high background in this 
region of the gel meant the bands were harder to detect. Higher levels of NSP I and 
NSP3 were precipitated from the unfractionated cell lysate compared to the samples 
fractionated by centrifugation. Only very low levels of NSPI and NSP3 were 
non-specifically precipitated by the pre-immune serum. VP2 and VP3NP4 were 
co-precipitated with VP6 from all fractions, however they were also precipitated by 
the pre-immune serum which brings into question the specificity of their 
co-precipitation with VP6. Visible levels of VPl were not detected on the gel 
fluorograph. 
7.7.2 NSPl complex contains only a small proportion of total VP6 in the cell 
Co-immunoprecipitation experiments with the available anti-VP6 mAb 
resulted in precipitation of small quantities of NSPI together with the complex 
proteins described previously. VP6 is an abundant structural protein while NSP 1 is 
only expressed at very low levels. Phosphoimager analysis showed that the percentage 
of VP6 contained in the NSP 1 complex was only about 4 % of the total VP6 in the 
cell lysate (Appendix 2.5.2). Hence, the proportion of molecules of VP6 contained in 
a complex with NSPI appears to be very low. 
The bands thought to be NSP 1 co-precipitated with VP6 were quite faint on 
the fluorograph. Prior isolation of the NSP I-containing complex with specific anti-
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Figure 7.8 Immunoprecipitation of UKtc rotavirus-infected cell Iysates with 
anti-VP6 monoclonaI antibody 
Confluent MAI04 cells were infected with a high m.o.i. of the UKtc strain of 
bovine rotavirus (m.o.i. = 20) and incubated for 7 hours at 37°C. The cells were 
labelled with 35S-methionine for 2 hours and harvested (Section 3.6.3). The cell 
lysate was fractionated by centrifugation at 10,{)()()Xg (11,{)()() rpm) in a Beckman 
TL 100 ultracentrifuge using the TLS 55 rotor for 1 hour at 4°C. The pellet was 
resuspended in an equivalent volume of 50 mM Tris.HCI pH 8.0 and samples of 
both the pellet and the supernatant were saved for analysis. The supernatant was 
then centrifuged at 30,OOOXg (19,000 rpm), the pellet was resuspended and 
samples saved as before. 50 J.lI aliquots of the pellet and supernatant of each cell 
fraction and also an unfractionated sample of the cell lysate were 
immunoprecipitated (Section 3.6.4) with 10 J.lI of pre-immune serum or anti-VP6 
monoclonal antibody. The immunoprecipitates were analyzed on a 5-11 % 
gradient polyacrylamide gel (Section 3.6.5), and the results visualized by dry gel 
fluorography (Section 3.6.6). 
A sample of the unfractionated cell lysate (2 J.lI) was loaded on the gel to show 
the characteristic pattern of rotavirus protein expression before 
immunoprecipitation (cell lysate). This lane represents a gel exposure time of 6 
days. Immunoprecipitation of a sample of the unfractionated cell lysate with pre-
immune serum (lane 1) and with the anti-VP6 monoclonal antibody (lane 2) was 
performed. Immunoprecipitation of the following cell fractions with the anti-VP6 
monoclonal antibody was performed: 1O,000Xg pellet (lane 3); 30,OOOXg pellet 
(lane 4); 10,OOOXg supernatant (lane 5). Lanes 1-5 represent a gel exposure time 
of 15 days. The identity of the viral polypeptides are indicated on the left of the 
lanes. VP indicates viral structural proteins. NSP indicates viral non-structural 
proteins. 
VPl 
VP2 
VP3IVP4 
NSPl 
VP6 
VP7 
NSP2 
NSP3 
cell 
lysate 
Pre-immune Immunoprecipitation with 
serum anti-VP6 monoclonal Ab. 
~ 
1 2 3 4 5 
Figure 7.8 
NSPl antibody, followed by selection with anti-VP6 antibody should allow a clearer 
resolution of the components of the complex. However, following the selection of the 
NSPl-containing complex by immunoprecipitation with anti-NSPl serum, it would 
then be necessary to dissociate the complex and antibody in a procedure that might 
cause disruption to the complex such that it was no longer recognised by the anti-VP6 
serum. Caution should therefore be exercised in the design and evaluation of such an 
experiment. 
7.8 Discussion 
This chapter describes initial studies on a previously unrecognised complex 
containing NSPl that was immunoprecipitated with anti-NSP1 serum from 
rotavirus-infected cells. Viral proteins VPl, VP2, VP3NP4, VP6 and NSP3 were 
specifically co-immunoprecipitated with NSP1 from infected cell lysates, and it was 
postulated that these proteins formed a novel complex in the infected cell. In addition, 
an anti-VP6 monoclonal antibody reciprocally precipitated small amounts of NSP 1. 
The presence of VP2 and VP6, which are the major structural proteins of the double-
layered virus particle, suggested that a complex or particle had been precipitated. 
Further experiments to examine various aspects of the formation of this complex were 
performed. Immunoprecipitation with anti-NSP1 serum of fractions created by 
centrifugation of celllysates showed this complex co-precipitated with NSPl mainly 
from the pellet of the low speed centrifugation sample. Phosphoimager analysis 
showed that only a small proportion of NSPl was contained in the complex with VP6. 
The VP6 found in the complex only represented a small proportion of total protein in 
the cell lysate. Therefore, it seems probable that this complex is only found in small 
amounts in the infected cell. 
Direct protein-protein interactions were not demonstrated between NSP 1 and 
other proteins in this complex using a yeast two-hybrid assay, consequently it was 
proposed that NSPI may be held in the complex indirectly via an interaction with 
viral mRNA. Treatment of the cell lysate with micrococcal nuclease resulted in a 
decrease in the quantity of VP2, VP3NP4 and NSP3 co-immunoprecipitating with 
NSP 1. This was particularly notable in the first 10 minutes of the incubation time 
when there was a considerable decrease in the amount of VP2 and VP3NP4 
co-precipitating with NSPI compared to the quantity which co-precipitated with a 
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similar amount of NSP 1 before nuclease treatment. This result supports the hypothesis 
that some interactions in the NSPI-containing complex might be mediated by 
RNA-binding. VP6 does not have RNA-binding activity and no visible decrease was 
observed in the quantity of VP6 which co-precipitated with NSP 1 on the addition of 
nuclease. VP6 must interact with the complex in a different manner, perhaps by 
protein-protein interactions with other members of the complex, and indeed there is 
evidence to suggest that VP6 interacts with VP2 in the formation of the 
double-layered virus particle (Zeng et al., 1994) (Estes, 1996). 
At present the function of this novel complex is unknown. It may be similar to 
the RIs which have been described previously (GaUegos and Patton, 1989), however 
in contrast with those complexes, NSPI appeared to be retained in the complex until 
after the addition of VP6. It seems to be present at low levels in the infected cell. 
Hence, it is possible that it is a transient assembly complex formed during the 
replication process, which is rapidly turned over so that only small amounts are 
present in the infected cell at anyone time. Future work should include an attempt to 
precipitate the complex with antisera raised against the other protein components and 
these experiments would help to confirm the composition of the complex. 
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S.l Discussion 
Rotavirus encodes six non-structural proteins whose functions in the virus 
infectious cycle have not as yet been well characterised. The non-structural proteins 
would be expected to play a role in the viral replication cycle, in association with the 
viral RNA and those structural proteins that operate in an enzymatic capacity in the 
cycle. In order to elucidate the details of the replication process, it is essential to 
characterise the nature of the interactions that occur between the protein~onstituents 
of replication complexes. The non-structural protein NSPl has been shown to be a 
component of a complex formed with several viral structural proteins at early times in 
the replication cycle (GaUegos and Patton, 1989). The primary aim of this project was 
to determine whether protein-protein interactions occurred between NSP 1 and the 
other components of the early replication complex in an attempt to elucidate the role 
of NSPl in the viral replication cycle. 
NSPl is unusual among the non-structural proteins 10 that it shows an 
extremely high level of divergence in its primary sequence. Despite this, the predicted 
secondary structure of the protein appears to be conserved, suggesting there is a 
selective pressure to maintain the overall structure of the protein to facilitate a 
function in the virus infectious cycle. A highly conserved, cysteine-rich region at the 
amino-terminus of the protein is proposed to be a functional domain and may contain 
a zinc finger motif (Mitchell and Both, 1990a). The protein has also been shown to 
have non-specific ssRNA-binding activity (Brottier et al., 1992). Early attempts to 
define complexes associated with the rotavirus replication cycle identified three 
replication intermediates (RIs) in the infected cell (Gallegos and Patton, 1989). NSP 1 
was found to be associated with the earliest complex, the pre-core RI, suggesting a 
role for the protein in the early stages of the replication cycle. The core RI is formed 
by the subsequent addition of VP2 to the pre-core RI. The intermolecular interactions 
between the components of these complexes were not defined. Clearly, in order to 
fully understand the virus replication cycle and the function of individual proteins 
within it, the protein-protein interactions that occur between the constituents of these 
complexes must be determined. 
To investigate potential protein-protein interactions between NSPI and the 
other protein components of the RIs, two different systems were employed. The yeast 
two-hybrid system is now established as a practical assay for quickly detecting 
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protein-protein interactions in vivo, and this system was chosen as the primary tool to 
investigate NSPl protein interactions. A second approach, based on an in vitro radio-
immunoprecipitation assay, was developed to confirm results obtained with the 
two-hybrid system. The protein-protein interactions occurring in the RIs were 
expected to be of a transient nature and this view was influential in the choice of the 
yeast two-hybrid system, as it is known to be a sensitive assay for detection of weak 
or transient interactions. 
A cloning strategy was devised to construct plasmids expressing fusions of the 
GAL4 DNA-binding and activation domains with the rotavirus proteins NSPI, NSP3, 
VPl, VP2, and VP3. The reading frame was maintained during the cloning procedure 
such that GAL4 domain fusion proteins would be produced. These plasmids were 
co-transformed into a reporter yeast strain to test for protein-protein interactions. The 
reporter gene used was lacZ, and consequently the detection of p-galactosidase 
indicated that the two proteins being studied were interacting. All proteins were tested 
in both the GAL4 DNA-binding and activation domains. This was because previous 
work has shown that this system can be subject to directionality, with the orientation 
of the proteins determining whether or not an interaction is detected (Estojak et al., 
1995). No self-interaction of NSPl with itself was detected and it also did not show 
any interaction with the other non-structural protein, NSP3, tested. In addition, no 
interactions were demonstrated between NSP 1 and the viral structural proteins VP 1, 
VP2 and VP3. 
There are a number of possible explanations as to why interactions between 
the rotavirus proteins were not demonstrated in the yeast two-hybrid assay. First, it is 
conceivable that NSPI does not form direct protein-protein interactions with the other 
protein components of the RIs but interacts with them indirectly. The implications of 
this possibility will be discussed later. A second explanation is that authentic 
protein-protein interactions exist but could not be detected under the conditions of this 
assay. There are a number of examples in the literature where proteins shown to 
interact with each other in other assays have failed to give a positive result in the yeast 
two-hybrid system. For example, use of the GAL4 domain two-hybrid vectors to 
characterise interactions among non-structural proteins of poliovirus failed to detect 
all the interactions which were shown with an in vitro system (Cuconati et al., 1998). 
Similarly. a study of the nucleocapsid proteins of rinderpest virus failed to show a 
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self-association of the N protein in the GAlA domain yeast two-hybrid system, 
despite the fact that the protein has been shown to self-assemble when expressed in E. 
coli (Shaji and Shalia, 1999). Clearly, genuine protein-protein interactions cannot 
always be detected in the two-hybrid system, and there are several explanations for 
this. First, if the interactions occur only weakly in yeast they may not be detected by 
the assay. Reporter systems used in two-hybrid assays have been shown to be subject 
to a threshold corresponding to the minimum affinity of the protein interaction 
required to score as positive in the assay (Estojak et al., 1995). Although the lacZ 
reporter system is known to be sensitive for some interactions, very weak interactions 
may still fall below the minimum threshold required for detection. Secondly, as the 
assay was performed in yeast and not in a mammalian cell, it is unlikely to represent 
the exact conditions that would be found in the mammalian cell. Although the yeast 
system should produce proteins more similar to their native state than that obtained in 
a bacterial system there are still modifications, such as proteins containing disulphide 
bonds, which cannot always be properly expressed in a nuclear-based system such as 
the two-hybrid system (Fields and Sternglanz, 1994). Thirdly, an interaction would 
not be detected if the fusion protein was not localised to the nucleus, although the 
possibility of this is unlikely for proteins that do not contain strong localisation 
signals for other compartments of the cell or for the plasma membrane. Further, it is 
possible that the fusion of the GAlA domains to the viral proteins may mean that the 
protein is misfolded or unstable. A point that must be taken into consideration is that 
the expression of the fusion proteins was not detectable by western blot. This was 
probably due to the low expression from the two-hybrid vectors pGBT9 and 
pGAD424, as even specific monoclonal antibodies (mAb) against the GAlA domains 
cannot detect fusion proteins expressed from these vectors by western blot analysis. 
The small possibility that fusion proteins were not stably expressed in the yeast cell 
cannot however be completely dismissed. Finally, in some cases the attached GAlA 
domain can occlude the protein interaction site. The proteins of interest are expressed 
as carboxy-terminal extensions of the GAlA domains, and the attached activation 
domain can sometimes block accessibility to the amino-terminus of the protein (Fields 
and Sternglanz, 1994). Hence, the orientation of the proteins - whether they are fused 
to the GAlA DNA-binding or activation domains - can be an important factor in the 
success of the assay. 
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It is perhaps surprising that protein-protein interactions were not detected 
between NSPl and the viral proteins with which it is associated in the pre-core RI, as 
the protein components of the RIs would probably be expected to interact. A possible 
explanation is that an additional component, such as viral mRNA, is needed to bridge 
the interactions between the proteins. As all the protein components of the pre-core 
RI, including NSP1, have mRNA-binding activity, it is a distinct possibility that 
protein interactions might be mediated by mRNA. If NSPl interacted with mRNA in 
the early replication complexes, rather than forming protein-protein interactions, then 
this would explain the negative results from the two-hybrid assays. Alternatively, 
interactions between the proteins may only occur when they are assembled in the RI, 
due to the presence of new interaction domains in the proteins exposed by the 
complex formation. A similar scenario has been proposed for the association of 
influenza NS 1 protein with the transcription-replication complex in influenza-infected 
cells, since direct protein interactions were not shown between NS 1 and the 
polymerase subunits in a two-hybrid assay (Mari6n et al., 1997). The yeast 
two-hybrid assay would not detect protein-protein interactions of this nature as viral 
RNA cannot be added to the system. 
While this work was in progress, the report by Gonzalez et al. (1998) appeared 
which presented data to suggest that NSPl interacted with the viral non-structural 
proteins NSP2, NSP3, NSP5 and NSP6, which are found associated at different times 
with the RIs. Using the GALA yeast two-hybrid system, NSPl was shown to interact 
with each protein, albeit at a low level. Interactions were only observed when NSPl 
was fused to the GALA DNA-binding domain, and this fusion protein also activated 
transcription at a low level in the absence of a GALA activation domain fusion 
counterpart. Immunoprecipitation analysis demonstrated co-immunoprecipitation of 
NSPI with each non-structural protein using specific sera, but reciprocal precipitation 
of the proteins with NSP 1 by anti-NSP 1 serum was not observed. 
In contrast to the results presented by Gonzalez et al. (1998), an interaction 
between NSP 1 and NSP3 was not observed using the yeast two-hybrid system in the 
present study. The reason for this discrepancy is unknown, but it has been noted that 
experiments performed with the same or similar plasmids, but different cell 
preparations, may not necessarily produce the same levels of interaction signal 
(Cuconati et al., 1998). Since the interactions observed by Gonzalez et al. (1998) 
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were not much higher than background, it is conceivable that contradictory results 
might be obtained under slightly different conditions in a heterologous system. 
Although the sequence of NSPl from the YM strain of porcine rotavirus used in the 
study by Gonzalez et al. (1998) has not been published, on the basis of previous 
sequence comparisons it would be expected to show a high level of divergence with 
the sequence of NSPl from the UKtc strain of bovine rotavirus used in this study. 
This expected variance in the two proteins may underlie the differences observed 
between the work of Gonzalez et al. (1998) and the present study. 
A self-interaction of NSP3 was demonstrated in the yeast two-hybrid assay, 
which confirmed, in vivo, earlier reports that NSP3 formed multimers in infected cells 
(Mattion et al., 1992). This correlated with recent two-hybrid data, although the 
strengths of the interactions were found to be different (Gonzalez et al., 1998) (Poncet 
et al., 1997). Recently, the dimerisation domain of NSP3 has been mapped between 
amino acids 150 and 206 - a region of the protein predicted to form a coiled coil 
structure - using a yeast two-hybrid assay (Piron et al., 1999). 
Future experiments to examine NSPl protein-protein interactions should 
include the use of a mammalian two-hybrid system, which may provide a more 
suitable environment in which to examine viral protein-protein interactions. 
Alternatively, the use of a different yeast two-hybrid system, such as the original 
LexA system or the amino-terminal fusion LexA system (Section 5.8.3), might be 
attempted. The use of high expression GAlA two-hybrid vectors might also yield a 
different result. If protein-protein interactions were demonstrated in the two-hybrid 
system, then deletion analysis of the proteins could be used to define the regions of 
the proteins involved in the interaction. In addition, the two-hybrid system could be 
used to screen a cellular protein library for proteins interacting with NSP 1, as it has 
been suggested previously that NSPl might interact with a cellular protein (Hua et al., 
1994) (Xu et al., 1994). It would also be interesting to determine if any of the other 
non-structural proteins, such as NSP3, associate with cellular proteins. 
Simultaneously with the yeast two-hybrid assays, co-immunoprecipitation 
experiments were performed with in vitro translated viral proteins in an attempt to 
support the results obtained in vivo. To investigate whether VP1, VP2, or VP3 were 
specifically co-precipitated with NSPl, mixtures of in vitro translated proteins were 
immunoprecipitated with anti-NSPl serum. Although VPl, VP2, and VP3 were 
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observed separately co-precipitating with NSPl, control experiments suggested that 
non-specific precipitations also occurred. The existence of specific protein-protein 
interactions was not clearly demonstrated, although it is possible that the non-specific 
precipitations obscured the identification of genuine co-precipitations of the core 
proteins with NSPl. These results suggested similar conclusions to the yeast 
two-hybrid assays, in that either protein-protein interactions do not occur or that 
existing interactions cannot be detected under the conditions of the assay. As 
indicated earlier this may be due either to a requirement for an intermediary such as 
viral mRNA or the prior assembly of the proteins into a complex. 
Further experiments should include reciprocal immunoprecipitation of protein 
mixtures with specific serum against VPI, VP2 and VP3. If a new anti-NSPl serum 
was available, then co-immunoprecipitation experiments with this serum might be 
attempted. The availability of an anti-NSPl serum that did not also specifically 
precipitate VP2 could be used to confirm the co-immunoprecipitation of VP2 with 
NSP 1. The immunoprecipitation of an in vitro translate of total denatured genomic 
RNA with the anti-NSPl serum might reveal some interactions betwt"en NSPl and 
other viral proteins. If the proteins required viral mRNA before they could interact, 
the study of protein-protein interactions in vitro would be complicated by the 
necessity of adding viral RNA to the protein binding mixture. This could perhaps be 
achieved by adding a translation inhibitor, such as emetine, to the in vitro translated 
proteins prior to adding viral mRNA for the binding reaction, followed by 
immunoprecipitation analysis. It would be imperative that the binding conditions were 
carefully optimised to allow association of the proteins with the viral mRNA, and the 
achievement of the ideal conditions would clearly be an important factor in the 
success of the experiment. 
The results discussed thus far suggested that the use of infected celllysates for 
co-immunoprecipitation experiments might be a more effective way of investigating 
NSP 1 protein-protein interactions. Immunoprecipitation of rotavirus-infected cell 
lysates with anti-NSPl serum co-precipitated viral proteins VPl, VP2, VP3NP4, VP6 
and NSP3, suggesting that NSPl formed a complex with these proteins in the infected 
cell. Due to the presence of the structural proteins VP2 and VP6, which are associated 
with the double-layered virus particle, it was suggested that a novel NSPl-containing 
complex or particle had been precipitated. This complex might be an intermediary in 
the morphogenesis pathway. Because previous work did not demonstrate direct 
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protein-protein interactions between NSPl and these proteins, it was proposed that 
viral RNA was an essential component of the complex, and immunoprecipitation of 
nuclease-treated cell lysates suggested that this was indeed the case. The fact that 
negative results were obtained in protein-protein interaction assays with NSPl 
perhaps indicates that it only interacts with mRNA in the complex, hence suggesting 
that these negative results might be valid. As VP6 has not been shown to have 
RNA-binding activity, it was proposed that VP6 might interact with another protein, 
such as VP2, in the complex. 
This newly recognised complex was notably different to the RIs described by 
Gallegos and Patton (1989). In contrast to their data, which demonstrated that NSP 1 
was not found in the single-shelled RI, in this study NSP 1 was found in a complex 
with VP6. The appearance of NSPl in a complex with VP6 is not without precedent, 
as a complex containing NSPl has been precipitated from RF rotavirus-infected cells 
using an anti-VP6 mAb (Aponte et al., 1996). This result was confirmed in the 
present study with a mAb against VP6. The mAb against VP6 precipitated small 
amounts of NSP 1 and the associated complex proteins. Only a relatively small 
fraction of the total NSPl and VP6 present in infected cells were found in the 
complex, and thus it was suggested that this newly recognised complex might be a 
transient complex with a high turnover rate. In the assembling virus particle NSP I 
might be lost as the VP6 layer is added. Further experiments to elucidate the function 
of this complex would initially require reciprocal immunoprecipitation of NSPl and 
the associated complex proteins with specific sera against each protein to confirm the 
association of each protein with the complex. Immunofluorescence studies could also 
be performed to assess whether NSPl co-localised with any of these proteins, and 
VP6 in particular. Isolation of this complex by gradient fractionation would confirm 
that the co-immunoprecipitation of VP6 and the associated proteins with NSP I 
actually represents a novel NSPl-containing complex or particle. 
Immunoprecipitation of cross-linked UKtc rotavirus-infected cells could be performed 
to determine whether viral RNA is associated with the NSP1-containing complex. 
UKtc rotavirus-infected cells, maintained in the presence of actinomycin D to inhibit 
cellular transcription and CH]uridine to label viral RNA products, would be treated 
with UV light to promote the formation of RNA-protein cross-links, and then 
immunoprecipitated with specific anti-NSPl serum to precipitate the complex. 
Polyacrylamide gel analysis of the immunoprecipitates would determine which 
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proteins were associated with the labelled viral RNA. Specific digestion with RNases 
prior to immunoprecipitation would reveal the nature of the RNA associated with the 
viral protein complex. If the complex could be purified then it would be interesting to 
determine if it is a functional intermediate in the viral replication cycle by 
investigating whether it has replicase activity. This could be assayed by dsRNA 
labelling in vitro by the addition of radioactive substrates for RNA synthesis. 
A function for NSPl in regulating translation versus replication of viral 
mRNA has been proposed (Patton, 1995). If NSPl bound to the 5'-end of mRNA, it 
would protect the 5'-end of the mRNA template during replication and prevent 
translation by blocking attachment of ribosomes. In this manner NSP 1 would play a 
role in the regulation of RNA replication, which indeed is thought to be regulated by 
factors other than simply the level of mRNAs in the infected cell (Estes, 1996). There 
is some doubt however as to whether NSPl has specific RNA-binding activity 
(Section 1.6.4). Nevertheless, if NSPl blocked translation by binding mRNA and then 
remained associated with the replicase complex until completion of dsRNA 
replication, which occurs concomitantly with the addition of VP6 to the core particle, 
this would give rise to an intermediate assembly complex similar in composition to 
the complex described in this study. Although VP3 was proposed to replace NSPI in 
binding to the 5'-end of mRNA in the pre-core RI (Patton, 1995), previous research 
has identified replicase particles containing NSPI but not VP3 (Helmberger-Jones and 
Patton, 1986). The binding of VP3 to the 5'-end of ssRNA is more likely to be related 
to its demonstrated activity as a guanylyltransferase in transcriptase particles. Recent 
structural data on the Reoviridae has indicated that proteins cannot be imported or 
exported from the core once the inner core protein shell (VP2 in rotavirus) has been 
completed (Section 1.3.2). The non-structural proteins associated with the pre-core RI 
must lose all direct contact with the inner core proteins following the assembly of the 
transcriptase complex (VPI and VP3), and the addition of the VP2 layer. In this case, 
NSP3 must be displaced from the 3'-end of mRNA, probably by the RNA polymerase 
VP 1 as previously suggested (Patton, 1995), prior to completion of the VP2 layer. The 
internal location of VP3 as part of the transcriptase complex within the subcore 
suggests that it does not displace NSP1, which remains bound to the 5'-end of mRNA. 
Replication of the dsRNA genome occurs by synthesis of the minus strand on the 
mRNA template starting at the 3'-end. If replication proceeds by the gradual passage 
of the mRNA into the suhcore through pores at the 5-fold axes, then NSPl might not 
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be displaced from the 5'-end until the completion of replication. In this model NSPI 
would remain bound to the 5'-end of mRNA as it is reeled into the transcription 
complex for replication, and would only be displaced as the final stretch of mRNA 
disappeared into the subcore of the virus particle. As replication and morphogenesis 
are concomitant processes, addition of the VP6 layer would occur during replication 
and before NSPI dissociates from the 5'-end of mRNA and is lost from the particle. It 
has also been demonstrated that NSP1 interacts with NSP2 and NSP5, both of which 
are found associated with the core and VP6 Rls in the viroplasm (Gonzalez et al., 
1998). This lends further support to the theory that NSPl remains associated with the 
assembling virus particle until the final stages of replication and after VP6 is added to 
the core particle. Such a role for NSPl in regulating replication might explain why 
viruses carrying mutant NSP I are viable, since replication would still proceed, albeit 
not at an optimal level. 
One of the most puzzling questions in the replication of the segmented dsRNA 
viruses is the mechanism by which the genome is packaged. Unlike the 
negative-stranded RNA viruses, these viruses do not contain a nucleoprotein that 
packages the genome, hence the details of the process are still in debate. It has been 
proposed that NSP1, perhaps in association with NSP3, might have a function in the 
selective assortment of the genome (Brottier et al., 1992), since both proteins bind 
ssRNA and are found in early replication complexes. However, the non-specific 
RNA-binding activity of NSP1 does not immediately suggest a mechanism for 
selective packaging of viral mRNAs. The mechanism of viral mRNA assortment in 
the closely related reovirus has not yet been elucidated, although the non-structural 
proteins oNS and IlNS of reovirus have been implicated (Section 2.1.2). 
Alternatively, NSPI may play a role in transporting the viral mRNA to the viroplasm 
for replication, possibly in association with a cytoskeletal element since NSP 1 is 
known to be associated with the cytoskeleton. NSP1 would then be displaced from the 
ensuing replication complex at some point during replication and morphogenesis of 
the virus particle. 
The availability of a gene rescue system for dsRNA viruses would generate a 
resurgence in the field of rotavirus research. A reverse genetics system would allow 
structure-function studies of viral genes and their corresponding protein products in 
the context of the infectious virus. For example, studies could be made of the effect of 
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non-structural protein mutants on replication and transcription. The characterisation of 
trans-acting elements and domains in specific viral proteins necessary for replication 
and packaging of viral RNA segments could be attempted. eis-acting packaging 
signals in viral mRNA might also be identified. Clearly. the development of such a 
system would considerably enhance the prospect of providing answers to the major 
questions still remaining in the replication cycles of these viruses. 
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Apendix 1 • Results Chapter 2 
Appendix 1.1 Calculation of p-galactosidase units 
1 Up-galactosidase is defined as the amount which hydrolyses 1 J.lmole ONPG to 0-
nitrophenol and D-galactose per minute. 
p-galactosidase units _ = 1000 X OD4201(t X V x OD6OQ) 
t = elapsed time (in minutes) of incubation 
V = 0.1 ml x concentration factor 
OD600 = Abs at 600 nm of 1 ml of culture 
Worked Example. Transformants carrying pGBT9-Gene 9 
OD4l0 t V OD6OO p-galactosidase units 
0.049 212 0.5 0.769 
0.054 212 0.5 0.769 
0.048 212 0.5 0.769 
0.11S lOS0 0.3 0.769 
0.137 1050 0.3 0.769 
0.129 lOS0 0.3 0.769 
I,X = Sum of p-galactosidase values = 3.41 
Mean = I,XIN = 3.41/6 = 0.57 
Standard Deviation (s) = 0.07 
Standard error of mean = s/~N = 0.027 
Students t test 
0.60 
0.66 
0.59 
0.47 
0.S6 
0.53 
95 % confidence limits = 0.57 ± to.os x 0.027, where t has five degrees of freedom 
i.e. 0.57 ± 2.571 x 0.027 
0.57 ± 0.07 P-galactosidase units 
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Appendix 1.2 Equation for calculation of the co-transformation efficiency of 
two-hybrid plasmids into yeast 
Co-Transformation efficiency (cfulJlg DNA) 
cfu x TV (Ill) 
VxDxDNA 
cfu = colony forming units on plate 
TV = Total suspension volume (JlI) 
V = Volume of suspension plated (JlI) 
D = Dilution factor of suspension plated 
DNA = Quantity of plasmid DNA used in transformation (Jlg) [in a 
co-transformation, this is the amount of limiting plasmid, Le. the lesser of the two 
plasmids, not the sum of them (usually 1 Jlg)] 
208 
Appendix 2 - Results Chapter 4 
Appendix 2.1 ImageQuant™ analysis of viral protein complex 
immunoprecipitated with anti-NSPl serum from UKtc rotavirus-infected cell 
Iysates (Figure 7.3) 
The 5-11 % gradient polyacrylamide gel shown in Figure 7.3 was exposed to the 
phosphoimager for 8 days. The proteins in the viral complex (NSPl, VP6, VP2, 
VP3NP4, VPl, NSP3) which were detected by phosphoimaging were quantified 
using ImageQuant™ software and the data analyzed using Excel™ software 
(Microsoft). The data presented are from the results of one experiment. 
The amounts of the precipitated proteins are displayed in arbitrary units assigned 
by the ImageQuant™ software. As radioactivity detected was a measure of the 
number of 35S-methionine residues in each protein and not the amount of protein, 
data were corrected for the methionine content of each protein. 
The IP reactions are indicated on the x axis: 
no serum = IP reaction with no serum/l JlI of 10 mglml ovalbumin 
pre-immune = IP reaction with pre-immune serum 
anti-NSPl = IP reaction with anti-NSPl serum 
boiled = IP reaction with cell lysate sample boiled for 2 minutes with cracking 
buffer (4 % SDS; 10 % J3-mercaptoethanol) and diluted lO-fold with water prior to 
incubation with anti-NSPl serum. 
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Appendix 2.2 ImageQuantTM analysis of viral protein complexes 
immunoprecipitated with anti·NSPI serum from cell fractions created by 
centrifugation at IO,OOOXg, 30,OOOXg and lOO,OOOXg (Figure 7.5) 
The 5-11 % gradient polyacrylamide gel shown in Figure 7.5 was exposed to the 
phosphoimager for 8 days. The proteins in the viral complex (NSPl, VP6, VP2, 
VP3NP4, VPl, NSP3) which were detected by phosphoimaging were quantified 
using lmageQuant™ software and the data anlysed using Excel™ software 
(Microsoft). The data presented are from the results of one experiment. 
The amounts of the precipitated proteins are displayed in arbitrary units assigned 
by the lmageQuant™ software. As radioactivity detected was a measure of the 
number of 35S-methionine residues in each protein and not the amount of protein, 
data were corrected for the methionine content of each protein. 
JP reaction samples shown on the x axis of each graph are as follows: 
(I) JP of cell lysate with pre-immune serum. 
(2) JP of cell lysate with anti-NSPl serum. 
(3) JP of 1O,OOOXg cell lysate pellet with anti-NSPl serum. 
(4) JP of lO,OOOXg cell lysate supematant with anti-NSPl serum. 
(5) JP of 30,OOOXg cell lysate pellet with anti-NSPl serum. 
(6) JP of 30,OOOXg cell lysate supematant with anti-NSPl serum. 
(7) JP of lOO,OOOXg cell lysate pellet with anti-NSPl serum. 
(8) JP of lOO,OOOXg cell lysate supematant with anti-NSPl serum. 
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Appendix 2.3 ImageQuantTM analysis of viral proteins immunoprecipitated 
with anti-NSPl serum from UKtc rotavirus-infected cell Iysates pre-treated 
with micrococcal nuclease for varying lengths of time (Figure 7.6) 
The 5-11 % gradient polyacrylamide gel shown in Figure 7.6 was exposed to the 
phosphoimager for 9 days. The proteins in the viral complex which were clearly 
visible on the phosphoimage (NSPl, VP6, VP2, VP3NP4) were quantified using 
ImageQuant™ software and the data analysed using Excel™ software 
(Microsoft). The data presented are from the results of one experiment. 
Graphs to show the changing amounts of each individual protein over the 
incubation time with micrococcal nuclease are shown. A graph comparing the 
changing amounts of each protein with increasing incubation time with 
micrococcal nuclease is also shown. 
The incubation time (minutes) of each sample with 1 mglml micrococcal nuclease 
at room temperature is shown on the x axis of the graph for each protein. 
The amounts of the precipitated proteins are displayed in arbitrary units assigned 
by the ImageQuant™ software. As radioactivity detected was a measure of the 
number of 35S-methionine residues in each protein and not the amount of protein, 
data were corrected for the methionine content of each protein. 
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Appendix 2.4.1 ImageQuantTM analysis of viral proteins immunoprecipitated 
with anti-NSPl serum from UKtc rotavirus-infected cell Iysates pulse-chase 
labelled with 35S-methionine at regular time intervals (FigUre 7.7) 
The 5-11 % gradient polyacrylamide gel shown in Figure 7.7 was exposed to the 
phosphoimager for 16 days. The proteins in the viral complex (NSPI, VP6, VPI, 
VP2, VP3NP4, NSP3) which were detected by phosphoimaging were quantified 
using ImageQuant™ software and the data analyzed using Excel™ software 
(Microsoft). The data presented are the volumes of each protein in the pulse-
labelled (Pulse) and pulse-chase labelled (Chase) samples at each time point from 
one experiment. 
The x axis indicates the time post-infection at which the cells were pulse-labelled. 
The cells were pulse-labelled with 35S-methionine for 30 minutes at I, 3, 5, or 7 
hours post-infection. After the pulse-labelling period, one well of cells was 
harvested and the second was chased with media containing looX unlabelled 
methionine for 2 hours before harvesting. 
The amounts of the precipitated proteins are displayed in arbitrary units assigned 
by the ImageQuant™ software. As radioactivity detected was a measure of the 
number of 35S-methionine residues in each protein and not the amount of protein, 
data were corrected for the methionine content of each protein. 
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Appendix 2.4.2 ImageQuantTM analysis of viral proteins immunoprecipitated 
with pre-immune and anti-NSPl serum from UKtc rota virus-infected cell 
Iysates pulse-chase labelled with 3sS-methionine at regular time intervals 
(Figure 7.7) 
The 5-11 % gradient polyacrylamide gel shown in Figure 7.7 was exposed to the 
phosphoimager for 16 days. The proteins in the viral complex (NSP1, VP6, VP1, 
VP2, VP3NP4, NSP3) which were detected by phosphoimaging were quantified 
using ImageQuant™ software and the data analyzed using Excel™ software 
(Microsoft). The data presented are the amounts of each protein 
immunoprecipitated with either pre-immune or anti-NSPI serum from pulse-
labelled (Pulse) and pulse-chase labelled (Chase) samples at each time point from 
one experiment. 
The x axis indicates the time post-infection at which the cells were pulse-labelled. 
The cells were pulse-labelled with 35S-methionine for 30 minutes at 1, 3, 5, or 7 
hours post-infection. After the pulse-labelling period, one well of cells was 
harvested and the second was chased with media containing l00X unlabelled 
methionine for 2 hours before harvesting. 
The amounts of the precipitated proteins are displayed in arbitrary units assigned 
by the ImageQuant™ software. As radioactivity detected was a measure of the 
number of 35S-methionine residues in each protein and not the amount of protein, 
data were corrected for the methionine content of each protein. 
14(00) 
~111XXXl § 
t' 1<XXXXl 
~ :e mXl 
~6OOXl ~ 
14(00) 
]11XXXl 
£ 0 
..--
.(:Us:~ 
• (:Us: ni-l&l 
o ma.:: ~innlne 
o ma.:: axi-l& 1 
r-
~ n 1:::1-
lnc:uboIloo ti.re (hours) 
W1 
~r----------------' r-------' 
• pR ~inmne 
7 
lnc:uboIloo t1.re (hours) 
Z5(XXl r---------
5 7 
mt.don 'J~ (hours) 
• pR ni-l&1 
o ma.:: ~imnne 
e ma.:: rti-l&1 
• tu' ~inmne 
• tu' 1n~m'1 
DdlR~inmne 
e dlRni-m'1 
Appendix 2.4.2 
45(XX) ,--- ---= - --, ~---~ 
'i 4(OO) .pR~ 
§ 35CXXl • (:Us: lIXi-m'1 
2' 300Xl 0 cha<e ~imnne 
j ~ Dcha<ellXi-m'1 
.!. 2OOX) 
~ 15CXXl 
" 1 Hrol 
c l ~ 
5 7 
InculJllioo lira (hours) 
VP2 
1 &XXI 
'ilfro) • poJrc ~imnne 
.~ 14(0) • poJrc lIXi-m'1 
t' 12CXXl o cha<e ~innlne I! 
.:::: I<XXX> r- e dla'I: lIXi-l&1 
!&XXI 
.. 
E fro) 
" e 4(0) lJl .~ 2CXXl e 0-- '-c.. 5 7 
Incubadon lira (hours) 
JISPJ 
14(XX) 
~lm> • (:Us: IJ"O'inmIle 
c 
• (:Us: m m'l 
" t' 1<XXX> r- o c/n<e ~inmne 
~ 8(XX) [] c/n<eni-m'l :e 
~ fro) r-j 4(XX) 
0 
.. 
] m> 
e o ~ f- - t-c.. '-
5 7 
ftubDtlon dra (hours) 
213 
Appendix 2.S.1 ImageQuantTM analysis of viral proteins immunoprecipitated 
with anti-VP6 monoclonal antibody from UKtc rota virus-infected cell Iysates 
(Figure 7.8) 
The 5-11 % gradient polyacrylamide gel shown in Figure 7.8 was exposed to the 
phosphoimager for 8 days. The viral proteins in the JP reactions (VP6, NSP1, 
VP2, VP3NP4, NSP3) which were detected by phosphoimaging were quantified 
using ImageQuant™ software and the data analyzed using Excel™ software 
(Microsoft). The data presented are from the results of one experiment. 
The amounts of the precipitated proteins are displayed in arbitrary units assigned 
by the ImageQuant™ software. As radioactivity detected was a measure of the 
number of 35S-methionine residues in each protein and not the amount of protein, 
data were corrected for the methionine content of each protein. 
The JP reactions are indicated on the x axis: 
(1) JP of unfractionated cell lysate with pre-immune serum 
(2) JP of unfractionated cell lysate with anti-VP6 monoclonal antibody 
(3) JP of 1O,OOOXg cell lysate pellet with anti-VP6 monoclonal antibody 
(4) JP of 30,OOOXg cell lysate pellet with anti-VP6 monoclonal antibody 
(5) JP of 10,OOOXg cell lysate supematant with anti-VP6 monoclonal antibody. 
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Appendix 2.5.2 Calculation of the proportion of total VP6 in the UKtc 
rotavirus-infected cell which is co-immunoprecipitated with NSPl 
The 5-11 % gradient polyacrylamide gel shown in Figure 7.5 was exposed to the 
phosphoimager for 8 days. The protein bands corresponding to NSPl and VP6 in 
both the cell lysate sample and the IP reaction with anti-NSPl serum from cell 
lysates were quantified using ImageQuant™ software and the data analysed using 
Excel™ software (Microsoft). 
The volumes of the protein bands are calculated in arbitrary units by the 
ImageQuant™ software. As radioactivity detected was a measure of the number of 
35S-methionine residues in each protein and not the amount of protein, data were 
corrected for the methionine content of each protein. 
Calculation of efficiency of immunoprecipitation reaction with anti-NSPl serum 
Volume of NSPl in celllysates (10 Ill) = l.7 x 105 
Volume (50 JlI) = 8.3 x 105 
Volume of NSPl precipitated by anti-NSPl serum = 5.4 x 1O~ 
Efficiency of IP reaction = (5.4 x 105)/(8.3 x 105) x 100 = 65.4 % 
Percentage of total VP6 in cell lysate which co-immunoprecipitated with NSPl 
Volume ofVP6 in cell lysate (10 Ill) = 1.6 x 106 
Volume (50 Ill) = 7.9 x 106 
Volume ofVP6 co-immunoprecipitated with NSPl by anti-NSPl serum = 1.9 x 105 
Percentage of total VP6 contained in complex with NSPl 
= (l.9 x 105)/(7.9 x 106) x 100 = 2.4 % 
Percentage of total VP6 contained in complex with NSP 1 (corrected for efficiency of 
IP reaction) 
= 100/65.4 x 2.4 = 3.7 % 
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